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Abstract 
Cytoplasmic dynein is a multisubunit complex responsible for the transport of cellular 
components from the cell periphery towards the nucleus. The role of the dynein complex 
in vesicle trafficking, organelle positioning and chromosome segregation during mitosis 
has been extensively studied but still little is known of specific roles of distinct subunits of 
the complex. Cytoplasmic dynein is a dimeric complex consisting of heavy chains, 
intermediate chains, light intermediate chains and three light chains. In order to 
investigate the roles of the cytoplasmic dynein subunits, two mouse lines with chemically 
generated single point mutations in the intermediate chain 1 and 2 genes (Dync1i1, 
Dync1i2) were subjected to a behavioural analysis. The mouse line carrying a mutation in 
the intermediate chain 2 showed working memory deficits which suggested impairment in 
hippocampal functions. 
 
In order to examine the effects of mutation at the cellular level primary mouse embryonic 
fibroblasts (MEFs) lines were derived from embryos carrying mutations in the 
intermediate chains and used as a model system. Cell functions, such as trafficking of 
epidermal growth factor (EGF) positive endosomes, Golgi assembly were examined. 
Furthermore, biochemical analyses were performed focused on the expression of dynein 
subunits and their assembly in the functional complex.  
 
Alternative splicing is known to produce multiple isoforms of the intermediate chains. The 
analysis of various splice variants of these genes in a panel of mouse tissues resulted in 
detecting new isoforms which were compared with bioinformatics data available for 
human and rat thus establishing the splicing pattern of the mouse intermediate chains. 
 
Legs at odd angles (Dync1h1
Loa
) is another mutant mouse line carrying a point mutation in 
the dynein heavy chain which results in neurological defects. Here the effects of the Loa 
mutation in the trafficking of membranous organelles were investigated by an infection of 
cultured MEFs with Salmonella enterica serovar Typhimurium. Furthermore, upon the 
induction of a cellular stress the wildtype and the Loa homozygous cells showed 
significant differences in stress granule assembly suggesting the impairment in the stress 
signaling. 
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1. Introduction  
1.1 Cytoplasmic dynein is a molecular motor  
Living cells are dynamic with organelles being in a constant movement. The flow of 
membranous organelles and protein complexes is possible thanks to molecular motors 
(kinesin, dynein, and myosin) and their interactions with filamentous polymers 
(microtubules, F-actin) (Hirokawa et al., 2010). Molecular motors convert the chemical 
energy derived from ATP hydrolysis into mechanical action, and precise spatial and 
temporal regulation of motor-based transport is essential to ensure efficient cargo 
delivery. While the actin cytoskeleton is crucial for processes in the sub-cortical region, 
the long-distance transport is mediated by motors associated with microtubules (MTs). A 
cell being a highly organised entity depends on kinesins and dyneins, which use energy to 
move along MTs thus preserving the spatial distribution of organelles and their structure. 
Although general features of transport mediated by the cytoplasmic dynein complex are 
the same in all cells, the polarisation often imposes specific adaptations on the transport 
machinery to maintain cell function (Yamada et al., 2010). Furthermore, defects in motor-
dependent transport are associated with a range of diseases, including 
neurodegeneration, tumorigenesis and developmental defects (Eschbach and Dupuis, 
2011). 
 
The characteristic morphology of neurons makes this type of cell a useful model to study 
mechanisms of a long range transport (Hirokawa et al., 2010). There are well distinguished 
compartments in a neuronal cell: an axon often extending far from a cell body and a 
network of much shorter dendrites. The cytoplasmic dynein complex is involved in the 
minus-end directed movement along microtubules (MTs (-)) in both axon and dendrites. 
The dynein has been shown to transport signalling endosomes after stimulation with 
neurotrophic factors (Deinhardt and Schiavo, 2005; Gauthier et al., 2004; Ha et al., 2008), 
mediate stress signalling (Perlson et al., 2009), transport receptor containing vesicles (e.g. 
AMPA) (Kapitein et al., 2010), and many more cargoes. Nonetheless, both detailed 
mechanisms of cargo selection or their regulation are not well known. 
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1.2 Molecular organisation of the dynein complex 
There are two known families of the dynein complexes: (1) axonemal dyneins driving 
intraflagellar transport (IFT) and movement of cilia, and (2) cytoplasmic dyneins. Analysis 
of the vertebrate genomic sequences revealed the presence of two gene families, which 
compose the cytoplasmic dynein complex (Pfister et al., 2006). Cytoplasmic dynein 
complex 2 (DYNC2) is found in cilia together with axonemal dyneins, while cytoplasmic 
dynein complex 1 (DYNC1) is the one responsible for the dynamics of the intracellular 
components and will be discussed in detail. Cytoplasmic dynein is made up of several 
subunits forming a functional complex, which is a dimeric assembly of heavy, 
intermediate, light intermediate, and three classes of light chains (Figure 1.1).  
 
 
 
Figure 1.1. Structure of the cytoplasmic dynein complex 
Representation of the complex with motor domain shaded blue, cargo binding domain marked in green; 
DYNC1H1 – heavy chains, DYNC1LI – light intermediate chains, DYNC1I – intermediate chains, DYNRB – light 
chains (Roadblock family), DYNLL – light chains (LC8 family), DYNLT – light chains (Tctex-1 family); reprinted 
with modifications from Cell vol. 112, Ronald D Vale, ‘The Molecular Motor Toolbox for Intracellular 
Transport’, p.14, © 2003, with permission from Elsevier 
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1.2.1 Cytoplasmic dynein heavy chain (DYNC1H1) 
The cytoplasmic dynein heavy chain (DYNC1H1) is the largest subunit of the complex and 
is capable of generating mechanical force through ATP hydrolysis. Phylogenetic analyses 
suggest that heavy chain does not share origins with other motor proteins, kinesins and 
myosins (Spudich, 2011). It is built of over 4,600 residues and has a molecular weight of 
530 kDa and was classified to a family of ATPases associated with various cellular activities 
(AAA), which feature a ring-shaped oligomeric structure (Hook and Vallee, 2006). The C-
terminal motor domain contains six AAA
+
 ATPase-like domains, however only four are 
catalytic. Additional structures, called ‘linker’ and ‘stalk’ have been implicated in the 
movement along microtubules. Both linker and catalytic domains are highly conserved 
(Hook and Vallee, 2006). The stalk contains a microtubule binding domain, whose affinity 
changes depending on the ATP-cycle (Figure 1.2) (Carter et al., 2011). Furthermore, the 
linker extends over the AAA
+
 domains, and was proposed to mediate the conformational 
changes during stepping. The N-terminal region called the ‘tail’, forms a platform where 
remaining subunits binds (Pfister et al., 2006). Known mutations in the dynein heavy chain 
cause neurological deficits in heterozygous animals (Dync1h1
Mut/+
) and lethality in 
homozygous (Dync1h1
Mut/Mut
), as discussed in section 1.5.1. 
 
 
Figure 1.2. Organisation of domains of the cytoplasmic dynein heavy chain 
Domains of the mouse DYNC1H1 (UniProt Q9JHU4) as annotated by Pfam 25.0 (Finn et al., 2010); DHC_N1 – 
N-terminal region 1; DHC_N2 – N-terminal region 2; AAA_6 – hydrolytic ATP-binding site; AAA_5 – AAA 
domain; AAA_7 – P-loop containing motor region; AAA_8 - P-loop containing motor region; MT – 
microtubule binding stalk; AAA_9 – ATP binding motor region; Dynein_heavy – C-terminal region without P-
loop (non-catalytic); for better visualisation divided into 4 parts running from: 1 – 1100, 1101 – 2220, 2221 – 
3300, 3301 – 4460, and 4460 – 4644 amino acid, drawing is to scale; no splice variants are known 
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1.2.2 Cytoplasmic dynein intermediate chains 1 and 2 (DYNC1I1, DYNC1I2) 
In the vertebrate genomes there are two genes encoding the dynein intermediate chains 
(Dync1i1, Dync1i2). Protein sequences of both chains are highly similar (83%, BioEdit) and 
in the native complex these proteins are found as dimers (Pfister et al., 2006). 
Intermediate chains function as an ‘interaction hub’ and are known to associate not only 
with heavy chains, but also with light chains (section 1.2.4), and adaptor complexes 
(section 1.3). This feature of the intermediate chains is characteristic for proteins 
containing WD domains, which form a structure known as a β–propeller (Figure 1.3) 
(Stirnimann et al., 2010). WD domains are localised in the C-terminal region, while the 
helical N-terminal region forms a flexible structure, which adopts more helical 
conformation upon binding of the light chains (section 1.2.5) (Barbar, 2008).  
 
Dynein intermediate chains are the most versatile subunits of the complex, due to their 
differential expression and posttranslational modifications. During transcription exons are 
alternatively spliced resulting in at least 6 isoforms of each gene (Chapter 6) (Kuta et al., 
2010). Furthermore, the expression pattern varies with DYNC1I1 found in the neural 
tissues and gonads, and DYNC1I2 localised in neural tissues except for one isoform. The 
only DYNC1I2 found in all mouse tissues was isoform DYNC1I2.C, which is the shortest 
variant known. The roles of distinct isoforms need to be determined, and the fact, that 
DYNC1I2.B was found to transport NTRK2-NGF vesicles suggests their significance in cargo 
selection (Ha et al., 2008). In addition, phosphorylation of different residues of the 
intermediate chains was shown to regulate their interactions with the dynactin complex 
during trafficking of membranous organelles (Vaughan et al., 2001), aggregation of 
pigment containing vesicles (Ikeda et al., 2011), and segregation of chromatids (Whyte et 
al., 2008).  
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Figure 1.3. Organisation of domains of the cytoplasmic dynein intermediate chains 
Domains of the mouse DYNC1I1 (upper panel, UniProt O88485, isoform DYNC1I1.B) and DYNC1I2 (lower 
panel, UniProt O88487, isoform DYNC1I2.B) as annotated by Pfam 25.0 (Finn et al., 2010); DIM – 
dimerisation domain (green); WD – WD repeat; depending on a source there are from 2 to 7 WD repeats 
distinguished in the intermediate chains sequence (red); drawings are to scale and extend from amino acid 1 
to 628 for DYNC1I1 and to 612 for DYNC1I2 
 
 
1.2.3 Cytoplasmic dynein light intermediate chains (DYNC1LI1, DYNC1LI2) 
Similarly to the intermediate chains, there are two genes known encoding dynein light 
intermediate chains 1 and 2 (Dync1li1, Dync1li2) (Pfister et al., 2006). The N-terminal 
region binds to the heavy chains. In many experimental systems they were shown to 
interact directly with various proteins, supporting their role in cargo selection. The 
expression patterns of the light intermediate chains is not uniform, with Dync1li1 
transcripts detected mostly in neural tissues, heart, and kidney, whereas Dync1li2 was 
present in brain, adipose tissue, muscle, spleen, testis, and bone (Gene Expression Atlas 
11.04, http://www.ebi.ac.uk/gxa). Furthermore, light intermediate chains can also be 
phosphorylated (Pfister et al., 2006).  
 
DYNC1LI1 was shown to directly interact with pericentrin (Tynan et al., 2000), RAB4A 
GTPase (Bielli et al., 2001), and RAB11A – FIP3 (Horgan et al., 2010b). DYNC1LIs were 
suggested to recruit the dynein complex to endosomal membranes thus increasing the 
accumulation of Transferrin (TfnR) in the perinuclear endosome recycling compartment 
(ERC) (Horgan et al., 2010b). Furthermore, not only were those subunits involved in 
endosomal sorting, but they also clustered on the late endosomal and lysosomal 
membranes, where DYNC1LI1 recruits the dynein complex independently of both Rab7-
interacting lysosomal protein (RILP) and dynactin (Tan et al., 2011). Expression of the 
Dync1li2 gene increased during neurite extension after growth factor stimulation 
(Angelastro et al., 2000).  
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1.2.4 Cytoplasmic dynein light chains (DYNLT1, DYNLT2, DYNLRB1, 
DYNLTRB2, DYNLL1, DYNLL2) 
Light chains are the only components of the dynein complex, which are also found to 
participate in processes different than dynein driven transport, and the same binding site 
is occupied by intermediate chains and competing interactors (Pfister et al., 2006). They 
are found as homodimers in vivo, and it has been proposed, that they might act during 
dimerisation as stabilising partners (Barbar, 2008). An assembly of the cytoplasmic dynein 
complex is discussed in section 1.2.5.  
 
DYNLT1 and DYNLT3 (known as Tctex-1 and Rp3 respectively) bind directly to the 
intermediate chains. They were detected in most of mouse tissues examined, including 
brain, lung colon, heart, pancreas in case of the DYNLT1, and brain, lung, kidney, liver in 
case of the DYNLT3 (Gene Expression Atlas 11.04, http://www.ebi.ac.uk/gxa). A body of 
evidence points towards specific functions of these subunits during mitosis and assembly 
of the mitotic spindle, although DYNLT1 was proposed to be involved in dynein 
independent pathways (Chuang et al., 2005). In developing neurons, DYNLT1 determines 
the orientation of the mitotic spindle via interactions with RHO/RAC guanine nucleotide 
exchange factor (GEF) 2 (ARHGEF2, LFC) (Gauthier-Fisher et al., 2009), whereas DYNLT3 
interacts with a mitotic spindle checkpoint protein BUB3 (Budding uninhibited by 
benzimidazoles 3 homolog (S. cerevisiae)) (Lo et al., 2007a). Furthermore, the expression 
of the DYNLT1 was elevated in neuronal progenitors and young neurons (Dedesma et al., 
2006), while DYNLT3 strongly marked populations of mature neurons (Chuang et al., 
2001).  
 
In growth cones of hippocampal neurons high levels of DYNLT1 were found to correlate 
with up-regulation of the RAS-related C3 botulinum substrate 1 (RAC1) signalling. A family 
of small GTPases (Rhod ras homolog gene family, member D (RHOD)) activates RAC1, 
which results in rearrangements of the actin cytoskeleton. In order to maintain the 
signalling, GTPases require activity of the guanidine exchange factor (GEF). A known 
RHOD/RAC1 specific GEF is ARHGEF2 (LFC), which was also found on the Golgi membrane 
and in the growth cones (Conde et al., 2010). DYNLT1 competed with tyrosine 3-
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monooxygenase/tryptophan 5-monooxygenase activation protein (YWHA/ 14-3-3) for the 
ARHGEF2 binding site, thus decreasing its activity (Meiri et al., 2009).  
 
Among cargos specific for DYNLT1 was C-terminal domain of rhodopsin (RHO) (Tai et al., 
1999), RAB3D GTPase (Pavlos et al., 2011), and voltage gated calcium channels type P/Q 
and N (CACNA1A/CACNA1B respectively) (Lai et al., 2005). In bone-desorbing osteoclasts 
RAB3D GTPase localised on the exocytic vesicles and the DYNLT1 binding was dependent 
on the GTP-GDP cycle, suggesting involvement of the dynein complex in the recycling of 
the RAB3D vesicles to the cell centre. Similarly, DYNLT1 was found important in the sorting 
and trafficking of the calcium dependent channels in the hippocampal neurons.  
 
DYNLRB1 and DYNLRB2 (Roadblock) bind in the intermediate chains also as a dimer, 
however not much is known about their functions. The expression pattern differs between 
tissues, with DYNLRB1 found in brain, lung, heart, kidney, and DYNLRB2 detected in 
trachea, lung, but not brain (Gene Expression Atlas 11.04, http://www.ebi.ac.uk/gxa). 
DYNLRB1 is enriched on the Golgi complex membranes where it interacts with RAB6 
GTPase (Wanschers et al., 2008). There are three isoforms of the RAB6 known, which are 
involved in exocytosis and vesicle transport from Golgi apparatus towards the plasma 
membrane. DYNLRB1 is found to bind in a GTP-GDP dependent manner, similarly to the 
association observed for the RAB3 and DYNLT1. Likewise, RAB6 was proposed as a 
regulator of the exocytic pathway (Grigoriev et al., 2007)  
 
On the other hand, DYNLRB2 was found in the complexes with SMAD family member 3 
(SMAD3) only, and it was phosphorylated after stimulation with transforming growth 
factor β (TGF-β) (Jin et al., 2009).  
 
Finally, light chains DYNLL1 and DYNLL2 (LC8 family) are loosely associated with the dynein 
complex and can be found as a free pool in the cytoplasm (Lo et al., 2007b). They were 
observed interacting with bassoon (BSN) and piccolo (PCLO) in the synaptic compartment 
(Fejtova et al., 2009), P21-activated kinase 1 (PAK1) (Vadlamudi et al., 2004), myosin VA 
(MYO5A) (Espindola et al., 2000), and many more proteins. They were proposed to act on 
a structural level by triggering the dimerisation of the intermediate chains (Barbar, 2008). 
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1.2.5 Assembly of the dynein complex 
Cytoplasmic dynein is a complex made up of six different subunits, which are often 
expressed in many isoforms, thus greatly increasing the number of possible pools of the 
dynein complexes (King et al., 2002). However, there are few mechanisms known, that 
tightly control distinct pools of the complexes - for example differential expression 
patterns of various subunits, their modifications - and an assembly of the dynein complex.  
 
Apart from the heavy chains, often at least two variants of intermediate, light 
intermediate, and light chains can be expressed in the same tissue, and they have distinct 
structural characteristics. Dynein functions as a dimeric complex, and the dimerisation 
modes of various subunits have been studied, showing that in vivo DYNC1I1 and DYNC1I2 
isoforms formed homo- and heterodimers (Myers et al., 2007), while DYNC1LIs were 
observed as homodimers only. Similarly, only homodimers of DYNLT1 or DYNLT3 were 
capable of binding to the intermediate chains (homo- and heterodimers), while all variants 
of the intermediate chains associated with both, homo- and heterodimers of the 
DYNLL1/DYNLL2 and DYNLRB1/DYNLRB2 (Table 1.1) (Ilangovan et al., 2005; Myers et al., 
2007). Furthermore, all the subunits, except for the DYNLL, were detected only in the 
holocomplex (Myers et al., 2007).  
 
 
 
Table 1.1. Summary of dimerisation modes 
Preferences of subunits of the dynein complex to form homo- or heterodimers marked as ‘+’ or ‘-‘; chains 
found as homodimers only shaded 
 DYNC1H1 
DYNC1I1 
DYNC1I2 
DYNC1LI1 
DYNC1LI2 
DYNLT1 
DYNLT3 
DYNLRB1 
DYNLRB2 
DYNLL1 
DYNLL2 
Homodimers + + + + + + 
Heterodimers - + - - + + 
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Biochemical and structural studies allowed further insight into the molecular dynamics of 
dynein complex assembly. Native dynein complex can be fractionated into two distinct 
subcomplexes, which might correspond to separate assembly processes (King et al., 2002). 
One pool consists of the heavy chains with bound intermediate chains, while intermediate 
and light chains constitute a second subcomplex. Association of the DYNC1LI homodimers 
is regulated by phosphorylation and can be abolished by dephosphorylating the light 
intermediate chains (Deng et al., 2010). The assembly of the intermediate chains with 
dimers of three classes of light chains is a more complicated process involving 
conformational changes. The N-terminal region of free DYNC1Is is unstructured and 
dimerisation is initiated by binding dimeric DYNLTs or DYNLLs (Hall et al., 2009). 
Association of the first dimer greatly enhances binding of the second pair of light chains 
(Figure 1.4). Upon dimerisation intermediate chains undergo a structural transition, 
resulting in formation of two extended β-sheets on the interface of bound DYNLTs and 
DYNLLs. Furthermore, this stage of the assembly changes the conformation of the 
intermediate chains in the distant region and a helical structure can be distinguished. 
Subsequently, a dimer of the DYNLRB is recruited to the intermediate chains (Nyarko and 
Barbar, 2011). Binding of the DYNLRBs is regulated by phosphorylation, and two 
phosphorylated residues were identified. Moreover, the region of interactions with the 
DYNC1Is is bigger than in case of the light chains, and it spans 27 and 22 residues 
respectively (Hall et al., 2010). Interestingly, the intermediate chains undergo another 
conformational shift, and binding of the DYNLRBs destroys the helix induced by the 
DYNLTs/DYNLLs. As a result, the subcomplex of the intermediate and light chains forms 
elongated and flexible scaffold, with unordered region of the DYNC1Is between DYNLLs 
and DYNLRBs (Nyarko and Barbar, 2011).  
 
Light chains were found to associate slightly more strongly with the complexes formed 
with DYNC1I1 than with DYNC1I2 (King et al., 2002). Furthermore, interactions with both 
heavy chains and P150
Glued
 were disrupted in the intermediate chains lacking light chain 
binding domains (King et al., 2003). All these observations suggest an existence of a 
precise mechanism regulating the assembly of the subunits in a functional dynein 
complex. 
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Figure 1.4. Model summarizing the light chains-dependent association of the intermediate chains 
N-terminal region of the intermediate chains shown as an unstructured fragment (red) which undergoes a 
structural shift and a helix formation upon binding of the dimeric DYNLTs (yellow) and DYNLLs (green); in 
case of binding of the DYNLRBs (blue) only intermediate chains are separated; assembly of all the light 
chains results in an elongated structure, where DYNC1Is can associate; numbers correspond to residues 
crucial for the assembly of the functional complex;  
This research was originally published in J Biol Chem., Nyarko A and Barbar E, ‘Light chain-dependent self-
association of dynein intermediate chain’ 2011, vol. 286 p9. 1556-66 © 2011 by The American Society for 
Biochemistry and Molecular Biology, Inc. 
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1.3 Complexity of adaptors – who keeps dynein at bay? 
Motility of the cytoplasmic dynein is often an outcome of interactions between many 
complexes, and their versatility reflects numerous cellular functions. Apart from 
adenoviruses, which leave early endosomes and bind directly to dynein via intermediate 
and light intermediate chains, the dynein complex does not interact directly with cargo, 
thus additional complexes serve as adaptors (Bremner et al., 2009). There are many 
adaptor complexes known, which regulate the recruitment of the cytoplasmic dynein 
complex and cargo transport along microtubules, and those interacting directly with the 
intermediate chains will be mentioned. 
 
1.3.1 Dynactin complex 
The dynactin complex mediates cargo binding and promotes the activity of the 
cytoplasmic dynein. It is built from several subunits, out of which DCTN1 (P150
Glued
) 
interacts directly with the dynein intermediate chains (Pfister et al., 2006). It contains a 
CAP-Gly domain which interacts directly with microtubules, while a basic domain 
increases dynein processivity via stabilising the motor on the MTs (Culver-Hanlon et al., 
2006). Few single point mutations in the DCTN1 gene were found in patients diagnosed 
with motor neuron disease (MND) (Munch et al., 2004; Puls et al., 2003). The dynactin 
complex binds EB1 at the tips of growing MTs and it is released after phosphorylation of 
its P150
Glued
 subunit (Schuster et al., 2011). Moreover, the recruitment of the dynein 
complex to endosomal membranes seems to be sequential; first the dynactin complex 
associates with cargo membranes via interactions with regulatory complexes (RAB 
GTPases) and then by actin-related protein (ARP1) binding to β-III-spectrin (Holleran et al., 
2001). A missense mutation in β-III-spectrin (L253P), causative of spinocerebral ataxia type 
5 (SCA5), has been recently shown to disrupt release of plasma membrane proteins from 
the Golgi complex due to loss of its interactions with the ARP1 subunit of dynactin 
(Clarkson et al., 2010). Furthermore, the P150
Glued 
subunit of dynactin was found to 
accumulate in the ERC (Chen et al., 2008), interact with SEC23 on vesicles budding from ER 
(Watson et al., 2005), associate with RAB7 via RILP during maturation of late endosomes 
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(Jordens et al., 2001); while p50/DYNAMITIN interacted with RAB6 and BICAUDAL-D 
during exocytosis (Akhmanova and Hammer, III, 2010).  
 
1.3.2 Huntingtin 
Another dynein adaptor is Huntingtin (HTT), which was observed associated with various 
vesicular organelles (Caviston et al., 2007). HTT is expressed in all the tissues examined, 
and the highest levels of the Htt transcript were noted for brain and testis (Dixon et al., 
2004). In addition three splice variants were detected in mouse tissues (Schmitt et al., 
1995). Predicted HTT protein structure resembles that of a molecular scaffold, which can 
be incorporated in lipid membranes. The HTT is known to directly interact with the N-
terminal region of the intermediate chains of the dynein complex (Caviston et al., 2007) 
and indirectly with kinesins, myosins, and RAB5. Furthermore, removal of HTT in HeLa 
cells resulted in mislocalisation of endosomal compartments (early, recycling, late, 
lysosomal), which were clustered in the actin rich cortical area. Whereas cells lacking 
cytoplasmic dynein heavy chain (DYNC1H1) also displayed a dispersed phenotype yet the 
vesicles were mostly associated with MTs (Caviston et al., 2011). Interestingly, expression 
of the full length HTT restored the retrograde endosomal transport, which supports the 
model of HTT acting as a scaffold on the endosomal membrane (Caviston and Holzbaur, 
2009). Moreover, endogenous HTT was shown to be a key component responsible for 
smooth transition of newly formed vesicles from actin to microtubule cytoskeleton. 
Finally, while HTT stimulated the dynein dependent movement, it had no effect on 
kinesin-1.  
 
1.3.3 NUD family (NDE1, NDEL1, LIS1) 
In recent years more attention has been directed at a family of genes first described in 
Aspergillus sp. called nuclear distribution (Nud). Mammalian homologs include platelet-
activating factor acetylhydrolase subunit 1b/Lissencephaly 1 (Pafah1b/Lis1, homolog of 
NudF), nuclear distribution gene E (Nde1), and nuclear distribution gene E-like 1 (Ndel1) 
(Lam et al., 2010). Both NDE1 and NDEL1 dimerise and bind dynein intermediate chains 
upon phosphorylation of the C-terminal domain and form scaffold for a dimer of LIS1 
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interacting with AAA domains of the heavy chains (Zylkiewicz et al., 2011). As a result, the 
‘tail’ of the dynein complex is ‘cross-linked’ by a symmetric heterotetramer.  
 
NDE1, NDEL1, and LIS1 were originally observed in the kinetochore complex, and recently 
they were shown to regulate dynein driven trafficking of the membranous organelles (Lam 
et al., 2010). NDEL1 localised to the membranes of the Golgi complex and was essential 
for cargo binding and dynein transport. Furthermore, depletion of LIS1 resulted in 
dissociation of the intermediate chains from membranous organelles. 
 
1.4 Mutagenesis as a way to study gene function 
Information about an organism is stored in its DNA and genetic mutants have proved very 
useful in learning about functions of cellular components. The popularity of the laboratory 
mouse (Mus musculus) in biological research is reflected by a number of resources 
available, such as well characterised inbred strains, complete sequences of a mouse 
genome, and diversity of genetic manipulations successfully applied ((Nguyen and Xu, 
2008) and references therein). Furthermore, rodents and humans share physiological 
pathways and developmental mechanisms, thus so far a mouse is the best animal model 
to study humans disorders.  
 
1.4.1 Introduction of changes in genomic DNA 
Although naturally occurring mutants were at the foundation of genetics, over decades it 
became possible to manipulate genetic information, thus establishing lines of mutant 
organisms. In mouse, mutations can be described as randomly spread throughout the 
genome or targeted to a specific locus (Hardy et al., 2010).  
 
1.4.1.1  Random mutagenesis 
Random mutagenesis is often achieved by insertion of parts of DNA or by using chemical 
agents. Mammalian transposons constitute naturally occurring genetic elements capable 
of self-excision and insertion. Mobilisation of a transposon often results in the deletion of 
a part of a surrounding DNA, while insertion of a transposon within a gene may disrupt its 
architecture (Hardy et al., 2010). Although insertional mutations were known to 
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sometimes result in incomplete loss of function phenotypes, gene trap cassettes based on 
transposable elements have been used to create a library of mouse embryonic stem (ES) 
cell lines carrying mutations in single genes. For example, a reference library of gene trap 
sequence tags (GTST) from insertional mutations was generated by The German Genetrap 
Consortium (GGTC) (http://www.genetrap.de), with 2910 new clones released (April 
2011).  
 
Many disorders described in humans are caused by single point mutations, and chemical 
mutagenesis (e.g. with N-ethyl-N-nitrosourea, ENU) has been shown to generate useful 
models recapitulating complex phenotypes observed in clinical conditions (Acevedo-
Arozena et al., 2008). When used in doses high enough to overcome DNA repair 
mechanisms, ENU alkylates DNA bases in a random fashion, thus introducing single point 
mutations throughout a genome (Nolan, 2000). As a result, a broad range of mutations 
can be observed, including not only missense changes (64%), but also affecting splicing 
(26%) or causing premature termination (10%). Chemical mutagenesis displays high rate 
of changes with expected 1 mutation per 1.01 Mb of genomic DNA or 1.82 Mb of coding 
sequence depending on the dose used (Keays et al., 2006). An advantage of ENU induced 
mutations is that they are distributed across both coding and non-coding regions of the 
genome, therefore assumptions of the type of mutation and of causative gene function 
are avoided (Ching et al., 2010). Furthermore, a panel of animals carrying allelic mutations 
can be analysed , so giving an ‘allelic series’ which may provide new insight into gene 
function (Nolan et al., 2002). On the other hand, effects of the mutagen can depend on a 
mouse strain used, and usually several changes per a genome can be expected. A 
commonly used procedure involves induction of mutations in the premeiotic 
spermatogonia and analysis of the progeny of mutagenised male, but mutagenesis can be 
also carried out in embryonic stem (ES) cells (Acevedo-Arozena et al., 2008). 
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1.4.1.2  Transgenesis 
1.4.1.2.1 Transgenic mice 
In the conventional approach, DNA from a gene of interest in a vector is introduced into a 
fertilised oocyte which was then implanted into a pseudopregnant female. The 
transplanted embryos develop to term and then the animals are screened for the 
presence of the transgene (Hardy et al., 2010). Although this approach is popular and for 
example is used to model dominant disease, it is impossible to predict the integration site, 
orientation of the transgene or its copy number (Ohtsuka et al., 2010). Furthermore, the 
chromatin rearrangements or silencing of the exogenous DNA often affect the expression 
of the transgene.  
 
1.4.1.2.2 Gene targeted mice 
A different approach, gene targeting, overcomes the above problems that may arise with 
transgenic animals created by pronuclear injection. Because homologous recombination 
(HR) is a preferable mechanism of DNA repair in the ES cells, development of ES cell based 
protocols allowed precise targeting by the DNA introduced on specially designed vectors. 
ES clones which have undergone HR can then be selected and injected into host 
blastocysts, which are then implanted into pseudopregnant females. These chimeric 
embryos come to term and result in chimeric mice (Hardy et al., 2010). If the 
homologously recombined ES cell component is in the gonads of the chimeric mice, they 
may be bred to produce gene targeted animals. Although generation of chimeric mice and 
germ-line transmission of the targeted allele are limiting steps, this approach gained in 
popularity as only one copy of the mutation is introduced in the original locus. Thus, a 
range of manipulations can be achieved, including knock out (KO), knock in (KI), 
conditional and inducible mutations. 
 
1.4.2 Phenotypic analysis of mutant mice 
Phenotyping of a mutant animal is usually the final goal of most projects that use mouse 
genetics, therefore accurate characterisation should be a priority. There are two main 
approaches applied when working with mutant animals: a phenotype-driven screen 
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followed by mapping of the genetic locus which segregates with the phenotype (forward 
genetics), which is often applied in random mutagenesis programs. Alternatively, changes 
in a gene of interest are introduced and the phenotype of mutant animals is characterised 
(reverse genetics) (Nolan et al., 2002). Both approaches have been successfully applied in 
the ENU-mutagenesis programs and are briefly described in the following paragraphs. 
 
In the phenotype based screens of ENU-treated animals, mutagenised males are mated 
with wildtype females and the progeny (G1) are tested. The phenotypically aberrant 
animals identified in this round of testing carry dominant mutations. In order to detect 
phenotypes caused by recessive alleles intercrossing of other generations (G2, G3), which 
are subjected to analysis, is necessary; in either case the inheritance of the phenotype is 
also tested to ensure the phenotype arises form a germ-line mutation rather than a 
sporadic defect. One of the advantages of the phenotype based approach is that no 
assumptions are made about genes or pathways affected. Even though studies have 
reported that only approximately 25% of ENU induced mutations are dominant alleles 
(Brown and Nolan, 1998), high-throughput phenotype based studies have resulted in 
identifying many mutant mouse lines (Acevedo-Arozena et al., 2008). Furthermore, ENU 
mutagenesis has been shown successful in analysis of modifiers of the known phenotype.  
 
Taking the second approach, the genotype based approach, an archive of mutated DNA 
made from F1 mutant males can be screened in order to identify mutations in a specific 
gene. The method has gained on popularity thanks to the availability of the whole genome 
sequencing, genome-wide association studies, and applying a range of techniques to 
detect potential mutations (Acevedo-Arozena et al., 2008). Once a mutation in a specific 
DNA sample is identified, the equivalent frozen sperm sample can be used for IVF and the 
mouse rederived. In this way a panel of allelic mutations can be found fairly quickly and 
animals can be rederived to be phenotyped. 
 
Both approaches broaden our understanding of a gene’s function by using standardised 
phenotyping regimes suitable for mouse. Standardising is essential, especially in case of 
complex traits or mild phenotypes, e.g. behaviour is very sensitive to various factors 
(Crawley, 2008). On the other hand high-throughput screens, when thousands of 
36 
individuals are analysed, require robust yet sensitive tests in order to yield good quality 
data (Brooks and Dunnett, 2009). Nevertheless, before performing behavioural tests 
several things should be considered. Decades of mouse breeding resulted in the 
generation of over 450 inbred strains, which due to their genetic background, often show 
different performances in various tasks (Phenome Database, http://www.phenome. 
jax.org). An appropriate inbred strain with moderate behavioural phenotypes should be 
then chosen when breeding a cohort of mutant mice that will be behaviourally tested; it is 
also beneficial to characterise effects of a mutation in a genetic context of at least two 
inbred strains. As an animal itself constitutes a very complex system a phenotype 
observed can be caused by many factors which should be taken into account while 
performing behavioural tasks. Thus in order to avoid misinterpretation of results, 
observations of general health of an animal are often included in a phenotyping pipeline, 
e.g. many neurological disorders affect locomotor ability. Moreover, performing several 
tests measuring the same behaviour (e.g. anxiety, memory) helps to discriminate even 
mild phenotypes. Finally, when a mouse is subjected to a series of various tasks, they 
should be carried out starting from the least stressful (Crawley, 2008).  
 
Appropriate data analysis is extremely important and for example, Karp and colleagues 
(Karp et al., 2010) discuss issues of variation between mice and an appropriate statistical 
validation of results. Most of the data obtained during phenotyping have hierarchical 
structure (e.g. genotype /treatment  animal  measurements) which should be taken 
into account; the authors propose 3-level random effect nested analysis of variance 
(ANOVA) with adjustments for multiple trials as a robust and powerful test.  
 
One of the first protocols designed for phenotyping of large cohorts of mice was SHIRPA 
(SmithKline Beecham Pharmaceuticals; Harwell, MRC Mouse Genome Centre and 
Mammalian Genetics Unit; Imperial College School of Medicine at St Mary’s; Royal London 
Hospital, St Bartholomew’s and the Royal London School of Medicine; Phenotype 
Assessment), which consisted of over 40 quantitative measurements (Rogers et al., 1997). 
Initially SHIRPA was designed into three stages: (1) observation of basic health and animal 
performance (e.g. gait, overall appearance), (2) behavioral and pathological (e.g. 
37 
locomotor activity), and (3) more specific and invasive investigations such as behavioural 
tasks (e.g. anxiety, learning). The SHIRPA protocol was successful in characterizing 
behavioral traits in inbred strains (Rogers et al., 1997), and adapted for long time 
observations of progressive neurological phenotypes (Lalonde et al., 2004; Rogers et al., 
2001).  
 
1.4.2.1  The MRC Mammalian Genetics Unit, Harwell, ENU mutagenesis 
 programme 
ENU mutagenesis, as mentioned before, is a powerful tool and a set of mutant animals 
can be generated in a short time. On the other hand numerous cohorts of mice need to be 
tested in a high-throughput manner before a specific phenotype may be detected 
(Acevedo-Arozena et al., 2008). MRC Mammalian Genetics Unit, Harwell, UK is one centre 
generating novel mutant mouse lines in an ENU mutagenesis programme. A robust 
pipeline aimed to identify mutation-related phenotypes in all areas examined was applied 
in a screen of over 26000 mutagenised F1 mice (Nolan et al., 2000). The primary screen 
consisted of sets of non-invasive tests which were performed sequentially: at weaning 
mice were assessed for developmental dysmorphologies, followed by modified SHIRPA, 
and biochemical analysis of blood. Nolan and colleagues (2000) reported dominant alleles 
having given rise to diverse phenotypes at a level of 2%. Following primary screens 
secondary phenotyping is designed for a specific area; for instance neurological deficits 
can be characterised with the SHIRPA protocol (as mentioned), long time behavioural 
observation coupled with computer based video analysis (Jhuang et al., 2010), or tests 
scoring social interactions (Silverman et al., 2010).  
 
1.4.2.2  Data capture 
The high-throughput ENU screens, of which the programme at MRC Harwell is just one, 
generate huge amount of data which need to be managed so that they are easily 
accessible. Therefore, in many European centers several projects have been initiated in 
order to provide the community with standardised procedures and accessible data, 
including EUMORPHIA (http://www.eumorphia.org), EMPReSS (http://empress.har. 
mrc.ac.uk), and EuroPhenome (http://www.europhenome.org). The main purpose of the 
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EUMORPHIA (European Union Mouse Research for Public Health and Industrial 
Applications) project was to develop new approaches in mouse mutagenesis and 
phenotyping, thus establishing EMReSS (European Mouse Phenotyping Resource of 
Standardised Screens) (Brown et al., 2005). The EMPReSS database contains sets of 
individual standard operating procedures (SOPs) applicable in various phenotyping 
screens. Because the main objective was to provide robust yet sensitive protocols which 
would produce comparable results, the EMPReSS procedures were validated by screening 
four inbred mouse strains (Mandillo et al., 2008). Moreover, EMPReSS slim phenotyping 
pipelines were designed to describe a comprehensive multi-system phenotypic pipeline 
and were used in primary high-throughput screens performed by the EUMODIC (European 
Mouse Disease Clinic) consortium (Gates et al., 2010). The visual representation of a 
timescale of tests included in two EMPReSS slim pipelines is presented in Figure 1.5. 
Finally, all the data obtained from various screens are deposited in the EuroPhenome 
database (Mallon et al., 2008); at present characteristics of 266 mutant and 44 inbred 
mouse strains can be accessed (March 2011).  
 
Another resource initiated by the Jackson Laboratory is the Mouse Phenome Database 
(http://phenome.jax.org), in which genotypic and phenotypic data of inbred mouse strains 
are collected (Grubb et al., 2009). Apart from versatile characteristics of mouse lines 
deposited by researchers, the database provides detailed protocols used in each study 
and informatics tools for data exploration, analysis and comparison. At present (March 
2011) the MPD contains data from 118 phenotype strain survey projects and information 
of over 600 inbred strains. 
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Figure 1.5. Simplified representation of Empress slim pipelines 
EUMODIC screens consist of several tests covering various areas of animal physiology and behavior; they are 
performed on age-matched cohorts of 10 male and 10 female mice in a weekly intervals (the age of mice 
marked above each test); IPGTT - intra-peritoneal glucose tolerance test, DEXA – bone densitometry, PPI – 
pre-pulse inhibition, FACS – fluorescence – activated cell sorting. 
 
 
 
1.5 Phenotypes of animal models carrying mutations in the cytoplasmic 
dynein and dynactin complexes 
The cytoplasmic dynein complex is crucial for cell functioning and survival, as it 
participates in a range of cellular processes. Analysis of phenotypes of mouse models 
carrying mutations in the genes of the dynein complex is invaluable source of knowledge, 
giving insight into functions of the cytoplasmic dynein in a context of different tissues and 
developmental stages, and of the whole animal.  
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1.5.1 Mutant lines in the cytoplasmic dynein heavy chain (Dync1h1) 
1.5.1.1  Dync1h1
tm1Noh
 mouse 
There is one mouse line known carrying a targeted mutation resulting in a null allele of the 
dynein heavy chain (Dync1h1
tm1Noh
) (Harada et al., 1998). Lack of the heavy chain in the 
homozygous animals Dync1h1
-/-
 resulted in lethality of 8.5 days old embryos, while 
heterozygous mice Dync1h1
+/-
 were indistinguishable from their wildtype Dync1h1
+/+
 
littermates. When cultured in vitro, homozygous Dync1h1
-/-
 embryonic cells failed to 
proliferate and blastocysts died after few days. On the cellular level, complete disruption 
of the heavy chain caused fragmentation of Golgi apparatus and mislocalisation of the 
endosomal compartment to the cell periphery.  
 
1.5.1.2  Loa mouse (Legs at odd angles) 
A founder of the ‘Legs at odd angles’ (Loa) mutant mouse line was identified in the screen 
of ENU-mutagenised animals (Hafezparast et al., 2003). It displayed abnormal body 
posture, limb grasping, reduced grip strength. A missense point mutation was found in the 
Dync1h1 gene resulting in the amino acid substitution F508Y which is a causative of 
neurological deficits in heterozygous Dync1h1
Loa/+
 mice (Figure 1.6). Although homozygous 
Dync1h1
Loa/Loa
 animals were born, they died  in late gestation or just after birth.  
 
Detailed analysis of the heterozygous Dync1h1
Loa/+
 animals revealed sensory neuropathy 
associated with degeneration of muscle spindles and neurons in lumbar dorsal root 
ganglia (DRGs) (Chen et al., 2007). Furthermore, in sciatic nerve two distinct populations 
of retrogradely transported endosomes were observed, where a slower component 
corresponded to impaired axonal transport in sensory neurons (Bilsland et al., 2010). 
Biochemical analysis of a single motors revealed impairment in coordination between 
motor domains of the heavy chains, resulting in marked decrease in run length and 
velocity of a single run (Ori-McKenney et al., 2010). Effects of the impairment in the 
function of heavy chain were also observed in adipose tissue. Heterozygous Dync1h1
Loa/+
 
animals differed in adiposity and cold tolerance, features associated with impaired 
lipolysis and morphological abnormalities in brown fat tissue 
phenotype was caused by deficits in norepinephrin release and signalling. 
 
The effects of mutation were pronounced in cells and tissues isolated from homozygous 
Dync1h1
Loa/Loa
 animals, including defects in migration of neuronal populations in 
hindbrain, branching and elongation of peripheral nerves, and delays in reassembly of the 
Golgi complex (Hafezparast
the interactions between different subunits of the complex 
 
1.5.1.3  Cra1 mouse (Cramping 1)
The ‘Cramping 1’ (Cra 1) 
carries a point mutation changing tyrosine to cysteine (Y1055C) (
et al., 2003). The mutation is allelic to 
characteristics as the Dync1h1
Dync1h1
Cra1/Cra1
 mice and neuronal phenotypes in heterozygous 
Sensory neuron degeneration was observed in 
motor neurons were unaffected 
defects in assembly of synapses were proposed to reflect structural defects of 
neuromuscular junctions (NMJ) 
Dync1h1
Cra/+
 mice recapitulated 
Dync1h1
Loa/+
 animals.  
 
Figure 1.6. Protein map of the cytoplasmic dynein heavy chain showing the location of the mutations 
Cra1 and Swl 
The motor domain consists of the six known AAA
domain (AAAC); the microtubule
protein contains the intermediate (DYNC1I), light
from Banks and Fisher (2008
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(Eschbach
 et al., 2003). Furthermore, the mutation affected dynamics of 
(Deng et al.
 
mouse line was created in an ENU-mutagenesis experiment, 
Figure 
Dync1h1
Loa
, and Dync1h1
Cra1
 animals have similar 
Loa
 animals, including embryonic lethality of homozygous 
Dync1h1
heterozygous (Dync1h1
(Dupuis et al., 2009). Furthermore, developmental 
(Courchesne et al., 2011). Finally, heterozygous 
the adipose tissue phenotype observed in the 
-ATPase domains (AAA 1 to 6) and an unrelated seventh 
-binding domain lies between AAA4 and AAA5; the N
-intermediate (DYNC1LI) and heavy (DYNC1H1); adapted 
) © 2008 by BioMed Central 
 et al., 2011). This 
 
, 2010). 
and 
1.6) (Hafezparast 
Cra/+ 
animals. 
Cra1/+
) mice, while 
 
Loa, 
-terminal region 
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1.5.1.4  Swl mouse (Sprawling) 
The ‘Sprawling’ (Swl) mutant was generated via radiation induced mutagenesis and carries 
a 9 bp deletion (GIVT1040A) within the dimerisation domain of the heavy chain (Figure 
1.6) (Chen et al., 2007). Mutation causes neurological deficits in heterozygous 
(Dync1h1
Swl/+
) animals, and embryonic lethality of the homozygous Dync1h1
Swl/Swl
. 
Heterozygous Dync1h1
Swl/+
 animals can be identified by an unsteady gait, and decrease in 
the grip strength of hind limbs. This behaviour results from a neuropathy of sensory 
neurons and degeneration of muscle spindles in hind limbs. Detailed histological analysis 
showed decrease in number of proprioceptors and sensory neurons located in the DRG. At 
the same time peripheral and spinal motor neurons were not affected.  
 
1.5.2 Dync1li1N235Y mouse 
A reverse genetics approach was employed to identify a single point mutation in the 
cytoplasmic dynein light intermediate chain 1 (Dync1li1) in the genomic DNA isolated from 
ENU mutagenised animals in the MRC Harwell archive. Mutant mouse line was rederived 
and detailed phenotype of homozygous Dync1li1
N235Y/N235Y
 animals assessed (Banks et al., 
2011). Interestingly, mutant animals displayed phenotypes distinct from the mouse lines 
carrying mutations in the dynein heavy chain. Dync1li1
N235Y/N235Y
 animals showed 
increased levels of anxiety along with lower spontaneous locomotor activity and subtle 
gait impairment. Histological analysis revealed abnormal dendrite outgrowth and 
migration pattern of the cortical neurons, while dendrite branching was enhanced in 
sensory neurons. On the cellular level, impairment of housekeeping functions of the 
dynein complex was observed, namely EGF trafficking and Golgi complex reassembly.  
 
1.5.3 P150Glued transgenic models 
A single point mutation (G59S) in DYNACTIN 1 (DCTN1/P150
Glued
) was described in a family 
with distal spinal and bulbar muscular atrophy (dSBMA, previously classified as motor 
neuron disease, MND) (Chevalier-Larsen et al., 2008; Puls et al., 2003). Since then, two 
different transgenic mouse lines carrying G59S were described showing distinct 
phenotypes. 
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Transgenic mouse lines expressing human cDNA of DCTN1
G59S
 under a control of motor 
neuron specific promoter were compared with lines transgenic for a wildtype of the 
DCTN1 (Chevalier-Larsen et al., 2008; Laird et al., 2008). Animals carrying mutant 
transgene displayed late onset progressive muscle weakness although whether their 
lifespan was affected needs to be clarified (Chevalier-Larsen et al., 2008). Furthermore, 
expression of the human DCTN1
G59S
 caused distal degeneration associated with axonal 
swelling and changes in the NMJs. Although axonal transport was not impaired, there 
were enlarged tertiary lysosomes and cytoplasmic granules observed in neuronal cells, 
suggesting impairment in vesicular transport and degradation. 
 
Alternative mouse models carrying the same mutation but in the mouse Dctn1 gene were 
created by applying the targeted mutagenesis approach (Lai et al., 2007). Established 
mouse lines had the wildtype allele replaced by mouse mutant alleles (Dctn1
G59S
 – amino 
acid substitution, Dctn1
∆2-3 
- deletion of exons 2 and 3, Dctn1
neo
 – knock-out allele), which 
inhibited embryogenesis of homozygous animals (Dctn1
G59S/G59S
, Dctn1
∆2-3/∆2-3
). Although 
levels of wildtype DCTN1/P150
Glued
 in spinal cord protein lysates were lower by 50% in 
animals heterozygous for each of the alleles, the structure of the dynactin complex was 
not affected. Furthermore, only Dctn1
G59S/+
 animals developed neurological deficits similar 
to motor neuron disease. There was no impairment in locomotor performance except for 
shortening of the stride length in the Dctn1
G59S/+
 males. In addition, structural 
abnormalities of the NMJs were observed with accumulation of neurofilaments (NFs) and 
synaptophysin (SYP). Finally, number of motor neurons in the lumbar spinal cord was 
lower in the heterozygous Dctn1
G59S/+
 animals. 
 
1.5.4 Summary of dynein and dynactin mouse mutants 
This summary of known mouse models mutant in the dynein/dynactin complexes suggests 
that there is a crucial role of retrograde transport in the neuronal cells. Interestingly, 
phenotypes associated with the cytoplasmic heavy chain (Dync1h1) and dynactin 1 (Dctn1) 
mutant alleles had dominant pattern of inheritance, which supports their critical role for 
the activity of the cytoplasmic dynein complex. 
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Table 1.2. Summary of mouse model mutant in the cytoplasmic dynein and dynactin complexes 
Abbreviations used: Dync1h1 – cytoplasmic dynein heavy chain 1, Dctn1 – dynactin 1 (P150
Glued
), Dync1li1 – 
cytoplasmic dynein light intermediate chain 1, MNJ – neuromuscular junction, MN – motor neuron, NF – 
neurofilament, SYP – synaptophysin 
 
Mouse 
model 
Gene and 
mutation 
Behavioural 
phenotype 
Histological 
phenotype 
Cellular phenotype 
Dync1h1
tm1Noh
 
Dync1h1, 
knock-out 
allele 
Homozygotes 
embryonic lethal 
 
Homozygous embryos 
fail to proliferate 
Disruption of Golgi 
apparatus 
Dync1h1
Loa
 
Dync1h1,  
F508Y 
mutation 
Homozygotes die 
before/after birth 
Abnormal gait and 
performance on 
locomotor tasks 
Sensory neurons 
neuropathy 
Abnormal adiposity 
Defects in neuronal 
migration 
Delayed retrograde 
axonal transport 
Delay in reassembly of 
Golgi apparatus 
Impaired interactions 
between subunits 
Dync1h1
Cra1
 
Dync1h1,  
Y1055C 
mutation 
Homozygotes 
embryonic lethal 
Sensory neurons 
neuropathy 
Abnormal adiposity 
Defects in 
neuromuscular junctions 
 
Dync1h1
Swl
 
Dync1h1,  
GIVT1040A 
deletion 
Homozygotes 
embryonic lethal 
Unsteady gait, 
decrease in grip 
strength 
Sensory neurons 
neuropathy 
Muscle spindles 
degeneration 
 
Dync1li1
N235Y
  
Dync1li1, 
N235Y 
mutation 
Homozygotes show 
increased anxtiety, 
gait impairment  
Abnormal dendrite 
architecture and 
neuronal migration 
Impaired EGF trafficking, 
Golgi complex assembly 
DCTN1
G59S
 
DCTN1, human 
transgene with 
G59S mutation 
Muscle weakness 
Distal degeneration with 
axonal swelling  
Ambormalities in NMJs 
Enlarged tertiary 
lysosomes and 
cytoplasmic granules 
Dctn1
G59S
, 
Dctn1
∆2-3
 
Dctn1, 
targeted 
mutation 
Homozygotes 
embryonic lethal 
Neurological defects 
Gait abnormalities 
Degeneration of MN in 
lumbar spinal cord 
Accumulation of NFs and 
SYP 
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1.6 Project outline  
Activity of cytoplasmic dynein complex is indispensable for cell function and survival, 
however there are still many unanswered questions regarding cargo assembly, roles of the 
individual subunits, and regulation of the complex. A great part of our knowledge about 
the dynein complex comes from studies employing cellular models, which although very 
useful, are not devoid of limitations. Many isoforms of the subunits are expressed in a 
tissue specific manner, which is difficult to replicate in a cell line. Furthermore, many 
reports come from studies, in which specific subunits were depleted often resulting in 
disruption of the whole dynein complex. However, many diseases associated with 
impairment of the intracellular transport are caused by point mutations. 
 
With the above considerations in mind, we decided to use a mouse genetics approach to 
investigate the function of the cytoplasmic dynein intermediate chains. We chose these 
subunits, as being in the heart of the dynein complex they form a platform where many 
accessory complexes and cargos are known to bind. Using a reverse-genetics approach we 
performed a screen of the MRC Harwell DNA archive isolated from ENU-mutagenised 
mice. The screen resulted in detection of two mice heterozygous for coding point 
mutations in the intermediate chains 1 and 2. Mouse lines were rederived and colonies 
established in order to characterise phenotype of the mutant animals. The presented 
work was focused on: 
• Behavioural analysis of mouse lines carrying mutations in the intermediate chains 1 
and 2 (Dync1i1
G482D
, Dync1i2
T172I
). 
• Investigation of the effects of the mutations on the housekeeping functions of the 
dynein complex using cellular models. 
• Comparison of response to stress between cell lines carrying mutations in the 
intermediate (Dync1i1
G482D 
Dync1i2
T172I
) and heavy chains (Dync1h1
Loa
). 
• Detailed analysis of the alternative splicing of the dynein intermediate chains 1 and 2 
(Dync1i1, Dync1i2) in mouse tissues. 
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2. Methods  
 
2.1 Experimental animals 
The animal experiments described were carried out under the “Guidance on Operation of 
Animals (Scientific Procedures Act 1986) March 2000” and Home Office Project license No. 
30/2290. All mice were housed in a controlled environment in the animal facility on site 
(Table 2.1).  
 
Table 2.1. Controlled environment details of animal housing  
Isolation and conditioning Ventilated racking 
Cage type ICV (individual isolated cage), Tecniplast 
Bedding 
Grade 5, dust-free, autoclaved wood bedding (Datastand Diet 
Service UK) 
Diet RM1, RM3, 2919 
Room temperature 19-  23°C 
Room humidity 55 ± 10% 
Ventilation 60-70 m³/h 
 
The Dync1i1
G482D
 and Dync1i2
T172I
 mutant mice were rederived at the MRC Mammalian 
Genetics Unit, MRC Harwell, UK. The point mutations resulted from the treatment of 
BALB/c males with an N-ethyl-N-nitrosourea (ENU) as described in Nolan, 2000. After 
recovery males were mated to C3H/HeH females in order to produce F1 (C3H/HeH x 
BALB/c) progeny. Subsequently frozen sperm samples with the identified mutation of 
interest were used for in vitro fertilisation (IVF) with C57BL/6J females. The animals 
carrying the mutations in the cytoplasmic dynein intermediate chains 1 and 2 
(Dync1i1
G482D
 or Dync1i2
T172I
) were used as founders of the colonies and treated as 
generation N0.  
 
C57BL/6J mice were provided by Harlan Laboratories. 
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2.1.1 Breeding protocols 
Mutant Dync1i1
G482D/+ 
and Dync1i2
T172I/+ 
animals were backcrossed to C57BL/6J mice with 
the aim of producing congenic strains or intercrossed to produce homozygous mutant 
animals. Furthermore, a colony of double heterozygous Dync1i1
G482D/+
 Dync1i2
T172I/+
 
animals on a C57BL/6J background was established at the MRC Mammalian Genetics Unit, 
MRC Harwell, UK. 
 
Mutant Dync1h1
Loa
 mouse line (Hafezparast et al., 2003) was established as congenic line 
and maintained by crossing to C57BL/6J mice. 
 
Timed matings were set up with a purpose of collecting embryos at a certain age. 
Copulation plug checking was carried out in the morning as mating usually occurred during 
the dark cycle in the evening. When a plug was present a male was removed from the 
cage and the date was recorded as day E0.5; otherwise the animals were left together to 
mate. 
 
2.1.2 Genotyping protocol 
DNA was extracted from ear biopsies collected from post-weaning pups as described in 
2.3.1. The single point mutations introduce or destroy sequences recognizable by 
restriction enzymes, thus routine genotyping was performed by PCR and subsequent 
digestion with a restriction enzyme. The details of the DNA amplification, restriction 
digest, and primer sequences are shown in Table 2.2 and Appendix 10.12.1 respectively. 
The digested PCR products were visualised on an agarose gel (section 2.3.6) together with 
samples isolated from animals of known genotype. Depending on the genotype of animal 
distinctive patterns of bands were observed as summarised in Table 2.3.  
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Table 2.2. The summary of genotyping protocol  
Cycling steps (denaturation of a template, annealing of primers, and extension of a product) marked in grey 
 
Mouse line Dync1i1G482D Dync1i2T172I Dync1h1Loa 
PCR Mix 
5 μl MegaMix Gold 
1 μl 10μM primer mix 
1 μl DNA 
3 μl H2O 
8.5 μl MegaMix Blue 
1.0 μl 5μM primer mix 
0.5 μl DNA 
10 μl MegaMix Gold 
1 μl 5μM primer mix 
1 μl DNA 
8 μl H2O 
 95°C for 2 min 95°C for 2 min 95°C for 5 min 
Thermal 
cycling 
program 
94°C for 30 s 
57°C for 30 s   } 35 cycles 
72°C for 45 s 
94°C for 30 s 
60°C for 30 s   } 35 cycles 
72°C for 45 s 
94°C for 30 s 
58°C for 30 s   } 35 cycles 
72°C for 45 s 
 72°C for 5 min 72°C for 5 min 72°C for 5 min 
Restriction 
digest 
(added to 
the PCR 
reaction) 
3.0 μl NEB Buffer 4 
0.5 μl MboII 
16.5 μl H2O 
 
Incubated at 37°C for  
2 hours 
3.0 μl NEB Buffer 1 
0.5 μl Tsp45I 
0.3 μl BSA 
16.2 μl H2O 
Incubated at 65°C for  
2 hours 
3.0 μl NEB Buffer 1 
0.5 μl RsaI 
6.5 μl H2O 
 
Incubated at 37°C for  
2 hours 
 
Table 2.3. The summary of the pattern of the restriction digest 
Wildtype allele denoted as Gene
+/+
, heterozygous as Gene
Mut/+
, homozygous as Gene
Mut/Mut 
 
Mouse line Dync1i1G482D 
Genotype Dync1i1+/+ Dync1i1G482D/+ Dync1i1G482D/G482D 
Bands (bp) 325 325, 246, 79 246, 79 
Mouse line Dync1i2T172I 
Genotype Dync1i2+/+ Dync1i2T172I/+ Dync1i2T172I/T172I 
Bands (bp) 149, 121 270, 149, 121 270 
Mouse line Dync1h1Loa 
Genotype Dync1h1+/+ Dync1h1Loa/+ Dync1h1Loa/Loa 
Bands (bp) 322, 226 322, 226, 187, 135 226, 187, 135 
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2.1.3 Phenotyping protocols 
Behavioural phenotyping of the wildtype and Dync1i1
G482D/G482D
 female littermates, 
wildtype and Dync1i2
T172I/T172I
 female littermates was carried out at the Department of 
Experimental Psychology, University of Oxford by Dr Robert Deacon and Dr Samantha 
Line. The tests performed were: 
 
Accelerating rotarod 
Mice were placed on the rotarod whilst it was rotating at 4 revolutions per min (rpm). If 
the animal fell off the rod before 10 sec had elapsed, the test was restarted (if the animal 
fell three times, the test was ended and a score of 4 rpm was recorded). After 10 sec at 4 
rpm, the rod began to accelerate at 20 rpm/min. The speed at which the rod was rotating 
when the animal fell off was recorded. If an animal held on to the rod and made a full 
revolution, it was considered to have fallen off, and the speed of rotation was recorded. 
The rotarod was built in-house and similar to the Ugo Basile model (7650). 
 
Multiple Static Rods 
The multiple static rods consisted of three horizontal bars attached to a shelf at one end. 
Animals were placed on the distal end of the first (widest) rod facing away from the shelf 
and the time taken for them to turn 180° (orient) and walk from the far end of the rod to 
the shelf (traverse) was recorded.  
 
Wheel running 
Mice were singly housed in a cage containing a running wheel (Bio-Serv Fast-Trac wheel 
attached to a mouse igloo) attached to a pedometer. After 24 hour the distance run, 
average speed and maximum speed were recorded. Testing was performed for 5 days. 
 
Food consumption 
Mice were housed individually with accesses to food (standard laboratory chow, PCD 
Mod; Special Diet Services, Witham, Essex, United Kingdom) and water ad libitum. 
Consumption of food and water was measured over a period of 3 days.  
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Glucose preference 
Mice were housed individually with access to food ad libitum, and were provided with 
both water and 7.5% (w/v) glucose solution. The bottles were weighed after 24 hours and 
the ratio of glucose: water consumption was calculated. The test was performed on 4 
consecutive days. 
 
Locomotor Activity 
Animals were placed in individual chambers for 23 hours and their locomotor activity was 
recorded. Testing was begun at 1 pm, with the dark phase from 7 pm to 7 am. 
 
Burrowing  
Test for burrowing was performed as described in Deacon (2006b). Briefly, mice were 
placed in burrows filled with 200 g of food pellets. After 1 or 3 hours the burrows were 
weighted and the difference from the starting weight was a measure of displaced 
material. Two tests were performed. 
 
Nesting 
The quality of nests built overnight was assessed in a scale from 1 to 5 as described in 
Deacon (2006a). 
 
Successive alleys 
The successive alleys apparatus consisted of four increasingly anxiogenic, linearly 
connected wooden alleys. Each alley was 45 cm in length. The alleys had the following 
dimensions: alley 1 = 9 cm wide, 29 cm-high walls, painted black; alley 2 = 9 cm wide, 2.5 
cm-high walls, painted grey; alley 3 = 6.7 cm wide, 0.5 cm-high walls, painted white; alley 
4 = 5 cm wide, 0.3 cm-high walls, painted white. A 2 cm step down led from alley 2 to alley 
3, with a further 0.5 cm step down between alleys 3 and 4. The apparatus was elevated 1 
m above the floor in a well-lit laboratory. Mice were placed individually at the closed end 
of Alley 1, facing the wall. Each trial lasted for 300 sec (5 min) and for each section the 
total time spent in each Alley, and the numbers of entries were recorded. 
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Light/Dark Box 
The light/dark box task was also a test of anxiety-like behaviour. Animals were placed in 
the dark compartment and measurements for the latency to emerge, the number of 
entries to the light area and the time spent in the light area were recorded over 5 
minutes.  
 
Spontaneous alternation  
Spontaneous alternation was assessed in a gray, wooden, enclosed T-maze. On each trial, 
the mouse was placed into the start arm facing the end wall and allowed to enter a goal 
arm of its own choice. The mouse was confined in the chosen goal arm for 30 sec, then 
placed back at the beginning of the start arm and allowed a free choice of either goal arm. 
Whether or not the mouse alternated was recorded. Two trials were performed per day 
for six days.   
 
Sanderson Y-maze 
Detailed description of a test and analysis can be found in Sanderson et al., 2009. The Y-
maze test consisted of training phase and a novelty preference test. During the 2 min long 
training mice were allowed to explore freely 2 arms of the maze (called Start and Other 
arm) while third arm (called Novel) was blocked. Subsequently, mice received a novelty 
preference test, during which animals were allowed to explore 3 arms (Start, Other, and 
Novel). The exploratory behaviour was assessed for 2 min, when the time spent in each 
arm and numbers of entries were recorded. 
 
CatWalk XT 
Mice were allowed to walk spontaneously up and down the glass CatWalk XT walkway 
while images were collected by a video camera placed below. Four crosses of the walkway 
were analysed for each animal and the data averaged. A number of parameters were 
examined, including regularity, base of support, size of paw prints, step phase, and speed 
of a swing. 
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2.1.4 Collection of mouse tissues 
Animals were culled according to Schedule 1, which methods included exposure to CO2 or 
cervical dislocation (“Guidance on Operation of Animals (Scientific Procedures Act 1986) 
March 2000”). 
 
2.1.4.1  Tissue harvesting  
Embryonic tissues were used for the extraction of total RNA and cell cultures of primary 
embryonic fibroblasts. Timed matings were set up as described in section 2.1.1; embryos 
were harvested at day E13.5 (preparation of mouse embryonic fibroblasts – section 2.6.1) 
or E17.5 (RNA extraction – section 2.2.2).  
 
For RNA extraction embryonic brain and spinal cord were collected. Furthermore, a set of 
tissues was collected from 6-8 weeks old C57BL/6J mice (brain, spinal cord, ovary, testis, 
spleen, lungs, kidney, heart, intestine, muscle, liver) and brains from adult mice dissected 
into cortex, cerebellum, brain stem, hippocampus and olfactory bulbs. Immediately after 
collecting tissues were transferred into RNase-free 1.5 ml tubes (Biopur, Eppendorf) and 
immersed in RNAlater reagent (Qiagen) in order to minimize RNA degradation. Tissues 
were stored at 4°C overnight and transferred to -80°C the next day. Similarly, neuronal 
tissues (spinal cord, cortex, and hippocampus) were collected from 12-13 weeks old 
wildtype and Dync1i2
T172I/T172I 
male and female mice and processed according to the RNA 
extraction protocol (section 2.2.2). 
 
2.1.4.2  Histological protocols  
Histological analysis of whole brains was performed in collaboration with Prof. Sebastian 
Brandner and Jacqueline Linehan (Institute of Neurology, UCL). Whole brains from 6 
months old wildtype and Dync1i2
T172I/T172I
 female littermates were removed and fixed in 
4% PFA/PBS by immersion. Tissues were then prepared prior to analysis as described in 
Wadsworth et al., 2008. The sagittal brain sections were stained with haematoxylin and 
eosin (H&E) and antibodies against glial fibrillary protein (GFAP), calbindin (CALB1). 
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2.2 General RNA protocols 
All the procedures were carried out in RNase-free conditions: reagents based on DEPC-
treated water (Invitrogen) and RNAZap (Ambion) to clean all the surfaces and equipment 
were used. 
 
2.2.1 Total RNA extraction using TRIreagent 
Muscle and liver were found to be difficult to extract RNA from due to: (1) fibrous nature 
and an abundance of proteins, and (2) high content of lipids. Therefore TRIreagent 
(Ambion) was used and the extraction protocol was modified.  
 
Tissues were homogenized on ice in TRIreagent (1 ml per 30 mg tissue) using a Dounce 
Tissue Grinder, homogenates were centrifuged in 15 ml Falcon tubes at 4°C for 30 min at 
5000 x g. Cleared supernatant was transferred to a fresh tube and RNase-free Mussel 
Glycogen (Sigma-Aldrich) was added to a final concentration 250 μg/ml. After 5 min of 
incubation 0.1 ml bromo-chloro-propane (BCP, Sigma-Aldrich) per 1 ml TRIreagent was 
added, the mixture was shaken vigorously and incubated for 2-3 min at room 
temperature. Another centrifugation step followed (4°C for 30 min at 5000 x g) which 
resulted in separation of lysate into 3 phases. The upper aqueous phase containing RNA 
was carefully transferred to a fresh tube and 0.3 ml isopropanol (IPA) and 0.2 ml high salt 
solution (0.8 M sodium citrate, 1.2 M sodium chloride) per 1 ml TRIreagent were added. 
Samples were incubated for 10 min at room temperature. After centrifugation step (4°C 
for 30 min at 5000 x g) RNA precipitated at the bottom of the tube and was washed with 
75% ethanol (VWR), volume equal to TRIreagent, and centrifuged (4°C for 30 min at 5000 
x g). Supernatant was removed; another portion 75% ethanol was added (1 ml) and 
transferred with the pellet to an RNase-free 1.5 ml tube (Biopur, Eppendorf). 
Resuspended RNA was centrifuged at room temperature for 5 min at 14000 x g and 
supernatant carefully removed. The RNA pellet was air dried and resuspended in RNase-
free water. 
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2.2.2 Total RNA isolation and RNA clean-up using RNeasy columns 
RNeasy Mini Kit (Qiagen) was used to extract total RNA from tissues, unless stated 
otherwise, according to manufacturer’s instructions with additional on-column DNase I 
digest (RNase-free DNase Set, Qiagen). The detailed protocol and working principle can be 
obtained online from http://www1.qiagen.com/Products /RnaStabilizationPurification/ 
RNeasySystem/ RNeasyMini.aspx?rp=1000291&rpg=0#Tabs=t2. Briefly, tissues were 
weighed and homogenized on ice in RLT buffer supplemented with β-mercaptoethanol 
(Sigma-Aldrich) using Dounce Tissue Grinder (Wheaton Industries INC, VWR). The amount 
of lysate corresponding to 30 mg tissue was transferred onto QIAshredder column 
(Qiagen) and centrifuged while the remaining lysate was stored in a Biopur tube 
(Eppendorf) in -80°C. The detailed procedure is presented in Table 2.4. Total RNA was 
eluted with 60 μl pre-warmed (65°C) RNase-free water and stored in -80°C for further 
application. 
 
Furthermore, total RNA extracted with TRIreagent (section 2.2.1) was cleaned and treated 
with DNase following the manufacturer’s protocol provided with the RNeasy Mini Kit. 
Briefly, 100 μg total RNA in a volume of 100 μl was mixed with 350 μl RLT buffer and 250 
μl 100% ethanol. Samples were mixed and applied on an RNeasy column, centrifuged for 
15s at 14000 x g. The filtrate was reapplied on the column and centrifuged once more. The 
washing steps, DNase digest, and elution are the same as described above. 
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Table 2.4. Details of RNA extraction from mouse tissues 
 
 Tissue 
Weight 
[mg] 
RTL volume -
homogenate 
Volume of lysate 
used in extraction 
Comments 
1 Brain 200 3 ml 500 μl Half used 
2 Spinal cord 100 2 ml 500 μl  
3 Ovary 80-90 2 ml 500 μl Both used 
4 Testis 80-90 2 ml 500 μl One used 
5 Spleen 120 3 ml 600 μl QIAshredder 
6 Lung 160 3 ml 600 μl QIAshredder 
7 Kidney 120 3 ml 600 μl 
One used, 
QIAshredder 
8 Heart 120 3 ml 600 μl QIAshredder 
9 Intestine 400 4 ml 600 μl QIAshredder 
10 Muscle 150 TRIreagent – whole tissue 
11 Liver 200 TRIreagent – whole tissue 
12 Embryo 200 3 ml 600 μl QIAshredder 
13 Embryonic brain 30 1 ml 500 μl QIAshredder 
14 Em. spinal cord 10 1 ml 500 μl QIAshredder 
15 Cortex 120 2 ml 600 μl QIAshredder 
16 Cerebellum 50 1 ml 500 μl QIAshredder 
17 Brain stem 40 1 ml 500 μl QIAshredder 
18 Hippocampus 20 1 ml 500 μl QIAshredder 
19 Olfactory bulbs 10-20 1 ml 500 μl QIAshredder 
 
2.2.3 RNA precipitation and storage 
Purified total RNA was used in downstream reactions and prepared for storage. It has 
been shown that RNA is best preserved as ethanol precipitate or suspended in formamide 
(Chomczynski, 1992). Therefore 3 volumes 100% ethanol, 0.1 volume 3M sodium acetate 
and 20 μg RNase-free Mussel Glycogen were added to each RNA sample and incubated 
overnight at -80°C. Subsequently samples were centrifuged at 4°C for 30 min at 14000 x g. 
Supernatant was carefully removed and washing with ice-cold 75% ethanol followed. After 
another centrifugation step supernatant was removed, the RNA pellet air dried and 
transferred to -80°C for long-term storage. 
 
2.2.4 RNA quantification 
Quantity and purity of RNA were determined using a NanoDrop® ND-1000 
Spectrophotometer (Labtech) by measuring absorbance at 260 nm and 280 nm (OD260, 
OD280). The instrument was blanked against water and UV measurements of 1.4 μl RNA 
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samples were taken using the NanoDrop® software. Ratio values of OD260/280 and RNA 
concentrations (OD260 1.0 = 40 μg/ml RNA) were automatically computed by software. 
RNA purity was assessed by OD260/280 ratio, with acceptable values above 1.9. 
 
2.3 General DNA protocols 
2.3.1 DNA isolation  
Genomic DNA 
Genomic mouse DNA was isolated from ear biopsies and used in the subsequent 
reactions. Tissue samples were incubated in 75 μl NaOH extracting solution (25 mM 
NaOH, 0.2 mM EDTA) at 98°C for 1 hour. After the incubation 75 μl Tris neutralisation 
buffer (40 mM Tris-HCl, pH 5.5) was added to each sample, briefly mixed and centrifuged 
at room temperature for 5 min at 14000 x g. The resulting supernatant was used directly 
in the genotyping PCR (section 2.1.2). 
 
DNA isolation from cultured cells 
DNeasy Blood & Tissue Kit (Qiagen) was used in order to extract genomic DNA from 
cultured mouse embryonic fibroblasts (section 2.6.1) following manufacturer’s protocol. 
Purified DNA was then used in the genotyping PCR (section 2.1.2). DNA concentration was 
measured and samples were stored at -80°C. 
 
Plasmid DNA 
Plasmid DNA was isolated from Escherichia coli (E. coli) using a GenElute Plasmid Miniprep 
Kit (Sigma-Aldrich) and following the manufacturer’s protocol. Cells were grown overnight 
in LB medium supplemented with 50 μg/ml kanamycin and 5 ml suspension were used in a 
single plasmid preparation. Briefly, cells were lysed; DNA was bound to a silica membrane, 
washed, and eluted with water. DNA concentration was measured and samples were 
stored at -80°C. 
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2.3.2 DNA quantification 
Quantity and purity of DNA were determined using a NanoDrop® ND-1000 
Spectrophotometer (Labtech) by measuring absorbance at 260 nm and 280 nm (OD260, 
OD280). The instrument was blanked against water and UV measurements of 1.4 μl DNA 
samples were taken using the NanoDrop® software operating on the computer. OD260/280 
ratio and RNA concentrations (OD260 1.0 = 50 μg/ml dsDNA) were automatically computed 
by software. DNA purity was assessed by OD260/280 ratio, with acceptable values between 
1.7 – 2.0. 
 
2.3.3 Reverse Transcription (RT) 
All the reactions were performed on a DNA Engine Tetrad 2 Peltier Thermal Cycler (BioRad 
Laboratories).  
 
AccuScript High Fidelity Reverse Transcriptase (Stratagene) was used in order to synthesize 
full length cDNA of mouse cytoplasmic dynein intermediate chain 1 and 2 from different 
tissues, and was chosen due to its high accuracy (http://cp.literature.agilent.com 
/litweb/pdf/TB108_71067.pdf). The Reverse Transcriptase (RT) reaction was set up as 
described in Table 2.5. The master mix containing RNA, oligo-dT primer, dNTPs and RT 
buffer was incubated at 65°C for 5 min and cooled to allow primer annealing, reactions 
were supplemented with DTT and AccuScript HF RT to the final volume 20 μl; negative 
control reactions were also prepared where the addition of the reverse transcriptase was 
omitted. Complementary DNAs were produced at 42°C for 45 min. Prepared cDNAs were 
diluted 1:10 and aliquots used in downstream reactions. 
 
QuantiTect Reverse Transcription Kit (Qiagen) was used in order to prepare cDNAs for the 
Real-Time PCR (section 2.3.9). The detailed protocol and working principle can be 
obtained online from http://www.qiagen.com /products /pcr /quantitectpcrsystems/ 
quantitectrevtranscriptionkit .aspx#Tabs=t1. Following the manufacturer’s instructions, 
500 ng of total RNA extracted from neuronal tissues of the wildtype (Dync1i2
+/+
) and 
homozygous Dync1i2
T172I/T172I
 mice were used in a single reaction. The negative reactions, 
containing only RNA and reaction buffer were also prepared. 
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2.3.4 Polymerase Chain Reaction (PCR) 
All the reactions were performed on a DNA Engine Tetrad 2 Peltier Thermal Cycler (BioRad 
Laboratories). A list of primers used in different applications is described in an Appendix 
10.12. 
 
PfuUltra High Fidelity DNA polymerase  
In order to amplify full length cDNA of mouse Dync1i1 and Dync1i2 the PfuUltra HF DNA 
polymerase (Stratagene) was used according to the protocol in Table 2.5.  
 
MegaMix Gold 
MegaMix Gold (Microzone) is a ready to use double concentrated mix with optimized Hot-
Start Taq DNA polymerase, anti-Taq DNA polymerase monoclonal antibodies, 400 µM 
dNTPs, and 6mM MgCI2, in buffer with stabilizer. The reactions were set up as in Table 2.5, 
the annealing temperature depended on primers used. 
 
Multiplex PCR Kit  
Multiplex PCR Kit (Qiagen) provides Master Mix with Hot-Start Taq DNA polymerase and a 
unique PCR buffer containing the novel synthetic Factor MP. Thus, specifically bound 
primers are stabilized and an efficient extension of all primers in the reaction without 
optimization is enabled (details can be found at http://www.qiagen.com /products /pcr 
/multiplexpcrsystem /multiplexpcr .aspx#Tabs=t1). Reaction conditions used are described 
in Table 2.5. 
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Table 2.5. PCR protocols and conditions 
 
Component 
Final 
amount per 
reaction 
Volume per 
reaction 
Step 
Tempera-
ture (°C) 
Duration 
Reverse Transcription (RT)     
Total RNA 400 ng      
10x RT buffer  2.0 μl     
Oligo dT primer 25 ng/μl      
dNTP mix 4 mM      
DTT 10 mM      
AccuScript HF RT  1.0 μl     
Nuclease-free H2O  Up to 17 μl     
PfuUltra High Fidelity PCR 
cDNA template  1.0 μl Initial 
denaturation 
95°C 1 min  
10x RT buffer  2.5 μl 
Primers 0.4 μM  Denaturation 95°C 30 s 
} 35 
times 
dNTP mix 8 mM  Annealing 58°C 30 s 
MgCl2 1 mM  Elongation 68°C 3 min 
PfuUltra HF  0.5 μl Final 
elongation 
68°C 10 min 
 
Nuclease-free H2O  Up to 25 μl  
MegaMix Gold 
cDNA/DNA template  0.25 - 1.0 μl 
Initial 
denaturation 
95°C 3 min 
 
 
MegaMix Gold  5.0 μl Denaturation 94°C 30 s 
} 35 
times 
Primers 0.25 μM  Annealing 52 - 60°C  10 s 
Nuclease-free H2O  Up to 25 μl 
Elongation 72°C 1 - 2 min 
Final 
elongation 
72°C 10 min  
Multiplex PCR Kit 
cDNA template  
 
1.0 μl 
Initial 
denaturation  
95°C 15 min 
 
  
Master Mix  10.0 μl Denaturation 94°C 30 s 
} 35 
times 
Primers 0.25 μM  Annealing 52 - 60°C  90 s 
Q solution  2.0 μl Elongation  72°C 1 min 
Nuclease-free H2O  Up to 20 μl 
Final 
elongation  
72°C 10 min  
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2.3.5 PCR product purification with ethanol/salt precipitation 
In order to remove the excess of primers and salts from PCR products, amplified DNA was 
precipitated by adding 0.1 volume 3 M sodium acetate, 0.1 volume 125 mM EDTA and 2 
volumes 100% ethanol. Samples were mixed briefly, incubated at room temperature for 
15 min, then centrifuged at 4°C for 30 min at 3000 x g. Solvent was initially removed by a 
gentle inversion of the tube, followed by further removal of any residual solvent by 
placing the tube inverted on absorbent tissue paper. The DNA pellet was washed with 4 
volumes 70% ethanol and centrifuged for 15 min at 2000 x g. The solvent was removed as 
before and samples were left to air dry. Clean DNA was resuspended in nuclease-free 
water. 
 
Alternatively PCR products were purified using QIAquick PCR Purification Kit (Qiagen) 
according to manufacturer’s instructions. 
 
2.3.6 Agarose gel electrophoresis 
Appropriate volumes and concentration (%w/v) of agarose gels were prepared by 
dissolving agarose in 1x TBE buffer (National Diagnostic) and microwaving at high power 
for 1-2 minutes. The gel solution was allowed to cool slightly before the addition of 
ethidium bromide to final concentration 0.5 μg/ml (Sigma-Aldrich). The gel solution was 
then poured into a gel casting tray and left at room temperature for 30-40 min to solidify. 
Prior to electrophoresis DNA samples were mixed with DNA loading buffer (1:5). 
Electrophoresis was carried out in 1x TBE buffer at 7 V/cm at room temperature. Gels 
were visualised and imaged on a UV transilluminator and digital imaging system (BioRad 
Laboratories). 
 
2.3.7 DNA Sequencing  
Automated sequencing was carried out with the BigDye Terminator Ready Reaction Kit 
(Applied Biosystems) on a 3130XL Genetic Analyser (Applied Biosystems). Prior to 
sequencing reactions, unbound primers, primer dimers and unused nucleotide 
triphosphates were removed from the template PCR products using one of the methods 
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described in section 2.3.5. Sequencing PCRs were set up as follows: 
 
Component 
Final concentration 
per reaction 
Volume per 
reaction 
DNA template 30 – 50 ng  
Better Buffer  5.0 μl 
Primers 0.25 μM  
BigDye Terminator  1.0 μl 
Nuclease-free H2O  Up to 15 μl 
 
Conditions of the sequencing PCR cycling program and run parameters were: 
Step Temperature (°C) Duration 
Denaturation 96°C 30 s 
} 30 
times 
Annealing 50°C  15 s 
Elongation  60°C 3 min 
 
Parameter Setting 
Length of detector 50 cm 
Polymer/gel type POP7 
Sampling rate  2.801 Hz 
Injection time  7 s 
 
Fluorescently labeled PCR products were purified by ethanol/salt precipitation and 
resuspended in 20 μl Hi-Di Formamide (Applied Biosystems). Before the sequencing 
analysis samples were incubated at 95°C for 5 min and immediately cooled on ice for 
several minutes. The chromatograms were analysed using Sequence Analysis 5.2 (Applied 
Biosystems) and BioEdit Sequence Alignment Editor v5.0.9. 
 
2.3.8 Fragment analysis 
The automated fragment analysis system uses capillary array electrophoresis to perform 
fragment size separation of fluorescently labeled DNA samples and calculates their sizes 
based on an internal standard. For fragment analysis reverse primers (section 10.12.4) 
were conjugated with 5-Carboxyfluorescein (5-FAM) and Multiplex PCRs were run. DNA 
concentration was measured and subsequently 100 ng DNA were suspended in 9 μl Hi-Di 
Formamide together with 0.5 μl GeneScan – Liz 1200 Size Standard (Applied Biosystems) 
as an internal standard. Before analysis samples were incubated at 95°C for 5 min and 
immediately cooled on ice for several minutes. The chromatograms obtained were 
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analyzed using Gene Mapper software (Applied Biosystems). Run modules on the 3130XL 
Genetic Analyser were as follows: 
Parameter Setting 
Length of detector capillary 50 cm 
Polymer/gel type POP7 
Run voltage 8500 
Injection voltage 1800 
Injection time  7 s 
Temperature 60°C 
Laser power 15 
 
2.3.9 Quantitative Real-Time PCR (qRT-PCR) 
Complement DNA was prepared as described in section 2.3.3. The cDNA was diluted 1:4 in 
water and this dilution was used for the template in qRTPCR reactions, which were run 
using Power SYBR PCR master mix (Applied Biosystems) on a 7500 Fast Real-Time PCR 
System (Applied Biosystems). The primers were used in reactions were: Dync1li1 (For and 
Rev), Dynlt1 (For and Rev), Dynlt3 (For and Rev), Dynll1 (For and Rev) Dynll2 (For and Rev) 
(Appendix 10.12.5).  
 
Ribosomal protein L13A (RPL13A) was used as the reference gene. Each reaction was run 
in triplicate per trial and on three independent trials. The ∆∆CT of each reaction was 
calculated as a comparison with the average wildtype ∆CT. 
 
2.4 Plasmid cloning 
2.4.1 Adding 3’ A-overhangs 
TOPO TA (Invitrogen) technology requires the presence of a terminal adenosine 
nucleotide in the PCR product. PfuUltra HF DNA polymerase lacks the terminal 
deoxynucleotidyltransferase (TdT) activity, which is characterized by the addition of non 
template-directed nucleotide(s) at the 3´ end of PCR-generated fragments (Hu, 1993). 
Thus, 3’ A-overhangs were added to the purified PCR products (section 2.3.5) prior to the 
cloning reaction using Taq DNA polymerase. The protocol was as below and samples were 
incubated at 72°C for 10 min and used directly in cloning reaction. 
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Component 
Final concentration per 
reaction 
Volume per 
reaction 
DNA 500 ng  
10x Reaction buffer  5.0 μl 
dATPs 0.5 mM 2.5 μl 
Taq DNA polymerase  0.5 μl 
Nuclease-free H2O  Up to 50 μl 
 
2.4.2 TOPO TA cloning 
TOPO TA Cloning Kit for Sequencing (Invitrogen) was used to generate clones of the 
mouse full length Dync1i1 and Dync1i2 cDNA. Samples from brain and spinal cord were 
prepared as described above and 4 μl DNA were ligated into pCR4-TOPO® vector 
(Invitrogen) according to manufacturer’s instructions.  
 
2.4.3 Transforming competent cells 
TOP10 E. coli chemically competent cells were transformed with 6 μl of ligation reaction 
according to the manufacturer’s protocol. Clones were selected on Luria Broth Agar 
(Sigma-Aldrich) plates containing 50 μg/ml kanamycin. Additionally, 40 μl 20 mg/ml stock 
solution of X-Gal (Sigma-Aldrich) in DMF (Sigma-Aldrich) was spread on each plate to 
facilitate the selection of transformants. Plates were incubated overnight at 37°C and 
single colonies selected the next day for further expansion in antibiotic supplemented 
Luria Broth (Sigma-Aldrich). 
 
2.4.4 Analysing transformants 
Bacterial colonies which remained white in the presence of the X-Gal were inoculated on a 
96-well plate in 200 μl LB with 50 μg/ml kanamycin and incubated at 37°C with shaking. 
Cell suspension was left at 37°C for 2 hours in order to initiate bacterial growth and then 
used as a template in a PCR based screen. Inserts were amplified in 30 μl reaction using 
MegaMix Gold (section 2.3.4) and the vector specific primer pair M13F – M13R (Appendix 
10.12.2). The PCR products were run on a 0.7% agarose gel; DNA was purified by 
ethanol/salt precipitation and sequenced. 
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2.4.5 Glycerol stocks 
Colonies selected for further expansion were grown overnight in 5 ml LB containing 50 
μg/ml kanamycin, at 37°C with shaking at 250 rpm. The following day 800 μl of the culture 
was mixed with 200 μl of autoclaved glycerol (Sigma), mixed and stored in -80°C. 
 
2.5 General protein protocols 
2.5.1 Total protein extraction from mouse tissue 
Mice were culled by a cervical dislocation, brains were extracted from skulls, weighed, and 
homogenised in ice-cold 0.1% Triton X-100/TBS (50 mM Tris-HCl, 150 mM NaCl, pH 7.6) 
buffer supplemented with Halt Protease and Phosphatase Inhibitor Cocktail (Thermo 
Scientific) (10% w/v). The homogenate was centrifuged at 4°C for 20 min at 14 000 x g, 
supernatant transferred to a fresh cooled 1.5 ml tube, and protein concentration 
measured as described in section 2.5.3.  
 
2.5.2 Total protein extraction from cultured cells 
Cells were counted (section 2.6.2.2) and seeded on 6-well plates (Corning). Plates were 
placed on ice, culturing medium aspirated and cells were washed with 1 ml ice cold D-PBS 
(without Ca
2+
/Mg
2+
). Depending on density of a culture, 200 μl (MEFs) or 500 μl (HEK293T, 
section 2.6.7) RIPA buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% deoxycholate, 0.1% 
SDS, 1% NP-40) supplemented with Halt® Cocktail was applied per well and cells were 
scraped with a sterile cell scraper. The lysate was transferred into a sterile chilled 1.5 ml 
tube and 0.5 μl Benzonase (Roche) was added in order to shear genomic DNA. Samples 
were incubated on ice for 15 min, centrifuged at 4°C for 15 min at 14 000 x g, and 
supernatant transferred to a fresh chilled 1.5 ml tube. The concentration of protein was 
measured (section 2.5.3); samples were stored at -80°C. 
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2.5.3 Protein quantification 
Protein concentration was measured using DC Protein Assay (Bio-Rad) in microplate 
format following manufacturer’s instructions. Briefly, samples were prepared in triplicate 
(5 μl per well) on a 96-well plate, incubated with relevant reagent and absorbance at 650 
nm was measured. BSA at known concentrations (0.2, 0.4, 0.6, 0.8, 1.0, 2.0 mg/ml) was 
used as a protein standard and the concentration of protein in the samples was calculated 
from a standard curve. Prepared lysates were used in western blotting (section 2.5.4). 
2.5.4 Western blotting  
Protein separation and transfer onto polyvinylidene fluoride membranes (PVDF, 
ImmobilonP, Milipore) were performed using NuPAGE electrophoresis system and 
following manufacturer’s instructions; all the details can be found in the ‘NuPAGE 
Technical Guide’ (Invitrogen). In order to detect phosphorylated proteins buffers based on 
TBS were used instead of PBS. 
2.5.4.1  Protein denaturation 
Protein samples were mixed with NuPAGE LDS Sample Buffer (4x, Invitrogen) containing 
NuPAGE Reducing Agent (10x, Invitrogen) or 2% β-mercaptoethanol, heated at 70°C for 10 
min, and loaded on a polyacrylamide gel.  
2.5.4.2  Polyacrylamide gel electrophoresis (Nu-PAGE) 
Proteins were separated using 4-12% NuPAGE Novex Bis-Tris precast gels (1.5 mm thick, 
Invitrogen) and NuPAGE MOPS SDS Running Buffer (20x, Invitrogen). Electrophoresis was 
performed at 160 V for 60-90 min. SeeBlue Plus2 Pre-Stained Standard (Invitrogen) was 
loaded together with samples in order to facilitate visualisation. 
2.5.4.3  Protein transfer 
Immediately after the electrophoresis proteins were transferred to pre-wet PVDF 
membrane using XCell II Blot Module (Invitrogen). The cassette was filled with 1x NuPAGE 
Transfer Buffer (20x, Invitrogen) containing 20% methanol and transfer was carried out for 
2 hours at 35 V. 
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2.5.4.4  Immunodetection  
After the transfer PVDF membranes were dried and blocked in 5% HS/TBS or 5% BSA/PBS 
buffer for 1 hour at room temperature. Primary antibodies (Appendix 10.11) were diluted 
in 5% HS/TBS or 5% BSA/0.05% Tween-20/PBS and incubated at 4°C overnight. 
Membranes were washed several times in relevant buffers containing 0.05% Tween-20 
and incubated with infrared IRDye - labeled secondary antibodies (LI-COR) diluted in 5% 
HS/0.05% Tween-20/TBS or 5% BSA/0.05% Tween-20/PBS for 1 hour. After washing 
membranes were kept in TBS or PBS and imaged using Odyssey system (LI-COR). During all 
the steps membranes were kept on a horizontal shaker. 
2.5.4.5  Image acquisition and analysis (Odyssey) 
Membranes were visualised using Odyssey Imager (LI-COR), which allowed detection of a 
fluorescent signal in the near infra-red range of spectrum. The intensity settings where 
adjusted for individual channels in order to achieve an optimal signal. 
 
2.6 Mammalian cell culture 
2.6.1 Isolation of mouse embryonic fibroblasts (MEFs) 
The protocol used for the isolation of mouse primary fibroblasts has been modified from 
Reznikoff et al. (1973). A pregnant female was sacrificed at day E13.5 post coitum by 
cervical dislocation, embryos were separated and kept in Leibovitz’s L-15 GlutaMAX I 
medium (Gibco, Invitrogen) on ice prior to processing. Head and visceral organs were 
removed and remaining tissues were minced using razorblades and suspended in 1.5 ml 
0.05% Trypsin (Gibco, Invitrogen) in Dulbecco’s PBS (with Ca
2+
/Mg
2+
) supplemented with 
DNase I (200U, Invitrogen). Tissues were incubated at 37°C for 20 min, transferred into 4 
ml warm culturing medium (D-MEM GlutaMAX I supplemented with 10% FBS and 1/100 
(v/v) penicillin/streptomycin). Remaining pieces of tissue were allowed to settle to the 
bottom of a 15 ml Falcon tube while cell suspension was transferred into cell culture flasks 
and plated as P0 (P75, Nunc). Fresh medium was added the next day, and cells were split 
when grown to subconfluency (section 2.6). 
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2.6.2 Culturing condition 
All procedures were carried out in a tissue culture hood with aseptic technique. Unless 
stated otherwise, medium and supplements used throughout culture were ordered from 
Gibco, Invitrogen: 
• Dulbecco’s Modified Eagle Medium (D-MEM with GlutaMAX I, 4500 mg/L D-Glucose, 
Sodium Pyruvate) 
• 10% Fetal Bovine Serum (Qualified, preferentially from Australia or New Zealand). 
 
Cells routinely were cultured in P75 flasks (Nunc) and grown in a DH Autoflow Air-Jacketed 
Incubator (Nuaire) at 37°C in a humid environment and 5% CO2. 
2.6.2.1  Cell splitting 
Cultured cell grew in monolayer and the level of confluency was assessed qualitatively 
under a phase contrast microscope (Olympus CK40); cells were split 1:3 (MEFs) or 1:5 
(HEK293T) once they grew to subconfluency. All the buffers were used pre-warmed to 
37°C. First medium was removed by aspiration and cell layer was washed gently with 
Dulbecco’s PBS (without Ca
2+
/Mg
2+
). Subsequently cells were incubated with TrypLE 
Express for 3-4 min at 37°C and once detached, as visible ‘cloudy’ suspension, warm full D-
MEM was added in order to dilute TrypLE Express. The surface of the flask was gently 
washed with medium and the cells were transferred to a sterile Falcon tube. At this stage 
cells were counted and seeded on sterile glass coverslips for immunofluorescence based 
experiments (sections from 2.6.3 to 2.6.6), 6-well plates (Corning) for protein extraction 
(section 2.5.2), plated on a new flask at appropriate density, or frozen. 
2.6.2.2  Cell counting 
Harvested cells were counted using Bright-Line Hemacytometer (Warner-Lambert 
Technologies) with the improved Neubauer rulings. Briefly, ruling pattern covers 9 mm
2
, 
boundary lines are the main lines in the groups of 3. The central square millimeter is ruled 
into 25 groups of 16 small squares, each group separated by triple lines, the middle one of 
which represents the boundary. The ruled surface is 0.10 mm below the cover glass, so 
that the volume over each of the 16 small squares is 0.00025 mm
3
 (Figure 2.1). 
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Cell suspension was thoroughly mixed and 20 μl was applied on the counting chamber. 
The cells were counted using a phase contrast microscope at magnification 100x and the 
number of cells observed in 4 large corner squares, each corresponding to 1 mm
2
, was 
recorded. In case of a diluted sample, when fewer than 100 cells were observed, 
additional squares were taken into account (more details can be found on 
http://www.ruf.rice.edu /~bioslabs /methods /microscopy /cellcounting.html). The 
density of the culture, expressed as the number of cells per ml, was calculated as follows: 
 
 
 
Figure 2.1. A pattern of an improved Neubauer ruling 
The area is marked by triple boundary lines which mark area of 1 mm
2
; single lines divide the area further 
into squares of 0.0625 mm
2
 and 0.0025 mm
2
; adapted from http://www. hausserscientific.com/ 
hausserbrightlinedirect.htm 
 
 
2.6.2.3  Cell freezing and storage 
A frozen stock of MEFs was prepared with cells at a second passage (P2). Cells were 
harvested as described above and centrifuged for 5 min at 230 x g. Supernatant was 
gently removed and cell pellet was reconstituted in cold freezing mix containing 
FBS/DMSO in ratio 9:1. Cell suspension was transferred to 1.8 ml cryogenic vials (Corning) 
as 1 ml aliquots containing between 5x10
6
 – 10
7
 cells. The cryovials were placed in ‘Mr. 
Frosty’ (Nalge Nunc) and stored in the - 80°C overnight. The cryo-freezing container filled 
( )dilution
countedsquaresofnumber
countedcellsofnumberdensity ××
−−−
−−−
=
410
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with isopropanol allowed freezing the cells slowly by reducing the temperature at 
approximately 1°C per minute. For long term storage frozen vials were transferred to 
liquid nitrogen tank. 
2.6.2.4  Cell thawing 
Frozen vials were removed from liquid nitrogen storage and thawed quickly (1-2 min) in a 
37°C water bath. Once thawed, cells were resuspended in few ml warm medium and 
pelleted by centrifugation for 5 min at 230 x g. The supernatant containing DMSO was 
aspirated and cells were gently resuspended in fresh medium and plated on P75 culture 
flask (Nunc). 
 
2.6.3 Golgi complex reassembly after microtubule disruption 
Mouse embryonic fibroblasts (MEFs) were seeded on sterile glass coverslips (12 mm 
diameter, 1.5 mm thick, VWR) placed in a 24-well plate (TTP). In order to obtain the 
optimal level of confluency (approximately 70%) cells were counted and 4 x 10
4
 cells were 
plated per each coverslip. The next day standard medium was replaced with standard D-
MEM containing 15 mM HEPES (Gibco, Invitrogen) and the cells were left on ice for 30 
min. Subsequently, the medium was replaced with D-MEM-HEPES containing 10 μg/ml 
nocodazole (Sigma – Aldrich) and cells were returned to the incubator for 3 hours. Cells 
were washed 3 times with the standard medium, fixed at 0 min or returned to the 
incubator for a recovery. Nocodazole treated and untreated control cells were fixed after 
20 min, 50 min and processed as described in section 2.6.8.  
 
2.6.4 EGF uptake assay 
MEFs were seeded on glass coverslips in 4-well plates. Before experiment, fibroblasts 
were washed with D-PBS (without Ca
2+
/Mg
2+
) and incubated in serum-free D-MEM for 2 
hours at 37°C. After starvation cells were stimulated with 50 ng/ml Alexa Fluor 555 
conjugated EGF (Molecular Probes, Invitrogen) in the serum-free D-MEM supplemented 
with 0.1% BSA (Sigma – Aldrich) for 1 hour at 4°C. The medium was replaced with fresh 
serum-free D-MEM and the EGF – AF 555 trafficking was followed at 37°C over the time 
course. Before fixing cells were washed with ice-cold D-PBS (without Ca
2+
/Mg
2+
) and fixed 
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at 0 min, 15 min, 30 min, 45 min, and 60 min after the EGF – AF 555 internalization. 
Coverslips were processed as described in section 2.6.8. 
 
2.6.5 Infection with Salmonella enterica ser. Typhimurium  
All the experiments were carried out in collaboration with Prof. David Holden at Imperial 
College London and detailed description of bacterial strains used and culturing conditions 
can be found in Beuzon et al., 2000 and Guignot et al., 2004.  
 
Briefly, on a day before the infection MEFs were seeded on sterile round coverslips (12 
mm diam., VWR), 2 x 10
4
 cells per a coverslip; WT and SifA
-
 strains were grown in LB 
supplemented with appropriate antibiotics. The next day bacteria were diluted in fresh LB 
and cultured at 37°C with shaking to an OD600 between 1.8 – 2.0. Prior to infection 
standard D-MEM was replaced with EBSS (Sigma – Aldrich) and 2.5 μl bacterial suspension 
were added per well. The infection was allowed to proceed for 15 minutes at 37°C in 5% 
CO2. The cells were washed 3 timed with standard D-MEM containing 100 μg/ml 
gentamicin and incubated for 1 hour in D-MEM with 100 μg/ml gentamicin, after which 
time the concentration of antibiotic was decreased to 20 μg/ml gentamicin in standard D-
MEM. Eight hours post infection cells were washed with D-PBS (without Ca
2+
/Mg
2+
), fixed, 
and processed for immunofluorescence (section 2.6.8). 
 
2.6.6 Induction of stress granules 
Fibroblasts were seeded on sterile round coverslips (12 mm diam., VWR), 4 x 10
4
 cells per 
a coverslip. The next day cells were washed with standard D-MEM and incubated at 37°C 
in 5% CO2  for 1 hour or 45 min in D-MEM containing 1 μM thapsigargin (Calbiochem) or 
200 μM sodium arsenate (SA, VWR) respectively. Cells were washed with D-PBS (without 
Ca
2+
/Mg
2+
) and fixed or 50 μg/ml emetine (Sigma – Aldrich) was added and cells were 
incubated for another hour, washed with D-PBS (without Ca
2+
/Mg
2+
), and fixed. 
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2.6.7 Plasmid transfection of HEK293T 
HEK293T (ATCC® number: CRL-11268™) were derived from HEK293 cell line, which was 
generated by transformation of human embryonic kidney (HEK) cell cultures with sheared 
adenovirus 5 DNA (Sena-Esteves et al., 1999). Those cells (kind gift from Ms Astrid Authier, 
UCL) were cultured as described (section 2.6.2) and used to express isoforms of dynein 
intermediate chains fused with green fluorescent protein (GFP) (kind gift from Dr M. 
Hafezparast, University of Sussex). 48 hours before transfection with adequate plasmid 
DNA cells were split 1:5, seeded into 6-well plates (Corning) and cultured in standard D-
MEM. Lipofectamine 2000 (LFA, Invitrogen) and plasmid DNAs were made up in 50 μl 
Opti-MEM I Reduced Serum Medium (Gibco, Invitrogen) in ratio 3 μg DNA per 10 μl LFA. 
After 5 min incubations DNA and LFA were mixed together (100 μl final volume) and 
incubated for 20 min at room temperature to form DNA:LFA complexes. Transfection mix 
was added to wells; the medium was replaced after 4 hours and cells were cultured for 48 
hours before protein extraction (section 2.5.2).  
 
2.6.8 Immunofluorescence  
Although general principles of staining cells with antibodies prior to a fluorescence 
microscopy analysis were followed, the particular steps differed depending on antibody 
used or cell structures of the interest. Therefore, the details of each staining are 
summarised in Table 2.6 while the dilutions of antibodies can be found in Appendix 10.11. 
Briefly, at the end of each experiment MEFs grown on glass coverslips were washed with 
D-PBS (without Ca
2+
/Mg
2+
), fixed, washed, permeabilised in order to expose intracellular 
structures. Then cells were blocked in buffers containing serum proteins, stained with 
primary antibodies against a target protein, washed at least twice, incubated with 
secondary antibodies conjugated with fluorescent dyes (Alexa Fluor, Rhodamine Red-X), 
washed again, and mounted on microscope slides. During incubation steps coverslips 
were kept in a humidified chamber in order to minimize evaporation. Slides were analysed 
as described in section 2.7, and kept at -20°C. Phosphate buffer saline (PBS) was used in 
washing steps and to prepare solutions, unless stated otherwise. 
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Table 2.6. The detailed protocol of immunostaining of cultured mouse embryonic fibroblasts, reagents 
used and time of each step are specified 
Headings correspond to experiments carried out as described in sections 2.6.3, 2.6.4, 2.6.5, and 2.6.6; EGF – 
epidermal growth factor, PFA – paraformaldehyde, RT – room temperature, AF – Alexa Fluor dye, PBS – 
phosphate buffer saline, D-PBS – Dulbecco’s PBS (without Ca
2+
/Mg
2+
), BSA – bovine serum albumin, NHS – 
normal horse serum, RR-X – Rhodamine Red-X, DAPI – 4’,6-diamidino-2-phenylindole (DNA stain), NaN3 – 
sodium azide, host species annotated as follows: (d) – donkey, (g) – goat, (m) – mouse, (r) – rat, (rb) – rabbit, 
æ – denotes an antigen for secondary antibody; N/A – not applicable; h – hours 
 
 
Step 
Cytoplasmic 
dynein 
Golgi complex 
reassembly 
EGF uptake 
Salmonella 
Typhimurium 
Stress granules 
Fixative 
-20°C methanol 
10 min at RT 
-20°C methanol 
10 min at RT 
4% PFA/PBS 
10 min at RT 
4% PFA/PBS 
15 min at RT 
4% PFA/PBS 
15 min at RT 
Permeabi-
lising 
buffer 
0.1% Triton X-
100/ PBS, 5 min 
at RT 
0.1% 
saponin/PBS 
5 min at RT 
-20°C methanol 
10 min at RT 
Blocking 
buffer 
5% HS (NaN3)/ 
PBS, 1 h at RT 
5% HS(NaN3)/ 
PBS, 1 h at RT 
1% BSA/PBS 
30 min at RT 
 
5% HS (NaN3)/ 
PBS, 1 h at RT 
Primary 
antibody 
(targeted 
to) 
(m)IC74, (rb) 
DIC1, (rb) 
DIC2(60) 
in 0.1% saponin 
/ 10% NHS/PBS 
2 h at RT 
(rb) GIANTIN 
 
in 0.1% saponin 
/10% NHS/PBS 
 
2 h at RT 
(m) α-TUBULIN 
AF 488 
in 1% BSA/PBS 
 
 
45 min at RT 
(r) LAMP-1 
(m) GM130 
in 0.1% saponin 
/ 10% NHS/PBS 
 
2 h at RT 
(m) G3BP 
(g) TIAL1 
in 5% NHS/D-
PBS 
 
2 hours at RT 
Washing 
buffer 
0.1% saponin/ 
PBS 
0.1% saponin/ 
PBS 
PBS 
0.1% saponin/ 
PBS 
PBS 
Secondary 
antibody 
(species 
and dye) 
d-æ-m AF 633 
d-æ-rb AF 546 
in 0.1% saponin 
/ 10% NHS/PBS 
 
45 min at RT 
d-æ-rb AF 546 
in 0.1% saponin 
/ 10% NHS/PBS 
 
 
45 min at RT 
N/A 
d-æ-r  RR-X 
d-æ-m AF 647 
in 0.1% saponin 
/ 10% NHS/PBS 
 
45 min at RT 
d-æ-m AF 488 
d-æ-g  AF 546 
in 0.05% 
saponin / 5% 
NHS/PBS 
45 min at RT 
Washing 
buffer 
0.1% saponin 
/PBS, PBS 
0.1%saponin 
/PBS, PBS 
N/A 
0.1% saponin 
/PBS 
PBS, H2O 
PBS 
H2O 
Additional 
staining 
(m) α-tubulin AF 
488 in D-PBS 
45 min at RT 
(m) α-tubulin AF 
488 in D-PBS 
45 min at RT 
DAPI/PBS 
 
5 min at RT 
N/A N/A 
Washing 
buffer 
PBS, H2O PBS, H2O PBS N/A N/A 
Mounting 
ProLong Gold 
Antifade + DAPI 
ProLong Gold 
Antifade + DAPI 
Dako 
Fluorescence 
Mounting 
Medium 
Mounting 
medium 
ProLong Gold 
Antifade + DAPI 
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2.7 Data acquisition and analysis 
2.7.1 Epifluorescence microscopy 
Cellular phenotypes were observed and scored blindly using fluorescence microscopes 
(BX50 Olympus, Axioplan 2, Zeiss) equipped with relevant filters. 
 
2.7.2 Laser scanning confocal microscopy (LSCM) 
Confocal fluorescent images were acquired with a Zeiss LSM 510 META confocal 
microscope equipped with 4 lasers: diode (405 nm) 25 mW, Argon (458, 477, 488, 514 nm) 
30 mW, HeNe1 laser (543 nm) 1 mW; HeNe2 laser (633 nm). Depending on the fluorescent 
dyes applied a signal from four channels could be viewed using Plan-Neofluar 40x/1.3 Oil 
DIC, and Plan-Apochromat 63x/1.4 Oil DIC objectives after applying immersion oil 
(IMMERSOL 518F, Zeiss). All the pictures used in further analysis were taken with a 
resolution of 1024 x 1024 pixels.  
 
2.7.3 Colocalisation analysis using Volocity®  
Volocity® software (Perkin Elmer, version 5.5) was used to measure the colocalisation as 
an overlap of intensities of 2 fluorescence markers. In order to obtain more accurate 
values images were processed using built-in Volocity Quantitation tasks:  
• Find objects using intensity (‘Green’ channel corresponding to MTs staining) 
• Exclude objects smaller that 1000 µm
2
 
• Fill holes in objects 
• Make ROIs from objects 
• Remove noise from objects (median filter with ‘fine’ matrix) 
Images were then cropped (segmentation) and tresholded Pearson’s correlation and 
Mander’s coefficients were calculated as described in Barlow et al. (2010).  
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2.7.4 CellProfiler image-based analysis 
Digital fluorescence images obtained with a laser scanning confocal miscroscope (LSCM) 
were analysed with CellProfiler software (v1.0.5122) (Carpenter et al., 2006;Vokes and 
Carpenter, 2008). ‘LSM’ images were converted to 8-bit ‘tiff’ files; different settings were 
used depending on the structures of interest as presented below. 
 
Golgi complex reassembly 
Membranes of the Golgi stacks were identified as objects positive for staining with anti-
giantin antibodies based on the intensity of a fluorescent signal and their parameters 
measured. 
 
EGF uptake analysis pipeline 
All the pictures representing distinct timepoints were analysed using the same settings: 
endosomes labelled with fluorescent EGF-AF 555 were identified based on intensity of the 
signal and their parameters measured. Due to a weak signal from the membrane bound 
EGF-AF 555 (cells imaged at 0 min) the threshold values of intensity were decreased to 
0.19 as marked in blue (*). Furthermore, in order to measure the rate of displacement of 
EGF-AF 555 containing endosomes a ratio was measured between the number of 
perinuclear objects to total number of objects in a cell; a boundary of the perinuclear 
region was marked at a distance equal to a radius of a nucleus as marked in green (**).  
 
Detection of stress granules 
Cytoplasmic stress granules were identified as objects positive for staining with anti-G3BP 
antibodies (stress granules marker) based on the intensity of a fluorescent signal and their 
parameters measured. 
 
 
 
 
Table 2.7. Detailed protocol of image analysis using CellProfiler (nex page). 
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Pipeline module Analysis parameters Golgi complex EGF Stress granules 
Load Images 
Load files 
Text – Regular 
expression 
Text-Exact match Text-Exact match 
Call images within CellProfiler OrigBlue OrigBlue OrigBlue 
Type of files  Individual images Individual images Individual images 
Color To Gray 
Call the image to be converted to Gray  OrigBlue OrigBlue OrigBlue 
Convert the color image  Split Split Split 
SPLIT options: call the image that was red/ green/ blue 
OrigRed/ 
OrigGreen/ 
OrigBlue 
OrigRed/ OrigGreen/ 
OrigBlue 
OrigRed/ 
OrigGreen/ 
OrigBlue 
Identify  
Primary 
Automatic 
Call the images to process  OrigBlue OrigBlue OrigBlue 
Call the objects identified by this module  Nuclei Nuclei Nuclei 
Typical diameter of objects, in pixel units  100, 1000 20, 300 50, 1000 
Discard objects outside the diameter range  Yes Yes Yes 
Try to merge too small objects with nearby larger objects  Yes Yes Yes 
Discard objects touching the border of the image  Yes Yes Yes 
Select an automatic thresholding method  
Robust Background 
Global 
Otsu Adaptive Otsu Adaptive 
Threshold correction factor  1 1 1 
Lower and upper bounds on threshold, in the range [0,1] 0.3, 1 0.1, 1 0.2, 1 
Size of smoothing filter, in pixel units      10 10 
Suppress local maxima within this distance     10 10 
Fill holes in identified objects  Yes Yes Yes 
Identify 
Secondary 
Call the primary objects to create secondary objects around Nuclei Nuclei Nuclei 
Call the objects identified by this module Cells Cells Cells 
Method to identify the secondary objects ** Propagation 
Propagation/ 
Distance-B 
Propagation 
Call the images to be used to find the edges of the secondary 
objects 
OrigGreen OrigGreen OrigRed 
Select an automatic thresholding method Otsu Global Otsu Global Otsu Global 
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Threshold correction factor 1 1/ 1 1 
Lower and upper bounds on threshold, in the range [0,1] 0.05, 1 0.05, 1/ 0.05, 1 0.05, 1 
For PROPAGATION/DISTANCE, enter the regularization factor/ 
number of pixels by which to expand the primary objects 
5 5/ Nuclear radius 5 
Identify Tertiary 
Subregion 
Call the larger identified objects Cells Cells Cells  
Call the smaller identified objects    Nuclei Nuclei Nuclei 
Call the new subregions Cytoplasm Cytoplasm Cytoplasm 
Crop 
Call the image to be cropped OrigRed OrigRed OrigGreen 
Call the cropped image  Cropped Cropped Cropped 
For RECTANGLE + ELLIPSE, shape to crop into Cytoplasm Cytoplasm Cytoplasm 
The cropping pattern - each image cycle cropped   Individually Individually 
Identify Primary 
Automatic 
Call the images to process  Cropped Cropped Cropped 
Call the objects identified by this module Golgi Vesicles SG 
Typical diameter of objects, in pixel units  12, 500 2,50 10, 100 
Discard objects outside the diameter range Yes Yes Yes 
Try to merge too small objects with nearby larger objects  Yes No Yes 
Discard objects touching the border of the image No No No 
Select an automatic thresholding method Otsu Global Otsu Adaptive Otsu Adaptive 
Two-class or three-class thresholding Three classes   
Minimize the weighted variace  Yes   
Assign pixels in the middle intensity class to Foreground    
Threshold correction factor     1 1 1 
Lower and upper bounds on threshold, in the range [0,1] 0.3, 1 0.25, 1 / 0.19, 1* 0.26, 1 
Method to distinguish clumped objects 
Laplacian of 
Gaussian 
Intensity Intensity 
Method to draw dividing lines between clumped objects Propagate Intensity Intensity 
Size of smoothing filter, in pixel     8 1 2 
Suppress local maxima within this distance     10 2 1 
Measure Object 
Area Shape 
Call the objects to measure  Nuclei, Golgi Nuclei, Vesicles SG 
Export To Excel  Objects to export  Golgi, Image Nuclei, Vesicles SG 
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2.7.5 Statistical analysis 
Statistical analysis of data was performed using GraphPad Prism v5.02 for Windows 
(GraphPad Software, San Diego California USA, www.graphpad.com). Depending on the 
structure of data, results were presented as mean value and standard error (SEM), a mean 
and standard deviation (SD), or median with interquartile range (IQR). All the tests 
reported two-tailed p-value; the difference was considered statistically significant for 
p< 0.05. 
 
Categorical data (sections 3.4.2, 3.4.3, and 4.4.4.2) were analysed in a format of a 
contingency table and two-sided p-values were reported with Fisher’s exact (for 2x2 
tables) or Chi-squared (χ
2
) (2x4 tables) test. In addition, the distribution of genotypes was 
analysed with Chi-square (χ
2
) test by comparison of observed to expected frequencies. 
This option was available from GraphPad QuickCalcs (http://secure. graphpad.com 
/quickcalcs/index.cfm). The test combines the observed and expected values into a 
variable, Chi-square (χ
2
). The Chi-square (χ
2
) is calculated by squaring the difference 
between observed and expected values for each category and dividing it by the expected 
value; final operation is the sum of the resulting divisions ((Observed - Expected)
2 
/Expected). The reported two-tailed p value with N-1 degrees of freedom expresses 
whether the data observed are sampled from the expected distribution. 
 
Dependence of two variables was measured by calculating Pearson correlation coefficient 
(r). The correlation coefficient quantifies the direction and magnitude of correlation 
ranging from 1.0 (perfect correlation) to -1.0 (lack of correlation). In addition, squared 
coefficient (R
2
) was also calculated, which corresponds to a fraction of the variance in X 
that can be explained by variation in Y (the fraction of the variance in the two variables 
that is ‘shared’). 
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3. Characterisation of mutant mouse lines carrying single point mutations in 
the cytoplasmic dynein intermediate chains 1 and 2 (Dync1i1G482D and 
Dync1i2
T172I)  
 
3.1 Introduction  
A genes’ function can be studied by analysing a phenotype of mutant organisms. Thus 
functions of the cytoplasmic dynein intermediate chains 1 and 2 in mouse were 
investigated by a genotype driven approach: single point mutations causing amino acid 
change in Dync1i1 and Dync1i2 genes were identified, mutant mouse lines established, 
and their behavioural phenotype assessed. 
 
The MRC Mammalian Genetics Unit, Harwell, UK is one of the centres which has a large-
scale ENU mutagenesis program. The archives of DNA and frozen sperm isolated from the 
F1 male progeny of mutagenised mice have been established which enabled genotype-
based screens for ENU-induced mutations (Nolan et al., 2002). Currently the archive 
consists of over 10,000 DNA samples from individual mice; mutant lines that have been 
characterized can be found in the MouseBook database (http://www.mousebook.org).  
 
To identify mutations in the Dync1i1 and Dync1i2, denaturing HPLC screening of the DNA 
archive was performed by Dr Gareth T. Banks as previously described (Quwailid et al., 
2004). Briefly, genomic samples of mutagenised DNA were used as templates to amplify 
regions of exonic sequences, which then were analysed for the presence of heteroduplex 
regions indicating a potential mutation. Identified samples were then sequenced in order 
to confirm the nucleotide change. Subsequently, mutant mouse lines were rederived at 
the MRC Harwell.  
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3.2 Identification of a missense point mutation in the cytoplasmic dynein 
intermediate chain 1 
A substitution was identified in exon 14 of the Dync1i1 gene (MGI: 107743): G to A in 
position 1628 (ENSMUST00000115555, Ensembl NCBI m37) which causes a glycine to 
aspartic acid change in the protein at residue 482 (ENSMUSP00000111217, Ensembl NCBI 
m37). The novel allele was annotated as Dync1i1
G482D
 and was not found in any of the 
inbred mouse strains (NCBI refSNP). The mutation was predicted to lie within the 5
th
 WD 
domain and a conservation profile was analysed using Jalview 2.6.1 (Waterhouse et al., 
2009). Representative protein sequences were acquired from GenBank (except for Mus 
musculus) and aligned using the MUSCLE algorithm (Edgar, 2004) (Figure 3.1). Because in 
the vertebrate lineage whole genome duplication occurred (‘2R’), there are 2 genes 
coding intermediate chains 1 and 2 and the protein sequences of DYNC1I1 are highly 
similar amongst the vertebrates (Pfister et al., 2006). Furthermore, conservation and 
alignment quality scores for each residue in the alignment, and the consensus sequence 
were calculated. The value of conservation was expressed as a number of physico-
chemical properties of each amino acid, which were conserved: the higher the score the 
more conserved residue (Livingstone and Barton, 1993). The alignment quality rated the 
likelihood of observing a mutation in the particular position (from 0 to 1). Furthermore, 
potential effects of the mutation on protein function were calculated using a ‘Sorting 
Intolerant From Tolerant’ algorithm (SIFT Blink, http://sift.jcvi.org) (Kumar et al., 2009). 
Briefly, position-specific scoring matrices (PSI-BLAST) were used to score sequence 
homology and the best BLAST hits from each organism were retrieved in order to build a 
multiple sequence alignment. Based on gathered data substitution matrices were 
calculated for each amino acid in the query sequence. 
 
Glycine at position 482 could be found in most of the taxonomic groups (from vertebrates 
to fungi), and in all the sequences aligned but the Drosophila homologue cDIC. A value of 
the conservation score was average (4 out of 11) while the alignment quality was scored 
over 0.68. The G482D mutation causes a change of glycine, classified as ‘tiny’ and 
‘hydrophobic’ into ‘small’ and ‘negatively charged’ aspartic acid (Livingstone and Barton, 
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1993). Furthermore, 85 homologous sequences (median conservation value 2.92) were 
retrieved by SIFT Blink, and G482D substitution was predicted to affect protein function. 
 
 
 
Figure 3.1. Bioinformatics analysis of DYNC1I1 protein sequence  
A. An alignment of representative sequences of cytoplasmic dynein intermediate chain 1 generated by 
Jalview 2.6, annotated by a species name and gene/protein symbol followed by amino acids displayed; 
residues and corresponding histograms shaded based on their conservation; the ENU induced mutation 
in the mouse sequence marked with an arrow; sequences aligned retrieve from GenBank except for 
mouse: Mus sp. (mouse) ENSMUSP00000111217, Rattus sp (rat) NP_062107, Canis sp. (dog) XP_850340 
- predicted in locus LOC475236, Homo sp. (human) NP_004402, Gallus sp. (chicken) XP_418672 –
predicted in locus LOC420571, Xenopus sp. (frog) NP_001106382 – hypothetical locus LOC100127187, 
Danio sp. (zebra fish) NP_001073459, Drosophila sp. (fruit fly) NP_477075, Caenorhabditis sp. 
(nematode) NP_501038, Dictyostelium sp. (amoeba) XP_640973; Aspergillus sp. (fungus) XP_747253 – 
predicted locus AFUA_8G04460 
B. Schematic representation of mouse DYNC1I1 protein (isoform A); protein domains marked as blocks, 
numbered exons marked in grey, position of the G482D mutation marked with arrow; DYNLT – binding 
region of Tctex-1 dynein light chain, DYNLL – binding region of LC8 dynein light chain, DIM – 
intermediate chain dimerisation domain, DYNLRB – binding domain of Roadblock dynein light chain, WD 
domains marked in green 
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3.3 Identification of a missense point mutation in the cytoplasmic dynein 
intermediate chain 2  
Another coding mutation from the ENU-treated DNA archive was identified in an exon 7 of 
the Dync1i2 gene (MGI: 107750). The mutation changes C in position 664 into T 
(NM_001198872, GenBank), and causes substitution of threonine with isoleucine in 
position 172 (NP_001185801, GenBank), thus the novel allele was annotated Dync1i2
T172I
. 
This substitution was not found in genomic sequences of the known mouse strains (NCBI 
refSNP). The new mutation was predicted to change threonine located in the dynein light 
chain LC8 binding domain (DYNLL) (Nyarko and Barbar, 2011) and this region of the 
intermediate chain was analysed in silico. The multiple alignments of representative 
protein sequences showed high similarity of the DYNC1I2 sequence within the 
vertebrates, but not with other taxonomic groups (Figure 3.2).  
 
Based on the alignment generated with the MUSCLE algorithm, threonine 172 is well 
conserved in vertebrates. However, there are dynein intermediate chain sequences 
obtained from 2 fungi (Laccaria bicolor, Coprinopsis cinerea, order Agaricales), which 
contain isoleucine in the corresponding position. The value of the conservation score was 
average (5 out of 11) while the alignment quality was scored 0.49. The T172I mutation 
causes a change of threonine, classified as ‘small’ and ‘hydrophobic’ into ‘aliphatic’ and 
‘hydrophobic’ Isoleucine (Livingstone and Barton, 1993). Moreover, 80 homologous 
sequences deposited in the GenBank (median conservation value 2.95) were retrieved by 
SIFT Blink (http://sift.jcvi.org), and the T172I substitution was predicted to be a tolerated 
variant.  
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Figure 3.2. Bioinformatics analysis of DYNC1I2 protein sequence  
A. An alignment of representative sequences of cytoplasmic dynein intermediate chain 2 generated by 
Jalview 2.6, annotated by a species name and a gene/protein symbol, amino acids displayed correspond 
to a light chain binding domain; residues and plots shaded based on their conservation; the ENU 
induced mutation in the mouse sequence marked with an arrow; sequences aligned retrieve from 
GenBank: Mus sp. (mouse) NP_001185801, Rattus sp (rat) NP_446332, Homo sp. (human) NP_001369, 
Canis sp. (dog) XP_859859 - predicted in locus LOC478797, Gallus sp. (chicken) NP_001006519, Xenopus 
sp. (frog) AAH86292 – due to discrepancy either gene nor locus are known, Danio sp. (zebra fish) 
XP_690115 – there are 2 loci annotated as Dync1i2, Aspergillus sp. (fungus) XP_747253 – predicted 
locus AFUA_8G04460, Coprinopsis sp. (fungus) XP_001831675, Laccaria sp. (fungus) S238N-H82 
XP_001883758, Drosophila sp. (fruit fly) AAF_73046, Caenorhabditis sp. (nematode) NP_501038; light 
chains binding sites marked with yellow (DYNLT) and green (DYNLL) as in Nyarko and Barbar, 2011 
B. Schematic representation of mouse DYNC1I2 protein (isoform D); protein domains marked as blocks, 
numbered exons marked in grey, position of the T172I mutation marked with arrow; DYNLT – binding 
region of Tctex-1 dynein light chain, DYNLL – binding region of LC8 dynein light chain, DIM – 
intermediate chain dimerisation domain, DYNLRB – binding domain of Roadblock dynein light chain, WD 
domain marked in green 
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3.4 Results  
3.4.1 Breeding and maintenance of the Dync1i1G482D mutant mouse line  
A mouse line carrying a coding mutation identified in the Dync1i1 gene was rederived by 
IVF. The heterozygous mice (Dync1i1
G482D/+
) were bred to C57BL/6J mice in order to 
produce a congenic line, or intercrossed to produce progeny. The wildtype (Dync1i1
+/+
)
 
and homozygous (Dync1i1
G482D/G482D
) littermates were subsequently tested for any 
phenotypic differences (section 3.4.4). The genotyping of pups was performed 3 weeks 
after birth (after weaning) by PCR and restriction digest as described (section 2.1.2). Due 
to space limitations the Dync1i1
G482D
 mutant mouse line was established and maintained 
by Dr A. Acevedo-Arozena at the MRC Mammalian Genetics Unit, Harwell, UK. Thus, no 
detailed data regarding the inheritance of this mutation are available.  
 
3.4.2 Breeding and maintenance of the Dync1i2T172I mutant mouse line  
The colony of Dync1i2
T172I
 mice was kept at the MRC Prion Unit animal facility in 
controlled conditions. The colony was founded by heterozygous (Dync1i2
T172I/+
) animals 
rederived by IVF of C57BL/6J oocytes with sperm from C3H/HeH x BALB/c male (F1 
progeny, section 2.1.1). Because of the mixed genetic background the ‘founders’ were 
annotated as generation N0. The genotyping of all progeny was performed 3 weeks after 
birth (post weaning), thus any cases of pup lethality were not detected. The Dync1i2
T172I
 
colony was bred in 2 regimes:  
• backcrossing heterozygous (Dync1i2
T172I/+
) animals with mice from C57BL/6J stock in 
order to segregate other point mutations and obtain a homogenous genetic 
background (up to N5), 
• intercrossing heterozygous (Dync1i2
T172I/+
) animals in order to produce cohorts of 
wildtype (Dync1i2
+/+
) and homozygous (Dync1i2
T172I/T172I
) mice.  
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3.4.2.1  C57BL/6J backcross 
We chose to breed the mutant line with a C57BL/6J inbred strain, which is well 
characterised and widely used. In addition, the C57BL/6J strain was classified as good 
breeder producing from 3 to 7 pups per litter (http://www.jax.org). The generations were 
numbered with each cross to C57BL/6J mouse, and starting from generation N5 mice were 
considered congenic, containing only 3% of paternal BALB/c DNA (0.5
5 
= 0.03125; Keays et 
al., 2006).  
 
The transmission of the Dync1i2
T172I
 allele was analysed in cohorts consisting of animals at 
N1, N5, and N7 and its distribution tested with Chi-square (χ
2
) test (GraphPad, section 
2.7.5). The detailed summary is shown in Table 3.1. There were 29 mice (14 males, 15 
females, p=0.8527) obtained from 5 litters in the first backcross (generation N1), which 
gave on average 5.8 pups per litter. The distribution of the genotypes was as expected for 
an independently segregating allele (1:1), and 16 wildtype (Dync1i2
+/+
) and 13 
heterozygous (Dync1i2
T172I/+
) animals were weaned (p=0.5775).  
 
Further breeding brought 74 mice from 12 litters at N5 with the average size of 6.2 pups. 
There was no difference in the sex ratio (36 males, 38 females, p=0.8162), but the number 
of wildtype (Dync1i2
+/+
, n=27) mice was lower compared with heterozygote (Dync1i2
T172I/+
, 
n=47, p=0.0201). However, the disproportion was observed neither in any other 
generation, nor when both the gender and the genotype were taken into account 
(p=0.1285).  
 
Furthermore, at N7 there were 29 mice born in 4 litters, which corresponded to 7.2 pups 
per litter. As before, both parameters tested did not differ from expected frequencies: 
there were 17 males and 12 females weaned (p=0.3532), out of which 12 carried wildtype 
allele (Dync1i2
+/+
) and 17 were heterozygous (Dync1i2
T172I/+
) (p=0.3532).  
 
The increase in the number of pups born in following generations may be the result of 
removing other random mutations, which might affect fertility or embryogenesis.  
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Table 3.1. Summary of the mutant Dync1i2
T172I 
allele distribution and litter statistics calculated for 
backcrosses to the C57BL/6J strain 
Numbers of mice weaned in each generation (N1, N5, N7) split by genotype and gender; the distribution 
analysed with Chi-square (χ
2
) test, df=1; genotypes correspond to wildtype (Dync1i2
+/+
) and heterozygous 
(Dync1i2
T172I/+
) animals; in case of statistically significant difference at N5 the expected number of pups given 
in brackets; for p<0.05 in bold 
 
Generation 
Males χ2, p Females χ2, p Mice χ2, p 
Litter 
size Genotype 
N1 
Dync1i2
+/+
 8 0.2860 
0.8527 
8 0.0670 
0.7963 
16 0.3100 
0.5775 
5.8 
Dync1i2
T172I/+
 6 7 13 
N5 
Dync1i2
+/+
 14 1.7780 
0.1824 
12 3.7890 
0.0516 
26 (37) 5.4050 
0.0201 
6.2 
Dync1i2
T172I/+
 22 25 47 (37) 
N7 
Dync1i2
+/+
 7 0.5290 
0.4669 
5 0.3330 
0.5637 
12 0.8620 
0.3532 
7.2 
Dync1i2
T172I/+
 10 7 17 
 
3.4.2.2  Intercross  
A group of mice was bred by crossing heterozygous (Dync1i2
T172I/+
) mice in order to 
produce cohorts of wildtype (Dync1i2
+/+
) and homozygous (Dync1i2
T172I/T172I
) littermates, 
which were used in phenotyping (sections 3.4.4 and 3.4.4.4) and molecular analysis 
(sections 2.6.1, 4.4.3 and 6.4.2). Mice intercrossed came from various generations and the 
inheritance of the Dync1i2
T172I
 mutation was analysed at N0 (colony founders), N5, and 
N7. Assuming a Mendelian distribution of alleles, 3 classes of genotypes were expected to 
segregate in ratio 1:2:1, corresponding to wildtype (Dync1i2
+/+
), heterozygous 
(Dync1i2
T172I/+
), and homozygous (Dync1i2
T172I/T172I
) animals (Table 3.2).  
 
Cohort at N0 was bred by crossing mice rederived by IVF thus there was a high proportion 
of C3H/HeH x BALB/c genetic material. There were 136 mice born and weaned from 20 
litters, which corresponds to 6.8 pups per litter on average. The gender ratio did not vary 
from normal (p=0.1227) with a small dominance of females (n=77) over males (n=59). The 
distribution of genotypes was as expected: 27 wildtype (Dync1i2
+/+
), 79 heterozygote 
(Dync1i2
T172I/+
), and 30 homozygote (Dync1i2
T172I/T172I
) mice (p=0.1579). However, when 
only females were compared there were more heterozygous (Dync1i2
T172I/+
) and fewer 
wildtype (Dync1i2
+/+
) animals (p=0.0464). The trend however, was not observed in other 
cohorts thus it was not considered relevant. Those mice were selected for a long time 
observation experiment, as described in 3.4.2.3.  
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A larger cohort, which consisted of 204 animals, was bred by crossing heterozygous 
(Dync1i2
T172I/+
) animals at N5. There were 38 litters, with the average of 5.4 pups per litter. 
The equal numbers of males (n=102) and females (n=102) were weaned (p=1.000), the 
genotype ratios were also normal (p=0.5059), with 44 wildtype (Dync1i2
+/+
), 105 
heterozygous (Dync1i2
T172I/+
), and 55 homozygous (Dync1i2
T172I/T172I
) animals. That cohort 
was regarded as congenic and subjected to a battery of behavioural test (sections 3.4.4 
and 3.4.4.4). 
 
The last set of intercrosses produced 53 animals at N7. There were 9 litters born with the 
average of 5.8 pups per litter, consisting of 26 males and 27 females (p=0.8907). As 
previously, the allele distribution in the cohort followed the classic 1:2:1 pattern: for 16 
wildtype (Dync1i2
+/+
), 20 heterozygous (Dync1i2
T172I/+
), and 17 homozygous 
(Dync1i2
T172I/T172I
) animals the reported value of p=0.1992. Although there seemed to be a 
disproportion of genotypes between females, more mice would be required to confirm 
this observation. The cohort was sacrificed and samples collected for further analysis 
(sections 2.1.4.1 and 6.4.2). 
 
We also showed that homozygous (Dync1i2
T172I/T172I
) mice at N1 were fertile and 1 litter of 
8 pup was produced. 
 
 
Table 3.2. Summary of the mutant Dync1i2
T172I
 allele distribution and litter statistics for intercrosses  
Numbers of mice weaned in each generation (N0, N5, N7) split by genotype and gender; the distribution 
analysed with Chi-square (χ
2
) test, df=2, genotypes correspond to wildtype (Dync1i2
+/+
), heterozygous 
(Dync1i2
T172I/+
), and homozygous (Dync1i2
T172I/T172I
) animals; in case of a noticeable difference at N0 the 
expected number of pups given in brackets; for p<0.05 in bold 
 
Generation 
Males χ2, p Females χ2, p Mice χ2, p 
Litter 
size Genotype 
N0 
Dync1i2
+/+
 15 
0.0510 
0.9749 
12 (19.2) 
6.1430 
0.0464 
27 
3.6910 
0.1579 
6.8 Dync1i2T172I/+ 30 49 (38.5) 79 
Dync1i2
T172I/T172I
 14 16 30 
N5 
Dync1i2
+/+
 23 
0.3530 
0.8382 
21 
1.1180 
0.5719 
44 
1.3620 
0.5059 
5.4 Dync1i2T172I/+ 52 53 105 
Dync1i2
T172I/T172I
 27 28 55 
N7 
Dync1i2
+/+
 7 
0.6920 
0.7074 
9 
3.000 
0.2231 
16 
3.2260 
0.1992 
5.8 Dync1i2T172I/+ 11 9 20 
Dync1i2
T172I/T172I
 8 9 17 
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3.4.2.3  Long term observation experiment  
In order to investigate effects of the Dync1i2
T172I
 mutation on survival of animals long term 
observation was carried out until mice reached the age of over 24 months. An 
experimental cohort consisted of 13 wildtype (Dync1i2
+/+
), 10 homozygous 
(Dync1i2
T172I/T172I
) males, 11 wildtype (Dync1i2
+/+
) females, and 12 homozygous 
(Dync1i2
T172I/T172I
) females, all at N0. The mice were kept undisturbed and any events of 
death or sickness were noted. During the course of the experiment 11 out of 24 wildtype 
(Dync1i2
+/+
) mice died, out of which 6 were males, 5 females. It was noted that first deaths 
were amongst males at age of 220 days, while all the wildtype females lived over 400 
days. This phenomenon might have been caused by fighting or increased level of stress, 
which is quite common for male mice. Amongst homozygous (Dync1i2
T172I/T172I
) mice, only 
5 out of 22 died by the end of the experiment, out of which 2 were males and 3 were 
females. Similar to the wildtype cohort, mutant Dync1i2
T172I/T172I
 males were noted to die 
slightly earlier than Dync1i2
T172I/T172I
 females.  
 
The results of the aging experiment were analysed in GraphPad using Kaplan-Meier 
survival plot, on which the fractional survival (Y) was depicted as a function of time (Days) 
(Figure 3.3). The survival curves were compared with Log-rank (Mantel-Cox) and Gehan-
Breslow-Wilcoxon tests, when the latter gave more weight to deaths at early time points; 
the details are shown in Table 3.3. The survival of the wildtype (Dync1i2
+/+
) animals did not 
differ from homozygous (Dync1i2
T172I/T172I
), although the trend towards longer lifespan 
was observed in the cohort of mutant mice (p=0.0790). However, it was less distinct when 
males and females were compared separately, thus in order to validate this differences a 
larger cohorts would need to be observed for a longer period of time. 
 
In conclusion, the lifespans of the wildtype (Dync1i2
+/+
) and homozygous (Dync1i2
T172I/T172I
) 
littermates were comparable with the median lifespan reported for inbred strains: 
908/914 days (males/females respectively) for C57BL/6J, 707/785 days (males/females) 
for BALB/cByJ, and 714/659 (males/females) for C3H/HeJ (Yuan et al., 2009). Furthermore, 
the survival curves might be affected by the presence of additional ENU-induced 
mutations (generation N0). 
88 
Table 3.3. The summary of the long term observation of aged cohorts of wildtype (Dync1i2
+/+
) and 
homozygous (Dync1i2
T172I/T172I
) mice 
Numbers of mice annotated as Dead or Alive at the end of the experiment, split by genotype and gender; 
the survival curves compared with 2 tests (details above), reported values of Chi-square (χ
2
) df=1; genotypes 
correspond to wildtype (Dync1i2
+/+
), and homozygous (Dync1i2
T172I/T172I
) animals 
 
Genotype Males Females Total Mice 
Dead 
Dync1i2
+/+
 6 5 11 
Dync1i2
T172I/T172I
 2 3 5 
Alive 
Dync1i2
+/+
 7 6 13 
Dync1i2
T172I/+
 8 9 17 
Log-rank (Mantel-Cox) test 
χ
2
 1.6630 1.7970 3.0860 
p 0.1972 0.1801 0.0790 
Gehan-Breslow-Wilcoxon 
test 
χ
2
 1.6920 1.4590 3.5420 
p 0.1933 0.2271 0.0598 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Kaplan-Meier survival curves of wildtype (Dync1i2
+/+
) and homozygous (Dync1i2
T172I/T172I
) mice 
(next page)  
Survival represented as percent of alive animals as a function of time (Days); a horizontal red line at Y=50; 
n – number of animals (next page) 
A. The survival curve of wildtype (Dync1i2
+/+
) and homozygous (Dync1i2
T172I/T172I
) males, the median 
lifespan of males from inbred strains marked with vertical lines: BALB/cByJ – red, C3H/HeJ – black 
B. The survival curve of wildtype (Dync1i2
+/+
) and homozygous (Dync1i2
T172I/T172I
) females; the median 
lifespan of females from inbred strains marked with vertical lines: BALB/cByJ – red, C3H/HeJ – black 
C. The survival curve of wildtype (Dync1i2
+/+
) and homozygous (Dync1i2
T172I/T172I
) animals  
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3.4.3 Breeding of double heterozygous mutant mice (Dync1i1G482D/+ 
Dync1i2
T172I/+) 
In addition to mutant lines carrying single mutations (Dync1i1
G482D
, Dync1i2
T172I
) a cohort 
of 10 male and 10 female double heterozygous mice (Dync1i1
G482D/+
 Dync1i2
T172I/+
) was 
established at MRC Harwell, which then were timed mated. Embryos harvested at E13.5 – 
14.5 were used to prepare MEF cell lines, DNA from remaining tissues was extracted and 
genotyping performed following standard protocol (section 2.1.2). There were 92 embryos 
collected from 9 litters, with an average of 10 embryos per litter. The genotypes of pups 
were expected to segregate as independent alleles (1:1:2:2:4:2:2:1:1) and all 9 genotypes 
were observed (Table 3.4). The Chi-square (χ
2
) equaled 9.696 and the two-tailed p value 
with 8 degrees of freedom equaled 0.2870. Thus the presence of both alleles (Dync1i1
G482D
 
and Dync1i2
T172I
) did not affect fertility or early embryogenesis of mutant animals. On the 
other hand, in case of mild or low penetrance phenotype a bigger sample would be 
required. The cell lines homozygous for one or both mutations were used as a model to 
study the effects of mutations in the cytoplasmic dynein intermediate chains on a cellular 
level (section 4.1).  
 
 
 
 
 
Table 3.4. Distribution of progeny genotypes from double heterozygous matings (Dync1i1
G482D/+
 
Dync1i2
T172I/+
) 
Genotypes are organized by allele of each gene; there were 92 pups and all 9 genotypes observed; expected 
numbers based on ratio of independently segregating alleles in brackets; in bold marked numbers of 
embryos/cell lines with the genotypes of interest: wildtype (Dync1i1
+/+
 Dync1i2
+/+
), Dync1i1
G482D
 homozygous 
(Dync1i1
G482D/G482D 
Dync1i2
+/+
), Dync1i2
T172I
 homozygous (Dync1i1
+/+ 
Dync1i2
T172I/T172I
), double homozygous 
(Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
)  
 
Allele Dync1i1+/+ Dync1i1G482D/+ Dync1i1G482D/G482D 
Dync1i2+/+ 6 (5.75) 10 (11.5) 2 (5.75) 
Dync1i2T172I/+ 20 (11.5) 21 (23) 9 (11.5) 
Dync1i2T172I/T172I 6 (5.75) 12 (11.5) 6 (5.75) 
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3.4.4 Behavioural phenotypes of the Dync1i1G482D and Dync1i2T172I mouse 
lines 
Detailed behavioural phenotyping of Dync1i1
G482D
 and Dync1i2
T172I 
mutant mouse lines 
was performed by Dr Robert Deacon and Dr Samantha Line at Department of 
Experimental Psychology, University of Oxford. All the tests were performed blind to 
genotype on age-matched littermates. Two phenotyping cohorts consisted of:  
• 10 wildtype (Dync1i1
+/+
), 10 homozygous (Dync1i1
G482D/G482D
) females at N4 C57BL/6J 
background 
• 14 wildtype (Dync1i2
+/+
), 14 homozygous (Dync1i2
T172I/T172I
) females at N5 C57BL/6J 
background.  
 
Few of the tests performed required prolonged periods of time when mice were 
transferred to individual cages, therefore females were chosen over males in order to 
avoid fighting often observed in males which were rehoused (Deacon et al., 2002). A 
variety of tests was used to assess motor function and coordination, general metabolic 
performance, species specific behaviour, anxiety-like behaviour, and learning and 
memory. The specific behaviour may be affected by many factors and at least two tests 
for similar behaviour were performed; their outcomes are grouped as mentioned. 
 
3.4.4.1  Analysis of motor function and coordination 
The motor performance of mutant mouse lines was tested on accelerating rotarod, 
multiple static rods, and during voluntary wheel running.  
 
The accelerating rotarod is a simple task commonly used to detect any neurological 
deficits, which would affect a coordination or muscle function. However, any differences 
in fatigue or body weight may affect the outcome (Brooks and Dunnett, 2009). 
 
The Dync1i1
G482D
 and Dync1i2
T172I
 mice were tested on the accelerating rotarod at the age 
of 14 months old and the speed of the rod when an animal fell was recorded. The 
performance of the Dync1i1
G482D/G482D
 mice (14.4 ± 1.4 rpm) was comparable with the 
wildtype (Dync1i1
+/+
) littermates (15.5 ± 1.4 rpm) (p=0.5567). Similarly, Dync1i2
T172I/T172I
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mice fell at the same speed as wildtype (Dync1i2
+/+
) littermates (p=0.7853). The detailed 
measurements and statistical analysis are summarised in Table 3.5 and Figure 3.4A. 
 
Multiple static rods are used to detect defects in coordination and balance. The test 
consists of three horizontal bars, each thinner than the previous. Time, in which an animal 
turns (Orient) and runs to a shelter (Traverse) gives a measure of the overall performance. 
At the same time posture or use of tail can be observed and noted (Mattsson et al., 1997). 
 
In a sequence of three rods the performance of Dync1i1
G482D/G482D
 females (n=10) did not 
vary from wildtype Dync1i1
+/+
 littermates (n=10), neither in the time to turn around 
(Orient, p=0.1068), nor in the time to walk from the far end of the rod to the shelf 
(Traverse, p=0.5210). However, mutant Dync1i1
G482D/G482D
 mice turned faster on the wider 
rod (Rod1) than wildtype Dync1i1
+/+
 (unpaired t-test with Welch’s correction, p=0.0319).  
 
The task did not show differences in Dync1i2
T172I/T172I
 females (n=14) when compared with 
wildtype Dync1i2
+/+
 littermates (n=14) in turning time (Orient, p=0.8814) and crossing time 
(Traverse, p=0.2610). The mutant Dync1i2
T172I/T172I 
animals were on average slightly faster 
on wide rods (Rod 1, Rod 2).  
 
Interestingly though, the multiple static rods revealed that Dync1i2
T172I
 cohort was much 
slower at leaving rods than a cohort of the Dync1i1
G482D
 mice: it took 53.9 ± 13.2 s for 
wildtype Dync1i2
+/+
 to cross the rod while the mean time of wildtype Dync1i1
+/+
 mice was 
8.6 ± 2.8 s. The reason for this discrepancy might be the origin of those colonies or 
underlying genetic variation (sections 3.4.1 and 3.4.2). The detailed measurements and 
statistical analysis are summarised in Table 3.5 and Figure 3.4B. 
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Table 3.5. Performance of the Dync1i1
G482D
 and Dync1i2
T172I
 mice in motor tasks  
Measurements from each task shown as mean ± SEM (standard error of the mean); on the left (vertical) 
shown the task performed, the results of statistical analysis shaded; genotypes annotated as follows: 
wildtype Dync1i1
+/+
, homozygous Dync1i1
G482D
 (Dync1i1
G482D/G482D
), wildtype Dync1i2
+/+
, homozygous 
Dync1i2
T172I
 (Dync1i2
T172I/T172I
); n - number of animals tested except for: *n=8, **n=13, ***n=12; rpm – 
rotations per minute, s – seconds, a.u. – arbitrary units; F(DFn, DFd) – F ratio calculated for DFn: degrees of 
freedom for the numerator, DFd: degrees of freedom for the denumerator; RM ANOVA – repeated 
measures analysis of variance; 
$ 
- in addition turning on Rod1 was tested with umpaired t-test with Welch’s 
correction for unequal variance; for p<0.05 in bold  
 
Task 
Dync1i1+/+ 
n=10 
Dync1i1G482D/G482D 
n=10 
Dync1i2+/+ 
n=14 
Dync1i2T172I/T172I 
n=14 
Statistics 
Rotarod [rpm] 
15.5 ± 1.4 14.4 ± 1.4 12.9 ± 1.9 13.5 ± 1.3 Unpaired 
t-test p=0.5567 p=0.7853 
M
u
lt
ip
le
 S
ta
ti
c 
R
o
d
s 
Rod 1 
[s] 
Orient$ 
13.6 ± 3.6 4.2 ± 1.1 
16.7 ± 8.1 16.6 ± 8.1 
Two-way 
RM 
ANOVA 
p=0.0319 
Traverse 8.6 ± 2.8 6.4 ± 1.3 53.9 ± 13.2 32.6 ± 10.7 
Rod 2 
[s] 
Orient 7.2 ± 2.1 9.0 ± 2.2 8.4 ± 3.4 7.9 ± 3.9 
Traverse 3.9 ± 0.6 3.5 ± 0.5 28.1 ± 9.8 16.0 ± 3.9 
Rod 3 
[s] 
Orient 19.9 ± 4.5 12.8 ± 2.8 20.1 ± 3.8 18.4 ± 3.8 
Traverse 9.9 ± 1.3 9.4 ± 2.2 53.3 ± 11.1 53.1 ± 9.6 
 
Orient F(1, 36)=2.8810, p=0.1068 F(1, 52)=0.0227, p=0.8814 
Traverse F(1, 36)=0.4285, p=0.5210 F(1, 52)=1.3200, p=0.2610 
W
h
e
e
l r
u
n
n
in
g
 
Day 1 
[a.u.] 
Distance 7.9 ± 2.9 5.0 ± 2.0 7.0 ± 1.7** 8.9 ± 2.4*** 
Two-way 
RM 
ANOVA 
Speed 1.8 ± 0.4 1.2 ± 0.3 1.7 ± 0.3 1.7 ± 0.3 
Max speed 12.4 ± 1.1 11.4 ± 2.3* 13.1 ± 0.8 13.2 ± 1.3 
Day 2 
[a.u.] 
Distance 16.4 ± 2.5 11.3 ± 2.5 9.2 ± 1.4** 8.7 ± 2.0*** 
Speed 3.3 ± 0.2 2.5 ± 0.4 2.7 ± 0.2 2.4 ± 0.3 
Max speed 13.1 ± 0.9 12.6 ± 2.0* 15.2 ± 0.6 14.8 ± 0.7 
Day 3 
[a.u.] 
Distance 20.5 ± 2.1 14.5 ± 1.8 13.6 ± 1.9** 14.4 ± 3.3*** 
Speed 4.0 ± 0.2 3.5 ± 0.3 3.3 ± 0.2 3.0 ± 0.3 
Max speed 14.4 ± 0.7 13.8 ± 1.4* 13.9 ± 0.5 13.4 ± 0.9 
Day 4 
[a.u.] 
Distance 26.4 ± 2.2 17.5 ± 2.9 17.4 ± 2.3** 16.6 ± 2.7*** 
Speed 4.5 ± 0.2 3.8 ± 0.4 3.7 ± 0.3 3.5 ± 0.3 
Max speed 13.5 ± 0.8 12.9 ± 1.1* 15.4 ± 0.5 12.4 ± 0.8 
Day 5 
[a.u.] 
Distance 31.5 ± 3.2 23.4 ± 4.0 21.0 ± 3.3** 20.6 ± 3.1*** 
Speed 4.8 ± 0.2 4.2 ± 0.4 3.9 ± 0.3 3.9 ± 0.3 
Max speed 13.5 ± 0.4 11.6 ± 1.1* 14.9 ± 0.6 12.8 ± 0.9 
Days 
1-5 
[a.u.] 
Distance F(1, 72)=3.8160, p=0.0665 F(1, 92)=0.0050, p=0.9444 
Speed F(1, 72)=3.9680, p=0.0618 F(1, 92)=0.1709, p=0.6832 
Max speed F(1, 64)=0.6828, p=0.4208 F(1, 92)=4.0230, p=0.0568 
 
Total 
distance 
102.7 ±11.4 71.8 ± 10.9 68.1 ± 9.1 69.2 ± 12.3 Unpaired 
t-test p=0.0665 p=0.9444 
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Figure 3.4. Performance of the Dync1i1
G482D
 and Dync1i2
T172I
 mouse lines in motor tasks 
Results plotted as means ± SEM (standard error of the mean), colours correspond to: wildtype Dync1i1
+/+
 
(black), homozygous Dync1i1
G482D/G482D
 (red), wildtype Dync1i2
+/+
 (grey), homozygous Dync1i2
T172I/T172I
 (blue), 
rpm – rotation per minute, sec – time in seconds, a.u. – arbitrary units; common legend for A-B and C-D-E 
Performance on an accelerating rotarod, the speed [rpm] at which a mouse fell recorded, at Y=4 (‘Start’) 
marked the speed at the beginning of the test 
A. Time taken to turn (Orient) and cross (Traverse) on a sequential static rods 
B. Running wheel: distance run recorder for 5 days 
C. Running wheel: average speed of running recorded for 5 days 
D. Running wheel: maximum speed of running recorded for 5 days 
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Wheel running measures voluntary locomotor activity of an animal, and because it takes 
place in a home cage anxiety levels are usually reduced. Furthermore, data acquisition is 
often automated, thus increasing the quality and accuracy of a measurement (Brooks and 
Dunnett, 2009). Mice can run long distance (e.g. approximately 5 km/day for C57BL/6J), 
and ‘pleasure’ of running can be also involved in the final outcome (R. Deacon, personal 
communication). The animals were housed in cages equipped with a running wheel for 5 
consecutive days and pedometer readings were taken daily; the distance and speed were 
measured in arbitrary units, relative to number of wheel turns.  
 
Each day of the testing period (Days 1 – 5) Dync1i1
G482D/G482D
 mice ran less (p=0.0665) and 
slower (p=0.0618) when compared with wildtype Dync1i1
+/+
. The mean maximum speed 
was also reduced in the mutant Dync1i1
G482D
 cohort, yet the trend was not clear 
(p=0.4208). Furthermore, the total distance run within 5 day also reflected worse than in 
wildtype Dync1i1
+/+
 (102.7 ± 11.4 a.u.) performance of the Dync1i1
G482D/G482D
 mice (71.8 ± 
10.9 a.u.) (p=0.0665). 
 
In a cohort of the Dync1i2
T172I
 mice 1 wildtype and 2 homozygous animals did not run 
during the testing period, thus they were not included in the final results. There were no 
differences observed between wildtype Dync1i2
+/+
 and homozygous Dync1i2
T172I/T172I
 mice, 
neither in the distance run each day (p=0.9444) nor in the average speed (p=0.6832). On 
the 4
th
 and 5
th
 day the maximum speed of Dync1i2
T172I/T172I
 animals decreased more than 
expected (p=0.0568), yet more data would be required as to the nature of a sudden 
change. The detailed measurements and statistical analysis are summarised in Table 3.5 
and Figure 3.4 C-F.  
 
In summary, in both cohorts a daily increase in a distance run can be observed, which 
might reflect the learning process. Furthermore, the static rods and running wheel were 
sensitive to detect the variation in performance of wildtype (Dync1i1
+/+
 and Dync1i2
+/+
) 
animals from 2 cohorts. 
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3.4.4.2  Food and water consumption 
General metabolic functions were assessed by monitoring the food, water intake, and 
glucose preference; the measurements were recorded for a period of 7 consecutive days. 
Mice were weighed several times over a period of 6 months, from 14 months to 20 
months of age, and the feeding behaviour was assessed in both cohorts at 20 months of 
age. For each animal the amount of food eaten was recorded every day for 3 days and 
calculated by (1) adding all the measurements and comparing total amount of food eaten 
(in grams) and by (2) correcting the total amount of eaten food for a body weight 
according to an equation: 
[g]weight
[g] eaten food totalFood 0.72corr = . The amount of water consumed, 
was similarly calculated either as (3) sum of water drunk within 3 days (in grams) or (4) as 
a corrected for body weight ratio: [g] weight
[g] drunk  watertotalWatercorr = . The double calculations 
were performed in order to examine any possible interaction or influence of a body 
weight on feeding. Subsequently, the cages were equipped with an additional solution of 
7.5% (w/v) glucose, which was closely monitored for another 4 days. The preference for 
glucose was calculated twice and expressed as ratios: (5) total amount of glucose solution 
drunk for 4 days (in grams) to body weight: [g] weight
[g] drunk glucose totalGlucoseweight = , and as (6) 
amount of glucose solution drunk daily to daily intake of water: 
[g]day  per drunk  wateraverage
[g]day  per drunk glucose averageGlucosewater = . The summary with statistical analysis is shown 
in Table 3.6. 
 
There were no differences in body weight between wildtype Dync1i1
+/+
 (n=10) and mutant 
Dync1i1
G482D/G482D
 littermates (n=10,) (p=0.6966), and both groups increased body mass at 
the age between 17 and 19 months by 6 grams on average (Figure 3.5 A). At the age of 14 
and 19 months the wildtype Dync1i1
+/+
 mice weighed 20.4 ± 0.6 g and 26.8 ± 0.7 g 
respectively; these results were slightly lower than data collected for aged C57BL/6J 
females (25,0 ± 2.1 g at 12 months, 27.8 ± 4.0 g at 18 months; Project ‘Yuan1’ 2007, 
MPD27012, MDP27013). Furthermore, the mean food consumption corrected for body 
weight was nearly equal (p=0.8719), with wildtype Dync1i1
+/+
 ratio of 1.06 ± 0.07 and 
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1.04 ± 0.08 calculated for homozygous Dync1i1
G482D/G482D
 females (Figure 3.5 B,C). 
Similarly, the relative amount of water drunk within 3 days was comparable, with mean 
value of 0.43 ± 0.04 for Dync1i1
+/+
 and 0.41 ± 0.04 for Dync1i1
G482D/G482D
 (p=0.5741) (Figure 
3.5 D,E). Finally, Dync1i1
G482D/G482D
 females displayed a trend in drinking more 7.5% 
glucose solution (daily consumption in relation to water: 3.68 ± 0.39) than wildtype 
Dync1i1
+/+ 
littermates (2.87 ± 0.30) (p=0.1192) (Figure 3.5F,G). 
 
The wildtype Dync1i2
+/+
 (n=14) females did not vary from homozygous Dync1i2
T172I/T172I
 
(n=14) littermates in body weight (p=0.5109), yet they were slightly heavier than the 
Dync1i1
G482D
 mice at the same age. There was also gain in a body mass observed between 
17 and 19 months of age (from 23.6 ± 0.6 g to 27.1 ± 0.7 g in Dync1i2
+/+
), reaching 
expected weight for 18 months old C57BL/6J females (27.8 ± 4.0 g) (Figure 3.5A). 
Furthermore, both groups consumed the same amounts of food when corrected for 
weight (Dync1i2
+/+
: 1.07 ± 0.06 and Dync1i2
T172I/T172I
:
 
1.08 ± 0.08, p=0.9981) (Figure 3.5 
B,C). Neither the amount of water drunk differed when corrected for weight (Dync1i2
+/+
: 
0.48 ± 0.03 and Dync1i2
T172I/T172I
: 0.45 ± 0.03, p=0.4330) (Figure 3.5 D,E). In addition, daily 
consumption of 7.5% glucose solution did not vary between wildtype Dync1i2
+/+
 (3.37 ± 
0.32) and homozygous Dync1i2
T172I/T172I
 (3.92 ± 0.28) animals (relative to water drank 
daily, p=0.2135) (Figure 3.5 F,G). On the other hand, mice from the Dync1i2
T172I
 cohort 
seemed to prefer glucose solution more than the Dync1i1
G482D
 mice, which might be 
related to their higher body mass. 
 
In summary, the mutant lines displayed similar feeding behaviour and body mass. 
Moreover, the weight of an animal should be taken into account during analysis of 
metabolic performance, especially when investigating nutrient preferences. 
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Table 3.6. Food and water consumption in the Dync1i1
G482D
 and Dync1i2
T172I
 cohorts 
Results are shown as mean ± SEM (standard error of the mean); on the left measurements performed over 
the period of 3 (food, water) or 4 (glucose) days, the results of statistical analysis for each category shaded; 
genotypes annotated as follows: wildtype (Dync1i1
+/+
), homozygous Dync1i1
G482D
 (Dync1i1
G482D/G482D
), 
wildtype (Dync1i2
+/+
), homozygous Dync1i2
T172I
 (Dync1i2
T172I/T172I
); numbers in brackets correspond to 
calculation used (see paragraph); n - number of animals tested; weight, amount of food eaten and water 
drunk in grams [g]; F(DFn, DFd) – F ratio calculated with ANOVA when DFn: degrees of freedom for the 
numerator, DFd: degrees of freedom for the denumerator; RM ANOVA – repeated measures analysis of 
variance 
Measurement 
Dync1i1+/+ 
n=10 
Dync1i1G482D/G482D 
n=10 
Dync1i2+/+ 
n=14 
Dync1i2T172I/T172I 
n=14 
Statistics 
Weight 
[g] 
14 months 20.4 ± 0.6 20.3 ± 0.7 22.8 ± 0.4 23.7 ± 0.9 
Two-way 
RM 
ANOVA 
17 months 20.9 ± 0.6 21.1 ± 0.6 23.6 ± 0.6 24.4 ± 1.0 
19 months 26.8 ± 0.7 26.4 ± 0.8 27.1 ± 0.7 27.9 ± 1.5 
20 months 28.3 ± 0.9 27.1 ± 1.0 27.9 ± 0.7 29.1 ± 1.7 
 F(1,54)= 0.1570, p=0.6966 F(1,78) =0.4443, p=0.5109 
Food consumption 
[g] 
[Day 1-3] (1) 
11.3 ± 0.7 10.8 ± 0.7 11.5 ± 0.6 11.5 ± 0.7 
Unpaired 
t-test 
p=0.6849 p=0.9941 
Food consumption 
corrected for weight 
[Day 1-3] (2) 
1.06 ± 0.07 1.04 ± 0.08 1.07 ± 0.06 1.08 ± 0.08 
p=0.8719 p=0.9981 
Water consumption 
[g] 
[Day 1-3] (3) 
11.6 ± 0.9 10.5 ± 0.7 13.0 ± 0.9 12.2 ± 0.7 
Unpaired 
t-test 
p=0.3333 p=0.4739 
Water consumption 
corrected for weight 
[Day 1-3] (4) 
0.43 ± 0.04 0.41 ± 0.04 0.48 ± 0.03 0.45 ± 0.03 
p=0.5741 p=0.4330 
Glucose 7.5% 
/weight 
[Day 1-4] (5) 
1.59 ± 0.13 1.96 ± 0.24 2.05 ± 0.16 2.28 ± 0.16 Unpaired 
t-test 
p=0.1964 p=0.3054 
Glucose 7.5% /water 
[Mean per day] (6) 
2.87 ± 0.30 3.68 ± 0.39 3.37 ± 0.32 3.92 ± 0.28 Unpaired 
t-test p=0.1192 p=0.2135 
 
 
Figure 3.5. Food, water, and glucose consumption in the Dync1i1
G482D
 and Dync1i2
T172I
 mouse lines (next 
page)  
Results plotted as means ± SEM, colours correspond to: wildtype Dync1i1
+/+
 (black), homozygous 
Dync1i1
G482D/G482D
 (red), wildtype Dync1i2
+/+
 (grey), homozygous Dync1i2
T172I/T172I
 (blue), combined legends 
for B-G; all measurements in grams [g] 
A. Body weight recorded over the period of 6 months, red lines mark an average body weight reported for 
12 - 18 months old C57BL/6J females (25.0 g – 27.8 g), m.o. – months old 
B. Mean amount of food eaten during the period of 3 days  
C. Mean amount of food eaten during the period of 3 days corrected for body weight 
D. Mean amount of water drunk during the period of 3 days 
E. Mean amount of water drunk during the period of 3 days corrected for body weight 
F. Mean amount of 7.5% (w/v) glucose solution consumed during 4 days related to body weight 
G. Mean daily consumption of 7.5% (w/v) glucose solution related to water drunk per day 
99 
 
100 
3.4.4.3  Species specific behaviour 
Mice display many behaviours specific for rodents, e.g. grooming, eating movements, food 
hoarding, burrowing, nesting etc. Those characteristics can be easily tested, and it has 
been reported that the outcome of rodent activities is related to integrity of the 
hippocampus and prefrontal cortex (Deacon and Rawlins, 2005). Accordingly, locomotor 
activity, nesting, and burrowing were assessed in the Dync1i1
G482D
 and Dync1i2
T172I
 mice. 
 
Locomotor activity of individual animals was monitored for 23 hours with a 12 hours long 
dark phase (time points 7 – 19h), which allowed us to compare the patterns of circadian 
activity. The activity counts were expressed in arbitrary units. Mice are nocturnal thus the 
activity counts increased in the dark phase and were low in the presence of light 
(representative data in Table 3.7).  
 
On overall, wildtype Dync1i1
+/+
 (n=6) and homozygous Dync1i1
G482D/G482D
 (n=7) mice did 
not display different patterns of the circadian rhythm (p=0.9136) (Figure 3.6 A).  
 
There were also no differences observed between wildtype Dync1i2
+/+
 (n=14) and 
homozygous Dync1i2
T172I/T172I
 (n=14) females (p=0.7217), which were mostly active during 
the dark phase (Figure 3.6 B).  
 
 
 
Table 3.7. Representative activity scores obtained for Dync1i1
G482D
 and Dync1i2
T172I
 cohorts 
The activity scores at different phase of the test are shown as mean ± SEM (standard error of the mean); 
genotypes annotated as follows: wildtype Dync1i1
+/+
, homozygous Dync1i1
G482D
 (Dync1i1
G482D/G482D
), wildtype 
Dync1i2
+/+
, homozygous Dync1i2
T172I
 (Dync1i2
T172I/T172I
); shaded measurements taken during the dark phase, 
n - number of animals tested; number in brackets correspond to a test time point, see Figure 3.6; h – hours; 
all the scores shown in arbitrary units 
 
Measurement point 
Dync1i1+/+ 
n=6 
Dync1i1G482D/G482D 
n=7 
Dync1i2+/+ 
n=14 
Dync1i2T172I/T172I 
n=14 
2h before dark phase (5) 169.0 ± 60.8 129.6 ± 41.8 129.9 ± 25.5 122.3 ± 41.4 
2h of dark phase (9) 701.7 ± 151.5 764.6 ± 108.9 686.5 ± 38.6 667.9 ± 49.4 
2h before light phase (17) 373.4 ± 139.4 355.7 ± 128.3 271.5 ± 57.4 393.0 ± 63.3 
2h of light phase (21) 187.2 ± 65.0 70.6 ± 21.9 91.5 ± 15.7 85.47 ± 12.4 
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Figure 3.6. Circadian activity charts of the Dync1i1
G482D
 and Dync1i2
T172I
 mice 
Data were collected for 23 hours period and locomotor activity of individual mice scored; a 12 hours long 
dark phase shaded (from 7 – 19); results plotted as means ± SEM (standard error of the mean); colours 
correspond to: wildtype Dync1i1
+/+
 (black), homozygous Dync1i1
G482D/G482D
 (red), wildtype Dync1i2
+/+
 (grey), 
homozygous Dync1i2
T172I/T172I
 (blue); representative time points shown in Table 3.7 marked with arrows (5, 
9, 17, 21 hours), a.u. – arbitrary units 
A. Mean locomotor activity of wildtype (Dync1i1
+/+
) and homozygous (Dync1i1
G482D/G482D
) females 
B. Mean locomotor activity of wildtype (Dync1i2
+/+
) and homozygous (Dync1i2
T172I/T172I
) females 
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Burrowing has been defined as displacement of material from the burrow and piling it 
around the entrance to the burrow (Deacon, 2006b). A pattern of coordinated movements 
can be observed, as a mouse digs with forelimbs and pushes the material out of the 
burrow with its hind limbs. Mice have been shown to burrow spontaneously regardless of 
the material used, and the burrowing has been suggested to be a rewarding activity. 
During the test the amount of the material displaced in a given time is measured. The test 
is usually performed 3 hours before the dark cycle and an additional practical ‘run’ helps 
in decreasing variability as animals get used to a new object introduced to the home cage. 
The amount of displaced material from a burrow was analysed with non-parametric 
Mann-Whitney test due to a data structure (ceiling effect, described in Deacon, 2006b). 
Therefore, all the values are reported as median and an interquartile range (IQR, 
difference between 25
th
 and 75
th
 percentile). The results and statistics applied are 
summarized in Table 3.8. 
 
A cohort of Dync1i1
G482D 
females was tested for burrowing ability at 20 months of age. The 
test was performed twice for 1 hour and an average from 2 measurements was used in 
statistical analysis. Dync1i1
G482D/G482D
 females (n=10) displaced less material (91.2 g; 57.3 – 
189.8) than wildtype Dync1i1
+/+
 (n=10) littermates during the same period of time (178.7 
g; 163.0 - 197.6) (p=0.2406) (Figure 3.7 A).  
 
The Dync1i2
T172I
 mice were allowed to burrow for 3 hours and the task was performed 
once. There were no differences in the amount of material removed between wildtype 
Dync1i2
+/+
 (n=14, 127.1 g; 44.4 - 198.9) and Dync1i2
T172I/T172I 
mice (n=14, 114.4 g; 8.1 - 
172.8)  (p=0.4894). In addition, there was no practice run and the numerical 
measurements were highly scattered (Figure 3.7B). Interestingly, the Dync1i2
T172I
 mice 
displayed much slower rate of burrowing when compared with the Dync1i1
G482D
 cohort, 
which may be explained by their different origin. 
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Table 3.8. Performance of the Dync1i1
G482D
 and Dync1i2
T172I
 cohorts in species-specific tasks 
Results are shown as median and IQR (interquartile range); on the left measurements performed, the results 
of Mann-Whitney test shaded; genotypes annotated as follows: wildtype (Dync1i1
+/+
), homozygous 
Dync1i1
G482D
 (Dync1i1
G482D/G482D
), wildtype (Dync1i2
+/+
), homozygous Dync1i2
T172I
 (Dync1i2
T172I/T172I
); n - 
number of animals tested; weight of displaced and left material in grams [g] 
 
Measurement 
Dync1i1+/+ 
n=10 
Dync1i1G482D/G482D 
n=10 
Dync1i2+/+ 
n=14 
Dync1i2T172I/T172I 
n=14 
Weight of material 
burrowed [g] 
178.7 
(163.0 -197.6) 
91.2 
(57.3 – 189.8) 
127.1 
(44.4 - 198.9) 
114.4 
(8.1 - 172.8) 
p=0.2406 p=0.4894 
Nest 
Score 
 (scale 1-5) 
5.0 (4.4 – 5.0) 4.8 (4.5 – 5.0) 4.5 (4.0 – 5.0) 4.0 (3.4 – 4.5) 
p=0.6960 p=0.1249 
Material left 
[g] 
0.0 (0.0 – 0.2) 0.0 (0.0 – 0.0) 0.0 (0.1 – 0.4) 0.3 (0.3 – 0.8) 
p=0.5036 p=0.3027 
 
 
 
 
Figure 3.7. Burrowing of the Dync1i1
G482D
 and Dync1i2
T172I
 mouse lines 
Results plotted as median and IQR (interquartile range), colours correspond to: wildtype Dync1i1
+/+
 (black), 
homozygous Dync1i1
G482D/G482D
 (red), wildtype Dync1i2
+/+
 (grey), homozygous Dync1i2
T172I/T172I
 (blue), weight 
of material displaced burrowing in grams [g], for Dync1i1
+/+ 
error bar marked in grey for a better 
visualisation 
A. Median amount of material removed from a burrow by Dync1i1
G482D
 mice measured after 1 hour  
B. Median amount of material removed from a burrow by Dync1i2
T172I
 mice measured after 3 hours  
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For a mouse an ability to build a nest is crucial, as it serves not only as a shelter but also as 
a way to conserve body temperature. Both males and females construct nests 
instinctively, thus nesting can be used in behavioural studies. On the other hand, the 
nesting is a complex behaviour which can be affected by many factors, e.g. hormonal 
balance. The standardised scoring protocol (in scale 1-5) with assigned illustrations of 
nests can be found in Deacon (2006a).  
 
Nests built by 20 months old Dync1i1
G482D
 and Dync1i2
T172I
 mice were scored visually and 
by weighing the unshredded material (if present). Similarly to burrowing task, the majority 
of mice would build good nests (score 5) using all the material, thus the data were 
analysed with a non-parametric test (Mann-Whitney) and median values with an 
interquartile range were reported (Table 3.8).  
 
Nearly all the nests build by the Dync1i1
G482D
 mice received high scores (above 4.5) and 
none was scored below 4.0. The comparison of nest quality of the wildtype Dync1i1
+/+
 
(n=10, 5.0; 4.4 – 5.0) and homozygous Dync1i1
G482D/G482D
 (n=10, 4.8; 4.5 – 5.0) mice 
showed neither differences in nest scores (p=0.6960) nor in the amount of material left 
(p=0.5036) (Figure 3.8 A, B).  
 
On the other hand, the nests built by the Dync1i2
T172I
 mice were scored lower than 
Dync1i1
G482D
, with median 4.5 (4.0 - 5.0) for wildtype Dync1i2
+/+
 (n=14) and 4.0 (3.4 – 4.5) 
for homozygous Dync1i2
T172I/T172I
 (n=14) animals (Figure 3.8 A, B). Although the nests built 
by the Dync1i2
T172I/T172I
 females were poorer the difference was within variation 
(p=0.1249). At the same time there was more unshredded material found in cages 
occupied by Dync1i2
T172I/T172I
 (0.3 g; 0.0 – 0.8) than in cages where Dync1i2
+/+
 mice were 
housed (0.0 g; 0.0 – 0.4) (p=0.3027). 
 
In summary, mice from both cohorts were capable of building nests, which were often 
scored above 4.0. On the other hand the results obtained for the Dync1i2
T172I
 mice were 
highly variable thus affecting the final analysis (Figure 3.8 C). Therefore, it might be 
beneficial to test a bigger cohort of animals or perform the nest assessment several times. 
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Figure 3.8. Nesting of the Dync1i1
G482D
 and Dync1i2
T172I
 mouse lines 
Results plotted as median and IQR (interquartile range), colours correspond to: wildtype Dync1i1
+/+
 (black), 
homozygous Dync1i1
G482D/G482D
 (red), wildtype Dync1i2
+/+
 (grey), homozygous Dync1i2
T172I/T172I
 (blue), weight 
of material displaced (burrowing) or left untorn (nesting) in grams [g], for Dync1i1
+/+ 
error bar marked in 
grey for a better visualisation; combined legends for A-B 
A. Median score of nests built by the Dync1i1
G482D
 and Dync1i2
T172I
 mice 
B. Median amount of nesting material left untorn, in case of the Dync1i1
G482D/G482D
 mice no material was 
found (median 0.0 g; 0.0 – 0.0) 
C. Frequency distribution of scores quantifying the quality of nests in a scale 1 – 5, the Dync1i2
T172I 
mice 
displayed more variability than Dync1i1
G482D
 
 
 
3.4.4.4  Anxiety-like behaviour (emotionality tests) 
Tests described as ‘emotionality tests’ quantify behaviour of an animal in situations when 
anxiety is induced. Those tasks are usually based on a mouse tendency to avoid bright 
light and open areas. On the other hand, animals can get accustomed to handling, which 
may affect the outcomes of anxiety tests (Deacon et al., 2002). All the measurements 
were taken for 5 min (300 s) and treated as non-parametric data; the analysis was 
performed using Mann-Whitney test and results reported as median and interquartile 
range (IQR, difference between 25
th
 and 75
th
 percentile) (Deacon et al., 2002).  
 
Successive alleys are an emergence task, which consists of 4 distinct compartments which 
gradually change from closed black area (Alley 1) to an open white lane (Alley 4). During 
the test a mouse is placed in an Alley 1 and time spent in each compartment, latency to 
enter each alley, and number of entries into each of the alleys are measured. The 
summary with the results of statistical analysis is shown in Table 3.9. 
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The Dync1i1
G482D
 mice spent most of the time in the Alley 1 (starting compartment, the 
least anxiogenic) and none of them ventured behind Alley 2. Seven wildtype Dync1i1
+/+
 
(n=10) and 4 mutant Dync1i1
G482D/G482D
 (n=10) mice stayed in the Alley 1; median times 
spent in the Alley 1 were thus 300.0 s (290.5 – 300.0) for Dync1i1
+/+
 and 289.0 s (276.5 – 
300.0) and did not differ (p=0.2465). The median latency time before entering Alley 2 was 
300.0 s (198.8 – 300.0) in Dync1i1
+/+
 and 210.0 s (157.0 – 300.0) in Dync1i1
G482D/G482D 
(p=0.2640). The mutant Dync1i1
G482D/G482D
 mice seemed to move sooner to a new 
compartment, but the result might reflect the fact that more wildtype Dync1i1
+/+ 
mice 
never left Alley 1 (Figure 3.9 A,B). Because mice ‘shuttled’ only between 2 compartments, 
they stayed for the rest of the testing period in Alley 2, with the median times measured 
for Dync1i1
+/+
: 0.0 s (0.0 – 9.5) and 11.0 s (0.0 – 23.5) for Dync1i1
G482D/G482D
. Number of 
entries into Alley 1 and 2 were the same and performance of the wildtype Dync1i1
+/+
 (0.0; 
0.0 – 1.2) did not vary from Dync1i1
G482D/G482D
 mice (1.0; 0.0 – 2.0) (p=0.3369) (Figure 
3.9 C, D).  
 
The Dync1i2
T172I
 mice were tested in two batches, and their behaviour strongly differed 
during the test. There were 5 wildtype (Dync1i2
+/+
) and 6 mutant (Dync1i2
T172I/T172I
) mice in 
the second batch tested, and almost all of them (except for 2) never left Alley 1. Because 
that behaviour was not informative and increased the skewness of the data sets when 
analysed (e.g. skewness value calculated for ‘Time in Alley 1’ increased 100% in Dync1i2
+/+
, 
and 28% in Dync1i2
T172I/T172I
), those mice were not taken into account during statistical 
analysis. From the first batch all but 2 Dync1i2
T172I
 mice left Alley 1, only 3 wildtype 
Dync1i2
+/+
 and 1 homozygous Dync1i2
T172I/T172I
 females entered Alley 3, and 2 passed all 
the way and reached Alley 4. Because they were not representative, the results from Alley 
3 and Alley 4 were not analysed.  
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Table 3.9. Performance of the Dync1i1
G482D
 and Dync1i2
T172I
 cohorts in the successive alleys 
Results are shown as median and IQR (interquartile range); on the left measurements performed, the results 
of Mann-Whitney test shaded; genotypes annotated as follows: wildtype (Dync1i1
+/+
), homozygous 
Dync1i1
G482D
 (Dync1i1
G482D/G482D
), wildtype (Dync1i2
+/+
), homozygous Dync1i2
T172I
 (Dync1i2
T172I/T172I
); n - 
number of animals tested; s – in seconds, time measured 
 
Measurement 
Dync1i1+/+ 
n=10 
Dync1i1G482D/G482D 
n=10 
Dync1i2+/+ 
n=9 
Dync1i2T172I/T172I 
n=8 
Alley 
1 
Time [s] 
300.0 
(290.5 - 300.0) 
289.0 
(276.5 - 300.0) 
283.0 
(271.0 - 295.5) 
282.5 
(263.8 - 294.0) 
p=0.2465 p=0.9615 
Alley 
2 
Time [s] 
0.0 (0.0 – 9.5) 11.0 (0.0 – 23.0) 17.0 (4.5 - 26.5) 17.5 (6.0 – 36.2) 
p=0.2465 p=0.6638 
Latency to 
enter [s] 
300.0 
(198.8 –300.0) 
210 
(157 – 300) 
105.0 
(37.5 - 197.5) 
111.0 
(38.5 – 245.0) 
p=0.2640 p=1.0000 
Number of 
entries 
0.0 (0.0 – 1.2) 1.0 (0.0 – 2.0) 2.0 (1.0 – 4.0) 2.0 (1.0 – 3.0) 
p=0.3369 p=0.7310 
 
 
 
Figure 3.9. Performance of the Dync1i1
G482D
 and Dync1i2
T172I
 mouse lines in tests for anxiety-like behaviour 
Results plotted as median and IQR (interquartile range), colours correspond to: wildtype Dync1i1
+/+
 (black), 
homozygous Dync1i1
G482D/G482D
 (red), wildtype Dync1i2
+/+
 (grey), homozygous Dync1i2
T172I/T172I
 (blue), time 
spent in each of compartments in seconds [sec]; because mice hardly entered Alleys 3 and 4 the results are 
shown only for Alleys 1 and 2; for Dync1i1
+/+ 
error bar marked in grey for a better visualisation; combined 
legends for A-B, C-D 
A. Median time spent in the Alley 1, compared with results reported for a cohort of healthy C57BL/6J 
(dashed line) and C57BL/6J mice with lesions in hippocampus (straight line) adapted from Deacon and 
Rawlins (2005) 
B. Median time before a mouse moved to Alley 2, compared with results reported for a cohort of healthy 
C57BL/6J (dashed line) mice 
C. Median time mice spent in Alley 2 
D. Median number of entries into Alley 2 
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There was no difference in the median time spent in Alley 1 (p=0.9615). Wildtype 
Dync1i2
+/+
 females (n=9) stayed for 283.0 s (271.0 – 295.5) while Dync1i2
T172I/T172I
 (n=8) 
stayed for 282.5 s (263.8 – 294.0) (Figure 3.9 A). Furthermore, the latency to enter a 
second compartment (Alley 2) was shorter by 100 s than in case of the Dync1i1
G482D 
mice, 
and nearly identical for both groups: Dync1i2
+/+
 entered Alley 2 after 105.0 s (37.5 – 
197.5), and Dync1i2
T172I/T172I
 entered at 111.0 s (38.5 – 245.0) (p=1.00) (Figure 3.9 B). Once 
in the Alley 2 Dync1i2
+/+
 mice stayed there for 17.0 s (4.5 – 26.5) and Dync1i2
T172I/T172I
 mice 
for 17.5 s (6.0 - 36.3), which was not different (p=0.6638). The analysis of number of 
entries to Alley 2 did not show differences between both groups (p=0.7310), with a 
median number of entries: 2 (1 – 4) in case of the wildtype Dync1i2
+/+
 mice and also 2 (1 – 
3) for Dync1i2
T172I/T172I
 (Figure 3.9 C, D).  
 
The performance of the Dync1i1
G482D
 and Dync1i2
T172I
 mice was compared with reported 
behaviour of healthy C57BL/6J and matched C57BL/6J with induced lesions in 
hippocampus (Deacon et al., 2002) (Figure 3.9 A, B). In general, both mutant cohorts were 
much slower in leaving the first compartment and stayed there much longer. This 
behaviour might be related with lower reactivity to a new situation, reduced exploration 
or much higher anxiety (also called emotionality).  
 
Light/dark Box is another test based on innate aversiveness to brightly light places. The 
main scope is assessing the preference for dark, small places, but it is also helpful in 
observations of the exploration level and alertness (Deacon and Rawlins, 2005). In the 
version of the test performed here, animals were placed in the dark compartment. The 
behaviour was scored for 5 minutes, during which the latency to emerge, number of 
entries to the light areas, time spent in light and defecations were recorded. Although the 
test seems to be straightforward to perform, there are many factors which constitute for 
the final performance. The summary with results of statistical analysis is shown in Table 
3.10. 
 
There were no differences in the ‘reaction’ time, when a mouse emerged from the dark 
box, between wildtype Dync1i1
+/+
 (n=10) and mutant Dync1i1
G482D/G482D
 (n=10) littermates 
(p=0.7328). In addition, 4 mice (2 wildtype Dync1i1
+/+
, 2 homozygous Dync1i1
G482D/G482D
) 
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never left the dark compartment which is in agreement with the results obtained with the 
successive alleys. On average, Dync1i1
G482D/G482D
 took slightly more time to exit the dark 
compartment (170.5 s; 65.8 - 273.8) than wildtype Dync1i1
+/+
 mice (142.5 s; 58.8 - 236.3) 
(Figure 3.10 A). Furthermore, Dync1i1
G482D/G482D
 mice stayed in the light compartment for 
as long as wildtype Dync1i1
+/+
 (24.6 s; 6.8 - 40.6 and 24.4 s; 2.2 - 53.6, respectively, 
p=0.8495) (Figure 3.10 B), and crossed the compartments similar number of times 
(p=0.8486). Finally, the events of defecation, which are thought to reflect fear and anxiety, 
were also comparable (p=0.7808), with 1.0 (0.0 - 3.0) recorded for Dync1i1
+/+
, and 1.0 (0.0 
- 1.2) recorded for Dync1i1
G482D/G482D
.  
 
When the Dync1i2
T172I
 mice were tested their overall performance did not show 
differences between the wildtype Dync1i2
+/+
 and mutant Dync1i2
T172I/T172I
 mice, although 
they stayed longer in dark and avoided light to a bigger extent than Dync1i1
G482D
 mice. 
Mutant Dync1i2
T172I/T172I
 females were slower to emerge from the dark (203.5 s; 129.0 - 
300.0) than wildtype Dync1i2
+/+
 mice (192.0 s; 34.0 - 242.0) (p=0.3440) (Figure 3.10 A). 
They also spent approximately 4.9 s (0.0 - 23.4) in the light chamber while wildtype 
Dync1i2
+/+
 stayed for 10.0 s (5.8 - 38.8) (p=0.0894). That behaviour was also reflected in 
lower number of entries to the light chamber as recorded for Dync1i2
T172I/T172I
 mice (1.0; 
0.0 - 1.5) when compared with the wildtype Dync1i2
+/+
 (1.0; 1.0 - 6.0) (p=0.0753) (Figure 
3.10 B, C). However, that result might be affected by the fact, that 4 Dync1i2
T172I/T172I
 
females never left the dark box. Finally, the events of defecation did not indicate 
increased fear reaction and it was recorded only for 3 wildtype Dync1i2
+/+ 
and 5 
Dync1i2
T172I/T172I
 mice (p=0.5673) (Figure 3.10 D).  
 
Interestingly, the Dync1i2
T172I
 cohort was slower than the Dync1i1
G482D
 mice to leave the 
dark, which is in the contrary to results obtained with the successive alleys. On the other 
hand, both cohorts tested (Dync1i1
G482D
 and Dync1i2
T172I
) performed much worse than 
reported for C57BL/6J (Deacon and Rawlins, 2005). The discrepancy might be caused by 
many factors, e.g. age of mice tested, handling.  
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Table 3.10. Performance of the Dync1i1
G482D
 and Dync1i2
T172I
 cohorts in the light/dark box 
Results are shown as median and IQR (interquartile range); on the left measurements performed, the results 
of Mann-Whitney test shaded; genotypes annotated as follows: wildtype (Dync1i1
+/+
), homozygous 
Dync1i1
G482D
 (Dync1i1
G482D/G482D
), wildtype (Dync1i2
+/+
), homozygous Dync1i2
T172I
 (Dync1i2
T172I/T172I
); n - 
number of animals tested; s – in seconds, time measured 
 
Measurement 
Dync1i1+/+ 
n=10 
Dync1i1G482D/G482D 
n=10 
Dync1i2+/+ 
n=13 
Dync1i2T172I/T172I 
n=14 
Latency to 
light [s] 
142.5 
(58.8 - 236.3) 
170.5 
(65.8 - 273.8) 
192.0 
(34.0 - 242.0) 
203.5 
(129.0 - 300.0) 
p=0.7328 p=0.3440 
Time in light 
[s] 
24.4 (2.2 - 53.6) 24.6 (6.8 - 40.6) 10.0 (5.8 - 38.8) 4.9 (0.0 - 23.4) 
p=0.8495 p=0.0894 
Entries to light 
3.0 (0.8 - 6.5) 2.5 (0.8 - 5.2) 1.0 (1.0 - 6.0) 1.0 (0.0 - 1.5) 
p=0.8486 p=0.0753 
Defecation 
1.0 (0.0 - 3.0) 1.0 (0.0 - 1.2) 0.0 (0.0 - 0.5) 0.0 (0.0 - 1.2) 
p=0.7808 p=0.5673 
 
 
 
Figure 3.10. Performance of the Dync1i1
G482D
 and Dync1i2
T172I
 cohorts in the light/dark box 
Results plotted as median and IQR (interquartile range), colours correspond to: wildtype Dync1i1
+/+
 (black), 
homozygous Dync1i1
G482D/G482D
 (red), wildtype Dync1i2
+/+
 (grey), homozygous Dync1i2
T172I/T172I
 (blue), time 
spent in each of compartments in seconds [sec]; values corresponding to C57BL/6J adapted from Deacon 
and Rawlins (2005) for Dync1i1
+/+ 
error bar marked in grey for a better visualisation; combined legends for A-
B, C-D 
A. Median time before a mouse moved from dark to light box, compared with results reported for a cohort 
of healthy C57BL/6J (dashed line) and C57BL/6J mice with lesions in hippocampus (straight line) 
B. Median time a mouse spent in the light compartment 
C. Median numbers of crosses between light/dark compartments, compared with results reported for a 
cohort of healthy C57BL/6J (dashed line) and C57BL/6J mice with lesions in hippocampus (straight line) 
D. Median number of defecations observed 
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3.4.4.5  Spatial working memory 
Assessing cognitive abilities of animals can be challenging, and usually certain domains are 
assessed, e.g. learning abilities or memory. In addition, the assessment of spatial memory 
in mice is often based on a natural tendency to explore and novelty-seeking. There are 
many tests designed to describe spatial memory, whether it is reference memory 
involving a reward, or spatial working memory based on exploration and novelty 
preference.  
 
Spatial working memory was assessed using a T-maze. Mice preferentially explore new 
location over the familiar one, and in the case of the T-maze they choose a new arm 
instead of the familiar one. This kind of behaviour is also called spontaneous alternation: 
the animal remembers an arm it entered during a first run and chooses another one in the 
second run. Thus, a healthy mouse should obtain high percent of alternations (over 50%). 
Data collected during sessions are usually expressed as a percent of correct alternations 
(‘the other arm’). In this case data were analysed as non-parametric data and all the 
values are presented as median and interquartile range (IQR). 
 
Dync1i1
G482D
 mice were tested at the age of 15 months. Twelve runs were performed over 
6 days and number of alternation was recorded. There were no differences between 
wildtype Dync1i1
+/+
 (n=10) and homozygous Dync1i1
G482D/G482D
 (n=10) females (p=0.2966), 
although mutant Dync1i1
G482D/G482D
 mice had higher score of correct alternations (95.8%, 
89.6 – 100.0) than wildtype Dync1i1
+/+
 littermates (87.5%; 81.2 – 100.0) (Table 3.11, Figure 
3.11 A). 
 
Dync1i2
T172I
 mice were also tested at the age of 15 months, and 20 runs were performed 
over 14 days. As above, the results were calculated as percentage of correct alternations 
and analysed as non-parametric data. Dync1i2
T172I/T172I
 mice (n=14) were found to 
alternate less than wildtype Dync1i2
+/+
 littermates (n=14). While wildtype Dync1i2
+/+
 
females alternate correctly 90% (80.0 – 90.0) of runs, mutant Dync1i2
T172I/T172I
 chose a new 
arm 82.5% (73.7 – 85.0) of all the runs (p=0.0174), which suggests an impairment in 
spatial working memory (Table 3.11, Figure 3.11 A). 
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Table 3.11. Performance of the Dync1i1
G482D
 and Dync1i2
T172I
 mice in T-maze 
Results are shown as median and IQR (interquartile range); on the left number of runs performed, the 
results of Mann-Whitney test shaded; genotypes annotated as follows: wildtype Dync1i1
+/+
, homozygous 
Dync1i1
G482D/G482D
, wildtype Dync1i2
+/+
, homozygous Dync1i2
T172I/T172I
; n - number of animals tested; for 
p<0.05 in bold 
 
T-maze 
Dync1i1+/+ 
n=10 
Dync1i1G482D/G482D 
n=10 
Dync1i2+/+ 
n=14 
Dync1i2T172I/T172I 
n=14 
Number of runs 12 12 20 20 
Percentage of 
correct 
alternations 
87.5 (81.2 –100.0) 95.8 (89.6 –100.0) 90.0 (80.0 – 90.0) 82.5 (73.7 – 85.0) 
p=0.2966 p=0.0174 
 
 
In order to confirm the deficits in the spatial working memory the Dync1i2T172I mice 
were tested for novelty preference in Y-maze, which consisted of 3 identical arms. In 
contrast to the T-maze, there was a 2 min long training session when mice were allowed 
to explore 2 arms (called Start and Other). This sample run was followed by 2 min long 
test run, during which another arm was opened (Novel) and animal’s behaviour was 
recorded. The preference for Novel arm over familiar Other arm of the maze was 
expressed by a discrimination ratio calculated for both number of entries and time spent 
in the Novel arm (Sanderson et al., 2009). Aditionally, the performance in the Y-maze is 
sensitive to deficits in spontaneous locomotor activity or exploratory motivation.  
 
The data were presented as mean ± SEM (standard error of the mean), whereas the 
novelty discrimination ratios (NDR) for time and number of entries were calculated as 
below: 
OtherNovel
Novel
TimeTime
Time
+
=TimeNDR
 (1), and OtherNovel
Novel
Entry EntryEntry
EntryNDR
+
=
 (2). 
In addition, the ratios were compared to a hypothetical value 0.5 using one sample t-test; 
p> 0.05 indicated a chance performance and lack of preference.  
 
 
113 
 
Figure 3.11. Performance of the Dync1i1
G482D
 and Dync1i2
T172I
 mice in tasks for working spatial memory  
Results from Y-maze plotted as means ± SEM (standard error of a mean), the legend refers to all graphs and 
colours correspond to: wildtype Dync1i1
+/+
 (black), homozygous Dync1i1
G482D/G482D
 (red), wildtype Dync1i2
+/+
 
(grey), homozygous Dync1i2
T172I/T172I
 (blue); sec – seconds, abbreviations used correspond to Start arm (S), 
Other arm (O), Novel arm (N) 
A. Percentage of correct alternations in a T-maze plotted as median and IQR (interquartile range), for 
Dync1i1
+/+ 
error bar marked in grey for a better visualisation 
B. Performance of the Dync1i2
T172I
 mice in Y-maze: value of discrimination ratio describing preference for a 
new location calculated for time (plain bars) and number of entries in arms (dotted bars); dashed line at 
Y=0.5 indicates chance performance 
C. Total time of exploration calculated as a sum of times a mouse spent in any of the arms, total duration 
of the test: 2 min (120 s) 
D. Total time of exploration split by arms mouse occupied for a given time 
E. Total number of entries recorded during the test 
F. Total number of entries split by the arms a mouse entered during the test 
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Both groups explored all 3 arm of the maze (Start, Other, Novel) for the same amount of 
time (p=0.3209), when Dync1i2
T172I/T172I
 mice (n=14) spent 92.5 ± 4.6 s and wildtype 
Dync1i2
+/+
 littermates 98.2 ± 3.3 s (Table 3.12). Comparison of times corresponding to 
distinct arms however, showed that homozygous Dync1i2
T172I/T172I
 mice spent on average 
less time in the Novel arm (38.9 ± 3.1 s) than wildtype Dync1i2+/+ (53.6 ± 6.0 s) (p=0.0426). 
Furthermore, both wildtype Dync1i2
+/+
 and Dync1i2
T172I/T172I
 occupied the Other (familiar) 
arm for the same time (p=0.7366), but homozygous Dync1i2
T172I/T172I
 stayed longer in the 
Start arm (24.6 ± 3.8 s) than wildtype Dync1i2+/+ animals (18.1 ± 2.8 s) (p=0.1796) (Figure 
3.11 C, D). A time-dependent discrimination ratio for a Novel arm preference described 
the level of exploration of an unfamiliar area. The value calculated for wildtype Dync1i2
+/+
 
animals was 0.677 ± 0.057, the result different from value (0.5) expected for a random 
choice (t(13)=3.100, p=0.0085) (Figure 3.11 B). On the other hand, the ratio of novelty 
preference calculated for the Dync1i2
T172I/T172I 
females was much lower (0.578 ± 0.041), 
and that result was very likely caused by random alternation and lack of preference 
(t(13)=1.920, p=0.0771). Likewise, the values of the discrimination ratio did not vary 
(p=0.1715) when wildtype Dync1i2
+/+
 and homozygous Dync1i2
T172I/T172I
 were compared. 
 
In a similar manner the number of entries into each arm of the Y-maze was analysed, as it 
often reflects exploratory motivation of a mouse. There were no differences detected in 
the total number of entries (p=0.2380) and homozygous Dync1i2
T172I/T172I
 mice (n=14) 
made on average more entries (11.6 ± 1.1) than wildtype Dync1i2
+/+
 littermates (n=14, 9.8 
± 1.0) (Table 3.12). The comparison of entries into individual arms revealed that 
Dync1i2
T172I/T172I
 mice entered Other (familiar) arm more often than wildtype Dync1i2+/+, 
with 3.9 ± 0.4 entries recorded for Dync1i2
T172I/T172I
 and 2.5 ± 0.3 entries for Dync1i2
+/+
 
(p=0.0164) (Figure 3.11 E, F). The difference may express a reduction in spontaneous 
alternation while exploration was not affected. Moreover, a trend could be observed 
when the mutant Dync1i2
T172I/T172I
 animals preferentially entered the Start arm 
(Dync1i2
+/+
: 2.0 ± 0.4 and Dync1i2
T172I/T172I
: 2.6 ± 0.3, p=0.1884), while wildtype Dync1i2
+/+
 
females chose more often the Novel arm (Dync1i2+/+: 5.3 ± 0.5 and Dync1i2T172I/T172I: 5.0 ± 
0.5, p=0.6924). Finally, the novelty discrimination ratio calculated for the number of 
entries was much higher in the group of wildtype Dync1i2
+/+
 animals (0.691 ± 0.033) than 
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in mutant Dync1i2
T172I/T172I
 (0.567 ± 0.024), which supported observations of reduced 
events of spontaneous alternation in homozygous Dync1i2
T172I/T172I
 mice (p=0.0054). 
Although the value of NDR was strongly reduced in the Dync1i2
T172I/T172I
 mice, it was not 
proven to be a result of random choices (one sample t-test, p=0.0164). 
 
In conclusion, while no deficits in spatial working memory were observed in the 
Dync1i1
G482D
 mouse line, the Dync1i2
T172I
 females had slightly impaired performance in the 
spontaneous alternation task. Furthermore, reduction in exploration of a new area and 
repetitive returning to a familiar location suggest impairment in the working memory. A 
comparable performance was described in the GluA1
-/-
 mice (Sanderson et al., 2009), and 
it would be beneficial to investigate long-term and reference memory in the Dync1i2
T172I
 
mice. 
 
 
 
Table 3.12. Performance of the Dync1i2
T172I
 mice in the Y-maze 
Results are shown as mean ± SEM (standard error of a mean); on the left parameter analysed; the results of 
unpaired t-test shaded; genotypes annotated as follows: wildtype Dync1i2
+/+
, homozygous Dync1i2
T172I/T172I
; 
n - number of animals tested, s – seconds, (1), (2) refer to equations used, reported two-tailed p values 
significant at p<0.05, * - unpaired t-test with Welch’s correction for unequal variances whereas 
F(13,13)=3.620 and p=0.0275; for p<0.05 in bold 
 
Observation 
Dync1i2+/+  
(n=14) 
Dync1i2T172I/T172I 
(n=14) 
Statistics 
Total exploration time [s] 98.2 ± 3.3 92.5 ± 4.6 p=0.3209 
Time spent in arms [s] 
Start 18.1 ± 2.8 24.6 ± 3.8 p=0.1796 
Other 26.5 ± 6.4 28.9 ± 3.5 p=0.7366 
Novel 53.6 ± 6.0 38.9 ± 3.1 p=0.0426 
Total number of entries 9.8 ± 1.0 11.6 ± 1.1 p=0.2380 
Number of entries in arms 
Start 2.0 ± 0.4 2.6 ± 0.3 p=0.1884 
Other 2.5 ± 0.3 3.9 ± 0.4 p=0.0164 
Novel 5.3 ± 0.5 5.0 ± 0.5 p=0.6924 
NDRTime  (1) 0.677 ± 0.057 0.578 ± 0.0409 p=0.1715 
NDREntry (2) 0.691 ± 0.033 0.567 ± 0.0245 p=0.0054 
Chance performance for NDRTime=0.5 p=0.0085 p=0.0771  
Chance performance for NDREntry=0.5 p < 0.0001 p=0.0164  
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3.4.5 Detailed gait analysis with CatWalk XT 
An analysis of gait is usually performed together with locomotor tasks and it is helpful in 
detecting abnormalities in the animal’s posture or difficulties during walking, which often 
accompany neurological deficits. The gait in the Dync1i1
G482D
 and Dync1i2
T172I
 mice was 
recorded and analysed using CatWalk XT, which is an automated system designed to 
capture paw prints during a free run. The system consists of an enclosed walkway on a 
glass plate that is illuminated from underneath and coupled with a high speed camera. An 
animal is let on a walkway and each footprint is recorded and classified. The images from 
the walking sequence are analysed and numerous parameters retrieved, e.g. width and 
length of an individual paw, relative print positions, sequence of footprints (Angeby-
Moller et al., 2008). The CatWalk XT has been applied in studies on neuropathic pain 
(Angeby-Moller et al., 2008), effects of sciatic nerve injury (Eickholt et al., 2007), ataxia 
associated with Refsum neuropathy (Ferdinandusse et al., 2008), recovery from early 
chronic spinal cord injury after transplantation of human neural stem cells (Salazar et al., 
2010), and many other studies. An example of a run is presented in Figure 3.12, when 
footprints are visible as areas and right/left sides marked green/red, respectively. 
 
The gait patterns were recorded for both mutant mouse lines (Dync1i1
G482D
 and 
Dync1i2
T172I
) and several parameters were analysed in detail. Parameters were 
automatically calculated by the CatWalk XT software and for each mouse values from 4 
successive runs were collected. Although it was possible to analyse data split into 4 sets 
corresponding to prints of all paws, means of front (left-right) and hind (left-right) paws 
prints, which were also computed, were chosen as raw data. By having done so, the 
reported bias towards higher values for one side than the other was avoided (Angeby-
Moller et al., 2008). Summing up, the gait of each mouse was described by comparing gait 
parameters of front and hind paws, which were defined by average of 4 runs. The means 
from 4 runs are therefore measurements referred to in following paragraphs. 
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Figure 3.12. An example of a footprint pattern registered with CatWalk XT 
Each paw is assigned in relation to an animal (left, right, front, hind) and after extracting background noise 
various parameters are measured. Picture kindly provided by Samantha Line 
 
 
In order to detect even mild effects of mutations on the mouse phenotype, multiple 
parameters, which quantified many aspects of the gait, were analysed. Initially, parameter 
values for front and hind prints (raw data) were grouped and their means compared 
between wildtype (Dync1i1
+/+
, Dync1i2
+/+
) and mutant (Dync1i1
G482D/G482D
, 
Dync1i2
T172I/T172I
) animals. Unfortunately, statistical testing with two-way repeated-
measures ANOVA probably lacked power and in some cases failed to give definite result 
within assumed 95% confidence intervals (Appendix 10.1). The difficulty might have 
resulted from the nature of measurements, because all the parameters were derived from 
objects (paw prints) identified automatically by the CatWalk software. Therefore, the 
quality of individual runs was also examined, and 3 runs from 3 mice were discarded (time 
of initial and maximum contact was above 3 s whereas average time was 0.8 s). In addition 
‘Print area’ was used to calculate front to hind paws area ratio (F/H), which served as a 
coefficient to control the quality of the raw data. The calculated values for area (F/H) were 
expected to be between 0.4 – 1.0 based on the assumption, that (1) front paws had 
smaller print area than hind paws (≤ 1), and (2) front paws were placed on the glass 
surface strongly enough to provide support during the walk. Proportional values for all the 
mice fitted in the boundaries described apart from 1 wildtype Dync1i1
+/+ 
 (1.22) and 1 
wildtype Dync1i2
+/+
 (0.27), which were not considered during analyses. In the second 
round, parameters for prints of front and hind paws were tied in proportions and 
expressed as relative values whenever possible; this operation reduced variation within 
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the subjects and facilitated hypothesis testing. The scatter of data was estimated by 
comparing values of coefficient of variation (% CV, see analysis of print width and length).  
 
The tested cohorts consisted of 10 wildtype Dync1i1
+/+
, 10 homozygous Dync1i1
G482D/G482D
, 
9 wildtype Dync1i2
+/+
, and 8 homozygous Dync1i2
T172I/T172I
 females, however, after 
detailed analysis 1 wildtype Dync1i1
+/+
 and 1 wildtype Dync1i2
+/+
 were discarded. For 
simplicity, all the descriptions and detailed results can be found in Appendix 10.1, while 
and only parameters, which differed between wildtype (Dync1i1
+/+
, Dync1i2
+/+
) and 
homozygous (Dync1i1
G482D/G482D
 or Dync1i2
T172I/T172I
) females are discussed here in details. 
The results, unless stated otherwise, are shown as mean ± SEM (standard error of the 
mean). There were few gait parameters, for which only trends were observed with values 
of p< 0.10: p=0.0636 for ‘Swing’ and p=0.0852 for ‘Print length’ in the Dync1i1
G482D
 cohort; 
p=0.0735 for ‘Maximum contact at’ in the Dync1i2
T172I 
cohort. The gait parameters, which 
associated with a mutant phenotype, were regularity index, base of support, and swing 
speed. 
 
Regularity index (%), which expresses number of steps in a sequence which are aligned 
with an established pattern relative to the total number of paw placements. The regularity 
is a fractional measure of inter-paw coordination and is often affected after a spinal cord 
injury. Theoretically, a healthy animal should reach 100%. Data were analysed using a 
non-parametric test (Mann-Whitney) and presented as median and interquartile range 
(IQR).  
 
Interestingly, the median RI for the Dync1i1
G482D/G482D
 mice (n=10; 100.0%; 99.00 - 100.0) 
was higher than median RI calculated for wildtype Dync1i1
+/+
 females (n=9; 98.5%; 97.5 - 
99.5) (p=0.0340) (Table 3.13).  
 
The median step regularity of the Dync1i2
T172I/T172I
 mice (n=8; 99.0%; 98.5 - 100.0) seemed 
to be slightly impaired when compared with wildtype Dync1i2
+/+
 (n=8; 100.0%; 100.0 - 
100.0) (p=0.0772) (Figure 3.13 A). 
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Base of support (BOS) is an average width between prints of front (left-right) or hind (left-
right) paws, and it is often used as a measure of animal stability during walking. 
Furthermore, the BOS parameter has been shown to be sensitive to gait impairment 
caused by a trauma to the spinal cord (Hamers et al., 2001).  
 
Since BOS values for front and hind paws did not vary, the ratio of BOS of front to hind 
paws - BOS (F/H) was calculated. The proportion (F/H) would reflect changes in the 
parameter for both pairs of paws and could be tested with unpaired t-test. That method 
proved to be sensitive enough, and differences in the paws placement were observed in 
the mutant Dync1i1
G482D/G482D
 mice (n=10; 0.520 ± 0.026) when compared with wildtype 
Dync1i1
+/  
littermates (n=9; 0.597 ± 0.019). The difference in the mean value of BOS (F/H) 
was an effect of simultaneous change in position of both sets of paws, with mean width of 
the front paws shorter by 0.9 mm, and the mean width of the hind paws longer by 1.0 mm 
(p=0.0289) when compared to the wildtype Dync1i1
+/+
 littermates. 
 
 
Table 3.13. Analysis of selected gait parameters of the Dync1i1
G482D
 and Dync1i2
T172I
 mice 
Results are shown as mean ± SEM (standard error of a mean) or as medians and IQR (interquartile range); on 
the left parameter analysed; genotypes annotated as follows: wildtype Dync1i1
+/+
, homozygous 
Dync1i1
G482D/G482D
, wildtype Dync1i2
+/+
, homozygous Dync1i2
T172I/T172I
; n - number of animals tested, m/s – 
meters per second, F/H refers to ratio(s) obtained by division of values for front paws by hind paws, 
WTH/LTH corresponds to ratio(s) obtained by division of width by length of a print; results of statistical tests 
shaded, *- unpaired t-test with Welch’s correction for unequal variances, F(7,7)=12.2700, F(DFn, DFd) is F 
ratio calculated for DFn: degrees of freedom for the numerator, DFd: degrees of freedom for the 
denumerator; reported two-tailed p values significant at p<0.05, bolded results of statistical tests where 
p<0.05 
Parameter 
Dync1i1+/+ 
n=9 
Dync1i1G482D/G482D 
n=10 
Dync1i2+/+ 
n=8 
Dync1i2T172I/T172I 
n=8 
Statistics 
Regularity 
Index (%) 
98.5 (97.5 - 99.5) 100 (99.0- 100) 100 (100- 100) 99.0 (98.5 - 100) Mann-
Whitney p=0.0340 p=0.0772 
Base of 
support 
F/H 
0.597 ± 0.019 0.520 ± 0.026 0.512 ± 0.042 0.533 ± 0.012 
Unpaired 
t-test p=0.0289 p=0.6389* 
WTH/LTH 
F 
H 
1.006 ± 0.016 
0.924 ± 0.016 
1.048 ± 0.012 
0.991 ± 0.023 
1.005 ± 0.041 
0.981 ± 0.015 
0.988 ± 0.031 
0.977 ± 0.020 
Two-way 
RM 
ANOVA 
 
F(1,17)=8.0690, p=0.0113 
Bonferroni post-test p<0.05 for H 
F(1,14)=0.1331, p=0.7207 
Swing 
speed 
[m/s] 
F 
H 
0.539 ± 0.060 
0.560 ± 0.041 
0.402 ± 0.030 
0.436 ± 0.037 
0.422 ± 0.027 
0.432 ± 0.025 
0.428 ± 0.029 
0.463 ± 0.031 
 F(1,17)=5.1380, p=0.0367 F(1,14)=0.2321, p=0.6374 
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Figure 3.13. Representative parameters calculated during gait analysis on the CatWalk XT (next page) 
Selected gait parameters plotted as means ± SEM (standard error of the mean), or median and IQR 
(interquartile range); a legend refers to all graphs below and colours correspond to: wildtype Dync1i1
+/+
 
(black), homozygous Dync1i1
G482D/G482D
 (red), wildtype Dync1i2
+/+
 (grey), homozygous Dync1i2
T172I/T172I
 (blue); 
mm – millimetres, mm
2
 – square millimetre, m/s – meter per second 
A. Regularity index (RI, median and IQR) is a measure of inter-paw coordination, fraction of steps which 
were placed within a pattern, for Dync1i1
+/+ 
error bar marked in grey for a better visualisation 
B. Base of support is a width between pairs of paws (front or hind), here expressed as a ratio of values for  
front to hind paws 
C. Front paw print parameters plotted as coordinates, when X – print length, Y – print width 
D. Hind paw print parameters plotted as coordinates, when X – print length, Y – print width 
E. Print ‘shape’ as determined by WTH/LTH ratio, when Y=1 defines square print, Y<1 print longer than 
wide (area shaded) 
F. Area of prints of front and hind paws, described in Appendix 10.1 
G. Speed of swing of front and hind paws, expresses speed of paws during swing phase (when paws are 
not touching the glass walkway) relates the stride length to duration of the swing phase 
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The homozygous Dync1i2
T172I/T172I 
(n=8) did not differ from wildtype Dync1i2
+/+
 (n=8) in the 
values obtained for BOS (p=0.8588). Neither values of BOS (F/H) suggested abnormal gait 
(p=0.6389), even though the homozygous Dync1i2
T172I/T172I
 showed a bit higher mean 
(0.533 ± 0.012) than wildtype Dync1i2
+/+
 littermates (0.512 ± 0.042) (Figure 3.13 B). 
 
Width and length [mm] of a paw print can be described as width and length of a rectangle 
containing a complete print, which depends on the spread and paw positioning on a 
surface. The measurements of print width and length were used to detect impairment in 
paw placement (Deumens et al., 2007) and monitor recovery after sciatic nerve injury 
(Bozkurt et al., 2008).  
 
Initially the paw print parameters (width-length) were grouped and the walking pattern 
was analysed for front and hind paws separately. In general the trend was observed within 
the Dync1i1
G482D/G482D
 mice suggesting differences in the shape of front and hind paws 
prints when compared with wildtype Dync1i1
+/+
 mice (width: p=0.2296, length: p=0.0852). 
As mentioned before, scatter was estimated with % CV, which ranged from 8.6 % to 21.7 
% in the data for front paws, and from 11.0 % to 18.0 % in the set of hind paws prints. On 
the other hand, by drawing both parameters in the proportion the number of data sets 
was reduced from 4 (width and length of front and hind paws) to 2 (front - hind paws). In 
addition, the variation within new parameters (WTH/LTH) in both cohorts did not exceed 
11.6 % for front paws or 7.2 % for hind paws. Furthermore, both parameters (width-
length) served as coordinates in a two-dimensional space thus a placement of each paw 
could be described as relative outcome of a toe spread (width), and the use of plantar 
surface of a paw (length) (Figure 3.14).  
 
 
Figure 3.14. Schematic representation of relation between print parameters generated with CatWalk XT  
A footprint is recorded for each paw when it is placed on the walkway; parameters described correspond to 
measurements taken during stand phase: print width [mm] (vertical arrow) and length [mm] (horizontal 
arrow) parameters reflect the foot placement and toe spread. Print area [mm
2
] corresponds to the total 
surface, adapted from ‘CatWalk XT 8.1 Reference Manual’, Noldus Information Technology 
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Mutant Dync1i1
G482D/G482D
 mice (n=10) tended to display smaller prints of front and hind 
paws than wildtype Dync1i1
+/+
 littermates (n=9), in terms of both width/length and area 
(Figure 3.13 C, D, F; Appendix 10.1). However, mean WTH/LH ratios calculated for front 
(1.048 ± 0.012) and hind (0.991 ± 0.023) paws of Dync1i1
G482D/G482D
 animals were bigger 
than the relative values calculated for front (1.006 ± 0.016) and hind (0.924 ± 0.016) paws 
of Dync1i1
+/+
 (p=0.0113). The diversity resulted mostly from different parameters for hind 
paws prints (Bonferroni post-test p< 0.05) (Figure 3.13 E). The results suggested a subtle 
change in the placement of paws during walking observed in the homozygous 
Dync1i1
G482D/G482D
 females, with an increase in print width corresponding to spread of toes 
or decrease in print length reflecting lifting a part of foot above the glass surface. 
 
On the other hand there were no differences in relative print size between homozygous 
Dync1i2
T172I/T172I
 (n=8) and wildtype Dync1i2
+/+
 females (n=8) (p=0.7207), although prints 
recorded for front and hind paws of the Dync1i2
T172I/T172I
 animals were slightly longer 
(WTH/LTH <1.0) than corresponding prints of wildtype Dync1i2
+/+
 animals (Figure 3.13 E).  
 
One of the parameters describing dynamic movement of paws is swing speed, which 
expresses the speed of paws during swing phase. It is calculated as ratio of stride length 
[mm] to time of swing [s] with m⁄s as a unit, where stride is a distance between successive 
placements of the same paw, and swing describes the time, during which a paw is lifted 
and does not contact a glass plate.  
 
The mean swing speed of front and hind paws recorded for the Dync1i1
G482D/G482D
 females 
(n=10; 0.402 ± 0.030 
m
⁄s and 0.436 ± 0.037 
m
⁄s, front and hind paws respectively) was 
smaller than in the wildtype Dync1i1
+/+
 (0.539 ± 0.060 
m
⁄s, and 0.560 ± 0.041 
m
⁄s) 
(p=0.0367). The swing speed is an outcome of many parameters, which affect the mouse 
gait; as mentioned before, the Dync1i1
G482D/G482D
 females had smaller paws prints, which 
might result in shorter strides (e.g. Dync1i1
G482D/G482D
 hind paws were placed on average 
every 50.4 ± 1.6 mm and 54.0 ± 2.4 mm in Dync1i1
+/+
) and longer swing phase (e.g. hind 
paws lifted for 124.5 ± 7.3 ms in Dync1i1
G482D/G482D
 and 106.2 ± 6.7 ms in Dync1i1
+/+
).  
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Furthermore, Dync1i2
T172I/T172I
 (n=8) and Dync1i2
+/+
 (n=8) mice did not vary in the swing 
speed (p=0.6374), however, their performance was very similar to mean values observed 
for the Dync1i1
G482D/G482D
 females (0.432 ± 0.025
m
⁄s, and 0.463 ± 0.031
m
⁄s for Dync1i2
+/+
 
and Dync1i2
T172I/T172I
 hind paws respectively) (Figure 3.13 G).  
 
The parameters discussed above suggest differences in the locomotor performance 
caused by the Dync1i1
G482D
 mutation, when positioning of paws and speed of paws 
placement seem to be affected the most. The deficit, however, was limited only to few 
parameters, and it is likely to be associated with a mild phenotype. On the other hand, the 
Dync1i2
T172I/T172I
 females did not vary from wildtype Dync1i2
+/+
 littermates in any of the 
parameters analysed. Furthermore, there were no differences in the weight within 
animals from the same cohort; although Dync1i2
T172I
 mice were slightly heavier than 
Dync1i1
G482D
 females (see section 3.4.4.2). In addition, in some cases dissimilarities were 
noted between cohorts of the wildtype (Dync1i1
+/+
 and Dync1i2
+/+
) females, which were 
likely to be caused by the variation in the genetic background. 
 
CatWalk XT was initially developed to study gait impairment in rats (Hamers et al., 2001) 
but it has been successfully adapted to mouse. Thanks to automated data collection and 
multiparametric analysis the accuracy and sensitivity of measurements are greatly 
improved when compared with a traditional method of ink and paper. On the other hand, 
there are many factors known to affect the measurements and interpretation of results, 
including weight of animals and speed of movement. Therefore, some researchers train 
animals to move fluently before the recorded runs (Bozkurt et al., 2008). Moreover, high 
variation was observed within measurements recorded for the Dync1i1
G482D
 and 
Dync1i2
T172I
 mice, therefore raw data were checked before final analysis.  
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3.4.6 Histological analysis of brains of the Dync1i2T172I/T172I mice 
Saggital sections of brains isolated from 6 months old wildtype Dync1i2
+/+
 and 
homozygous Dync1i2
T172I/T172I
 females were stained and their morphology assessed, with 
focus on hippocampal formation and cerebellum, where dynein intermediate chain 2 was 
found to be expressed at high levels (Allen Mouse Brain Atlas, ©2009 by the Allen 
Institute for Brain Science, http://mouse.brain-map.org) (Figure 3.15). Apart from general 
staining with H&E, specific antibodies against glial fibrillary acidic protein (GFAP) and 
calbindin (CALB1) were used, which expression is often affected in neurological deficits. In 
general, on the anatomical level no differences were found between brain structures of 
the aged wildtype Dync1i2
+/+
 and homozygous Dync1i2
T172I/T172I
 females (Figure 3.16 and 
Figure 3.17). 
 
 
 
 
 
 
 
Figure 3.15. Expression patterns of cytoplasmic dynein subunits in mouse brain 
In situ-hybridisation with probes detecting Dync1i2 adapted from Allen Mouse Brain Atlas (©2009 by the 
Allen Institute for Brain Science, http://mouse.brain-map.org) showing expression pattern (top) and relative 
abundance where red corresponds to high and blue to low signal (bottom) 
A., D. whole brain, scale bar 2.0 mm 
B., E. hippocampus, scale bar 500 µm 
C., F. cerebellum, scale bar 500 µm 
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Figure 3.16. Representative pictures of hippocampi isolated from Dync1i2
T172I
 mice 
Brain sections of wildtype Dync1i2
T172I
 and homozygous Dync1i2
T172I/T172I
 mice were stained with 
heamatioxylin and eosin (H&E), antibodies against glial fibrillary protein (GFAP), and calbindin; scale bar 500 
µm 
 
 
 
 
Figure 3.17 Representative pictures of cerebella isolated from Dync1i2
T172I
 mice (next page) 
Brain sections of wildtype Dync1i2
T172I
 and homozygous Dync1i2
T172I/T172I
 mice were stained with 
heamatioxylin and eosin (H&E), antibodies against glial fibrillary protein (GFAP), and calbindin; scale bar 500 
µm 
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3.5 Discussion 
In Chapter 3 we describe the origin of 2 novel mouse mutants carrying ENU-induced point 
mutations in the cytoplasmic dynein intermediate chains 1 and 2 and the analysis of their 
phenotype. Detailed behavioural test were also carried out, after carefully considering the 
breadth of possible mutant phenotype and time constrains. The mutations identified: 
Dync1i1
G482D
 and Dync1i2
T172I
 are placed in different domains of the intermediate chains, 
which were predicted to participate in interactions between different subunits of the 
cytoplasmic dynein complex. 
 
Both mutant mouse lines were established on the C57BL/6J genetic background and 
homozygous Dync1i1
G482D/G482D
 and Dync1i2
T172I/T172I
 animals were viable, therefore their 
phenotype was tested in relation to wildtype littermates (Dync1i1
+/+
 and Dync1i2
+/+
). 
While no breeding data of the Dync1i1
G482D
 line were available, the Dync1i2
T172I
 mutation 
did not affect an allele transmission, Dync1i2
T172I/T172I
 mice were fertile and showed 
slightly longer survival (section 3.4.2). In addition, the presence of both mutated alleles 
(Dync1i1
G482D
 and Dync1i2
T172I
) did not affect an embryo development at least till E14.5 
(section 3.4.3). 
 
The phenotypes arising from mutations are discussed in sections 3.5.1 and 3.5.2, and 
behavioural traits which were not affected are summarised below. Both mouse lines had 
normal motor functions (see Dync1i1
G482D
 mice discussed in details), consumed the same 
amounts of food, water, and glucose solution maintaining very similar weight. Behaviour 
typical for rodents was not affected, as assessed by measuring locomotor activity, 
burrowing and nesting skills. When anxiety-like behaviour was tested mice did not 
perform very well (did not leave apparatus), thus small differences might have been 
missed. Finally, while performance of the Dync1i1
G482D
 mice on the spatial working 
memory task was normal, the spatial working memory was impaired in the Dync1i2
T172I
 
mice (Table 3.14).  
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Table 3.14. Summary of behavioural phenotypes of the Dync1i1
G482D
 and Dync1i2
T172I
 mouse lines 
Results of tasks performed presented based on the results of statistical tests, where n.s. corresponds to lack 
of significant differences for p>0.05; trends were noted if p<0.1; NRD – novelty discrimination ratio; 
genotypes correspond to homozygous mutant Dync1i1
G482D/G482D
 or Dync1i2
T172I/T172I 
animals; N/A – not 
applicable 
 
Behaviour/task Dync1i1G482D Dync1i2T172I 
 Locomotion (section 3.4.4.1) 
Accelerating rotarod n.s. n.s. 
Multiple 
static rods 
Orient 
n.s. (Dync1i1G482D/G482D  
turned faster on rod 1) 
n.s. 
Traverse n.s. n.s. 
Wheel 
running 
Distance 
Dync1i1
G482D/G482D 
tended to run less 
n.s. 
Average speed 
Dync1i1
G482D/G482D 
tended to run slower 
n.s. 
Maximum speed n.s. 
Dync1i2
T172I/T172I tended 
to run slower 
 Metabolic functions (section 3.4.4.2) 
Animal weight  n.s. n.s. 
Food consumption n.s. n.s. 
Water consumption n.s. n.s. 
Glucose consumption (7.5%) n.s. n.s. 
 Species specific behaviour (section 3.4.4.3) 
Circadian activity n.s. n.s. 
Burrowing n.s. n.s. 
Nesting n.s. n.s. 
 Anxiety-like behaviour (section 3.4.4.4) 
Successive 
alleys 
Time in alley 1 n.s. n.s. 
Time in alley 2 n.s. n.s. 
Number of entries to alley 2 n.s. n.s. 
Light/dark 
box 
Latency to emerge from dark n.s. n.s. 
Time spent in light n.s. 
Dync1i2
T172I/T172I tended 
to spend less time 
Number of entries to light 
compartment 
n.s. 
Dync1i2
T172I/T172I tended 
to make fewer entries 
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Table 3.14. Continued 
Behaviour/task Dync1i1
G482D
 Dync1i2
T172I
 
 Spatial woking memory (short-term habituation) (section 3.4.4.5) 
T-maze (number of correct alternations) n.s. 
Dync1i2
T172I/T172I made 
fewer alternation 
Y-maze 
Exploration time N/A n.s. 
Time spent in novel arm N/A 
Dync1i2
T172I/T172I  spent 
less time 
Time spent in other (familiar) 
arm 
N/A n.s. 
NRDTime N/A n.s. 
Total number of entries N/A n.s. 
Number of entries to novel 
arm 
N/A n.s. 
Number of entries to other 
(familiar) arm 
N/A 
Dync1i2
T172I/T172I made 
more entries 
NRDEntry N/A 
Dync1i2
T172I/T172I  showed 
lower values 
 Gait (section 3.4.5) 
Regularity index 
Dync1i1
G482D/G482D 
showed increase 
n.s. 
Base of support (front/hind paws) 
Dync1i1
G482D/G482D 
showed decrease 
n.s. 
Foot print (widht/length) 
Dync1i1
G482D/G482D 
showed increase 
n.s. 
Swing speed 
Dync1i1
G482D/G482D 
showed decrease 
n.s. 
 
 
 
Several of the tasks described in the chapter showed, that both cohorts were diverse 
despite having been bred with a well known inbred mouse strain (C57BL/6J ). All mice 
were housed and tested in the same environment, but they were established and bred 
with C57BL/6J in two places (MRC Harwell and MRC Prion Unit). Furthermore, the 
Dync1i1
G482D
 were at N4 and Dync1i2
T172I
 at N5 when all the tasks described were 
performed, therefore the genetic background was the most likely factor responsible for 
variation observed between wildtype Dync1i1
+/+
 and Dync1i2
+/+
. 
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3.5.1 Mutant phenotype caused by the Dync1i1G482D mutation  
Mutant animals, homozygous for the new allele (Dync1i1
G482D/G482D
) were compared with 
littermates carrying the wildtype version of the gene (Dync1i1
+/+
). However small, there 
were differences observed in gait, namely increase in step regularity, paws placement and 
decrease in speed of paws movement. Furthermore, homozygous Dync1i1
G482D/G482D
 
females oriented faster than wildtype Dync1i1
+/+
 on the widest static rod (p=0.0319), and 
all but one Dync1i1
G482D/G482D
 females shredded all the material used for nest while two 
Dync1i1
+/+
 animals left twice as much nest-let untorn.  Although the observations were 
not conclusive, an increase in paw coordination in the Dync1i1
G482D/G482D
 animals would 
explain faster orientation on the rod and more effective shredding. Building a nest 
involves use of fore paws to pull material apart and break it down (Upchurch and 
Schallert, 1983).  
 
In addition, performance of the mutant Dync1i1
G482D/G482D
 mice on the running wheel was 
worse than Dync1i1
+/+
 littermates, regarding both average speed (p=0.0618) and distance 
run (p=0.0665). Because the results obtained on rotarod were comparable for both 
Dync1i1
+/+
 and Dync1i1
G482D/G482D
 mice, fatigue was not the factor affecting the wheel 
running. On the other hand, wheel running could also reflect the ability to learn motor 
skills, and the steady increase in running speed was often used as a learning index. A 
similar reduction in running was reported for a mutant Foxp2
R552H/+
 mouse line, which 
apart from impaired motor learning skills, displayed also deficits in synaptic plasticity. 
Interestingly though, neither Foxp2
R552H/+ 
nor Dync1i1
G482D/G482D
 mutant mice differed from 
wildtype animals when anxiety and working memory were tested (Groszer et al., 2008).  
 
Gait is often affected by impairment or damage to the central nervous system. Solberg et 
al. (2006) carried out a comprehensive quantitative analysis of various parameters across 
4 modes of locomotion, showing that defects of overground walking could be detected 
with high accuracy by assessing body height, base of support, stride length, paw position, 
front hind paws coordination, and pattern of footfalls. Furthermore, animal’s gait 
depended on a nature of injury or manipulation, and distinct parameters also differed 
accordingly. The examples of gait parameters assessed in various conditions using the 
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CatWalk XT system are given for comparison in Table 3.15. The gait of the 
Dync1i1
G482D/G482D
 females might share characteristics with a model of neuropathy and 
sciatic nerve injury. On the other hand, the increase in the paw width in relation to paw 
length (WTH/LTH) seemed to be unique feature of the mutant Dync1i1
G482D
 mice. In a 
model of the sciatic nerve injury the increase in the print length is accompanied by 
decrease in the spread of toes due to denervation of foot muscles (Deumens et al., 2007).  
 
 
 
 
Table 3.15. Summary of changes in gait parameters recorded with the CatWalk XT  
Three rodent models presenting different neurological deficits were compared in relation to the 
Dync1i1
G482D
 mice, on the left selected gait parameters, in bold features similar to the Dync1i1
G482D
 mouse 
line, in case of sciatic nerve injury 2 publications are referred and distinguished by underline; arrows indicate 
direction of change (↓ decrease or ↑ increase), paws taken into account marked as F – front paws, H – hind 
paws, F/H – ratio of front to hind paws, HL/HR – ratio of left to right hind paw, arbitrary annotation used to 
measure effects of an unilateral injury, WTH/LTH – ratio of width to length of a print, n. s. – effect not 
significant, in brackets arrows indicate direction of a trend observed 
 
Deficit and 
reference 
Dync1i1
G482D
 
Neuropathy induced 
by phytanic acid 
(Refsum disease) 
Ferdinandusse et al., 
(2008) 
Neurotmesis (sciatic 
nerve resection) or 
sciatic nerve crush 
Bozkurt et al., (2008) 
Deumens et al., (2007) 
Neuropathic pain in 
induced monoarthritis 
 
Angeby-Moller et al., 
(2008) 
Model used Mouse Phyh-/- mouse Adult rat Adult rat 
Regularity ↑  
n.s. 
n.s 
↓ 
BOS 
↓ (F/H) 
↓ (H) ↑ (F) 
↓ (H), F n.s. ↓ (H)  
Stride 
length 
n.s.  n.s.  
Print area n.s. (↓) ↓ (F, H) 
↓ (HL/HR) 
↓ (HL/HR) 
↓ (H) 
Print width 
n.s. (↓) 
↑ WTH/LTH 
↓ (H) 
↓ (HL/HR) 
↓ (HL/HR) 
 
Print length n.s. (↓)  
↓ (HL/HR) 
↓ (HL/HR) 
 
Swing n.s. (↑)  
↓ (HL/HR) 
↑ (HL/HR) 
 
Stand n.s. n.s. 
↓ (HL/HR) 
↓ (HL/HR) 
↓ (H) 
Swing 
speed 
↓  ↓ (HL/HR)  
Duty cycle n.s (↓)  ↓ (HL/HR)  
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3.5.2 Defects in the short-term memory in the Dync1i2T172I/T172I mice  
There are several types of memory distinguished in the behavioural studies, and often the 
same apparatus is used with various setups, depending on a method of data collection 
and analysis different behaviours are described. Therefore, a phenotype displayed by the 
Dync1i2
T172I
 mutant mice was compared with a mouse model, which had a similar 
performance under the same conditions. The Dync1i2
T172I
 mice were tested in the novelty 
preference task with 2 min habituation in the Y-maze, the results were recorded and 
analysed as described in Sanderson et al., 2009. The comparison of two parameters (time 
spent and arm entries) showed that mutant Dync1i2
T172I/T172I 
females performed in a very 
similar fashion as GluA1
-/-
 mice, which supports the notion of an impaired working (short-
term) memory. Moreover, this outcome was not replicated in mice with lesioned 
hippocampal formation (Sanderson et al., 2009). The deficits in the GluA1
-/-  
mice were 
specifically restricted to working memory, whereas long-term memory was enhanced and 
learning crucial for spatial reference memory intact, thus evaluation of the 
Dync1i2
T172I/T172I
 mice in relevant task would be priority.  
 
The discrepancy in the nomenclature should also be noted, as spontaneous alternation in 
rodents does not model perfectly human working memory; therefore, Sanderson and 
Bannerman, (2010) suggested a term of short-term habituation to spatial stimuli.  
 
3.5.3 Future directions 
Two new mutant mouse lines carrying single point mutations in the cytoplasmic dynein 
intermediate chains, Dync1i1
G482D
 and Dync1i2
T172I
 are a valuable resource and extend the 
knowledge of the cytoplasmic dynein complex. Both mutations cause distinct phenotypes 
when present in the homozygous state, with Dync1i1
G482D/G482D
 affecting gait and possibly 
causing mild neuropathy and Dync1i2
T172I/T172I
 impairing working spatial memory. Both 
phenotypes are specific to these lines and were not described in any of the known mouse 
lines with mutations in other subunits of the cytoplasmic dynein (see section 1.5.1). 
Nonetheless, in all the mutants characterised so far the mutations cause various neuronal 
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deficits, thus supporting notion of the importance of the cytoplasmic dynein complex in 
functions of neurons.  
 
Because the mutant phenotypes were mild, there were few traits which would require 
more detailed analysis, including more mice, mixed sex, or cohorts of mice at different 
age. Likewise, The performance of the Dync1i1
G482D/G482D
 mice on a running wheel 
suggested a decrease in the motor skills which might be related to the learning ability. On 
the other hand, data obtained during gait analysis point towards deficits in the peripheral 
nerves or distinct coordination. Therefore, more detailed tasks evaluating learning, precise 
paw movement (e.g. grasping, (Kieran et al., 2005; Tucci et al., 2007) or physiological 
measurements of nerve conductance would be required.  
 
As far as the homozygous Dync1i2
T172I/T172I
 mice were concerned, it would be crucial to 
assess the functions of reference and long-term memory. Furthermore, brains isolated 
from mutant Dync1i2
T172I/T172I
 animals were structurally normal; the functional analysis of 
hippocampal region and neuronal plasticity might be helpful in dissecting the roles of 
cytoplasmic dynein in formation of memory. Recently, electrophysiology was combined 
with fMRI in a study of working memory deficits related to neurofibromin resulting in a 
model of increased inhibition of a circuits in medial prefrontal cortex (mPFC) (Shilyansky et 
al., 2010). Furthermore, although time consuming, the long term observation of survival 
of bigger (over 20 per genotype) cohorts would bring definite answers as to the impact of 
the Dync1i2
T172I
 mutation on the longevity of a mouse.  
 
Introduction of additional mutant alleles by crossing different lines often results in 
progeny displaying modified phenotype or completely new features, as in case of the 
Dync1h1
Loa
 mice (Banks et al., 2009; Kieran et al., 2005). Therefore, another step would be 
characterisation of double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 mice, as so far 
we only know that the presence of both alleles does not cause developmental deficits at 
least till midgestation (section 3.4.3). 
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So far several mutant alleles of mouse cytoplasmic dynein 1 intermediate chains (Dync1i1, 
Dync1i2) have been deposited in the International Mouse Strain Resource database (IMSR, 
v.2.45, http://www.findmouse.org). The majority of mutations have arisen in a gene 
trapping or targeted mutagenesis experiments and causes disruption of a gene structure 
(null allele); those are available as embryonic stem (ES) cell lines. The ES cell lines carrying 
null alleles of Dync1i1 have been generated by the NIH Knock-Out Mouse Project (KOMP, 
CSD30098) while conditional knock-out alleles of the Dync1i2 have been created by 
European Conditional Mouse Mutagenesis Program (EUCOMM, ID 31464) at the 
Wellcome Trust Sanger Institute, UK. As for today, the transmission of a targeted mutation 
in the Dync1i2 gene to a germ line and the mutant genotype of the progeny have been 
confirmed, yet a phenotype of mutant animals needs to be assessed. More details can be 
found at the International Knock-out Mouse Consortium website 
(http://www.knockoutmouse.org). All those line will further our understanding in the 
functions of the cytoplasmic dynein intermediate chains. 
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4. Insight into effects of single point mutations in the cytoplasmic dynein 
intermediate chains Dync1i1G482D and Dync1i2T172I using cellular models 
 
4.1 Characteristics of mouse embryonic fibroblast cell lines 
Fibroblasts are heterogeneous population of cells present in stroma of all organs, although 
their features are not well defined. In adult mammals fibroblasts produce extracellular 
matrix (EMC), thus providing mechanical support and a framework for organs. 
Furthermore, they can produce cytokines in response to tissue damage (Flavell et al., 
2008). The functional heterogeneity may reflect different cellular populations (primary 
mesenchyme, local epithelial mesenchyme, bone marrow precursors) from which 
fibroblasts are thought to originate. Usually, fibroblasts were characterised as terminally 
differentiated cells, adherent to plastic, which displayed contact inhibition, and generate 
EMC. In addition, the cellular markers associated with fibroblasts included vimentin (VIM), 
α-smooth muscle α-actin (α-SMA), collagen I (COL1A1) (Alt et al., 2011). However recently, 
the usefulness of these diagnostics was questioned, because for example commonly used 
human skin-derived fibroblasts (hSDFs) displayed the same cellular markers and 
differentiation potential as adipose tissue-derived stem cells (hASCs) (Alt et al., 2011). 
 
Mouse embryonic fibroblasts (MEFs) are isolated from ventral tissues of a whole embryo 
between E12.5 – E14.5 days of age, and they are used to study genetic alteration, cell 
differentiation, or as a feeder layer for embryonic stem cells (ESC). MEFs are primary cells, 
which display signs of cellular senescence, which limits the ‘life-span’ to 10-20 passages 
(vom Brocke J. et al., 2006). This feature, however, results from oxidative stress in 
culturing conditions (~ 20% of oxygen) and the process of senescence can be withheld 
when fibroblasts are kept in atmosphere with low (3%) oxygen levels. Nonetheless, if kept 
in culture, MEFs immortalise spontaneously due to genetic alterations, which resemble 
transformations seen in tumours, with the majority of genetic aberrations located in 
known suppressor genes (e.g. p53/p19
ARF
) (Odell et al., 2010). The immortalisation often 
follows a period of limited growth, and increase in proliferation indicates the outgrowth of 
transformed clones.  
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The first stable MEF lines were derived from spontaneously mutated clones, and this 
feature was reflected in cell properties, which differed depending on the conditions 
employed (Todaro and Green, 1963). The immortalised Swiss/3T3 MEF line displayed 
contact inhibition and inability to form tumours when transplanted into a mouse, in spite 
of bearing chromosomal rearrangements and hypotetraploidity. 
 
MEFs were used to study cytoskeletal rearrangements and signalling pathways active 
during wound healing. In migrating cells necdin (NDN) initiated polarisation of 
cytoskeleton via cell division cycle 42 (CDC42) mediated phosphorylation of myosin light 
chain (MLC) (Bush and Wevrick, 2010), while protein phosphatase 1, regulatory (inhibitor) 
subunit 15A (PPP1R15A) was shown to regulate both translation via eIF2α, and migration 
by inhibiting expression of non-muscle myosin heavy chain 2A (MYH9) (Tanaka et al., 
2010). Furthermore, MEFs were used as a support for embryonic myoblasts, increasing 
their attachment and differentiation in cardiac cells (Pfannkuche et al., 2010).  
 
Embryonic fibroblasts originate from mesenchymal cells and specific tissue lineages can be 
derived in the presence of morphogenetic factors. S-phase kinase-associated protein 2 
(SKP2) was shown to be a component in the adipocyte differentiation pathway (Okada et 
al., 2009), adipogenesis was also induced by treatment with a bone morphogenetic 
protein 2 (BMP-2) (Sun et al., 2009). In addition, depending on the BMP-2 concentrations 
MEFs were transformed in chondrocytes via up regulation of SRY-box containing gene 9 
(SOX9) transcription (Pan et al., 2008). Adipocitic and osteoblastic potentials of MEFs were 
found to be modified by Krüppel-like factor 7 (KLF7) (Caiazzo et al., 2010). Moreover, 
MEFs can be reprogrammed into pluripotent stem cells (iPSC), with features of stem cells 
on both, transcriptional and epigenetic levels. Examples of proteins involved in the 
reversal include an orphan nuclear steroid hormone receptor β (ESRRB) acting with 
transcription factors (POU5F1 and SOX2) (Feng et al., 2009), or human mitochondrial 
ribosomal protein S18-2 (MRPS18-2) (Kashuba et al., 2009). 
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4.2 Roles of the cytoplasmic dynein complex in retrograde vesicular 
transport 
The intra-cellular trafficking is one of the basic properties of a cell regardless of the 
organism or a cell type. Retrograde transport often refers to the dynein dependent 
movement of a vesicular compartment, which consists of endosomes, Golgi network, and 
endoplasmic reticulum (ER). A general mechanism involves internalisation of a cargo 
(receptor, proteins) at the plasma membrane and formation of early endosomes (EE). 
Endosomes are transported to perinuclear endocytic recycling compartment (ERC), where 
cargo is sorted from receptors (Stenmark, 2009). During the sorting, receptors and 
cargoes are directed to subsequent compartments, whose functions are well determined: 
recycling endosomes move receptors back to the plasma membrane (e.g. transferrin 
receptor, TfnR), late endosomes (LE) fuse with lysosomes and cargoes are degraded after 
fusion with lysosomes or phagosome (e.g. EGF receptor, EGFR), or endosomes can enter 
trans-Golgi network (TGN). In addition many enzymes and structural proteins are shuffled 
from ER back to the Golgi complex (Johannes and Popoff, 2008 and references therein).  
 
Each step on the route is strictly regulated and often involves several protein complexes 
interacting in a well defined manner. All the events are controlled by RAB GTPases, whose 
presence identifies a membrane compartment and they are actively involved in vesicle 
budding, fusion, recruitment of effectors and motility (Stenmark, 2009). There are over 60 
different RAB GTPases known in the human genome, and the GTP hydrolysis causes 
conformational change, which is necessary for docking at the membrane. Many of RAB 
GTPases have been characterised, including RAB5, which initiates vesicle budding and 
early endosomes formation. During maturation to late endosomes RAB5 is replaced with 
RAB7, which directs vesicles to degradation. On the other hand, RAB4 and RAB11 are 
found in the compartment of fast and slow recycling endosomes (Chen et al., 2008). The 
dynein complex does not only move early endosomes towards the Golgi complex as it also 
promotes receptor sorting, membrane fusion and maturation to late endosomes (Driskell 
et al., 2007). In addition, cytoplasmic dynein was found to interact with sorting nexin-4 
(SNX4) and WW, C2 and coiled-coil domain containing protein 1 (WWC1/KIBRA) (Traer et 
al., 2007). Discrete endocytic compartments are associated with cytoplasmic dynein, 
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which is recruited to vesicles by RAB GTPases and their accessory complexes, however the 
mechanisms of its recruitment and detailed interactions are not always known 
(Hutagalung and Novick, 2011).  
 
In parallel with characterisation of mutant mouse lines, we assessed effects of the single 
point mutations in various subunits of the cytoplasmic dynein complex on the retrograde 
trafficking in MEFs. 
 
4.2.1 Assembly and positioning of Golgi apparatus 
The Golgi complex lies next to the MTOC, and is an organelle with both distinct functions 
and spatial organisation. It forms ribbon made of interconnected stacks of membranes 
with well defined polarity (cis, trans) maintained by many protein complexes. However, 
strict boundaries between endoplasmic reticulum (ER) and Golgi complex are hard to 
define (Hehnly and Stamnes, 2007). A general route starts in ER where proteins are 
synthesised and are packed in vesicles at ER exit sites (ERES), which then fuse with tubular 
ER-Golgi intermediate compartment (ERGIC) and are sorted. Translocation through the 
Golgi cisterns (from cis- to trans-) is associated with modifications, sorting and packing in 
secretory vesicles (Wilson et al., 2010).  
 
In unpolarised mammalian cells Golgi ribbon is located in the vicinity of centrosomes, 
where it closely associates with microtubules (MTs) and a matrix of actin filaments. 
Furthermore, additional MTs are nucleated in the region of the cis-network, where γ-
tubulin ring complex (γ-TuRC) interacts with A-kinase anchor protein 9 (AKAP9) and golgin 
A2 (GOLGA2). Consequently, the Golgi apparatus is surrounded by actin and MTs based 
motor complexes, which along with trafficking vesicles to and from the Golgi network, also 
maintain its organisation. Therefore, any disturbance in motor function affects the 
structure or positioning of the Golgi apparatus. Cytoplasmic dynein complex 1 (DYNC1) 
was shown to associate preferably with the peripheral membranes of the network (ERGIC 
and the intermediate part of the Golgi apparatus) and it cycles between ER and Golgi 
membranes (Roghi and Allan, 1999). Moreover, cytoplasmic dynein 2 heavy chain 1 
139 
(DYNC2H1) was also found associated with Golgi membranes in cells devoid of cilia 
(Vaisberg et al., 1996).  
 
4.2.2 Overview of the epidermal growth factor (EGF) uptake, trafficking, and 
degradation 
Epidermal growth factor (EGF) belongs to a well characterised family of peptides, which 
mediate cell survival, proliferation, and differentiation (Sorkin and Duex, 2010). The EGF 
binding to its receptor (EGFR) initiates both signal transduction and endocytosis leading to 
lysosomal degradation, however this chapter focuses on endosomal trafficking.  
 
In the presence of EGF, the monomeric receptors dimerise and autophosphorylate, which 
results in fast internalisation of the EGF-EGFR complex within 10 min (Schmidt-
Glenewinkel et al., 2009). The endosomes undergo temporal and spatial evolution during 
which number of vesicles and their size increase reaching its maximum 30 min after 
stimulation. During this phase EGF is found in early endosomes, which are transported by 
cytoplasmic dynein towards the perinuclear area (Rink et al., 2005). The sorting step is 
crucial in the EGF-EGFR trafficking, and in normal conditions the ligand-receptor 
complexes are directed to multivesicular bodies (MVB), which fuse with lysosomes, thus 
degrading both ligand and its receptor (Traer et al., 2007). Approximately 60 min after 
stimulation mature MVBs could be easily identified, which coincided with on going 
lysosomal degradation of the EGF (50% degraded) (Futter et al., 1996). One of the long 
term-effects of the EGF on the epithelial cells was stimulation of locomotion and changes 
in cell morphology due to cytoskeleton remodelling (Torok et al., 1996). Furthermore, 
increased motility was associated with induction of expression of the cytoplasmic dyneins 
observed 10 hours after the EGF treatment.  
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4.2.3 Salmonella enterica ser. Typhimurium as an alternative model to study 
endocytosis 
A eukaryotic cell with its complex processes makes a desirable environment for many 
pathogens, which are known to take over cellular machinery. Apart from viruses 
(mentioned in section 1.3), there are many pathogenic bacteria, which manipulate cellular 
machinery in an intricate manner; therefore pathogens can be used as a tool to study 
cellular responses. Bacteria responsible for intestinal and systemic infections are Gram-
negative Salmonella enterica, which infect a variety of animals but can also survive in the 
environment (Ramsden et al., 2007a). There are several serovars characterised; except for 
serovar Typhi, all of them cause localised intestinal infections (Spano and Galan, 2008).  
 
Out of those, serovar Typhimurium (referred later on as Salmonella typhimurium) is often 
used to study molecular mechanisms of infection. Once bacteria cross a plasma 
membrane, they exploit the endocytic pathway to create an intracellular compartment, in 
which Salmonella typhimurium replicate (Ramsden et al., 2007a). Many cell types are 
susceptible to the bacteria, and in vivo Salmonella are usually found in macrophages, 
dendritic cells, gut epithelium (enterocytes), and fibroblasts (Garcia-del et al., 2008). 
Moreover, both an entry mode and replication efficiency of intracellular Salmonella 
typhimurium, are cell specific: only macrophages are capable of active phagocytosis, 
bacteria replicate easily in cytoplasm of epithelial cells, whereas cytoplasm of 
macrophages and fibroblasts is not permissive for replication (Beuzon et al., 2002).  
 
The genome of Salmonella typhimurium contains 2 clusters of genes thought to be 
responsible for virulence (Ramsden et al., 2007b). Their products are secreted by bacteria 
and interact with host proteins, thus modifying the cellular environment. Proteins coded 
by Salmonella pathogenicity island 1 and 2 (SPI-1, SPI-2) form type III secretion systems 
(T3SS), which are activated and deposited in host membrane during invasion and 
intracellular phase respectively. As mentioned before, only macrophages actively uptake 
Salmonella typhimurium, therefore bacteria evolved diverse mechanisms of entry into 
non-phagocytic cells (Aiastui et al., 2010). Invasion of epithelial cells (HeLa) requires 
activity of the SPI-1 T3SS, which induces membrane ruffling and formation of filopodia due 
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to activation of Rho GTPases and actin rearrangement. The F-actin meshwork surrounds 
newly internalised bacteria, due to SteC kinase activity, which was found to mimic Raf-1 
signalling (Poh et al., 2008). However, during invasion of fibroblasts additional 
mechanisms are employed, which while independent of SPI-1, require actin and 
microtubule cytoskeleton. Furthermore, activity of both phosphatidylinositol 3-kinase 
(PIK3) and mitogen-activated protein kinase kinase 1 (MAP2K1) is necessary while 
activation of Rho GTPase family kinases depends on a cell line (Aiastui et al., 2010). 
 
A switch in expression from SPI-1 to SPI-2 T3SS marks the intracellular phase, during which 
wildtype Salmonella typhimurium use the endocytic pathway to move and replicate in a 
vesicular compartment. The effectors present on the membranes of Salmonella containing 
vesicles (SCV) actively control all the steps by direct interactions with eukaryotic 
complexes (Ramsden et al., 2007a). The SCV undergo maturation, which is marked by 
proteins associated with early (EEA1, TfnR, RAB5, RAB11) and then late (LAMP-1, -2, RAB7) 
endosomes (Guignot et al., 2004). At the same time the recruitment of the kinesin-1 and 
cytoplasmic dynein enables retrograde transport along MTs (Boucrot et al., 2005). The 
molecular motors are engaged by bacterial effectors interacting with endsomal complexes 
(kinesin-1 through SifA - PLEKHM2, cytoplasmic dynein by RAB7 – RILP). Furthermore, the 
kinesin-1 and cytoplasmic dynein, by pulling membranes along MTs, form a network of 
tubular Salmonella induced filaments (Sifs) (Mota et al., 2009). The final destination of 
Salmonella typhimurium in epithelial cells (HeLa) is a perinuclear region containing Golgi 
apparatus, where bacteria replicate and form tight clusters, although positioning of 
microcolony is not essential for replication (Ramsden et al., 2007b). The Salmonella 
microcolonies are relatively immobile once they reach the Golgi stacks; this feature is 
dependent on SPI-2 and suggests an active tethering to the eukaryotic membranes 
(Ramsden et al., 2007b). In addition, the activity of SPI-2 effectors disrupts vesicular 
transport from trans-Golgi to the plasma membrane (Kuhle et al., 2006) and bacteria were 
found to modify a secretory pathway by interacting with secretory carrier-associated 
membrane proteins (SCAMP 2 and 3) (Mota et al., 2009). Furthermore, after incorporation 
in the membranes around Salmonella typhimurium, SCAMP3 is actively sorted from Sifs 
containing endosomal markers and moved to the separate tubular compartment (Sits, as 
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Salmonella-induced SCAMP3 tubules). The exact function of the process is not known, 
although it might be a mechanism to acquire nutrients and membranes.  
 
The importance of the membrane surrounding each cell of Salmonella typhimurium may 
be reflected by the number of effectors involved in spatial and temporal maintenance of 
the SCV. Bacteria, which loose the membranes are killed when released to cytosol in 
macrophages (Beuzon et al., 2002). In the case of epithelial cells, damaged SCV are 
labelled with LC3 and directed to autophagosomes (Birmingham and Brumell, 2006). The 
role of SifA, one of SPI2-T3SS, has been studied thanks to the SifA
-
 mutant strain, which 
poses a distinct phenotype (Beuzon et al., 2000). Membrane dynamics of the SifA
- 
strain 
are strongly impaired and bacteria loose the SCV membranes. Furthermore, these strains 
seldom can be observed in vicinity of the Golgi complex (Ramsden et al., 2007b).  
 
In some cases Salmonella typhimurium stays in a state of latency in fibroblasts, which 
causes asymptomatic persistent infections. Although intracellular growth is restricted in 
fibroblasts, prolonged residence results in establishment of small colony variants (Cano et 
al., 2003). The bacteria isolated are genetically stable variants selected for survival in 
specific conditions. These mutations fall mostly within genes involved in metabolic 
pathways, and are associated with anaerobic respiration, decreased virulence yet increase 
in intracellular persistence. 
 
Finally, there are few examples showing complex responses of the host cells to the 
invading bacteria. George et al. (2005) suggested, that increased levels of interferon (IFN) 
in response to Salmonella typhimurium infection induced the expression and alternative 
splicing of mouse Adar1. The role of RNA editing by ADAR1 was also implicated in viral 
growth after IFN stimulation (Li et al., 2010). Furthermore, bacterial infections have an 
impact on surrounding tissues, and often result in inflammatory reaction. Likewise, 
Salmonella was implicated as an arthritogenic agent acting via infected rat synovial 
fibroblasts (Zhang et al., 2004). Infection caused increase in expression of tumor necrosis 
factor ligand (TNFSF11), which formed a complex with the tumor necrosis factor receptor 
(TNFRSF11A), thus inducing osteoclast differentiation and bone resorption. 
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4.3 Project overview 
Trafficking of membranous organelles was investigated using as a model MEFs lines, which 
were isolated from wildtype and mutant animals (Dync1i1
G482D
, Dync1i2
T172I
, and 
Dync1h1
Loa
). The cellular localisation of the dynein complex was examined along with 
dynamics of the Golgi complex, endosomal degradation and trafficking.  
 
4.4 Results 
This chapter presents results of various assays employed to investigate the effects of 
mutations in subunits of the cytoplasmic dynein on membrane trafficking. The mouse 
lines, from which cells were rederived were Loa, carrying a mutation in the heavy chain 
(Dync1h1
Loa
), newly characterised animals with mutation in the intermediate chain 2 
(Dync1i2
T172I
), and cells isolated from embryos carrying double homozygous mutant alleles 
of the intermediate chains 1 and 2 (Dync1i1
G482D 
Dync1i2
T172I
). In all cases MEF lines were 
compared with wildtype ‘littermate’ lines. In all experiments described the same cell lines, 
derived from animals carrying wildtype and mutant alleles of the cytoplasmic dynein 
subunits were used.  
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4.4.1 Colocalisation of the cytoplasmic dynein complexes with microtubules 
in wildtype (Dync1i1+/+ Dync1i2+/+) and homozygous (Dync1i1G482D/G482D 
Dync1i2
T172I/T172I) mouse embryonic fibroblasts 
 
4.4.1.1  Remarks on quantification and statistical approach 
Fluorescence based microscopy provides great tools for visualisation of intracellular 
structures and processes. Along with a qualitative description the quantitative analysis is 
possible, although it has many limitations, determined by optical resolution, physical 
properties of fluorochromes, method of acquisition etc., which are discussed in detail in 
Bolte and Cordelieres, 2006. One of the frequently quantified features is colocalisation of 
intensities of different markers, which represents physical overlap of cellular components. 
Recently, a term ‘protein – protein proximity’ was suggested as a replacement for 
‘colocalisation’, as because of limited resolution it is simply impossible to locate 
interacting proteins directly (except for FRET, which is not discussed) (Wu et al., 2010). 
Several quantitative methods have been proposed, however they are often based on 
assumptions which are rarely fulfilled by biological samples. The intensity correlation 
coefficient based (ICCB) analysis employs a statistical approach to calculate parameters, 
which express an overlap of pixel intensities from 2 sources (Bolte and Cordelieres, 2006). 
Because all the pixels in the picture are taken into account (global statistics), the results 
are affected by many factors (e.g. noise, background, uneven intensities), some of which 
can be reduced by applying intensity thresholds. Therefore, object based analysis has 
been proposed, when the level of colocalisation is calculated only in the area defined by 
objects of interest. Because methods restricted to a certain region of interest (ROI) are not 
free from bias caused by a chance distribution, additional steps are required (Fletcher et 
al., 2010). Simulations of sets of images with randomly distributed intensities have been 
shown to accurately estimate levels of chance colocalisation, which then can be applied to 
accurately estimate statistical significance of results observed in biological samples. 
Furthermore, image manipulations, which remove noise and subtract non-specific or out 
of focus intensities (median filtering, image restoration/deconvolution) were shown to 
greatly increase signal-to-noise ratio thus improve accuracy of subsequent colocalisation 
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(Landmann and Marbet, 2004). A multi-step protocol, which employs an improved image 
cross-correlation spectroscopy (ICCS) approach, has been recently proposed by Wu et al., 
(2010). The output value corresponding to the fraction of colocalised fluorescent 
molecules was described as protein-protein proximity index (PPI). When compared with 
other popular methods, estimations obtained with PPI were more accurate and less 
sensitive to intrinsic heterogeneity. 
 
4.4.1.2  Analysis of cytoplasmic dynein complex associated with 
microtubules in MEFs  
The colocalisation module provided with the Volocity software (Perkin Elmer) is based on 
a method described by Mander, yet improved due to applying additional thresholding, 
which corrected bias caused by non-specific background (Barlow et al., 2010). Although 
Mander’s method is sensitive to noise and no spatial exploration is possible, it gives 
reliable estimates of colocalisation when sets of pictures are compared. The algorithm 
reports thresholded Pearson’s correlation coefficient (PCC), Mander’s coefficients for both 
channels (MX, MY), and voxel ratio Ch.X/Ch.Y (referred as pixel ratio as all the images were 
taken only in XY plane). Values of PCC range from -1.0 to 1.0 and refer to a linear 
relationship between intensities of 2 channels within the set thresholds. MX and MY 
described fractions of pixels from each channel (X or Y), which colocalised with the other 
channel (Y or X) in relation to total intensities of pixels in channel X or Y. Colocalisation 
coefficients (e.g. MX) ranged between 0.0 and 1.0, when 0 indicated that none of the 
signal within threshold in channel X existed as colocalised with the channel Y. These 
coefficients were suggested to be useful in evaluating proportions of colocalised signals 
(Bolte and Cordelieres, 2006). Finally, values of pixel ratio X/Y referred to the ratio of 
number of pixels in channel X to number of pixels in channel Y, which were within 
threshold.  
 
Localisation of the cytoplasmic dynein complex in relation to the microtubules (MTs) was 
examined in mouse embryonic fibroblasts carrying wildtype (Dync1i1
+/+ 
Dync1i2
+/+
, n=3) 
and homozygous mutant alleles of the cytoplasmic dynein intermediate chains 1 and 2 
(Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
, n=3). Cells were fixed, α-tubulin and dynein 
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intermediate chains (1 and 2) labelled as described in section 2.6.8. In order to obtain 
accurate images, Plan-Apochromat 63x/1.4 Oil DIC objective was used with twice 
magnified (2x zoom) field of view, so that the size of imaged area was 73.1 µm
2
. Digital 
images were recorded in 12-bit mode, processed by removing noise (fine median filter) 
and defining ROI based on cell outline. Colocalisation of signal intensities was calculated 
for microtubules in channel X (annotated with MTs) and dynein intermediate chains in 
channel Y (annotated with IC74). Upper and lower intensity thresholds were set for each 
channel: 100 – 4090 for MTs signal and 800 – 4090 for IC74 signal.  
 
An objective with high magnification was used, and most of the pictures contained only a 
portion of a cell, where bundles of microtubules were clearly visible. On the other hand, 
the cytoplasmic dynein complex was not distributed evenly throughout the cell, and the 
signal corresponding to the intermediate chains was often enhanced in the perinuclear 
area. Therefore, in order to control for possible differences caused by cell topology, values 
of ratio MTs/IC74 were used as a criterion to annotate cell images to bins: bin 1 (ratio: 1 - 
2), bin 2 (ratio: 2 – 4), and bin 3 (ratio: 4 – 5) (Figure 4.1). Within bins, colocalisation 
parameters (PCC, MMTs, and MIC74) calculated for each image were compared for effect of 
genotype on distribution of the cytoplasmic dynein complex.  
 
Distribution of the cytoplasmic dynein complex was assessed in untreated MEF cell lines, 
which were derived from wildtype Dync1i1
+/+ 
Dync1i2
+/+
 (n=3) and double homozygous 
Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 (n=3) embryos. Twenty pictures of each cell line 
analysed by calculating colocalisation parameters as described. Bins distinguished 
corresponded to amount of MTs staining relative to IC74 signal, and most images were 
located in Bin 2 while only few were annotated to Bin 3 (Table 10.2, Appendix 10.2, Figure 
4.2A). Results are summarised in Table 4.1. 
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Figure 4.1. Representative pictures of wildtype (Dync1i1
+/+ 
Dync1i2
+/+
) MEFs and the annotation to 3 bins 
Intracellular structures were stained with antibodies against α–tubulin (MTs, green) and cytoplasmic dynein 
intermediate chains (IC74, red); cells were annotated to bins (1-3) based on the thresholded value of pixel 
ratio of MTs/IC74 as shown for each picture sequence; scatter plots correspond to pixels colocalised in each 
channel; nuclei were not labelled and only their outlines are visible; scale bar 5µm 
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Table 4.1. Summary of analysis of colocalisation of MTs and dynein intermediate chains 
Colocalisation of microtubules and cytoplasmic dynein complex presented based on the results of statistical 
tests, where n.s. corresponds to lack of significant differences for p>0.05; trends were noted if p<0.1; for 
cells annotated to distinct bins values of each parameter were compared between wildtype 
Dync1i1
+/+
Dync1i2
+/+
 and double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 cell lines; detailed analysis is 
presented in Appendix 10.2  
 
 
 
 
 
 
 
Figure 4.2. Analysis of colocalisation parameters calculated for MTs and cytoplasmic dynein intermediate 
chains 
Parameters calculated for 3 bins represented as mean±standard deviation (SD); legend refers to all graphs 
and colours correspond to wildtype Dync1i1
+/+
 Dync1i2
+/+
 (grey), double homozygous Dync1i1
G482D/G482D
 
Dync1i2
T172I/T172I
 (violet) cell lines; each bin marked with distinct pattern 
A. Distribution of images to 3 bins based on the MTs/IC74 pixel ratio, points represent average value from 
each cell line  
B. Values of Pearson’s colocalisation coefficient (PCC) calculated for images in each bin 
C. Values of Mander’s coefficient (MMTs) corresponding to fraction of MTs colocalising with cytoplasmic 
dynein intermediate chains 
D. Values of Mander’s coefficient (MIC74) corresponding to fraction of the dynein complexes colocalising 
with MTs 
 
Parameter Bin 1 Bin 2 Bin 3 
Pearson’s colocalisation coefficient (PCC) n.s. n.s. n.s. 
Mander’s colocali-sation coefficient MT 
intensities (MMTs) 
n.s. 
Dync1i1
G482D/G482D
Dync1i2
T172I/T172I 
tended to show lower values 
n.s. 
Mander’s colocalisation coefficient IC74 
intensities (MIC74) 
n.s. n.s. n.s. 
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Pearson’s colocalisation coefficient (PCC) did not differ between wildtype and mutant cells 
(p=0.2876, p=0.8011, p=0.1768) (Figure 4.2B). However, calculations of PCC employed all 
the pixels within the ROI, therefore Mander’s coefficients were also compared, so that 
proportions of both signals could be related. Values of MMTs corresponded to fraction of 
MTs signal associated with staining for the dynein intermediate chains and were slightly 
lower in the mutant Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 fibroblasts when compared with 
wildtype Dync1i1
+/+ 
Dync1i2
+/+
 cells (Figure 4.2C); the distinction was the biggest in case of 
images annotated to the second bin (p=0.0737). Furthermore, the MMTs decreased within 
subsequent bins relative to the increase in MTs signal and MTs/IC74 pixel ratio. On the 
other hand, the MIC74 displayed fairly constant values, which indicated colocalisation of 
over 95% of the intermediate chains with MTs (Figure 4.2D). Nonetheless, there were no 
differences observed between wildtype Dync1i1
+/+ 
Dync1i2
+/+
 and homozygous 
Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 fibroblasts. 
 
In conclusion, single point mutations in both cytoplasmic dynein intermediate chains 
(Dync1i1
G482D
 and Dync1i2
T172I
) affected neither the distribution of the dynein complex nor 
it association with microtubules within cells examined. 
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4.4.2 Reassembly of the Golgi complex after nocodazole treatment of MEFs 
isolated from wildtype (Dync1i1+/+ Dync1i2+/+) and double homozygous 
(Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
) embryos 
Disruption of microtubule cytoskeleton causes dramatic changes in structure of the Golgi 
apparatus, which locates at periphery in a form of small stacks (Cole et al., 1996). The 
‘mini’-Golgi were found to reorganise near the ER exit sites as functional complexes. 
When MTs repolymerise, the Golgi apparatus is reassembled around microtubule 
organising centre (MTOC) thanks to the dynein driven transport (Roghi and Allan, 1999). 
Therefore, the activity of the cytoplasmic dynein can be assessed by monitoring the 
process of the reassembly of the Golgi stacks after MTs disruption. The Golgi reassembly 
was assayed in MEFs as described in 2.6.3. Briefly, cells were treated with nocodazole and 
fixed at 0, 20, and 50 min after nocodazole washout. The overall morphology of the 
complex was assessed by scoring cells untreated and fixed after 0, and 50 min; whereas 
detailed image analysis was performed for cells untreated, and fixed at 0, 20, and 50 min. 
 
4.4.2.1  Analysis of morphology of the Golgi complex 
Wildtype Dync1i1
+/+ 
Dync1i2
+/+
 and double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I 
cells were examined for Golgi complex morphology at different time points after 
nocodazole washout. Two experiments were performed and in each at least 300 cells 
were scored blindly to genotype and experiment for the appearance of the Golgi labelling. 
There were 3 types distinguished, corresponding to perinuclear complex (reticular or 
compact), and fragmented within a cytosol (Figure 4.3). In all wildtype (Dync1i1
+/+ 
Dync1i2
+/+
, n=3) and double homozygous (Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
, n=3) cell 
lines, fractions of cells with the distinct morphology were compared across different 
conditions. The detailed analysis can be found in Appendix 10.3 and Table 10.3, while the 
results are summarised in Table 4.2, all the values correspond to mean±standard deviation 
(SD). 
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Figure 4.3. Representative pictures of wildtype (Dync1i1
+/+ 
Dync1i2
+/+
) MEFs showing various 
morphologies of the Golgi complex  
Intracellular structures were stained with antibodies against Golgi protein (giantin, red) and chromatin 
(DAPI, blue); cell boundaries outlined; distinct morphology was visible in untreated or incubated in the 
presence of nocodazole (0 min) cells; at 50 min majority of the Golgi membranes was reassembled around a 
nucleus; 5 µm scale bar. 
 
 
 
Time point ‘0 min’ corresponded to cells observed in the presence of nocodazole, which 
prevented polymerisation of microtubules (MTs). In all cells examined the Golgi 
membranes, visualised by labelling of giantin, were found as small fragments throughout 
the cell body (Figure 4.3). Therefore, the results obtained at this time point were not 
discussed in detail. 
 
The ‘reticular’ structure was scored when interlaced Golgi stacks could be distinguished as 
ribbons located in the perinuclear area. The fraction of untreated wildtype Dync1i1
+/+ 
Dync1i2
+/+
 cells with a reticular structure was 0.503±0.068, whereas the proportion was 
slightly smaller in the untreated double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 
fibroblasts: 0.416±0.095 (Table 10.3). The opposite trend was observed in cells, in which 
MTs were allowed to repolymerise for 50 min, during which 0.379±0.026 of wildtype 
Dync1i1
+/+ 
Dync1i2
+/+
 and 0.405±0.051 of mutant Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 
fibroblasts displayed the reticular network of Golgi complex. While no difference was 
found between MEFs (p=0.3732 for untreated, p=0.5767 at 50 min), fewer wildtype cells 
reassembled the Golgi stack to the levels observed in the untreated fibroblasts (p=0.0355) 
(Table 4.2, Figure 4.4A). 
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Cells annotated to the ‘compact’ category displayed a perinuclear labelling of the Golgi 
apparatus with tight stacks, where tubules were not well defined (Figure 4.3). In the 
population of the untreated wildtype Dync1i1
+/+ 
Dync1i2
+/+
 MEFs 0.412±0.057 of cells 
were scored as having the compact structure, while in the double homozygous 
Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 cells the fraction was 0.504±0.107 (Table 10.3). After 
disruption and MTs repolymerisation for 50 min the fractions were lower in both groups, 
with 0.363±0.028 of wildtype Dync1i1
+/+ 
Dync1i2
+/+
 and 0.364±0.072 of mutant 
Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 fibroblasts showing compact Golgi stacks (Figure 4.4B). 
The mutant allele did not affect the formation of the compact stacks neither in the 
untreated cells (p=0.3866) nor after nocodazole washout (p=0.9898). However, at 50 min 
fibroblasts carrying double mutant allele (Dync1i1
G482D/G482D
Dync1i2
T172I/T172I
) failed to 
reach the same proportion of the compact Golgi as the untreated cells (p=0.0219) (Table 
4.2, Figure 4.4B). 
 
Finally, a ‘fragmented’ morphology corresponded to the giantin-positive membranes 
dispersed in the cytosol or in a form of discontinuous tubular structures. It also reflected 
the capacity of cytoplasmic dynein complex to transport Golgi membranes towards the 
MTOC. While in the untreated cells only small numbers of fibroblasts were observed to 
have fragmented Golgi apparatus (0.086±0.011 of the wildtype Dync1i1
+/+
Dync1i2
+/+
, and 
0.080±0.036 of mutant Dync1i1
G482D/G482D
Dync1i2
T172I/T172I
 MEFs), the disruption of the MTs 
increased the proportions to 0.257±0.006 and 0.231±0.022 of wildtype Dync1i1
+/+ 
Dync1i2
+/+
 and mutant Dync1i1
G482D/G482D
Dync1i2
T172I/T172I
 MEFs respectively (Table 10.3). 
Nonetheless, the results were not different in any of conditions described (p=0.7412 for 
untreated and p=0.2338 at 50 min) (Figure 4.4C). 
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Table 4.2. Summary of analysis of Golgi apparatus reassembly after nocodazole treatment 
Results of analysis of Golgi complex morphologies presented based on the results of statistical tests, where 
n.s. corresponds to lack of significant differences for p>0.05; trends were noted if p<0.1; for cells annotated 
to distinct bins values of each parameter were compared between wildtype Dync1i1
+/+
Dync1i2
+/+
 and double 
homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 cell lines; detailed analysis is presented in Appendix 10.3.  
 
Morphology/ 
time point 
Reticular Compact Fragmented 
Untreated n.s. n.s. n.s. 
0 min - - - 
50 min n.s. n.s. n.s. 
Reassembly after 
50min to the level 
of untreated cells 
Dync1i1
+/+ 
Dync1i2
+/+ cells 
did not reassemble 
(p=0.0355) 
Dync1i1
G482D/G482D 
Dync1i2
T172I/T172I cells did not 
reassemble (p=0.0219) 
n.s. 
 
 
 
 
 
 
 
 
Figure 4.4. Analysis of Golgi apparatus morphology in untreated and fibroblasts treated with nocodazole 
Fractions of cells with annotated to different classes represented as mean±SD; legend refers to all graphs 
and colours correspond to wildtype Dync1i1
+/+
 Dync1i2
+/+
 (grey), double homozygous Dync1i1
G482D/G482D
 
Dync1i2
T172I/T172I
 (violet) cell lines; 0 min and 50 min refer to time after nocodazole washout, when Golgi 
apparatus was observed 
A. Fraction of MEFs with Golgi showing perinuclear localisation and reticular morphology  
B. Fraction of MEFs with Golgi showing perinuclear localisation and compact morphology 
C. Fraction of MEFs with Golgi fragmented (often dispersed in the cytosol) 
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4.4.2.2  Image based analysis of the Golgi complex in wildtype 
 (Dync1i1
+/+
 Dync1i2
+/+
) and double homozygous   
 (Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
) MEFs 
In addition, a detailed analysis of the Golgi structure at different time points was 
performed by comparing high resolution images of individual cells. The pictures were 
taken and analysed as described in sections 2.7.2 and 2.7.3. From each condition (0 min, 
20 min, and 50 min, and untreated) at least 5 pictures of each cell line were taken, thus 
over 15 pictures of wildtype Dync1i1
+/+
Dync1i2
+/+
 (n=3) and double homozygous 
Dync1i1
G482D/G482D
Dync1i2
T172I/T172I
 (n=3) fibroblasts were analysed. For each cell image 
performed analysis was based on identification of objects positive for giantin labelling, for 
which a set of parameters was automatically calculated by the software (Cell Profiler). The 
parameters compared included: ratio of Golgi stacks number to their total area, form 
factor, eccentricity, and perimeter (in pixels). For each cell a mean value of a parameter 
was recorded and those were averaged giving a mean from a cell line. Due to high 
variation between cell lines, means from each time point were normalised to mean values 
recorded for untreated cells. The final relative values were analysed using paired t-test 
(the genotype effect at different time points), repeated measures one-way ANOVA (the 
time point effect on results obtained) followed by Dunnett's multiple comparison test 
(results for each time point tested against results for untreated cells). In all analyses two-
tailed p-values were reported, statistically significant for p<0.05. The detailed analysis can 
be found in Appendix 10.3 and Table 10.4, while the results are summarised in Table 4.3. 
 
Number of objects related to their area was used as a way to describe a global structure of 
the Golgi complex in a similar manner as described in section 4.4.2.1. Although the values 
were arbitrary, it increased for cells with fragmented Golgi membranes. At 0 min in all 
fibroblasts examined, Golgi complex was dispersed throughout the cytosol in a form of 
small fragments. The mean normalised values ranged 2.533 – 3.275 in the wildtype 
Dync1i1
+/+
Dync1i2
+/+
 (n=3) and 2.406 - 3.125 in the double homozygous Dync1i1
G482D/G482D 
Dync1i2
T172I/T172I
 (n=3) fibroblasts (p=0.4681) (Table 10.4). By 20 min the normalised ratio 
decreased approximately by half, while by 50 min mean values were comparable with 
untreated cells (for which normalised values were 1), which corresponded either to fewer 
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stacks observed or increase in the measured area due to membrane rearrangements. At 
both time points the double homozygous Dync1i1
G482D/G482D 
Dync1i2
T172I/T172I
 fibroblasts 
showed lower mean ratio (1.163 - 1.432 at 20 min, 0.848 - 1.169 at 50 min) than wildtype 
Dync1i1
+/+ 
Dync1i2
+/+
 cells (1.280 - 1.522 at 20 min, 0.953 - 1.319 at 50 min) (Figure 4.5A). 
The difference observed at 20 min (p=0.0063) and 50 min (p=0.0183) might reflect faster 
reassembly of the Golgi membranes in the double homozygous Dync1i1
G482D/G482D
 
Dync1i2
T172I/T172I
 MEFs. Finally, untreated cells did not vary when the raw values of the 
ratio were tested (p=0.1420). 
 
The effect of time on the observed values were also tested and compared to the 
‘untreated’ cells in order to evaluate the kinetics of the process of Golgi reassembly. There 
were differences observed within both wildtype Dync1i1
+/+
Dync1i2
+/+ 
(p=0.0003) and 
double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 (p=0.0002) fibroblasts. However, 
in both groups only values recorded at ‘0 min’ were different from the ‘untreated’ cells 
(p<0.001), and this result confirmed the visual observations of complete fragmentation 
and dispersal of Golgi membranes. Furthermore, because the normalised values of the 
ratio did not vary at any other time point, these results suggested that 20 min after the 
nocodazole washout the Golgi complex membranes were already reassembled to a level 
comparable with the untreated cells.  
 
On the other hand, within both genotypes the form factor varied depending on the time 
point, which likely reflected dynamics of the Golgi reassembly. In the wildtype 
Dync1i1
+/+
Dync1i2
+/+
 cells (p=0.0288), the shape of the Golgi membranes was affected the 
most at 0 min (p< 0.05), whereas 20 min and 50 min after the nocodazole washout the 
normalised values of form factor were comparable with untreated cells. Similar results 
were obtained for double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 MEFs 
(p=0.0072), and only at 0 min the form factor varied from the values recorded for the 
untreated cells (p<0.05) (Figure 4.5B). 
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Another shape parameter that was taken into account was object eccentricity and its 
mean values were calculated for each cell and cell line. The eccentricity of the ellipse that 
had the same second-moments as the object identified was defined as the ratio of the 
distance between the foci of the ellipse and its major axis length. The values ranged from 
0 to 1, where the eccentricity of circular objects was 0 and 1 characterised a line segment.  
 
 
 
 
 
 
 
Table 4.3. Summary of the image based analysis of shape parameters of Golgi complex membranes 
Results of analysis of Golgi complex shape parameters presented based on the results of statistical tests, 
where n.s. corresponds to lack of significant differences for p>0.05; trends were noted if p<0.1; for cells 
annotated to distinct bins values of each parameter were compared between wildtype Dync1i1
+/+
Dync1i2
+/+
 
and double homozygous Dync1i1
G482D/G482D
Dync1i2
T172I/T172I
 cell lines; detailed analysis is presented in 
Appendix 10.3. 
 
Parameter/ 
time point 
0 min 20 min 50 min Untreated 
Ratio number/ 
area 
n.s. 
Dync1i1
G482D/G482D 
Dync1i2
T172I/T172I 
showed lower 
normalised values 
Dync1i1
G482D/G482D 
Dync1i2
T172I/T172I 
showed lower 
normalised values 
n.s. 
Form factor n.s. n.s. n.s. n.s. 
Eccentricity 
Dync1i1
G482D/G482D 
Dync1i2
T172I/T172I 
tended to have 
higher normalised 
valued 
Dync1i1
G482D/G482D 
Dync1i2
T172I/T172I 
tended to have 
higher normalised 
valued 
Dync1i1
G482D/G482D 
Dync1i2
T172I/T172I 
tended to have 
higher normalised 
valued 
Dync1i1
G482D/G482D 
Dync1i2
T172I/T172I 
showed lower 
values 
Log of 
perimeter 
[a.u.] 
n.s. n.s. n.s. n.s. 
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Figure 4.5. Analysis of shape parameters of the Golgi complex in the wildtype (Dync1i1
+/+ 
Dync1i2
+/+
) and 
double homozygous (Dync1i1
G482D/G482D
Dync1i2
T172I/T172I
) fibroblasts treated with nocodazole 
Results obtained for individual cell lines (aligned dots) represented together with a mean (horizontal line) 
and standard deviation; legend refers to all graphs and colours correspond to wildtype Dync1i1
+/+ 
Dync1i2
+/+
 
(grey) and double homozygous Dync1i1
G482D/G482D
Dync1i2
T172I/T172I
 (violet) MEFs; 0min, 20min, and 50min 
refer to time after nocodazole washout, when Golgi apparatus was analysed; for each time point and cell 
line mean values were normalised to mean values recorded for the untreated cells, here marked with 
dashed line at Y=1 
A. Mean values of number of particles to total area ratio 
B. Mean values of a form factor as a measure of shape 
C. Mean values of eccentricity as a measure of shape 
D. Mean values of total perimeter of objects identified transformed using function: Y=log(Y) 
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In case of the Golgi membranes, fragmented stacks (0 min) showed the lowest eccentricity 
values, which then increased during the time course. At all time points there was a trend 
observed in the double homozygous Dync1i1
G482D/G482D 
Dync1i2
T172I/T172I
 fibroblasts 
towards higher normalised mean eccentricity values when compared with the wildtype 
Dync1i1
+/+
Dync1i2
+/+
 cells (at 0 min p=0.0648, at 20 min p=0.0684, and at 50 min 
p=0.0837) (Table 10.3, Table 4.3). In contrast, the untreated wildtype Dync1i1
+/+
Dync1i2
+/+
 
cells displayed higher values of the mean eccentricity (0.749 - 0.782) than double 
homozygous Dync1i1
G482D/G482D 
Dync1i2
T172I/T172I
 fibroblasts (0.727 - 0.741) (p=0.0325). 
Furthermore, during the time course the normalised mean eccentricity values varied only 
in the wildtype Dync1i1
+/+ 
Dync1i2
+/+
 MEFs (p=0.0380) and the differences were noted for 
cells examined at 0 min (p< 0.05). On the contrary, the normalised mean eccentricity of 
the double homozygous Dync1i1
G482D/G482D
Dync1i2
T172I/T172I 
cells was comparable with 
values observed in the untreated cells at all time points examined (p=0.0819) (Figure 
4.5C).  
 
The summed perimeter of all objects identified as Golgi membranes was also analysed, 
however data displayed high variability and a broad range of values. Therefore, they were 
transformed using a function:  = 	, and log(perimeter) values were used in 
subsequent analyses. Overall, there were no differences observed between wildtype 
Dync1i1
+/+ 
Dync1i2
+/+
 and double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 
fibroblasts at any of the time points examined (Table 4.3). Moreover, at 20 min and 50 
min normalised mean values of log(perimeter) were higher than untreated wildtype 
Dync1i1
+/+ 
Dync1i2
+/+
 MEFs (p=0.0311). On the other hand, the values recorded for double 
homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 cell lines did not vary at any of the time 
points examined (p=0.6522) (Figure 4.5D).  
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In this chapter the effects of point mutations in the cytoplasmic dynein intermediate chain 
1 (Dync1i1
G482D
) and chain 2 (Dync1i2
T172I
) were investigated using a Golgi complex 
reassembly assay. Various features of Golgi-associated membranes were observed at 
different time points during microtubule repolymerisation after nocodazole treatment. As 
a model primary MEF lines were used, which were isolated from animals carrying either 
both wildtype alleles (Dync1i1
+/+ 
Dync1i2
+/+
) or both mutant alleles (as double 
homozygotes, Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
) of the cytoplasmic dynein intermediate 
chains 1 and 2. The process of Golgi reassembly at certain time points was analysed using 
different approaches: qualitative scoring of global structure of Golgi membranes (section 
4.4.2.1), and quantitative image-based analysis of shape parameters (section 2.7.3).  
 
One of the advantages of the qualitative scoring was a big number of cells analysed in a 
short time. Cells were scored at 0min and 50min by classifyng cells depending on Golgi 
morphology and there were no differences observed between wildtype 
Dync1i1
+/+
Dync1i2
+/+
 and double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 cells. It 
should be noted though, that while this method was used to characterise effects of 
disruption of genes (Bechler et al., 2010), it might lack sensitivity in case of mild 
phenotypes. 
 
Therefore, quantitative analysis of high-resolution images was also performed. Although 
the method applied consisted of several steps, it was automated and few parameters 
describing individual stacks were retrieved. Parameters taken into account were the ratio 
of number to total area, form factor, eccentricity, and total perimeter, however, the 
values object perimeter were very variable thus posing difficulties in analysis and 
interpretation. On the other hand, number to area ratio, form factor, and eccentricity 
gave consistent results, showing differences in Golgi structure and shape only early after 
nocodazole wash out (up to 20 min) in the wildtype Dync1i1
+/+ 
Dync1i2
+/+
 fibroblasts. The 
changes observed likely corresponded to early events of fusion of small fragments 
(number to area ratio values descreased) and reshaping of membranes from circular to 
more elongated structures (form factor descreased, eccentricity increased). However it 
should be noted, that changes in both number and area of Golgi membranes contributed 
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to the the ratio values, therefore the interpretation was not straightforward. MEFs 
homozygous for mutations in both cytoplasmic dynein intermediate chains 1 and 2 
(Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
) displayed lower values of the number to area ratios 
during the time course (20 min, 50 min) than wildtype Dync1i1
+/+ 
Dync1i2
+/+
 cells. 
Furthermore, while relative values of form factor were comparable with the wildtype 
Dync1i1
+/+ 
Dync1i2
+/+
 at all time points examined, the mean eccentricity of the Golgi 
complex in untreated cells was lower, yet during the time course the eccentricity tended 
to be slightly higher in the double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 cells.  
 
In conclusion, while mutations in the intermediate chains 1 and 2 (Dync1i1
G482D
, 
Dync1i2
T172I
) did not affect global structure of the Golgi complex or kinetics of its 
reassembly, detailed quantitative analysis revealed subtle differences in distribution of 
Golgi membranes and their shape parameters. 
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4.4.3 Time course of EGF uptake in wildtype (Dync1i2+/+) and homozygous 
(Dync1i2
T172I/T172I) embryonic fibroblasts 
As mentioned, there are many distinct events, which contribute to EGF endocytosis. 
During translocation to a perinuclear region early endosomes mature to late endosomes, 
in processes which involve changes in number and size (Rink et al., 2005). As EGF 
trafficking is tightly controlled, the endosome dynamics was shown to reflect changes in 
the endocytosis, and number of endosomes, area, and distance from nucleus were 
recently used in a quantitative high-throughput screen of EGF and TfR endocytosis 
(Collinet et al., 2010).  
 
Endosomal motility was investigated using fluorescently labelled EGF in MEFs isolated 
from wildtype Dync1i2
+/+
 (n=2) and homozygous Dync1i2
T172I/T172I
 (n=2) embryos. Cells 
were observed at different time points after EGF stimulation: 0 min, 15 min, 30 min, 45 
min, and 60 min (Figure 4.6). Images of individual cells obtained from 2 experiments were 
analysed and parameters describing EGF-positive (EGF
+/ve
) endosomes were calculated: 
the rate of translocation, endosome number and area. It should be also noted, that EGF 
gets internalised in a complex with the EGF receptors, and the amount of EGF observed 
depends on the number of receptors present in the plasma membrane. Consequently, 
during the analysis the total number of vesicles was normalised relatively to the cytoplasm 
area (Collinet et al., 2010). Because values of parameters obtained deviated from 
Gaussian distribution, raw data were transformed using:  = 	 and log values were 
used in all the analysis performed. Details of labelling, time course, and analysis can be 
found in sections 2.6.4 and 2.7.3 respectively.  
 
Figure 4.6. Representative pictures of wildtype (
 
Dync1i2
+/+
) MEFs showing retrograde movement of 
EGF
+/ve
 endosomes (next page) 
Intracellular structures were stained with antibodies against α-tubulin protein (grey) and chromatin (DAPI, 
blue); distinct position of endosomes loaded with fluorescently labelled EGF (red) was observed during the 
time course; panel below each picture correspond to image of EGF only; yellow pseudocoloring present in 
case of overlapping intensities from EGF and α-tubulin; images not in scale 
A. MEF imaged 0 min after EGF stimulation 
B. MEF imaged 15 min after EGF stimulation 
C. MEF imaged 30 min after EGF stimulation 
D. MEF imaged 45 min after EGF stimulation 
E. MEF imaged 60 min after EGF stimulation 
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4.4.3.1  Analysis of endosomal transport  
MEFs are a highly heterogeneous population in terms of both shape and size; therefore an 
indirect approach was used in order to quantify the rate of movement from cell periphery 
to perinuclear area. In images of each cell (at least 20 per time point) numbers of 
identified vesicles were recorded for both the area of whole cell and perinuclear area. For 
each cell the perinuclear ring had a width of a nuclear radius. Finally, a ratio of perinuclear 
to total number of endosomes was calculated, with values raging from 0 in case of EGF 
bound at the plasma membrane, to 1 when all the EGF
+/ve
 vesicles were found in the 
perinuclear area. Ratios were analysed twice: (1) by comparing means normalised to time 
point ‘0 min’ and (2) by fitting an exponential model (one-phase association) (Motulsky 
and Christopoulos, 2004).  
 
The ratio of perinuclear to total number of vesicles was used as a measure of a transport 
towards the nucleus, and it increased during the time course reaching over 0.5 (50% of 
vesicles translocated) or 3 times when relative means were compared after 60 min of 
stimulation with EGF (Table 4.4). It should be noted, that variability within results likely 
reflected different efficiency of transport within fibroblasts. Furthermore, due to small 
sample size only relative means were tested statistically (two-way ANOVA). There were no 
differences found in the efficiency of transport at the time points examined (p=0.0979), 
although homozygous Dync1i2
T172I/T172I
 (n=2) cells showed a trend towards slower 
movement than wildtype Dync1i2
+/+
 (n=2) fibroblasts (at 60 min: 2.743 and 3.698, 4.766 
and 2.925 respectively) (Figure 4.7A).  
 
 
164 
Table 4.4. Image based analysis of retrograde transport of EGF
+/ve 
endosomes 
Digital images were taken and analysed at different time points after stimulation with EGF; for each cell line 
mean values were normalised to values recorded for the untreated cells (in italics), while raw data are 
shown as mean±standard deviation (SD); genotypes annotated as follows: wildtype (Dync1i2
+/+
), 
homozygous (Dync1i2
T172I/T172I
); result of two-way ANOVA and reported two-tailed p-values shaded grey, n - 
number of cell lines derived from animals 
Time point 
Dync1i2+/+  
n=2 
Dync1i2T172I/T172I  
n=2 
Number of 
cells 
0 min 19 14 16 18 
15 min 29 19 29 18 
30 min 30 26 33 24 
45 min 31 20 35 20 
60 min 28 21 23 28 
Ratio 
perinuclear
/ total 
0 min 
0.124±0.122 0.175±0.116 0.208±0.190 0.149±0.171 
1.0 1.0 1.0 1.0 
15 min 
0.343±0.162 0.251±0.096 0.249±0.182 0.247±0.109 
2.758 1.438 1.197 1.662 
30 min 
0.413±0.198 0.479±0.188 0.419±0.176 0.373±0.132 
3.321 2.740 2.016 2.505 
45 min 
0.534±0.152 0.510±0.200 0.551±0.199 0.477±0.159 
4.293 2.917 2.650 3.201 
60 min 
0.593±0.193 0.511±0.199 0.571±0.205 0.551±0.184 
4.766 2.925 2.743 3.698 
 Two-way ANOVA, F(1,10)=3.333, p=0.0979 
 
 
Figure 4.7. Analysis of movement of the EGF
+/ve
 endosomes in the wildtype (Dync1i2
+/+
) and homozygous 
(Dync1i2
T172I/T172I
) fibroblasts observed at different time points after EGF stimulation 
Increase in perinuclear/total number ratio represented as means of individual cell lines (aligned dots) in a 
function of time; legend refers to all graphs and colours correspond to wildtype Dync1i2
+/+
 (grey) and 
homozygous Dync1i2
T172I/T172I
 (blue) MEFs 
A. Mean values of ratio normalised to mean values recorded at 0 min (marked with dashed line at Y=1) 
B. Mean values of ratio shown as mean ± SD with fitted exponential model (dash lines) 
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In addition the time course data were analysed using non-linear regression. Although a 
simple model only describing retrograde transport could not be found, an exponential 
equation was used to calculate parameters of folate receptor recycling (Chen et al., 2008). 
Values of ratio were fitted in GraphPad using one-phase association model: 
	 = 	
  +   − 	
 ∗ 1 − 
∗, 
where 	
 was the 	 value at time 0 min, Plateau was the Y value at infinite times 
(constrain to <1.0 or not), and K was the rate constant expressed in min
-1
. Initially, the 
Plateau was restricted to a maximum of 1, relevant to all of the vesicles in the perinuclear 
area. The data recorded for wildtype Dync1i2
+/+
 cells was fitted with the exponential 
model. This was not possible for the set of data for homozygous Dync1i2
T172I/T172I
 MEFs 
(‘Hit constraint’) (Table 4.5). This result might suggest some other than exponential 
kinetics for the transport observed in the homozygous Dync1i2
T172I/T172I
 cells (Figure 4.7B). 
When the constraint was lifted allowing for the best fit to the data, the values of Plateau 
calculated for both sets from homozygous Dync1i2
T172I/T172I 
(n=2) cells were comparable 
(1.315 ± 1.496, 1.367 ± 1.675), although above 1.0, thus biologically irrelevant. It should  
also be noted that the values of the rate constant (K) calculated for wildtype Dync1i2
+/+
 
(n=2) cells were much higher (0.02435 ± 0.01137, 0.03212 ± 0.01654) than observed in the 
homozygous Dync1i2
T172I/T172I
 (n=2) fibroblasts (0.00795 ± 0.01313, 0.00684 ± 0.01150). 
Nonetheless, all of the parameters were had high standard deviations, likely due to high 
variability within the data sets.  
 
In summary, the rate of retrograde transport was expressed as fraction of endosomes 
identified in the perinuclear area calculated for each cell at different time points. The 
comparison of mean values normalised to ‘0 min’ showed no differences between 
wildtype Dync1i2
+/+
 and homozygous Dync1i2
T172I/T172I
 MEFs in the retrograde transport 
over the period of 60 min. An alternative approach to data analysis was also employed 
and the data from the time course were fitted to an exponential model in order to 
calculate parameters describing the kinetics of the transport. Given the calculations 
performed, the conclusion of different kinetics of the transport observed in the 
homozygous Dync1i2
T172I/T172I
 cells could be drawn, as the data could not be described 
with the exponential model. At the same time, an equation for Boltzmann sigmoidal 
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seemed to be more suitable (data not shown). Unfortunately, further interpretation of 
numerical values was hindered by the big spread of values and a more sophisticated 
mathematical analysis would be required.  
 
 
 
 
Table 4.5. Parameters of the exponential model 
Values of ratio of perinuclear to total number of vesicles were analysed using exponential model (one-phase 
association) according to equation: 	 = 	
  +   − 	
 ∗ 1 − 
∗, where 	
 - 	 value at time 0 
min, Plateau - Y value at infinite times (constrain to <1.0 or not), K - the rate constant [min
-1
]; best fit values 
of parameters shown as mean±standard deviation (SD); genotypes annotated as follows: wildtype 
(Dync1i2
+/+
), homozygous (Dync1i2
T172I/T172I
); R² - correlation factor square, corresponds to goodness of fit; 
n - number of cell lines derived from animals 
 
Parameter 
Dync1i2+/+  
n=2 
Dync1i2T172I/T172I  
n=2 
Constraints Plateau < 1.0 Plateau < 1.0 [Hit constraint] 
Best fit 
values 
	
 0.129 ± 0.036 0.148 ± 0.045 0.162 ± 0.045 0.137 ± 0.035 
Plateau 0.794 ± 0.199 0.604 ± 0.104 ~1.000 ~1.000 
K [min
-1
] 0.02007 ± 0.02435 
0.03212 ± 
0.03212 
0.01212 ± 
0.00795 
0.01080 ± 
0.00684 
 R² 0.4732 0.3512 0.3389 0.4698 
Absolute sum of 
squares 
3.542 2.961 4.906 2.562 
Constraints None None 
Best fit 
values 
	
 0.136 ± 0.038 0.148 ± 0.045 0.169 ± 0.044 0.143 ± 0.035 
Plateau 0.726 ± 0.143 0.604 ± 0.104 1.315 ± 1.496 1.367 ± 1.675 
K [min
-1
] 0.02435 ± 0.01137 
0.03212 ± 
0.01654 
0.00795 ± 
0.01313 
0.00684 ± 
0.01150 
 R² 0.4379 0.3512 0.3396 0.4704 
Absolute sum of 
squares 
3.882 2.961 4.901 2.559 
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4.4.3.2  Analysis of endosomal dynamics 
The parameters of endosomes were analysed at 0min, 15min, 30min, 45min, and 60min. 
Pictures of individual cells were analysed as before and values calculated included ratio of 
total number of endosomes to cytoplasm area (multiplied by 1000 for facilitate 
visualisation), number and total area of vesicles in the perinuclear area (nuclear radius 
marked the width of a ring around a nucleus), and Pearson correlation between number 
and area. All the data were transformed ( = 	) before final analysis. The detailed 
analysis can be found in Appendix 10.4 and Table 10.5, while the results are summarised 
in Table 4.6. 
 
The ratio of endosome number to cytoplasm area described changes in the EGF
+/ve
 
vesicles and would decrease with time due to fusion during sorting and maturation. The 
values obtained during the time course showed a mild increase with a maximum at 30 min 
and constant decrease till 60 min after the EGF stimulation. Because EGF was not 
degraded within the first 30 min (Driskell et al., 2007), the fluctuation observed might 
reflect maturation of early endosomes involving fusion-fission of vesicles (Rink et al., 
2005). Subsequent decrease might then be due to formation of late endosomes in the 
perinuclear area. The comparison of number/cytosol area ratio at different time points did 
not show differences between wildtype Dync1i2
+/+
 (n=2) and homozygous Dync1i2
T172I/T172I
 
(n=2) fibroblasts (Table 10.5), although 60 min after the EGF uptake homozygous 
Dync1i2
T172I/T172I
 cells tended to have more endosomes than wildtype Dync1i2
+/+
 MEFs 
(p=0.0774). Furthermore, the number/area ratio calculated for the wildtype Dync1i2
+/+
 
cells decreased at constant rate (test for linear trend, p=0.0362), while it was not linear 
when homozygous Dync1i2
T172I/T172I
 cells were analysed (p=0.0811) (Figure 4.8A,B).  
 
The mean endosomal content of the EGF was shown to remain constant and to be tightly 
regulated through changes in number and total load of endosomes (Collinet et al., 2010). 
Therefore, these two parameters were also analysed in relation to both time point and to 
each other. In order to normalise the differences in the cell area only endosomes 
identified in the perinuclear area were taken into account. Following this design, the 
number of vesicles was an outcome of both retrograde transport (increase with time), and 
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endosomal maturation and fusion, as late endosomes clustered in the perinuclear area 
(decrease). At the same time, the total area, corresponding to the total amount of 
internalised EGF, was affected by both transport (accumulation of endosomes) and EGF 
degradation (decrease in fluorescent signal).  
 
The number of perinuclear endosomes first increased from 0 min to 30 min, which likely 
reflected the translocation of endosomes. Following that, the values decreased, which 
would correspond to fusion of vesicles. The wild type Dync1i2
+/+
 (n=2) and homozygous 
Dync1i2
T172I/T172I
 (n=2) fibroblasts did not vary when the number of EGF
+/ve
 endosomes was 
compared at any of the time points (Table 10.5, Table 4.6). However, at 15 min and 45 min 
homozygous Dync1i2
T172I/T172I
 MEFs displayed trends towards lower (p=0.0811) and higher 
(p=0.0503) numbers of endosomes when related to cell lines isolated from wildtype 
Dync1i2
+/+
 animals. These results might correspond to both slightly slower transport (at 15 
min) and impaired membrane fusion (at 45 min) (Figure 4.8C,D).  
 
 
 
Table 4.6. Summary of the image based analysis of number and area of EGF
+/ve
 endosomes 
Parameters of the endosomes presented based on the results of statistical tests, where n.s. corresponds to 
lack of significant differences for p>0.05; trends were noted if p<0.1; for each parameter  values obtained at 
different timepoints were compared between wildtype Dync1i2
+/+
 and homozygous Dync1i2
T172I/T172I
 cell 
lines; detailed analysis is presented in Appendix 10.4 
 
Parameter/ 
time point 
Number of endosomes/ 
cytosol area 
Perinuclear endosomes - 
NUMBER 
Perinuclear endosomes - 
AREA  
0 min n.s. n.s. n.s. 
15 min n.s. 
Dync1i2
T172I/T172I tended to 
have lower values 
n.s. 
30 min n.s. n.s. 
Dync1i2
T172I/T172I tended to 
have lower values 
45 min n.s.  
Dync1i2
T172I/T172I showed 
higher values 
60 min 
Dync1i2
T172I/T172I tended to 
have higher values 
n.s. n.s. 
 
169 
 
 
Figure 4.8. Analysis of parameters of the EGF
+/ve 
endosomes in the wildtype (Dync1i2
+/+
) and homozygous 
(Dync1i2
T172I/T172I
) fibroblasts observed at different time points after EGF stimulation 
Raw data collected for individual cell lines represented as median and interquatrile range (IQR) (two-tone 
symbols) while log transformed values shown as mean ± standard deviation (SD), for easier visualisation SD 
bars extended in 1 direction only; legend refers to all graphs and colours correspond to wildtype Dync1i2
+/+
 
(grey) and homozygous Dync1i2
T172I/T172I
 (blue) MEFs; time points marked on the X-axis refer to time after 
EGF stimulation, a.u. – arbitrary units; patterns of symbols correspond to paired cell lines  
A.B. Median/mean values of ratio of number of endosomes to cytosol area (x 1000) 
C.D. Median/mean values of number of endosomes identified in the perinuclear area 
E.F. Median/mean values of total area of perinuclear endosomes, corresponding to amount of the EGF 
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The changes of the total area of the endosomes in the perinuclear area in relation to time 
showed more prominent effect of retrograde transport, as the total area increased almost 
10-fold within 30 min due to accumulation of the EGF
+/ve 
vesicles. The values then 
decreased slightly reflecting lysosomal degradation and approximately 50% of the EGF 
was reported to be degraded by 60 min after stimulation (Ren et al., 2008). The initial flow 
of the EGF observed at 0 min and 15 min did not vary when wildtype Dync1i2
+/+
 (n=2) and 
homozygous Dync1i2
T172I/T172I
 (n=2) fibroblasts were compared (p=0.7048, p=0.1047 
respectively) (Table 10.5, Table 4.6). However, total area of the perinuclear endosomes 
observed in the homozygous Dync1i2
T172I/T172I
 cells tended to be slightly lower at 30 min 
(p=0.0817), while it was higher at 45 min (p=0.0246). This result might be explained by 
delay in the retrograde transport affecting other processes, e.g. sorting (Figure 4.8E,F). 
There were no differences by 60 min (p=0.1418), suggesting that the rate of EGF 
degradation at this time points was comparable between cell lines. Nonetheless, a delay in 
the initiation of lysosomal degradation would explain the differences observed at 45 min. 
In addition, the values of total area calculated for homozygous Dync1i2
T172I/T172I
 MEFs 
increased in a linear fashion (0min – 30min, p=0.0329), which was not observed in the 
wildtype Dync1i2
+/+
 cells.  
 
Various parameters of the endosomal machinery are often functionally linked and their 
dependency can be statistically expressed as a correlation. A high positive correlation 
between the number of endosomes and total internal cargo was suggested to be a way to 
control the distribution of intracellular EGF (Collinet et al., 2010).  
 
For perinuclear endosomes observed at various time points Pearson correlation 
coefficients were calculated between their number and their total area (Table 10.5). In all 
data sets the values of coefficient were above 0.85 showing a very high positive 
correlation (Figure 4.9).  
 
The dynamics of EGF
+/ve
 endosomes is a combination of different processes often acting 
simultaneously over certain time, therefore different parameters were analysed in order 
to investigate effects of a point mutation in the cytoplasmic dynein intermediate chain 2 
(Dync1i2
T172I
). A maturation from early to late endosomes, which was known to involve 
171 
receptor sorting and fusion of vesicles, was assessed by comparing parameters describing 
number of vesicles. Furthermore, total area of vesicles corresponded to changes in the 
amount of internalised EGF. By limiting analysis to endosomes in the perinuclear area, the 
component of the transport was also included, as distance from the nucleus was shown to 
strongly influence other parameters (Collinet et al., 2010).  
 
 
 
 
Figure 4.9. Correlation between parameters of the EGF
+/ve 
endosomes in the wildtype (Dync1i2
+/+
) and 
homozygous (Dync1i2
T172I/T172I
) fibroblasts observed at different time points after EGF stimulation 
Number and total area recorded for endosomes in the perinuclear area represented as scatter graphs, log 
transformed values are plotted as dots corresponding to individual cells; shape of ‘clouds’ typical for positive 
correlation; legend refers to all graphs and colours correspond to wildtype Dync1i2
+/+
 (grey) and 
homozygous Dync1i2
T172I/T172I
 (blue) MEFs; a.u. – arbitrary units;  patterns of symbols correspond to paired 
cell lines 
A. Correlation between number and total area examined at 0 min 
B. Correlation between number and total area examined at 15 min 
C. Correlation between number and total area examined at 30 min 
D. Correlation between number and total area examined at 45 min 
E. Correlation between number and total area examined at 60 min 
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Fibroblasts isolated from homozygous Dync1i2
T172I/T172I
 embryos varied at different time 
points depending on the parameter analysed, which suggested kinetic differences in the 
dynein function affecting the EGF endocytosis. Total number of vesicles observed in the 
wildtype Dync1i2
+/+
 cells decreased steadily during the time course, whereas in 
homozygous Dync1i2
T172I/T172I
 MEFs the values were higher 60 min after EGF stimulation 
thus deviating from linear trend. This observation suggested delay in the endosomal 
fusion which might be related to transport. Furthermore, when perinuclear area was 
analysed, homozygous Dync1i2
T172I/T172I
 cells tended to have fewer EGF
+/ve 
endosomes at 
15 min but more at 45 min than wildtype Dync1i2
+/+
 at the same time points. Although the 
results were affected by variation thus inconclusive, they might indicate delayed 
accumulation of endosomes in the perinuclear area (at 15 min), which would relate to 
deficits in maturation and fusion of vesicles (at 45 min).  
 
4.4.4 Infection with Salmonella enterica ser. Typhimurium 
Salmonella typhimurium was used as a model to investigate whether point mutations in 
the subunits of cytoplasmic dynein (Dync1i1
G482D
, Dync1i2
T172I
, Dync1h1
Loa
) affect 
membrane dynamics or replication of intracellular bacteria. 
 
4.4.4.1  Multiplicity of infection (m.o.i.) adjusted for MEFs 
The efficiency of invasion strongly depends on properties of host cell (section 4.2.3), and 
the invasion assay was performed in order to adjust the amount of Salmonella 
typhimurium, expressed as multiplicity of infections (m.o.i.), used to infect MEFs.  
 
The efficiency of invasion of wildtype (WT) and SifA
-
 Salmonella was tested using wildtype 
Dync1h1
+/+ 
MEFs seeded at 2x10
4
 cells/ml per coverslips. The bacteria were in an 
exponential growth phase and used when OD600 measured against pure LB medium 
ranged 1.9 – 2.0. A series of aliquots was prepared by mixing 1.0 µl, 2.0 µl, 3.0 µl, 5.0 µl, 
and 7.0 µl bacteria with 1 ml EBSS used per each coverslip. The invasion proceeded for 15 
min, and MEFs were fixed and stained.  
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Coverslips were examined with fluorescent microscopy, as bacteria expressed green 
fluorescent protein (GFP). Ideally, each fibroblast should be invaded only by 1 bacterium, 
so that efficiency of bacterial replication could be estimated. Adding 1.0 µl of Salmonella 
typhimurium suspension (WT and SifA
-
, m.o.i. 1:1000) resulted in expected single 
invasions; however number of infected MEFs was very low, and it increased when 2.0 µl of 
Salmonella typhimurium culture were used. In case of m.o.i. higher than 1:350 (above 3.0 
µl bacterial culture per well) the multiple invasions were observed. In final experiments 
MEFs were infected with bacterial culture at m.o.i. 1:400 (2.5 µl bacteria per well).  
 
4.4.4.2  Phenotypes of the bacterial microcolonies observed in the 
 wildtype and homozygous (Dync1i1
G482D/G482D
Dync1i2
T172I/T172I
, 
 and Dync1h1
Loa/Loa
) cell lines 
The invasion of MEFs isolated from mouse lines carrying point mutations in subunits of 
the cytoplasmic dynein complex was carried out as described in section 2.6.5. Fibroblasts 
were fixed after 8 hours post infection (p.i.), and labelled with antibodies against LAMP-1 
(late endosomes, SCV) and GM130 (Golgi complex). Because secondary antibodies used 
against GM130 were conjugated with far red dye (Alexa Fluor 647), the Golgi complex was 
not taken into account during analysis performed. There were 6 cell lines used in both 
experiments, each was derived from individual embryos. MEFs isolated from embryos 
carrying wildtype or mutant alleles were selected to come from the same litter in order to 
limit possible variation. The cell lines included: one of wildtype Dync1i1
+/+
 Dync1i2
+/+
 and 
double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
, two of wildtype Dync1h1
+/+ 
and 
homozygous Dync1h1
Loa/Loa
. It should be noted that due to time constraints only 1 
experiment with each cell line was performed. From the statistical point of view, embryos 
should be treated as ‘independent’ subjects. Therefore, cell lines derived from embryos 
with mutations in the intermediate chains (Dync1i1
G482D 
Dync1i2
T172I
) were not tested 
statistically (n=1), cell lines with mutation in the Dync1h1
Loa 
were tested for n=2 with tests 
for categorical data (Fisher’s exact test, Chi-squared); results presented as mean (tables) 
or mean ± standard deviation (SD, figures). All MEF lines were seeded at the same 
concentration and passage. For MEFs infected with WT Salmonella typhimurium 
phenotypes of micro colony (split into 4 bins), approximate number of bacteria, and 
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association with LAMP-1 positive (annotated as LAMP-1
+/ve
) compartment were noted. 
Furthermore, for each fibroblast infected with the SifA
-
 mutant, features of LAMP-1
+/ve 
compartment were recorded along with number of bacteria. From each condition 120 
cells were scored blindly. The efficiency of 8 hour long infection with WT strain of 
Salmonella typhimurium was scored by 3 categorical parameters, which described the 
position and speed of replication of bacteria in each fibroblast. Those included: (1) 
position of bacteria in regards to nucleus (perinuclear or periphery), (2) ability to form 
micro colony (clustered or scattered), (3) and presence of fewer or more than 20 bacteria 
per fibroblast (Figure 4.10). The phenotypes of Salmonella typhimurium were allocated to 
8 categories and few approaches to testing were taken by analysing parameters 
individually or in pairs. Detailed analysis is presented in Appendix 10.5 and Table 10.6. 
 
While infection progresses in epithelial cells, wildtype (WT) Salmonella typhimurium form 
clustered micro colonies, which locate close to the Golgi complex and nucleus. The 
bacteria replicate in SCVs and a replication rate depends on a cell type: at 10 hours p.i. 
there were 20 bacteria observed in HeLa cells on average (Guignot et al., 2004), while at 8 
hours p.i. 90% MEFs contained fewer than 10 bacteria (Radtke et al., 2007). In all of cell 
lines examined, over 70% Salmonella micro colonies contained fewer than 20 bacteria. 
Furthermore, colonies with increased proliferation (>20) were evenly distributed in 4 bins, 
ranging from 4.2% to 5.8% for Dync1i1
G482D 
Dync1i2
T172I
 cell lines (10% in one case), and 
from 3.3% to 7.9% in Dync1h1
Loa 
cell lines. The contribution of this parameter was small 
(Figure 4.11). 
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Figure 4.10. Representative pictures of wildtype MEFs showing intracellular Salmonella typhimurium (WT, 
SifA
-
) 
Images showing various distribution of intracellular bacteria 8 hours after infection; bacteria (green), late 
endosomal compartment labelled with anti-LAMP-1 antibodies (red), additionally Golgi complex stained 
with anti-GM130 (blue), bacteria in LAMP-1 enriched SCV are pseudocolored yellow; host cell boundaries 
marked with white line; scale bar 5µm 
A. Wildtype (WT) Salmonella categorised based on their position (perinuclear or periphery) and 
morphology) (clustered in micro colony or scattered) 
B. SifA
- 
Salmonella mutant showing lack of colocalisation with LAMP-1 compartment due to disruption of 
the SCV membrane 
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The infection with wildtype Salmonella typhimurium was performed with only 1 wildtype 
Dync1i1
+/+
Dync1i2
+/+
 and 1 double homozygous Dync1i1
G482D/G482D
Dync1i2
T172I/T172I
 cell line, 
therefore the results obtained were not conclusive. The comparison of distributions in 8 
categories suggested, that bacteria were observed more often in a perinuclear area as 
clustered micro colonies in the double homozygous Dync1i1
G482D/G482D
Dync1i2
T172I/T172I
 cells 
(0.417) than in the wildtype MEFs (0.300) (Table 10.6, Table 4.7). Moreover, bacteria were 
annotated to other categories in small fractions of the mutant Dync1i1
G482D/G482D
 
Dync1i2
T172I/T172I
 cells (0.108, 0.100, 0.108) (Figure 4.11A); while within infected wildtype 
Dync1i1
+/+ 
Dync1i2
+/+
 cells more micro colonies were observed in the cell periphery (0.225) 
(Figure 4.11A). The comparison of fractional distributions calculated for individual or 
grouped parameters indicated a trend towards increase in the intracellular Salmonella 
observed in perinuclear area of the double homozygous Dync1i1
G482D/G482D
 
Dync1i2
T172I/T172I
 (0.675, 0.467 and 0.208, 0.525 and 0.150; Figure 4.12A,D,F) when related 
to wildtype Dync1i1
+/+ 
Dync1i2
+/+ 
fibroblasts (0.525, 0.350 and 0.175, 0.433 and 0.092; 
Figure 4.12A,D,F respectively).  
 
The course of Salmonella typhimurium infection of the Dync1h1
Loa/Loa
 fibroblasts did not 
differ from wildtype Dync1h1
+/+
 cells (Table 10.6, Table 4.7). In the cells homozygous for 
Dync1h1
Loa 
allele higher proportions of scattered and clustered bacterial colonies were 
observed at the cell periphery (0.246, 0.208 respectively) than in wildtype Dync1h1
+/+
 cells 
(0.196, 0.146) (Figure 4.11B). Furthermore, Dync1h1
Loa/Loa 
cells displayed a proportional 
decrease in the number of perinuclear clustered micro colonies (0.225) when compared 
with wildtype Dync1h1
+/+ 
lines (0.288) (Figure 4.11B). When individual parameters were 
analysed, in the Dync1h1
Loa/Loa
 cells more Salmonella typhimurium localised at the 
periphery (0.575) than in the wildtype Dync1i1
+/+ 
Dync1i2
+/+ 
MEFs (0.483, p=0.1958) 
(Figure 4.12A). Furthermore, the trend was more pronounced when both, position and 
number of bacteria were taken into account (p=0.0877). In the homozygous Dync1h1
Loa/Loa
 
cells WT Salmonella were observed more often in small number at the cell periphery 
(0.454) than at the nucleus (0.342) (Figure 4.12F). At the same time, in the wildtype 
Dync1h1
+/+ 
cells bacteria were observed more frequently in the perinuclear area (0.442) 
than at the periphery (0.342) (Figure 4.12F).  
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Figure 4.11. Distribution of colony features observed in MEFs infected with wildtype (WT) Salmonella 
typhimurium 
Frequency distribution plotted as fraction of total; colours correspond to wildtype Dync1i1
+/+
 Dync1i2
+/+
 
(light grey), double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 (pink), wildtype Dync1h1
+/+
 (dark grey), 
homozygous Dync1h1
Loa/Loa
) (green); cells with increased bacterial proliferation (>20) marked with cross-
hatched bars (PP-SC to PN-CL); Y-axis title refers to both graphs and dashed lines at Y=1.25 and Y=2.50 
indicate the chance distribution; abbreviations used annotate: PP-SC – periphery scattered, PP-CL – 
periphery clustered, PN-SC – perinuclear scattered, PN-CL – perinuclear clustered 
A. Distribution of Salmonella micro colonies in MEFs derived from Dync1i1
G482D 
Dync1i2
T172I 
embryos 
B. Distribution of Salmonella micro colonies in cells derived from Dync1h1
Loa 
embryos 
 
 
 
 
Table 4.7. Summary of analysis of the distribution of micro colony features observed in MEFs infected 
with wildtype Salmonella typhimurium  
Results of analysis of intracellular bacteria presented based on the results of statistical tests, where n.s. 
corresponds to lack of significant differences for p>0.05; trends were noted if p<0.1; distinct micro colony 
features were compared between wildtype Dync1h1
+/+
 and homozygous Dync1h1
Loa/Loa
 cell lines; detailed 
analysis is presented in Appendix 10.5. 
Category 
Position (1) 
Perinuclear or periphery 
Microcolony (2) 
Scattered or clustered 
Number (3) 
< 20 or > 20 
Position (1) n.s. (Figure 4.12A) - - 
Microcolony (2) n.s. (Figure 4.12D) n.s. (Figure 4.12B) n.s. (Figure 4.12E) 
Number (3) 
Dync1h1
Loa/Loa tended to show 
differences in distribution of bacteria 
(Figure 4.12F) 
- n.s. (Figure 4.12C) 
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Figure 4.12. Analysis of selected micro colony features observed in MEFs infected with wildtype (WT) 
Salmonella typhimurium  
Results for distinct categories were grouped depending on parameter(s) compared; the legend refers to all 
graphs and colours correspond to wildtype Dync1i1
+/+
 Dync1i2
+/+
 (light grey), double homozygous 
Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 (violet), wildtype Dync1h1
+/+
 (dark grey), homozygous Dync1h1
Loa/Loa
) 
(green) cell lines; each category marked with distinct pattern; on Y-axis plotted number of infected cells 
from each line (120); due to small sample size (n=2) MEFs carrying Dync1h1
Loa 
allele represented as mean ± 
SD 
A, B, C – comparison of individual parameters, where numbers were grouped relative to (A) position of 
 Salmonella within a host cell, (B) formation of micro colony, (C) and number of bacteria 
 above/below a value 
D, E, F – results compared in relation to 2 parameters, (D) position and micro colony appearance, (E) micro 
 colony and numbers of bacteria, (F) and position and number of bacteria 
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In conclusion, the single point mutations in the subunits of the cytoplasmic dynein 
complex (intermediate or heavy chains) did not affect progression of intracellular infection 
with Salmonella typhimurium, and the bacteria were found mostly in small clusters in the 
perinuclear area of the host cells. Bacterial micro colonies were scored by 3 parameters, 
however the parameter describing an assembled micro colony (clustered or scattered) was 
nearly equal in all groups examined (Figure 4.12B); the most likely it was irrelevant in the 
assay performed. On the other hand, at 8 hours p.i. the intracellular position and number 
of bacteria in fibroblasts displayed a level of correlation. In the cell lines derived from the 
Dync1i1
G482D
 Dync1i2
T172I
 embryos, the mutant allele was associated with the increase in 
the frequencies of small (<20) perinuclear micro colonies and more numerous colonies 
(both, at the periphery and around nucleus) (Figure 4.12F). This shift in position was 
reflected by the decrease in fraction of small peripheral colonies. Furthermore, the 
contrary effects were observed in the Dync1h1
Loa
 fibroblasts, and homozygous 
Dync1h1
Loa/Loa 
cells displayed more small peripheral micro colonies, whereas the 
frequencies of Salmonella in the remaining categories decreased (Figure 4.12F). Finally, 
results obtained for the wildtype cell lines (Dync1i1
+/+
 Dync1i2
+/+
 and Dync1h1
+/+
) were 
comparable, thus not affected by the genetic background. 
 
4.4.4.3  Progression of the infection with the Salmonella typhimurium 
 SifA
-
 mutant strain 
The SifA
-
 mutant strain, which looses the SCV membranes early after infection, proved 
useful in investigating membrane dynamics. The compartment, in which Salmonella 
enetrica replicate, is decorated with many proteins, yet markers associated with late 
endosomes are usually the most prominent. Therefore, MEFs were infected with WT and 
SifA
-
 Salmonella typhimurium and at 8 hours p.i. stability of bacterial vacuoles was 
investigated by following the distribution of LAMP-1 (Lysosomal-associated membrane 
protein 1). The data were collected from 120 cells (from each genotype and strain used) 
and recorded as a number of bacteria, which colocalised with LAMP-1 staining; they are 
represented as a fraction of Salmonella found in LAMP-1
+/ve 
compartment (Figure 4.10B).  
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In all MEF lines infected with WT Salmonella over 95% of internalised bacteria were 
surrounded by structures which labelled with LAMP-1, whereas less than 10% in case of 
infection with SifA
-
 strain (Table 10.7, Table 4.8). Furthermore, there were no differences 
between cell lines infected with either of strains: WT Salmonella was observed in 
association with LAMP-1 in 0.991 and 0.990 of wildtype Dync1i1
+/+ 
Dync1i2
+/+ 
and double 
homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 cells respectively, whereas the fractions 
were 0.989 and 0.986 in case of wildtype Dync1h1
+/+
 and Dync1h1
Loa/Loa
 cells respectively 
(Figure 4.13A). On the other hand, nearly all the SifA
-
 mutant bacteria lost the LAMP-1
+/ve 
membrane, except for: 0.075 and 0.109 of bacteria in the Dync1i1
+/+
Dync1i2
+/+
 cells and 
Dync1i1
G482D/G482D
Dync1i2
T172I/T172I
 MEFs, together with 0.078 and 0.091 of bacteria 
invading Dync1h1
+/+ 
and Dync1h1
Loa/Loa
 respectively (Figure 4.13B).  
 
 
 
 
 
 
Table 4.8. Summary of membrane dynamics observed in MEFs infected with wildtype (WT) and SifA
- 
Salmonella typhimurium 
Membrane dynamics presented based on the results of statistical tests, where n.s. corresponds to lack of 
significant differences for p>0.05; for each bacterial strain values obtained for each observation were 
compared between wildtype Dync1h1
+/+
 and homozygous Dync1h1
Loa/Loa
 cell lines; detailed analysis is 
presented in Appendix 10.5. 
 
Phenotype observed WT Salmonella SifA- Salmonella 
Salmonella in LAMP -1+/ve compartment n.s. n.s. 
MEFs with Salmonella in 2 compartments n.s. n.s. 
Salmonella with lost /retained LAMP -1+/ve membranes n.s. n.s. 
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Figure 4.13. Comparison of the LAMP-1
+/ve 
compartment in MEFs infected with wildtype (WT) and SifA
- 
Salmonella typhimurium 
Results for various features describing bacteria in relation to LAMP-1
+/ve 
compartment; the legend refers to 
all graphs and colours correspond to wildtype Dync1i1
+/+
 Dync1i2
+/+
 (light grey), double homozygous 
Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 (pink), wildtype Dync1h1
+/+
 (dark grey), homozygous Dync1h1
Loa/Loa
) 
(green) cell lines; bars corresponding to SifA
- 
strain striped; on Y-axis plotted fraction of Salmonella, due to 
small sample size (n=2) MEFs carrying Dync1h1
Loa 
allele represented as mean ± standard deviation (SD); 
number from pooled observations shown as median and interquartile range (IQR) 
A.  Fraction of total WT Salmonella, which colocalised with LAMP-1 staining 
B.  Fraction of total SifA
-
 Salmonella, which was retained in the LAMP-1
+/ve
 membranes  
C, D.  Fraction of MEFs examined in each group (120 cells), which showed misplaced WT and SifA
- 
bacteria  
E, F.  Fraction of WT and SifA
-
 Salmonella, which was mis-localised in cells shown in C and D (only bacteria 
 present in MEFs mentioned were taken into account) 
G.   Number of SifA
-
 Salmonella observed in MEFs at 8 hours p.i. 
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Eukaryotic cells are known to interact with Salmonella, and there are few cellular 
mechanisms described which participate in preserving stable membranes around SCVs 
(Radtke et al., 2007). Therefore, the cellular input in membrane stability was expressed as 
number of fibroblasts, in which bacteria were observed in 2 compartments and number of 
mis-localised bacteria. WT Salmonella typhimurium was observed in LAMP-1
+/ve
 
compartment in nearly all fibroblasts examined (Table 4.8). Values were comparable 
between wildtype Dync1i1
+/+ 
Dync1i2
+/+
 and homozygous Dync1i1
G482D/G482D 
Dync1i2
T172I/T172I
 cells, as 5 (0.042) and 6 (0.051) fibroblasts were found to have Salmonella 
in the cytosol (Figure 4.13C). Similar frequencies were noted for wildtype Dync1h1
+/+
 
(0.058) and homozygous Dync1h1
Loa/Loa
 (0.066) cells (Figure 4.13D). It should be pointed 
though, that results were not informative due to big spread of raw values recorded for 
both, wildtype Dync1h1
+/+
 (10 and 4) and homozygous Dync1h1
Loa/Loa
 (13 and 2) cells. 
Misplaced bacteria in those cells were then counted and cytosolic WT Salmonella 
represented 0.186 and 0.161 of bacteria observed in Dync1i1
+/+ 
Dync1i2
+/+
 and 
Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 respectively (Figure 4.13E). Closer analysis of 
Dync1h1
Loa
 fibroblasts did not show differences (p=0.8459), and frequencies were 
comparable to values obtained for the Dync1i1
G482D
 Dync1i2
T172I
 line, where 0.194 (in 
Dync1h1
Loa/Loa
) and 0.180 (in Dync1h1
+/+
) of examined bacteria were misplaced from the 
LAMP-1
+/ve 
compartment (Figure 4.13F). 
 
Similar analysis was performed for MEFs infected with SifA
-
 strain, but results were fairly 
uniform in all cell lines. Furthermore, the fraction of mutant bacteria, which retains LAMP-
1
+/ve
 membrane was suggested to represent defective trafficking of cellular components, 
thus not relevant (Beuzon et al., 2002). Overall, between 0.242 and 0.321 of MEFs 
examined displayed Salmonella associated with the LAMP-1
+/ve
 membranes (Table 10.7, 
Table 4.8). Within individual fibroblasts, SifA
- 
bacteria which retained SCVs comprised 
0.164 (in Dync1i1
+/+ 
Dync1i2
+/+
), 0.184 (in Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
), 0.203 (in 
Dync1h1
+/+
), and 0.151 (in Dync1h1
Loa/Loa
) of all the bacteria counted (Figure 4.13E, F). 
Finally, numbers of mutant Salmonella present in MEFs at 8 hours p.i. were noted as a 
measure of replication rate. Regardless of genotype WT Salmonella were found in colonies 
containing over 20 bacteria in 20% of fibroblasts, whereas the bacteria from SifA
-
 strain 
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were seldom observed in numbers higher than 20 (90
th
 percentile was from 4.5 to 8.7 
Salmonella per MEF). Furthermore, in both mutant cell lines 
(Dync1i1
G482D/G482D
Dync1i2
T172I/T172I
, Dync1h1
Loa/Loa
) fewer bacteria were observed (median 
1.0 and 6.0 respectively) than in corresponding wildtype cells (median 4.0 and 7.0 
respectively) (Table 10.7, Figure 4.13G). Results were not tested for statistical significance 
due to a small sample size. 
 
In summary, there were no differences in dynamics of LAMP-1
+/ve
 membranes when cell 
lines carrying alleles of cytoplasmic dynein intermediate (Dync1i1
G482D
 Dync1i2
T172I
) and 
heavy (Dync1h1
Loa
) chains. Nonetheless, the mutant SifA
-
 strain seemed to replicate 
slower in double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 cells, as expressed by 
number of bacteria observed 8 hours p.i.  
 
 
 
4.5 Discussion 
4.5.1 Mutations in the cytoplasmic dynein intermediate chains 1 and 2 
(Dync1i1G482D, Dync1i2T172I) affect membrane dynamics during 
reassembly of the Golgi apparatus 
Pericentriolar localisation of the Golgi complex depends on a constant flow of membranes 
and proteins mediated by microtubule associated motors. Stacks of membranes are also 
kept in tight clusters by Golgi tethering proteins (Vinke et al., 2011), and different 
phenotypes of the Golgi complex can be observed by interfering with either tethering or 
membrane transport. The disruption of tethering proteins results in a network of tubules 
and vesicular structures often localised in the perinuclear region (Lam et al., 2010). This 
morphology of the Golgi complex was observed during mitosis (Persico et al., 2009), or 
after cleavage of GRASP65 after caspase-3 activation (Lane et al., 2002). Furthermore, 
similar phenotype was caused by depletion of NDE1 and NDEL1, suggesting their role in 
maintaining Golgi structure. On the other hand, when retrograde transport is impaired, 
the Golgi complex becomes dispersed through the cytosol, as all the material diffuses 
towards ER and ERES. The most pronounced effect was observed after disruption of MTs 
(Cole et al., 1996), or the dynein-dynactin complex (Roghi and Allan, 1999). Moreover, the 
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Golgi complex is highly dynamic and a perturbation of the membrane transport driven by 
the cytoplasmic dynein complex was shown to affect the structural integrity of the Golgi 
apparatus. The fragmentation of stacks was reported after depletion of various subunits 
of the cytoplasmic dynein (Palmer et al., 2009), known interacting complexes, like LIS1 
(Lam et al., 2010), or dephoshorylation of the dynein intermediate chains (Vaughan, 
2005). On the other hand, up regulation of RAB11-FIP3 resulted in Golgi scattering due to 
sequestration of the DYNC1LI1 (Horgan et al., 2010a), while cells over-expressing any of 
LIS1, NDE1, or NDEL1 displayed Golgi stacks more compact than wildtype cells (Lam et al., 
2010). Partial decrease in the levels of intact dynein complex resulted an intermediate 
morphology of the Golgi consisting of reduced ribbon accompanied by small peripheral 
structures (Lam et al., 2010). Huntingtin was also shown to participate in positioning of 
the Golgi, however its lack does not cause complete scatter but Golgi membranes formed 
tubules which extended in the cytosol (Caviston et al., 2007). 
 
Although the involvement of many complexes in the dynein mediated movement is well 
known, its mechanism and regulation are still not well described. Therefore, in this work 
we used a cell model carrying point mutations in the subunits of the cytoplasmic dynein 
complex (Dync1i1
G482D
, Dync1i2
T172I
) in order to investigate their effect on Golgi membrane 
dynamics during reassembly. Once scattered, individual Golgi fragments coalesce via 
tubules into a ribbon and are transported towards MTOC in a dynein dependent 
movement (Bechler et al., 2010). Here, we observed these processes in the wildtype 
Dync1i1
+/+ 
Dync1i2
+/+
 MEFs as the changes in the number of fragments and their shape 
during 20 min after nocodazole wash out. Although the homozygous mutations in the 
intermediate chains 1 and 2 (Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
) did not cause severe 
impairment in Golgi structure, the rate of its reassembly was slightly higher than in 
wildtype Dync1i1
+/+ 
Dync1i2
+/+ 
fibroblasts. In addition, values of mean eccentricity of Golgi 
stacks in the double homozygous cells were lower and did not vary during the reassembly. 
These results might suggest quicker fusion of membranes and different dynamics and 
tubulation of the Golgi membranes observed in the cells carrying two single point 
mutations (Dync1i1
G482D
, Dync1i2
T172I
). There are 2 other mouse lines carrying point 
mutations in the subunits of the dynein complex, which on the cellular level have been 
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shown to affect Golgi reassembly. The mutation in the cytoplasmic dynein heavy chain 1 
(Dync1h1
Loa
) caused defects in coalescence of dispersed stacks, which were described as 
increased number of Golgi fragments at 20 min after nocodazole washout in the 
homozygous Dync1h1
Loa/Loa
 cells (Hafezparast et al., 2003). Furthermore, mutation in the 
light intermediate chain 1 (Dync1li1
N235Y
) was shown to affect the rate of the Golgi 
reassembly, as the values of number to area ratio were higher than in untreated 
Dync1li1
N235Y/N235Y
 cells as late as 50 min (Banks et al., 2011). However, no differences in 
the interactions between DLIC1 and RAB11-FIP3 were observed in the homozygous 
Dync1li1
N235Y/N235Y
 fibroblasts (M.W. McCaffrey, personal communication).  
 
4.5.2 Point mutations in the subunit of cytoplasmic dynein selectively 
influence the vesicular transport in the embryonic fibroblasts 
4.5.2.1  EGF trafficking  
Molecular motors were shown to take part in all the steps of the endosomal pathway, and 
the role of the dynein-dynactin complex in endosome movement is well documented, 
however, the exact role of its subunits in the domain of time is not well described. Apart 
from triggering a long range movement of endosomes, the cytoplasmic dynein complex 
was shown to actively participate in maturation of early endosomes and receptor sorting 
(Driskell et al., 2007). Disruption of the dynein complex delayed the procession from early 
endosomes to endocytic recycling compartment (ERC) (Traer et al., 2007), and reduced 
size distribution of endosomes observed and their movement (Driskell et al., 2007). 
Furthermore, cells with depleted dynein failed to establish a perinuclear ERC, although 
kinetics of endosomal processes (sorting, TfnR recycling, EGFR degradation) were not 
affected (Caviston et al., 2007). Also RAB7 was suggested to retain dynein complex on the 
vesicles with folate receptor (FR), therefore keeping them in the ERC and preventing their 
recycling to plasma membrane (Chen et al., 2008). A multiparametric screen for genes 
involved in the EGF trafficking also identified dynein heavy chain (DYNC1H1) and light 
chain RP3 (DYNLT3) (Collinet et al., 2010). It should be noted, however, that the majority 
of observations was recorded after complete disruption of the dynein complex or 
depletion of its components. Here, we describe the analysis of EGF endocytosis in the 
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presence of point mutation in the cytoplasmic dynein intermediate chain 2 (Dync1i2
T172I
). 
Small differences were identified at different time points affecting discrete parameters of 
the endosomal pathway. The fact that they were defined temporally and spatially suggests 
a specific role of the DYNC1I2 in the processes of maturation or membrane dynamics in 
the perinuclear area. Recently, another mouse line with point mutation in the dynein light 
chain 1 (DYNC1LI1) was reported, and homozygous Dync1li1
N235Y/N235Y
 fibroblasts displayed 
increase in the  number of EGF
+/ve 
endosomes 20 min and 40 min after the stimulation 
(Banks et al., 2011).  
 
4.5.2.2  Membrane dynamics in cells infected with Salmonella 
 typhimurium 
The involvement of the cytoplasmic dynein complex in the course of intracellular phase of 
infection has been well documented in HeLa cells, and lack of retrograde transport 
impaired both formation of vacuoles and bacterial replication (Guignot et al., 2004). 
Several groups reported that cytoplasmic dynein is recruited to SCVs by interactions of 
P150
Glued 
with RAB7-RILP complex (Marsman et al., 2004). Retrograde transport is initiated 
by activation of RAB7, and within 2 hours p.i. majority of bacteria can be found in the 
perinuclear region (Abrahams et al., 2006). Furthermore, disruption of the cytoplasmic 
dynein by over expression of P50/DYNAMITIN or truncated RILP caused dispersion of 
bacteria or redistribution of colonies towards cell periphery (Abrahams et al., 2006; 
Harrison et al., 2004). Salmonella micro colonies were also shown to sequester the dynein 
complex around SCVs; however the timescale and mechanism of this interaction remain 
controversial. On the contrary, although lysosomal compartment was redistributed to the 
periphery, the association of Salmonella typhimurium with LAMP-1 and their perinuclear 
positioning were unaffected despite disruption of the dynein-dynactin interactions 
(Guignot et al., 2004). Furthermore, detailed analysis of discrete movements of individual 
bacteria showed, that the movement along MTs was bidirectional and variable in terms of 
velocity, which suggested recruitment with both, kinesin-1 and dynein (Beuzon et al., 
2000). In addition, the activity of the cytoplasmic dynein was also implicated in bacterial 
replication, although both, decrease (Marsman et al., 2004) and increase (Abrahams et al., 
2006) in number of bacteria were reported in effect.  
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In this chapter the localisation of Salmonella micro colonies and number of bacteria in the 
different MEF lines carrying mutations in the subunits of the cytoplasmic dynein were 
examined 8 hours p.i. There were no differences observed neither in the replication nor 
fraction of bacteria in the perinuclear region in any of the mutant in dynein subunits cell 
lines, and usually over 50% of WT Salmonella were found in perinuclear micro colonies. 
On the contrary, between 70% to 80% of HeLa cells were reported to have micro colonies 
located close to the Golgi complex from 4 hours after infection (Ramsden et al., 2007a). 
Furthermore, a slight increase (9.2%) in the frequency of small (<20) perinuclear colonies 
was observed in the double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 cells when 
compared with wildtype Dync1i1
+/+ 
Dync1i2
+/+
. On the other hand, the fraction of mutant 
Dync1h1
Loa/Loa
 MEFs with the perinuclear micro colonies was smaller by 8.8% than in the 
wildtype cells.  
 
The membrane dynamics of the SCVs assembled by WT and SifA
-
 Salmonella was also 
investigated by comparing the association of both strains with the LAMP-1
+/ve
 
compartment. WT Salmonella were reported to maintain the SCV membrane intact during 
the infection, and in fibroblasts 97.1% of intracellular bacteria were surrounded by  
LAMP-1
+/ve 
membranes 8 hours p.i. (Radtke et al., 2007). On the contrary, the SifA
-
 strain 
loses the SCV membrane and replicates in the cytoplasm. In HeLa cells this process starts 
approximately 6 hours p.i., and results in translocation of over 95% of bacteria to the 
cytosol (Beuzon et al., 2002). Furthermore, the disruption of dynein-dynactin complex 
resulted in 60% of SifA
-
 bacteria remaining in SCVs 8 hours p.i. Finally, fibroblasts inhibit 
replication of intracellular Salmonella (Martinez-Moya et al., 1998), and levels of the 
intracellular nitric oxide (NO) were often elevated in response to infection (Garcia, 2001). 
This reaction is especially effective when bacteria are found in the cytosol, and the 
replication rate of the SifA
- 
strain in mouse fibroblasts was reduced to 10% of replication 
of WT Salmonella (Beuzon et al., 2002).  
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This analysis of MEFs with mutation in cytoplasmic dynein (Dync1h1
Loa
, Dync1i1
G482D
 
Dync1i2
T172I
) and infected with WT and SifA
-
 Salmonella did not show impairment in 
membrane trafficking, although the total number of mutant bacteria was lower than 
values recorded for MEFs infected with WT Salmonella. Furthermore, the median number 
of intracellular bacteria tended to be lower in both mutant (Dync1i1
G482D/G482D
 
Dync1i2
T172I/T172I
 and Dync1h1
Loa/Loa
) cell lines.  
 
Although in some cases results were inconclusive, it should be noted, that most of the 
work cited above was performed using HeLa cells as a model system. However, the role of 
cell type in pathogen-host interactions is a crucial factor, e.g. formation of Sifs in 
fibroblasts was shown to be reduced, while in HeLa cells a tubular network of SCVs 
membranous extensions is a common phenomenon (Martinez-Moya et al., 1998). 
Therefore, comparisons might not be informative, and it would be beneficial to observe 
the progression of the bacterial infection in our fibroblast with measurements taken at 
few time points or employ quantitative methods to evaluate Salmonella proliferation 
within MEFs. Nonetheless, wildtype and mutant strains of Salmonella typhimurium 
present a very good tool to study endocytic pathway and its perturbations.  
 
189 
5. Cytoplasmic dynein complex and the formation of stress granules 
5.1 Introduction  
Stress granules (SG) have recently gained increased attention as a universal mechanism 
controlling RNA metabolism and translation; however their function, structure, or 
dynamics are still not well understood. There are many classes of RNA containing granules 
and they have been well described elsewhere (Anderson and Kedersha, 2009; Buchan and 
Parker, 2009). 
 
5.1.1 Cellular stress and stress response pathways 
Stress granules are non-membranous cytoplasmic foci ranging in size from 0.1 to 2.0 μm, 
composed of non-translating messenger ribonucleoproteins (mRNPs) that rapidly 
aggregate in cells exposed to environmental conditions (Anderson and Kedersha, 2009). 
Many stresses act via decreasing stability of proteins (e.g. heat shock), which triggers 
mechanisms dealing with structurally changed molecules (e.g. unfolded protein response 
(UPR), activation of chaperones and proteosomes) (Ron and Walter, 2007). In many cases, 
the stress-induced phosphorylation of the translation initiation factor eIF2α (EIF2A) 
triggers stress granule assembly by preventing or delaying translational initiation. Arsenite 
(SA) is known to induce oxidative stress via: mimicking of phosphate, oxidation of 
proteins, depletion of antioxidants (Ventura-Lima et al., 2011). The imbalance in oxidative 
stress is a specific signal, which activates eukaryotic translation initiation factor 2α kinase 
1 (EIF2AK1) resulting in EIF2A phosphorylation (McEwen et al., 2005). Thapsigargin (TG) is 
a compound which inhibits an activity of ATPase Ca
2+
 pump 3 (ATP2A3) resulting in release 
of Ca
2+
 from ER stores and indirectly contributes to ER stress. The Ca
2+
 imbalance between 
cytosol and ER cisterns activates eukaryotic translation initiation factor 2α kinase 2 
(EIF2AK2/PKR) (Prostko et al., 1995), while ER stress triggers phosphorylation of 
eukaryotic translation initiation factor 2α kinase 3 (EIF2AK3/PERK) (Harding et al., 1999). 
The EIF2A is a common substrate for both kinases, and its modification initiates the 
assembly of stress granules. 
 
190 
5.1.2 Components of stress granules 
SG are primarily composed of the stalled 48S complexes containing bound mRNAs derived 
from disassembling polysomes (Anderson and Kedersha, 2009). These contain poly(A)+ 
RNA bound to early initiation factors (such as EIF4E, EIF3, EIF4A, EIFG) and small, but not 
large, ribosomal subunits. In addition to these core components, SG contain an eclectic 
assembly of proteins that vary with cell type and with the nature and duration of the 
stress involved. RNA-binding proteins, transcription factors, RNA helicases, nucleases, 
kinases and signalling molecules have been reported to accumulate in SG. In some cases, 
recruitment of signalling proteins into stress granules influences cell survival. More 
recently, stress granules have been shown to contain the Argonaute complex, microRNAs, 
a number of mRNA-editing enzymes, and proteins required for transposon activity (Detzer 
et al., 2011). 
 
5.1.3 Role of the cytoplasmic dynein complex in the assembly of stress 
granules 
The biophysical studies of SG assembly suggested an active mechanism driving RNA and 
proteins in the organised foci, and their kinetics could not be explained by diffusion 
(Chernov et al., 2009). One possibility involved an action of microtubules, as microtubule-
depolymerising drugs such as nocodazole inhibit SG formation, although smaller SG 
generally still form (Buchan and Parker, 2009). Recently, MT-associated motors have been 
observed in proximity to the SG and targeted depletion of the dynein heavy chain 
(DYNC1H1) strongly reduced the formation of cytosolic granules (Loschi et al., 2009). 
Furthermore, dynein inhibition or knockdown also increases protease sensitivity of TIA-1 
aggregates, providing additional evidence for a role in stress granule stability (Tsai et al., 
2009). 
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5.2 Project overview 
Formation of SG was investigated using as a model MEF lines, which were isolated from 
wildtype and mutant animals (Dync1i1
G482D
, Dync1i2
T172I
, and Dync1h1
Loa
). The cellular 
response to stress was examined along with detailed analysis of SG in individual cells.  
 
5.3 Results 
Cells were derived from mouse lines carrying double homozygous mutant alleles of the 
intermediate chains 1 and 2 (Dync1i1
G482D 
Dync1i2
T172I
) and Loa, carrying mutation in the 
heavy chain (Dync1h1
Loa
). In all cases MEF lines were compared with wildtype ‘littermate’ 
lines. Cellular stress was induced with sodium arsenite (SA, oxidative stress) and 
thapsigargin (TG, Ca
2+
 release and ER stress) and the phosphorylation of a eukaryotic 
translation initiation factor 2α (EIF2A) examined in response. Two well characterised 
markers: GTPase activating protein (SH3 domain) binding protein 1 (G3BP) and TIA1 
cytotoxic granule-associated RNA binding protein-like 1 (TIAL1) were used in order to 
visualise SG, and details of the treatment, analysis, and protein analysis were described in 
sections 2.6.6, 2.6.8, 2.7.1, and 2.5.4 respectively. Briefly, cells were incubated in medium 
containing 200 µM SA for 45 min, or 1 μM thapsigargin for 1 hour. The specificity of 
induced granules was assessed by additional treatment with 50 μg/ml emetine, which 
inhibits formation of SG (Kedersha and Anderson, 2007).  
 
5.3.1 Induction of stress granules in the wildtype and homozygous 
(Dync1i1G482D/G482D Dync1i2T172I/T172I, and Dync1h1Loa/Loa) MEFs  
Wildtype Dync1i1
+/+ 
Dync1i2
+/+
 (n=3), double homozygous Dync1i1
G482D/G482D
 
Dync1i2
T172I/T172I
 (n=3), wildtype Dync1h1
+/+
 (n=3), and homozygous Dync1h1
Loa/Loa
 (n=3) 
MEFs were examined for formation of SG. There were 3 experiments performed with each 
cell line and cells were scored for the presence of G3BP and TIAL1 positive structures. In 
all the cell untreated and incubated with emetine no granules were observed (over 200 
cells examined from each experiment), which confirms the specificity of an assay. Results 
are represented as mean ± standard deviation (SD). 
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5.3.1.1  Phosphorylation of EIF2A 
A state of cellular stress was examined in each cell line by assessing phosphorylation of 
the EIF2A, as both sodium arsenite (SA) and thapsigargin (TG) activate kinases specific for 
serine at a position 51. MEFs were treated as described in section 2.6.6 and cell lysates 
probed with antibodies specific for phosphorylated EIF2A at serine 51 (sections 2.5.2, 
2.5.3, and 2.5.4). From each sample 10 µg of total protein were loaded, as a positive 
control antibodies against β-actin (44 kDa) were used. 
 
An increase in signal of phosphorylated EIF2A (36 kDa) was observed in both wildtype 
Dync1i1
+/+ 
Dync1i2
+/+
 and double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 
fibroblasts after treatment with SA or TG (Figure 5.1). In all samples additional bands were 
observed which likely correspond to unspecific detection. Furthermore, even untreated 
cells showed low immunoreactivity against phosphorylated EIF2A, which might reflect a 
state of oxidative stress typical for MEFs cultured in the atmospheric levels of oxygen 
(discussed in section 4.1). 
 
Similar pattern was observed for protein extracts from wildtype Dync1h1
+/+
 and 
homozygous Dync1h1
Loa/Loa
 MEFs probed with antibodies against phosphorylated EIF2A 
(Figure 5.2). Treatment with either sodium arsenite (SA) or thapsigargin (TG) resulted in 
increased phosphorylation of the EIF2A when compared with the untreated cells.  
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Figure 5.1. Immunodetection of phosphorylated EIF2A in the wildtype Dync1i1
+/+ 
Dync1i2
+/+
 and double 
homozygous Dync1i1
G482D/G482D
Dync1i2
T172I/T172I
 fibroblasts 
Protein lysates from fibroblasts (3 cell lines) treated with sodium arsenite (SA, 200µM, 45min) or 
thapsigargin (TG, 1µM, 1hour) were separated (Bis-Tris NuPAGE), transferred on membranes (PVDF) and 
probed against phospho-EIF2A (arrow at 36 kDa, green channel) and β-actin (arrow at 44kDa, red channel); 
greyscale images show immunodetection of individual antigens while bottom image shows a ‘dual channel’ 
detection using Licor IR-Dye secondary antibodies; also visible unspecific bands detected by antibody aginst 
EIF2A(P) 
 
 
 
Figure 5.2. Immunodetection of phosphorylated EIF2A in the wildtype Dync1h1
+/+
 and homozygous 
Dync1h1
Loa/Loa 
fibroblasts 
Protein lysates from fibroblasts (3 cell lines) treated with sodium arsenite (SA, 200µM, 45min) or 
thapsigargin (TG, 1µM, 1hour) were separated (Bis-Tris NuPAGE), transferred on membranes (PVDF) and 
probed against phospho-EIF2A (arrow at 36 kDa, green channel) and β-actin (arrow at 44kDa, red channel); 
greyscale images show immunodetection of individual antigens while bottom image shows a ‘dual channel’ 
detection using Licor IR-Dye secondary antibodies; also visible unspecific bands detected by antibody aginst 
EIF2A(P) 
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5.3.1.2  Sodium arsenite treatment 
All cell lines examined displayed cytosolic foci positive for both G3BP and TIAL1 in 
response to SA treatment, which were present in approximately 30% of cells. There were 
no differences between cells isolated from the mutant intermediate chain 1 and 2 
(Dync1i1
G482D 
Dync1i2
T172I
) lines (p=0.3389), although double homozygous 
Dync1i1
G482D/G482D
Dync1i2
T172I/T172I
 (n=3) fibroblasts showed a slightly higher fraction of 
stressed cells (0.240 ± 0.044) than corresponding wildtype Dync1i1
+/+ 
Dync1i2
+/+
 (n=3) lines 
(0.199 ± 0.015) (Table 5.1).  
 
Cytosolic stress granules were also observed in the Dync1h1
Loa
 cell lines, and an average 
fraction of cells displaying G3BP
+/ve
 structures was higher than in the Dync1i1
+/+ 
Dync1i2
+/+ 
MEFs (Figure 5.3). The fraction of stressed cells was higher in the homozygous 
Dync1h1
Loa/Loa
 (n=3, 0.339 ± 0.032) cells than in the wildtype Dync1h1
+/+
 (n=3, 0.288 ± 
0.019) (p=0.0767) (Table 5.1). These results suggested that the presence of mutation in 
the cytoplasmic dynein heavy chain 1 (Dync1h1
Loa
) might interact with the signalling 
pathways triggering stress response, however it did not affect the overall susceptibility of 
fibroblasts to stress. 
 
 
Table 5.1. Analysis of stress granule formation after sodium arsenite (SA) treatment 
Results obtained in 3 experiments were pooled and shown as  total numbers of cells scored, fractions of 
G3BP
+/ve
 cells recorded for each cell line, and mean ± standard deviation (SD); genotypes annotated as 
follows: wildtype (Dync1i1
+/+
Dync1i2
+/+
) double homozygous (Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
), wildtype 
(Dync1h1
+/+
), homozygous (Dync1h1
Loa/Loa
); results of statistical analysis and reported two-tailed p-values 
shaded grey; n - number of cell lines derived from animals 
Observation 
Dync1i1+/+ Dync1i2+/+ 
  n=3 
Dync1i1G482D/G482D Dync1i2T172I/T172I  
n=3 
Number of cells 1828 1278 1202 1179 1799 1188 
G3BP+/ve 
0.216 0.187 0.195 0.209 0.291 0.221 
0.199 ± 0.015 0.240 ± 0.044 
  Paired t-test, p=0.3389 
Observation 
Dync1h1+/+ 
n=3 
Dync1h1Loa/Loa  
n=3 
Number of cells 753 574 740 509 953 825 
G3BP+/ve 
0.291 0.305 0.268 0.371 0.337 0.308 
0.288 ± 0.019 0.339 ± 0.032 
  Paired t-test, p=0.0767 
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Figure 5.3. Analysis of stress granule formation after sodium arsenite (SA) treatment 
Fractions of cells with G3BP
+/ve
 cytosolic structures represented as mean ± standard deviation (SD); legend 
colours refer to wildtype Dync1i1
+/+
 Dync1i2
+/+
 (grey), double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 
(violet), wildtype Dync1h1
+/+
 (dark grey), homozygous Dync1h1
Loa/Loa
 (green) cell lines 
 
 
5.3.1.3  Thapsigargin treatment 
Treatment with thapsigargin (TG) also triggered formation of SG, yet in twice as many cells 
as after sodium arsenite. This might be due to a dual action of TG: Ca
2+
 influx from 
endoplasmic reticulum (ER) activates a eukaryotic translation initiation factor 2-alpha 
kinase2 (EIF2AK2/PKR) (Prostko et al., 1995), whereas Ca
2+
 imbalance causes ER stress and 
activation of a eukaryotic translation initiation factor 2-alpha kinase 3 (EIF2AK3/PERK) 
(Harding et al., 1999). Both kinases phosphorylate EIF2A thus triggering the assembly of 
stress granules. 
 
Analysis of the Dync1i1
G482D
Dync1i2
T172I
 fibroblasts treated with TG indicated towards an 
increased formation of the SG in the double mutant cells, which was in agreement with 
results obtained for SA treated MEFs. Over half of the double homozygous 
Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 (n=3) cells examined displayed G3BP
+/ve
 foci (0.512 ± 
0.028), while the fraction of wildtype Dync1i1
+/+ 
Dync1i2
+/+
 (n=3) MEFs was slightly lower 
(0.427 ± 0.055) (Table 5.2). However, this observation was not significant (p=0.1345) 
(Figure 5.4). 
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Table 5.2. Analysis of stress granule formation after thapsigargin (TG) treatment 
Results obtained in 3 experiments were pooled and shown as  total numbers of cells scored, fractions of 
G3BP
+/ve
 cells recorded for each cell line, and mean ± standard deviation (SD); genotypes annotated as 
follows: wildtype (Dync1i1
+/+
Dync1i2
+/+
) double homozygous (Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
), wildtype 
(Dync1h1
+/+
), homozygous (Dync1h1
Loa/Loa
); results of statistical analysis and reported two-tailed p-values 
shaded grey and for p<0.05 in bold; n - number of cell lines derived from animals 
 
Observation 
Dync1i1+/+ Dync1i2+/+ 
 n=3 
Dync1i1G482D/G482D Dync1i2T172I/T172I  
n=3 
Number of cells 1957 1419 1494 2582 2149 1683 
G3BP+/ve 
0.398 0.393 0.490 0.483 0.538 0.515 
0.427 ± 0.055 0.512 ± 0.028 
  Paired t-test, p=0.1345 
Observation 
Dync1h1+/+  
n=3 
Dync1h1Loa/Loa  
n=3 
Number of cells 1116 1000 918 888 796 854 
G3BP+/ve 
0.601 0.581 0.662 0.664 0.695 0.787 
0.615 ± 0.042 0.715 ± 0.064 
  Paired t-test, p=0.0337 
 
 
 
Figure 5.4. Analysis of stress granule formation after thapsigargin (TG) treatment 
Fractions of cells with G3BP
+/ve
 cytosolic structures represented as mean ± standard deviation (SD); legend 
colours refer to wildtype Dync1i1
+/+
 Dync1i2
+/+
 (grey), double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 
(violet), wildtype Dync1h1
+/+
 (dark grey), homozygous Dync1h1
Loa/Loa
 (green) cell lines 
 
197 
On the other hand, TG induced the stress granules in relatively higher fraction of 
homozygous Dync1h1
Loa/Loa
 (n=3) MEFs (0.715 ± 0.064) than in the wildtype Dync1h1
+/+
 
cells (0.615 ± 0.042) (p=0.0337) (Table 5.2). The effect of thapsigargin was more 
pronounced than in case of arsenite, which might reflect the induction of stress response 
mediated through activation of different signalling pathways. 
 
In conclusion, the stress granules were successfully induced in mouse embryonic 
fibroblasts using different agents (SA, TG), which triggered different signalling pathways. 
In conditions used effects after the thapsigargin (TG) treatment were more pronounced 
than in case of the arsenite (SA), which might correspond to activation of more effective 
pathways or more specific cellular response to stress. Furthermore, treatment with SA for 
longer time (e.g. 1 hour) of with higher concentrations (e.g. 500 µM) often resulted in cell 
death (data not shown), therefore thapsigargin seems to be a better choice to induce SG 
formation in fibroblasts. 
 
The formation of the SG triggered by applying stressors was investigated in the cell lines 
carrying mutant alleles in the cytoplasmic dynein intermediate chains 1 and 2 
(Dync1i1
G482D
 Dync1i2
T172I
) and cytoplasmic dynein heavy chain 1 (Dync1h1
Loa
). The 
mutations in the intermediate chains 1 and 2 did not affect the observed response and the 
fractions of cells with G3BP
+/ve
 structures were comparable. On the other hand, in the 
presence of a homozygous Dync1h1
Loa
 mutation more cells were observed to assemble SG 
when treated with thapsigargin.  
 
It should also be noted, that differences observed between the cell lines (Dync1i1
G482D 
Dync1i2
T172I 
and Dync1h1
Loa
) are likely to be caused by different genetic background, as 
many genes are known to be involved in the stress response. While Dync1h1
Loa
 mice were 
congenic C57BL6/J, Dync1i1
G482D 
Dync1i2
T172I
 animals were N4 generation backcrossed 
onto the C57BL6/J inbred strain. 
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5.3.2 Image-based analysis of stress granules in the wildtype and 
homozygous (Dync1i1G482D/G482D Dync1i2T172I/T172I, and Dync1h1Loa/Loa) 
MEFs  
Disruption of dynein function was reported to affect not only the assembly of stress 
granules but also their size distribution (Loschi et al., 2009). Furthermore, in the presence 
of mutant TARDBP (TPD43) granules assembled were bigger but less numerous (Dewey et 
al., 2011). Therefore, a detailed analysis of the stress granules was performed by 
comparing high resolution images of individual cells. The pictures were taken and 
analysed as described in sections 2.7.2 and 2.7.3. From each condition (sodium arsenite, 
thapsigargin) at least 20 pictures of each cell line were taken from 2 experiments, thus 
over 40 pictures of wildtype Dync1i1
+/+
Dync1i2
+/+
 (n=3), double homozygous 
Dync1i1
G482D/G482D 
Dync1i2
T172I/T172I
 (n=3), wildtype Dync1h1
+/+
 (n=3), and homozygous 
Dync1h1
Loa/Loa
 (n=3) fibroblasts were taken (Figure 5.5). The number and total area of 
G3BP
+/ve
 objects were recorded for individual cells. Because values obtained for each cell 
line did not have Gaussian distribution, raw data were transformed ( = 	) prior to 
statistical analysis. All the parameter were analysed with two-way ANOVA. Detailed 
analysis can be found in Appendix 10.7 and Table 10.8 while results are summarised in 
Table 5.3. 
 
 
 
 
 
 
 
 
Figure 5.5. Representative pictures of wildtype (Dync1i1
+/+
Dync1i2
+/+
) MEFs showing stress granules (next 
page)  
Intracellular structures were stained with antibodies against G3BP protein (grey), TIAL1 protein (red) and 
chromatin (DAPI, blue); distinct foci were visible after treatment with sodium arsenite (SA, 200 µM for 45 
min) or thapsigargin (TG, 1 µM, 1 hour) whereas in untreated cells only TIAL1 was visible in the nucleus, in 
the presence of emetine (Em, 50 µg/ml, 1 hour) stress granules were dissolved and G3BP remained only in 
small puncta; images from separate channels shown in greyscale yellow pseudocoloring present in case of 
overlapping intensities; not in scale 
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5.3.2.1  Sodium arsenite treatment 
Number of G3BP
+/ve
 foci varied between cells ranging from 20 to 150. Although it was 
much higher than often reported (e.g. 5 – 10 in HEK293 cell, Dewey et al., 2011), it might 
originate as a characteristic of MEFs and automated analysis, when objects above 
threshold intensity and size were counted as stress granules. After treatment with 
arsenite the median number of SG in the wildtype Dync1i1
+/+ 
Dync1i2
+/+
 (n=3) cells ranged 
from 39 – 49, while double homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 (n=3) had 
median from 42 – 50 (Table 10.8, Figure 5.6A). The summed area of the G3BP
+/ve 
foci was 
measured in pixels and median values were in the range of 9308 – 10010 in the wildtype 
Dync1i1
+/+ 
Dync1i2
+/+
 and 8516 – 11291 in the double homozygous Dync1i1
G482D/G482D
 
Dync1i2
T172I/T172I
 fibroblasts (Figure 5.6B). These cells varied neither when number 
(p=0.4929) nor the total area of stress granules was analysed (p=0.8517) (Table 5.3).  
 
Cell lines derived from Dync1h1
Loa 
animals showed slightly higher numbers than 
corresponding Dync1i1
G482D
Dync1i2
T172I
 lines, which is in agreement with observed higher 
fraction of cells, which assembled stress granules. Furthermore, there were on average 13 
more granules observed in the homozygous Dync1h1
Loa/Loa
 (n=3) cells than in the wildtype 
Dync1h1
+/+
 (n=3), with medians ranging 49 – 57 and 62 – 64 in the wildtype Dync1h1
+/+
 
and homozygous Dync1h1
Loa/Loa
 MEFs respectively (p< 0.0001) (Table 5.3). Total area of 
the G3BP
+/ve
 foci was also higher in the homozygous Dync1h1
Loa/Loa
 cells (14519 – 16211) 
than in the corresponding wildtype Dync1h1
+/+
 lines (11796 – 16556) (p=0.0006) (Figure 
5.6.B). Because mutual increase in the number and total area of the granules bore a 
similarity to the EGF
+/ve 
endosomes (4.4.3.2), the Pearson correlation coefficients were 
calculated for the data obtained for the Dync1h1
Loa 
lines (Figure 5.6C). The high values of 
the coefficients (above 0.90) suggested a strong link between number and area, which 
might correspond to structural and functional characteristics of the stress granules.  
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Table 5.3. Summary of analysis of stress granules in individual cells after sodium arsenite (SA) treatment 
Parameters of cytoplasmic SG presented based on the results of statistical tests, where n.s. corresponds to 
lack of significant differences for p>0.05; trends were noted if p<0.1; for different cell lines (Dync1i1
G482D
 
Dync1i2
T172I
, Dync1h1
Loa
) values of each parameter were compared between wildtype and homozygous 
MEFs; detailed analysis is presented in Appendix 10.6. 
 
Parameter Dync1i1G482D Dync1i2T172I Dync1h1Loa 
Number of G3BP+/ve foci n.s. 
Dync1h1
Loa/Loa cells formed more SG 
(p<0.0001) 
Total area of G3BP+/ve foci  n.s. 
Dync1h1
Loa/Loa cells had higher area 
(p=0.0006) 
 
 
 
 
 
Figure 5.6. Analysis of parameters of the G3BP
+/ve
 granules in the fibroblasts observed after sodium 
arsenite treatment 
Data recorded as mean ± standard deviation (SD) of log transformed values; legend refers to all graphs and 
colours correspond to wildtype Dync1i1
+/+ 
Dync1i2
+/+
 (grey), double homozygous Dync1i1
G482D/G482D 
Dync1i2
T172I/T172I
 (violet), wildtype Dync1h1
+/+
 (dark grey), and homozygous Dync1h1
Loa/Loa
 (green) MEFs; a.u. 
– arbitrary units 
A. Mean values of log transformed number of stress granules 
B. Mean values of log transformed total area of stress granules 
C. Correlation between number and area of stress granules in the Dync1h1
Loa
 cells; log transformed values 
are plotted as dots corresponding to individual cells; shape of ‘clouds’ typical for positive correlation 
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5.3.2.2  Thapsigargin treatment 
The detailed analysis of stress granules induced by thapsigargin (TG) was performed in the 
same way as in the case of arsenite treated MEFs. There were no differences observed 
between wildtype Dync1i1
+/+ 
Dync1i2
+/+
 and double homozygous Dync1i1
G482D/G482D
 
Dync1i2
T172I/T172I
 fibroblasts neither in the number of granules (p=0.9487) nor their total 
area (p=0.5599) (Table 10.9). Median number of G3BP
+/ve
 foci indentified in the wildtype 
Dync1i1
+/+ 
Dync1i2
+/+
 cells was 40 – 50 with the median total area ranging 8462 – 11659 
(Figure 5.7A,B). These values were comparable with the parameters of stress granules 
induced with the sodium arsenite (p=0.8717 for ‘number’, p=0.9280 for ‘area’). Likewise, 
in the double homozygous Dync1i1
G482D/G482D
Dync1i2
T172I/T172I
 MEFs median 39 – 52 
granules were observed with the total area ranging 8988 – 10386. These parameters were 
not different from the values calculated for the cells treated with arsenite (p=0.6261 for 
‘number’, p=0.6433 for ‘area’) (Table 5.4). It should be noted however, that results were 
often affected by differences between cell lines. 
 
The features of thapsigargin (TG) induced granules in the wildtype Dync1h1
+/+
 and 
homozygous Dync1h1
Loa/Loa
 fibroblasts did not differ, which suggest different mechanism 
of granule assembly (Table 5.4). Although the homozygous Dync1h1
Loa/Loa
 (n=3) cells 
tended to form more G3BP
+/ve
 foci than wildtype Dync1h1
+/+
 cells (median 48 – 61, and 46 
– 64, respectively) (p=0.0948), the results were likely inconclusive due to high variation 
within cell lines (p=0.0006, not shown) (Table 10.9). Furthermore, total area was also 
comparable (p=0.5197), with median ranging 10903 – 12342 for the wildtype Dync1h1
+/+
 
and 10523 – 15156 for the homozygous Dync1h1
Loa/Loa
 fibroblasts (Figure 5.7AB). As 
before, both number and granule area were well correlated with correlation coefficients 
above 0.89 (Figure 5.7C). Parameters of the TG induced granules did not differ from SA 
induced in the wildtype Dync1h1
+/+
 cells (p=0.5622 for ‘number’, p=0.1247 for ‘area’), but 
vary within homozygous  MEFs (p=0.0004 for ‘number’, p=< 0.0001 for ‘area’).  
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The performed analysis of stress granules formed in the individual cells suggested 
differences in the distinct features of granules induced with different agents. While there 
were no effects observed in the cells carrying mutations in the dynein intermediate chains 
1 and 2 (Dync1i1
G482D 
Dync1i2
T172I
), the presence of mutation in the dynein heavy chain 
(Dync1h1
Loa
) caused increase in the number and total area of the stress granules in cells 
treated with sodium arsenite but not with thapsigargin.  
 
Table 5.4. Analysis of stress granule formation after thapsigargin (TG) treatment 
Parameters of cytoplasmic SG presented based on the results of statistical tests, where n.s. corresponds to 
lack of significant differences for p>0.05; trends were noted if p<0.1; for different cell lines (Dync1i1
G482D
 
Dync1i2
T172I
, Dync1h1
Loa
) values of each parameter were compared between wildtype and homozygous 
MEFs; detailed analysis is presented in Appendix 10.6. 
Parameter Dync1i1G482D Dync1i2T172I Dync1h1Loa 
Number of G3BP+/ve foci n.s. 
Dync1h1
Loa/Loa cells tended to form more 
SG (p=0.0948) 
Total area of G3BP+/ve foci  n.s. n.s. 
 
 
Figure 5.7. Analysis of parameters of the G3BP
+/ve
 granules in the fibroblasts observed after thapsigargin 
treatment 
Data recorded for represented as mean ± standard deviation (SD) of log transformed values; legend refers 
to all graphs and colours correspond to wildtype Dync1i1
+/+
Dync1i2
+/+
 (grey), double homozygous 
Dync1i1
G482D/G482D
Dync1i2
T172I/T172I
 (violet), wildtype Dync1h1
+/+
 (dark grey), and homozygous Dync1h1
Loa/Loa
 
(green) MEFs; a.u. – arbitrary units 
A. Mean values of log transformed number of stress granules 
B. Mean values of log transformed total area of stress granules 
C. Correlation between number and area of stress granules in the Dync1h1
Loa
 cells; log transformed values 
are plotted as dots corresponding to individual cells; shape of ‘clouds’ typical for positive correlation 
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5.4 Discussion 
Although the mechanisms and regulation of the formation of stress granules have not 
been described, microtubule associated molecular motors, dynein and kinesin were 
shown to play an important role in this process (Loschi et al., 2009). Depletion of the 
dynein heavy chain (DYNC1H1) resulted in decrease in fraction of cells positive for SG 
markers, while granules assembled tended to be smaller. Similar phenotypes were 
observed after disruption of MT cytoskeleton. Interestingly, the results presented in this 
chapter suggest a distinct role of the DYNC1H1 in the response to various stresses.  
 
When homozygous Dync1h1
Loa/Loa
 cells were treated with sodium arsenite, the level of 
cells with SG was comparable with response observed in the wildtype Dync1h1
+/+
 cells. 
However, individual cells carrying mutant Dync1h1
Loa
 allele displayed more foci, which 
summed area was also higher. On the other hand, thapsigargin triggered more 
pronounced response in the homozygous Dync1h1
Loa/Loa
 MEFs, which formed SG 
comparable in number and area with the structures observed in the wildtype Dync1h1
+/+
 
cells. While seemingly contradicting, these results suggest specific effects of the Loa 
mutation in the stress response. It can be hypothesised, that treatment with a potent 
agent, like thapsigargin, resulted in a strong response, which might feature different 
nucleation dynamics. Furthermore, the components of the SG are known to vary 
depending on the stress applied (Kedersha and Anderson, 2007), thus treatment with 
arsenite might promote specific interactions between mutant dynein heavy chain and yet-
to-be-described protein. It should also be noted, that mean area of stress granules was 
found to be constant, which might be one of the mechanisms regulating the processes 
involved in cellular stress. Because response to stress is cell-specific, it would be beneficial 
to investigate the formation of SG in other cell types or in live animals.  
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6. Investigation of the expression pattern of the cytoplasmic dynein 
intermediate chains in mouse  
 
6.1 Transcriptional regulation 
In recent years the vertebrate proteome has been outshone by the transcriptome and its 
complexity, as only a relatively small portion of the genome is transcribed into protein 
coding mRNAs. Although many classes of RNAs are described, what happens behind a 
nuclear envelope still awaits to be discovered. So far, over 10 different species of non-
coding RNAs have been described, including short (sRNA), intronic (ncRNA), micro RNA 
(miRNA) (Carninci, 2010). Majority of the non-coding RNA is essential for gene expression 
and it participates in transcription initiation, splicing of exons, RNA editing, silencing, and 
many more processes. Long intronic transcripts were shown to be tissue specific (Louro et 
al., 2009), and hypothesised to be a scaffold for various proteins thus initiating an 
assembly of RNP complexes (Hogg and Collins, 2008). Furthermore, distinct RNP 
complexes were observed during stress, which suggested their function in adaptation to 
environmental conditions.  
 
Splicing of transcribed pre- mRNA is catalysed by spliceosomes, which so far are the 
biggest known nuclear complexes (Valadkhan and Jaladat, 2010). A core of every 
spliceosome consists of highly conserved small nuclear RNAs (snRNA), which were 
suggested to evolve from class II self splicing introns. Linear pre-mRNA is formed by 
sequential exons and introns, and their boundaries are recognised by the molecular 
machinery. A basic splicing mechanism involves 5 snRNAs (U1, U2, U4, U5 and U6) in the 
protein complexes, which recognise intron splicing sites via base pairing (U1, and U2AF) (Li 
et al., 2007). This step is thought to initiate an assembly of the spliceosome, recruitment 
of the U4–U5–U6 tri-snRNP, and intermolecular rearrangement resulting in detaching of 
the U1 and U4. Final reactions involve ligation of exons and excision of introns and a form 
of closed lariat. Apart from the core catalytic subunits, there are over 150 different 
components known to form spliceosome in human cells (Valadkhan and Jaladat, 2010).  
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6.1.1 Alternative splicing and its evolution 
Alternative splicing can be defined as differential selection of splice sites in precursor 
mRNA, which creates another level of regulation of gene expression. Recent studies 
showed that over 90% percent of human genes are alternatively spliced (Wang et al., 
2008). A few modes of alternative splicing have been distinguished in vertebrates (Keren 
et al., 2010). Exon skipping is the most common event and it is thought to have the biggest 
impact on the translated protein. Furthermore, constitutive exons can have alternative 
splice sites (3’ and 5’ defined in regards to an intron), or alternative promoters and 
alternative polyadenylation sites are also observed. The activity of intragenic promoters 
was also found to be regulated by their methylation in a tissue specific manner 
(Maunakea et al., 2010).  
 
Vertebrate genes generally consist of short exons and usually much longer introns. The 
distinct gene architecture influences alternative splicing where exons surrounded by long 
introns are more likely to be excluded (Roy et al., 2008). Moreover, nucleosomes were 
suggested to actively participate in splicing. Nucleosomes were found associated with 
sequences enriched in CG pairs, but not with pseudoexons (Keren et al., 2010). During 
transcription, an RNA polymerase II (RNAPII) is paused by a nucleosome, which might 
facilitate interactions between complexes. In addition, histone methylation was shown to 
be lower within alternative exons (Kolasinska-Zwierz et al., 2009).  
 
Comparative analysis of alternative splicing brings discoveries not only about gene 
regulation, but also about evolution of whole genomes and their diversification. Many 
genes were found to have not only conserved sequences, but also their splicing pattern 
(Xing and Lee, 2006). The most conserved pattern of splicing was found in brain, while the 
testis and cancerous cells had the most diverged when human and mouse genomes were 
analysed (Kan et al., 2005). Furthermore, exon-intron boundaries of alternative exons, 
which contain splice signals, were also highly similar (Sugnet et al., 2004). These findings 
suggest an evolutionary pressure, which often correlates with protein function. Likewise, 
genes expressed in brain often coded proteins involved in signalling pathways, and the 
levels of transcripts were also correlated between species (Kan et al., 2005).  
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6.1.2 New exons and tissue specific alternative splicing 
Apart from exons expressed in a constitutive manner, alternative splicing can diverge and 
there are many examples of exons or patterns specific to a lineage or a species. Several 
mechanisms describing emergence or loss of exons have been proposed based on analysis 
of large datasets (Keren et al., 2010). Distinct protein domains are often coded by distinct 
exons, which support a hypothesis of intronic recombination. Furthermore, tandem 
duplications of an exon within the same gene (exon shuffling) were also observed, which 
was correlated with their mutual exclusion during splicing (Alekseyenko et al., 2007). 
 
Another mechanism, which often results in creation of a new or species specific splicing 
pattern, assumes exonification of intronic sequence. Alternative exons were found to 
originate from transposable elements (e.g. Alu), RNA editing, or random mutations (Keren 
et al., 2010). While Alu elements are found only in primate genomes (Modrek and Lee, 
2003), mutations changing splice sites are a more common phenomenon. The new 
isoforms are often expressed at low levels or restricted to a tissue or cell type. 
Furthermore, the cellular mechanisms degrade any aberrant transcript, thus imposing 
pressure towards maintaining open reading frame (ORF) of the mRNA (Resch et al., 2004).  
 
Tissue specific splicing is a well described phenomenon resulting from interactions 
between cis- and trans- acting elements. Sequence motifs within introns or exons (cis-) are 
recognised by RNA binding proteins (trans-), which in turn promote or suppress splicing in 
the region (Tao and Sampath, 2010). Consequently, alternative splicing is controlled by 
regulation of the expression of various components involved in the splicing machinery, 
both spatially or temporally. A prominent example is a glucocortycoid receptor (GR), 
which can be found as 13 different isoforms (Turner et al., 2010). Recently a new isoform 
of transducing-like enhancer of split 4 (TLE-4) has been described, which is expressed only 
in testis thanks to alternative splicing activated by germ cell specific nuclear factors 
(hnRNP G-T, RBMY) (Liu et al., 2009). 
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6.2 Bioinformatics tools useful in the analysis of the alternative splicing 
The completion of sequencing of many genomes enables insight into not only their 
functions but also their evolution. The advances in comparative genomics shed light on 
the evolutionary patterns and events taking places in closely related or distant species 
(Calarco et al., 2007). An in silico analysis of alternative splicing can be based on the 
comparison of expressed sequence tags (ESTs), which are available in many genome 
assemblies. When abundant in sequences, the ESTs databases often contain sequencing 
artefacts or underrepresented regions (Modrek and Lee, 2003). EST databases (e.g. 
http://genome.uscs.edu) contain single read sequences approximately 500bp long, which 
correspond to RNAs isolated from a sample, transcribed into cDNA, and cloned into a 
vector prior to sequencing. In addition, a retrieval of 5’ or 3’ ends can be increased by 
‘capturing’ relevant regions via chemical modifications (Kimura et al., 2006). In the 
following paragraph different tools useful in the analysis performed are briefly 
summarised. 
 
UCSC Genome Browser 
The UCSC Genome Browser was developed and is maintained by the Genome 
Bioinformatics Group within the Centre for Biomolecular Science and Engineering (CBSE) 
at the University of California Santa Cruz (UCSC) (Kent et al., 2002). It contains the 
reference sequence and working draft assemblies for a large collection of genomes and 
provides a portal to the Encyclopaedia of DNA Elements (ENCODE) project. The 2011 
update contains assemblies of 53 genomes (19 mammals, 10 vertebrates, 3 
deuterostomes, 13 insects, 6 nematotes, 2 ‘other’) with extensive comparative genomics 
tools (Fujita et al., 2011; Raney et al., 2011).  
 
UCSC Genes 
UCSC Genes, is a gene prediction track generated at UCSC; it is based on data from 
RefSeq, GenBank, CCDS (Consensus Coding DNA Sequences) and UniProt (Fujita et al., 
2011). Furthermore, RefSeq and mRNA tracks, which display aligned sequences from all 
organisms in GenBank, are updated nightly, and EST tracks are updated weekly. 
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Target Scan 
TargetScan 5.1 (Friedman et al., 2009) predicts biological targets of miRNAs by searching 
for the presence of conserved 8-mer and 7-mer sites that match the seed region of each 
miRNA (Lewis et al., 2005). In mammals, predictions are ranked based on the predicted 
efficacy of targeting as calculated using the context scores of the sites (Grimson et al., 
2007). Conserved targeting has also been detected within open reading frames (ORFs).  
 
6.3 Project overview 
This work aiming to establish the splicing pattern of the cytoplasmic dynein intermediate 
chains 1 and 2 (Dync1i1, Dync1i2) in mouse has been published in Kuta A. et al, (2010) 
Mouse cytoplasmic dynein intermediate chains: identification of new isoforms, alternative 
splicing and tissue distribution of transcripts, PLoS.One 5(7): e11682. In addition, 
expression levels of subunits of the cytoplasmic dynein complex were examined in neural 
tissues isolated from wildtype Dync1i2
+/+
 and homozygous Dync1i2
T172I/T172I
 mice. Finally, 
antibodies specific to the Dync1i2 were successfully raised and tested using cellular 
extracts. 
 
6.4 Results  
The pattern of alternative splicing was examined on the level of mRNA isolated from 
different mouse tissues (C57BL6/J strain). Initially, full length cDNA of the intermediate 
chains 1 and 2 was cloned and inserts sequenced in order to detect possible splice 
variants. Subsequently, a detailed assay was carried out confirming the presence of 
distinct isoforms. The nomenclature of isoforms described follows the annotations as in 
(Kuta et al., 2010). Briefly, 6 transcripts of the Dync1i1 were found only in neural tissue 
(annotated in relation to rat isoforms Dync1i1.A, Dync1i1.B, Dync1i1.D, Dync1i1.E, 
Dync1i1.C, Dync1i1.F), while isoform Dync1i1.C was also present in ovaries and testes. 
Extracts from brains and spinal cords were also enriched in multiple isoforms of the 
Dync1i2 (Dync1i2.D, Dync1i2.E, Dync1i2.A, Dync1i2.B, Dync1i2.C) and the only transcript 
detected in all the somatic tissues examined corresponded to isoform Dync1i2.C. In 
addition, transcript Dync1i2.F was found only during analysis of cloned cDNAs. 
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6.4.1 Investigating the alternative splicing of the mouse Dync1i1 and 
Dync1i2 genes 
A PCR-based approach allowed detection of transcripts of the intermediate chains 1 and 2, 
which were not published before. Furthermore, results of semi-quantitative analysis 
suggest subtle differences in the abundance of distinct isoforms depending on region 
examined.  
 
6.4.1.1  Cloning of splice variants and detailed survey of the splicing 
 pattern of Dync1i1 and Dync1i2 genes in mouse tissues 
A set of tissues was harvested from adult C57BL6/J mice (male and female): brain, spinal 
cord, ovary, testis, spleen, lungs, kidney, heart, intestine, muscle, liver (section 2.1.4.1). 
Total RNA was extracted as described in section 2.2. The RNA was transcribed into cDNA 
(section 2.3.3) and full length transcripts of the Dync1i1 and Dync1i2 (exon 1a, 1b) 
amplified using primers complementary to known sequences (UCSC, Uc009awn.1, 
Uc008kah.1, Uc008kak.1 respectively) (section 2.3.4). The resulting products were 
sequenced, and when multiple sequences for all individual products were obtained 
cloning was undertaken (section 2.4). Based on results of the cloning analysis, a survey of 
set of tissues was performed, aiming to detect all isoforms. 
 
As a result of the alternative splicing six isoforms of mouse Dync1i1 gene were detected 
arising from combinatorial use of three 3’ alternative splice sites (AS) in exon 4 and 
transcripts with exon 5 included or skipped. All of them were exclusively present in neural 
tissues and one (Dync1i1.C) was also expressed in gonads (Table 6.1). The transcripts 
Dync1i1.E and Dync1i1.F are new isoforms described during the study. An exon 5 (60bp) 
was present in the isoforms Dync1i1.A, Dync1i1.B, and Dync1i1.D, whereas it was skipped 
in transcripts Dync1i1.C, Dync1i1.E, and Dync1i1.F. Importantly, none of the splicing 
events resulted in a change of ORF, and isoforms differed by short polypeptides (in exon 4 
AS1 – AS2 spans 17amino acids, AS2 – AS3 spans 11 amino acids, exon 5 spans 20 amino 
acids) (Figure 6.1). Furthermore, all the splicing events were restricted within exons 4 
and 5.  
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Table 6.1. Isoforms of dynein intermediate chain 1 (Dync1i1) 
The isoforms were annotated with correspondence to previously used notation in rat; number of exons, 
amino acids shown, exon 4 refers to a splice site in the exon 4 used; isoforms detected in neural tissue only 
shaded, * new transcript described 
 
Isoform 
UCSC and/or ENSEMBL accession 
number for ‘reference sequence’ for 
each isoform 
Exons Exon 4 
Number of 
amino 
acids 
Dync1i1.A ENSMUST00000115555 1 to 17 AS1 645 
Dync1i1.B uc009awn.1/ENSMUST00000115559 1 to 17 AS2 628 
Dync1i1.D ENSMUST00000115556 1 to 17 AS3 617 
Dync1i1.E GU992206* 1 to 4, 6 to 17 AS1 625 
Dync1i1.C ENSMUST00000115554 1 to 4, 6 to 17 AS2 608 
Dync1i1.F GU992207* 1 to 4, 6 to 17 AS3 597 
 
 
 
 
Figure 6.1. Splicing pattern of mouse dynein intermediate chain 1 gene  
A. Summary of alternative splicing in Dync1i1, showing splice variants Dync1i1.A to Dync1i1.F, and the first 
6 exons (numbered 1, 2, 3, 4, 5, 6); primer binding sites used for isoform specific RT-PCRs are as 
indicated (Appendix 10.12.4); AS1, 2 and 3 refer to the alternative splice sites in exon 4; exons are 
drawn to scale 
B. Alternative splice sites in Dync1i1 exon 4; the nucleotide in bold is the first base pair of the exon; bases 
in lower case are intronic, bases in upper case are exonic 
Adapted from Kuta A. et al, (2010) Mouse cytoplasmic dynein intermediate chains: identification of new 
isoforms, alternative splicing and tissue distribution of transcripts, PLoS.One 5(7): e11682 
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In contrast to Dync1i1, the Dync1i2 gene possessed an additional first exon, thus two sets 
of transcripts containing different first exons were expressed suggesting the presence of 2 
active promoters. These non-coding exons, annotated 1a, 1b, did not overlap and were 
mutually exclusive. Because start codon ‘AUG’ was located in the second exon, the use of 
the first exon did not affect the protein sequence. The analysis was performed for both 
exons, and 11 transcripts coding 6 different proteins were detected (Table 6.2). As in the 
case of Dync1i1, all the transcripts were present only in neural tissues, while Dync1i2.C 
(exon 1a/1b) was the only variant ubiquitously expressed in all the tissues examined. Out 
of those, sequences of 3 new isoforms were obtained. The isoforms annotated as 
Dync1i2.D and Dync1i2.E contained a new exon located within intron 3 of mouse (Figure 
6.2). This additional exon was annotated as 3b and was 51bp long or 36 bp long when 
additional AS was used. Additional isoform Dync1i2.F was represented only by one clone 
and could not be detected during the PCR based survey. Although its expression seemed 
unclear, it could be translated into a complete polypeptide showing the splicing pattern 
similar to Dync1i1.F. Furthermore, exons 4 and 6 were alternatively spliced ‘cassette 
exons’, both present in variants Dync1i2.D (exon 1a/1b), Dync1i2.E (exon 1a/1b), and 
Dync1i2.A (exon 1a/1b). While transcripts Dync1i2.B (exon 1a/1b) lacked exons 3b and 4, 
isoform Dync1i2.F (exon 1a) was found to have exons 3b and 6 omitted. The shortest 
variant was coded by Dync1i2.C (exon 1a/1b), and it contained only constitutive exons. 
The alternative exons observed in the Dync1i2 transcripts did not change the open reading 
frame, and coded short peptides (exon 3b spans 17 amino acids, exon 4 spans 6 amino 
acids, exon 6 spans 20 amino acids). 
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Table 6.2. Isoforms of dynein intermediate chain 2 (Dync1i2) 
The isoforms were annotated with correspondence to previously used notation in rat;, number of exons, 
amino acids shown, exon 3b refers to a splice site in the exon 3b used; isoforms detected in neural tissue 
only shaded; * new transcript described 
 
Isoform 
UCSC and/or ENSEMBL accession 
number for ‘reference sequence’ for 
each isoform 
Exons 
Exon 
3b 
Number of 
amino 
acids 
Dync1i2.D GU992208* 1a to 18 AS1 655 
Dync1i2.E GU992209* 1a to 18 AS2 650 
Dync1i2.A ENSMUST00000112140 1a to3, 4 to 18  638 
Dync1i2.B uc008kah.1/ ENSMUST00000112142 1a to 3, 5 to 18  632 
Dync1i2.F GU992210* 
1a to 3, 4 to 5, 7 to 
18 
 618 
Dync1i2.C uc008kai.1/ ENSMUST00000112138 1a to 3, 5, 7 to 18  612 
Dync1i2.D GU992211* 1b to 18 AS1 655 
Dync1i2.E GU992212* 1b to 18 AS2 650 
Dync1i2.A ENSMUST00000112144 1b to3, 4 to 18  638 
Dync1i2.B ENSMUST00000100028 1b to 3, 5 to 18  632 
Dync1i2.C uc008kak.1/ ENSMUST00000081710 1b to 3, 5, 7 to 18  612 
 
 
 
Figure 6.2. Splicing pattern of mouse dynein intermediate chain 2 gene (Dync1i2) 
A. Summary of alternative splicing in Dync1i2 with exon 1a; the first seven exons (numbered 1a, 2, 3, 3b, 4, 
5, 6, 7), primer binding sites used for isoform specific RT-PCRs are indicated (Appendix 10.12.4); exons 
are drawn to scale 
B. Summary of alternative splicing in Dync1i2 with exon 1b, variant Dync1i2.F was not detected 
C. Alternative splice sites in Dync1i2 exon 3b, the nucleotide in bold is the first base pair of the exon, bases 
in lower case are intronic, bases in upper case are exonic 
Adapted from Kuta A. et al., (2010) ‘Mouse cytoplasmic dynein intermediate chains: identification of new 
isoforms, alternative splicing and tissue distribution of transcripts’, PLoS.One 5(7): e11682 
214 
6.4.1.2  Capillary electrophoresis of FAM-conjugated PCR products of 
 Dync1i1 and Dync1i2 genes 
The use of a fluorescence-based method, which has the advantage of being semi-
quantitative and could be multiplexed in one reaction, allowed us to estimate the levels of 
expression of different isoforms of mouse intermediate chains 1 and 2 (Charbonnier et al., 
2000). Capillary gel electrophoresis with laser induced fluorescence (CGE-LIF) provided 
high efficiency separation of nucleic acids up to a single base resolution by combining 
polyacrylamide in capillaries as medium and fluorescence based detection for better 
resolution. The results were produced in a form of chromatogram thus options for analysis 
and quantitation similar to those in high pressure liquid chromatography (HPLC) could be 
applied (Altria, 1996). Quantitation of the amount of nucleic acids can be achieved by 
relative or absolute estimates via applying external or internal standardisation. When an 
internal standard of a known concentration is analysed together with a sample an 
absolute concentration of PCR product can be determined by comparing the peak heights 
of a sample and standard on a CGE chromatogram (Lu et al., 1994). In addition, a ratio of a 
target DNA peak area to the peak area of added DNA internal standard gives an estimate 
of the relative amount of DNA in the sample (Richards M.P., 2005). When quantitative 
internal standards are not available, the standard can derive from amplification of genes 
that remain at constant levels in the sample (Richards M.P., 2005) or by integrating the 
area of all peaks of interests and adding them to give a total normalised area of 
electropherogram and calculating a ratio (Altria, 1996). Furthermore, when low copy 
number products are quantified a competitive PCR gives the most accurate means for 
quantification.  
 
Splice isoforms of mouse Dync1i genes were analysed using CGE – LIF; in this case reverse 
primers (DIC1_R rev, DIC2_R rev, section 10.12.4) were conjugated with 5-
carboxyfluorescein (5-FAM) and reactions run as described with cDNAs isolated from 4 
C57BL6/J mice (section 2.3.4). Chromatograms recorded contained sets of peaks 
separated by their sizes with the accuracy to one bp. By comparison of expected sizes of 
amplified isoforms with peak positions on a chromatogram, five isoforms of each gene 
were annotated. Relative amounts were calculated as fraction of peak area to the total 
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area of peaks identified and individual isoforms compared between samples. Detailed 
analysis can be found in Appendix 10.7 and Table 10.10, while the summary is presented 
in Table 6.3. 
 
There were 5 isoforms of the Dync1i1 annotated except for Dync1i1.E, likely due to very 
low abundance. Likewise, there were samples, in which the contribution of transcripts 
annotated as Dync1i1.A and Dync1i1.F to the total peak area was below 2%. In these cases 
the low abundant transcripts were not included in the statistical analysis. Samples from 
adult brain and spinal cord varied in fractions of isoforms Dync1i1.A (p=0.0314), Dync1i1.D 
(p=0.0068), and Dync1i1.C (p=0.0337) (Table 6.3, Figure 6.3A). On the other hand, in the 
samples from embryonic brain and spinal cord (collected at E17.5) there were differences 
in the amounts of 4 isoforms (Dync1i1.B, Dync1i1.D, Dync1i1.C, and Dync1i1.E) while 
Dync1i1.A was not detected (Figure 6.3B). Furthermore, samples isolated from various 
regions of an adult brain also displayed region specificity in the relative abundance of 
signal corresponding to distinct Dync1i1 transcripts (Figure 6.3C). When compared to 
results obtained for hippocampus, differences were observed in olfactory bulbs 
(transcripts Dync1i1.B, Dync1i1.D, Dync1i1.C, Dync1i1.F), cerebellum (transcripts 
Dync1i1.C, Dync1i1.F), and brain stem (transcripts Dync1i1.D, Dync1i1.C, Dync1i1.F).  
 
Chromatograms of PCR products with primers specific for the Dync1i2 showed in most 
cases peaks corresponding to 3 major isoforms annotated as Dync1i2.A, Dync1i2.B, and 
Dync1i2.C. If additional fluorescent signals matching the products of isoforms Dync1i2.E 
and Dync1i2.F were detected, their levels were below 1% and not included in further 
comparisons. Similar distribution was also observed in the PCR based analysis. In majority 
of samples the relative amounts were comparable when the use of the first exon (exon 1a 
or 1b) was examined (Table 6.3). In the adult brain and spinal cord, different levels of 
Dync1i2.A (exon 1a/1b) and Dync1i2.C (exon 1a/1b) were observed (Figure 6.3D,G), and a 
similar pattern was found in the embryonic tissues (Figure 6.3E,H). Moreover, the brain 
regions varied when transcripts Dync1i2.A (exon 1a/1b), Dync1i2.B (exon 1a/1b), and 
Dync1i2.C (exon 1b) were compared. Relative to the hippocampus, different levels of 
isoforms were found in all the other regions: cortical (Dync1i2.B exon 1a), olfactory 
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(Dync1i2.A exon 1a/1b, Dync1i2.B exon 1a/1b), cerebellar (Dync1i2.A exon 1b, Dync1i2.C 
exon 1b), and in the brain stem (Dync1i2.A exon 1a/1b, Dync1i2.B exon 1a/1b, Dync1i2.C 
exon 1b) (Figure 6.3I).  
 
 
 
 
 
Table 6.3. Summary of relative abundance of individual isoforms of Dync1i1 and Dync1i2 (exon 1a, exon 
1b) in mouse neural tissues  
Relative abundance of splice isoforms of the cytoplasmic dynein chains 1 and 2 presented as a ‘heat map’ 
when values were classified and color coded (blue for low and red for high levels); isoforms Dync1i1.E, and 
Dync1i2.D were not observed due to low sensitivity of the assay; marked transcripts detected at levels 
below 2%; n.d. – not detected; detailed analysis is presented in Appendix 10.7 
 
 
Tissue/ 
Isoform 
Dync1i1 Dync1i2 exon 1a Dync1i2 exon 1b 
1.A 1.B 1.D 1.C 1.F 2.E 2.A 2.B 2.F 2.C 2.E 2.A 2.B 2.F 2.C 
Brain <2%     n.d.   n.d.  n.d.   <2%  
Spinal cord      n.d.   n.d.  n.d.   n.d.  
Embryonic 
brain 
n.d.     <2%   n.d.  <2%   n.d.  
Embryonic  
sp. cord 
n.d.    <2% <2%   n.d.  n.d.   n.d.  
Cortex <2%     <2%   <2%  n.d.   n.d.  
Hippocampus <2%     n.d.   <2%  n.d.   <2%  
Olfactory bulbs <2%     <2%   n.d.  <2%   n.d.  
Cerebellum     <2% <2%   n.d.  n.d.   n.d.  
Brain stem     <2% n.d.   <2%  n.d.   <2%  
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Figure 6.3. Distribution of isoforms of Dync1i1 and Dync1i2 (exon 1a, exon 1b) in mouse neural tissues 
Relative amounts of distinct isoforms shown as fractions of total signal and plotted as mean ± standard error 
(SEM); results obtained for transcripts of each gene were grouped and compared between adult brain and 
adult spinal cord (A,D,G), embryonic brain and embryonic spinal cord (B,E,H), and different regions of adult 
brain (C,F,I); isoforms Dync1i1.E and Dync1i2.D were not detected in this assay 
A, B, C. Comparison of relative abundance of the Dync1i1 isoforms 
D, E, F. Comparison of relative abundance of the Dync1i2 isoforms containing exon 1a 
G, H, I. Comparison of relative abundance of the Dync1i2 isoforms containing exon 1b 
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6.4.2 The expression of subunits of the cytoplasmic dynein complex in 
neural tissues isolated from wildtype (Dync1i2+/+) and homozygous 
(Dync1i2T172I/T172I) mice 
Analysis of expression levels of different subunits was performed by Dr G. Banks. Briefly, 
total RNA was extracted from 12 week old wildtype Dync1i2
+/+
 (n=3) and homozygous 
Dync1i2
T172I/T172I
 (n=3) mice and cDNA synthesised (section 2.3.3). Levels of transcripts 
were examined using real-time PCR and relative quantification performed by calculating 
the ratio between the amounts of a target gene (dynein subunits) and a control gene (β-
actin). Calculations were based on the values of threshold cycle (CT), which was number of 
cycle, when a fluorescence increased above a set threshold. Firstly, CT values of β-actin 
were subtracted from values recorded for a dynein gene (∆CT). The ∆CT values recorded 
for wildtype Dync1i2
+/+
 mice (n=3) were averaged and used as ‘calibrating’ value when 
calculating ∆∆CT (∆∆CT=∆CT ‘calibrating’ - ∆CT sample). Finally, normalised expression 
levels of dynein subunits were calculated as 2
-∆∆CT
. Detailed description of the quantitative 
real-time PCR can be found in Qiagen handbook (Critical Factors for Successful Real-Time 
PCR). Each sample was run in triplicate and values averaged before analysis.  
 
 
Pairs of primers were designed to detect different subunits and isoforms of components 
of the cytoplasmic dynein complex: dynein intermediate chain 1 (Dync1i1, 6 isoforms), 
dynein intermediate chain 2 (Dync1i2, 6 isoforms), dynein light intermediate chain 1 
(Dync1li1), dynein light chains Tctex-1 (Dynlt1), RP3 (Dynlt3), light chains LC8 (Dynll1, 
Dynll2). Relative levels of expression of each gene were examined in samples isolated 
from adult brain cortex, hippocampus, and adult spinal cord. Unfortunately, we did not 
obtain results for rare isoforms of the intermediate chains 1 and 2 (Dync1i1.E, Dync1i1.F, 
Dync1i2.D, Dync1i2.E, Dync1i2.F), likely due to lack of sensitivity of the assay undertaken. 
All the results are presented as mean ± standard error (SEM) and values of normalised 
expression (2
-∆∆CT
) were analysed using t-test. Detailed analysis can be found in Appendix 
10.7 and Table 10.11, results are summarised in Table 6.4. 
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On overall, there were no major differences in the levels of RNA between wildtype 
Dync1i2
+/+
 (n=3) and homozygous Dync1i2
T172I/T172I
 (n=3) mice, although mutant mice 
displayed fluctuations within the same amplicon but between different tissue. 
Furthermore, although all mice were from one litter, high variation between samples 
isolated from individual animals was observed. There were 4 isoforms of the Dync1i1 
analysed (Dync1i1.A, Dync1i1.B, Dync1i1.D, and Dync1i1.C), and the levels of their 
expression were comparable in all tissue samples examined. Likewise, Dync1i2 was 
represented by 3 isoforms (Dync1i2.A, Dync1i2.B, Dync1i2.C), which did not vary between 
wildtype Dync1i2
+/+
 and homozygous Dync1i2
T172I/T172I
 mice (Table 6.4, Figure 6.4). 
However, the expression of Dync1i2.A in adult spinal cord tended to be elevated by 40% in 
the homozygous Dync1i2
T172I/T172I
 animals (p=0.0852). Furthermore, relative levels of light 
chain Rp3 (Dynlt3) but not Tctex 1 (Dynlt1) in the spinal cord were higher in homozygous 
Dync1i2
T172I/T172I
 mice (1.392±0.079) than in the wildtype Dync1i2
+/+
 animals (1.009±0.090) 
(p=0.0329). Interestingly, mutation in the intermediate chain 2 affected the expression of 
another gene coding for dynein light chain LC8-2 (Dynll2) but not LC8-1 (Dynll1). 
Homozygous Dync1i2
T172I/T172I
 animals showed decrease in the levels of Dynll2 in samples 
isolated from hippocampus (0.801±0.060; p=0.0491), while values tended to be higher in 
the spinal cord (1.828±0.168; p=0.0823). Normalised expression recorded in samples from 
wildtype Dync1i2
+/+
 littermates was 1.002±0.040 and 1.072±0.282 respectively (Table 
10.11). 
 
In conclusion, subtle differences between wildtype Dync1i2
+/+
 and homozygous 
Dync1i2
T172I/T172I
 mice were observed in the expression levels of 2 genes encoding dynein 
light chains (Dynlt3, Dynll2). Interestingly, only specific regions of the nervous system 
were affected, including hippocampus and spinal cord. The mutation Dync1i2
T172I 
was 
mapped to a  light chain binding domain (DYNLL) (Nyarko and Barbar, 2011). Although  
effects of mutation on the conformation of the intermediate chain are not known, we can 
hypothesise that it might affect interactions between subunits in the complex. If that was 
the case, this observation would suggest an existence of regulatory mechanism reacting to 
structural features of the complex. 
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Table 6.4. Summary of quantitative analysis of expression levels of dynein subunits in wildtype Dync1i2
+/+
 
and homozygous Dync1i2
T172I/T172I
 mice (next page) 
Expression levels of different subunits of the cytoplasmic dynein complex presented based on the results of 
statistical tests, where n.s. corresponds to lack of significant differences for p>0.05; trends were noted if 
p<0.1; for samples isolated from different brain parts the expression levels of genes examined were 
compared between wildtype Dync1i2
+/+
 and homozygous Dync1i2
T172I/T172I
 animals; isoforms of intermediate 
chains: Dync1i1.E, Dync1i1.F, Dync1i2.D, Dync1i2.E, and Dync1i2.F were not observed due to low sensitivity 
of the assay; genotypes correspond to wildtype Dync1i2
+/+
 and homozygous Dync1i2
T172I/T172I
 animals; 
Dync1li1 – dynein light intermediate chain1, Dynlt1, Dynlt3 – dynein light chains Tc-tex1, RP3, Dynll1, Dynll2 
– dynein light chains LC8-1 and 2; detailed analysis is presented in Appendix 10.27  
 
Gene Cortex Hippocampus Spinal cord 
Dync1i1.A n.s. n.s. n.s. 
Dync1i1.B n.s. n.s. n.s. 
Dync1i1.D n.s. n.s. n.s. 
Dync1i1.C n.s. n.s. n.s. 
Dync1i2.A n.s. n.s. 
Dync1i2
T172I/T172I tended to 
show higher level 
Dync1i2.B n.s. n.s. n.s. 
Dync1i2.C n.s. n.s. n.s. 
Dync1li1 n.s. n.s. n.s. 
Dynlt1 n.s. n.s. n.s. 
Dynlt3 n.s. n.s. 
Dync1i2
T172I/T172I showed 
higher level (p=0.0329) 
Dynll1 n.s. n.s. n.s. 
Dynll2 n.s. 
Dync1i2
T172I/T172I showed lower 
level (p=0.0491) 
Dync1i2
T172I/T172I tended to 
show higher level 
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Figure 6.4.Quantitative analysis of expression levels of dynein subunits in wildtype Dync1i2
+/+
 and 
homozygous Dync1i2
T172I/T172I
 mice 
Results of normalised expression levels (2
-∆∆CT
) shown as mean ± standard error (SEM); real-time PCRs were 
run using primers designed to detect 1 population of cDNAs (Appendix 10.12.5) and subunits detected 
shown; isoforms of intermediate chains: Dync1i1.E, Dync1i1.F, Dync1i2.D, Dync1i2.E, and Dync1i2.F were not 
observed due to low sensitivity of the assay; genotypes correspond to wildtype Dync1i2
+/+
 and homozygous 
Dync1i2
T172I/T172I
 animals; Dync1li1 – dynein light intermediate chain1, Dynlt1 – dynein light chain Tc-tex1, 
Dynlt3 – dynein light chain RP3, Dynll1 – dynein light chain LC8-1, Dynll2 – dynein light chain LC8-2; samples 
used were from adult brain cortex (CRX), hippocampus (HIP), and spinal cord (SPC) 
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6.4.3 Antibodies specific to mouse DYNC1I2 protein 
Protein sequences of the dynein intermediate chains 1 and 2 (DYNC1I1, DYNC1I2) share 
73% of identity and 85% similarity (DYNC1I1.A vs. DYNC1I2.D calculated with BLOSUM62 
matrix, BioEdit) and antibodies available commercially react to both peptides. Recently, 
we successfully raised antibodies recognising DYNC1I1 (Banks et al., 2011) and here we 
report antibodies binding specifically to the DYNC1I2.  
 
6.4.3.1  Epitope design 
Rabbit polyclonal anti-dynein intermediate chain 2 antibodies were generated by 
BioGenes GmbH (Berlin, Germany). Two peptide immunogens were selected, coupled to 
Limulus polyphemus hemocyanin (LPH, horseshoe crab hemocyanin), and injected into 2 
rabbits each. Antisera were purified and affinity purified antibodies tested.  
 
Epitope sequences were chosen to be the most divergent from the DYNC1I1: (1) 
GLTTDSPIEDSSFN corresponding to 68 – 81 amino acids, and (2) EEEKTLKKDEENDS 
corresponding to 182 – 195 amino acids of isoform DYNC1I2.E (D6Q0F6, UniProtKB) 
(Figure 6.5). Because antiserum isolated from rabbit immunised with peptide 2 (4257) 
failed initial test, 3 remaining affinity purified antibodies from 2 batches were tested using 
western blotting. Protein lysates from whole brain (section 2.5.1) and HEK293T cells 
expressing GFP-tagged isoforms of intermediate chains 1 and 2 (sections 2.5.2 and 2.6.7) 
were run on gels and probed with raised antibodies, and monoclonal IC74 (Millipore). 
There were 3 isoforms of the intermediate chain 1 (DYNC1I1.B, DYNC1I1.D, DYNC1I1.C) 
and 2 isoforms of the intermediate chain2 (DYNC1I2.B, DYNC1I2.C) expressed in the 
HEK293T cells. 
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Figure 6.5. Alignment of sequences of peptides used with mouse DYNC1I1.A and DYNC1I2.B 
Sequences shaded based on their similarity (JalView 2.6, BLOSUM62 matrix); although short sequences were 
designed based on sequence of DYNC1I2.E, they were tested against cell lysates transfected with isoforms 
Dync1i2.B and Dync1i2.C 
 
 
6.4.3.2  Antibody testing using western blotting 
Antibodies were affinity purified from antisera isolated from 3 rabbits annotated as 4258 
(immunised with peptide 2), 4259 and 4260 (immunised with peptide 1). Membranes 
were incubated simultaneously with antibodies against DYNC1I2, IC74, β-actin. All the 
antibodies (4258, 4259, 4260) detected GFP-DYNC1I2 chimaeric protein only but not GFP-
DYNC1I1 (Figure 6.6, Figure 6.7, Figure 6.8). However, a signal was weak when protein 
lysate from mouse brain was probed with antisera 4259 and 4260. Furthermore, antibody 
4258 detected human DYNC1I2 in the protein lysates extracted from HEK293T cells.  
 
In summary, we were successful in raising antibodies reacting with DYNC1I2 only, however 
further optimisation of blotting conditions would be required. 
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Figure 6.6. Western blots probed with antibodies raised against DYNC1I2 (peptide 2, rabbit 4258) 
Lanes correspond to protein lysates from: whole mouse brain, HEK293T cells transfected with GFP-tagged 
DYNC1I1.B, DYNC1I1.D, DYNC1I1.C, DYNC1I2.B, DYNC1I2.C, and lipofectamine only (LFM); membranes were 
incubated with antibodies reactive to DYNC1I2 (upper panel), IC74 (middle panel), β-actin (lower panel); 
bands correspond to DYNC1I2 – GFP chimearic (100 kDa), unmodified DYNC1I (74 kDa), and β-actin (44 kDa); 
antisera 4258 reacted with DYNC1I2 – GFP and human DYNC1I from cell lysed but did not detect mouse 
DYNC1I from brain lysate; IC74 gave strong signal only in the brain lysate 
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Figure 6.7. Western blots probed with antibodies raised against DYNC1I2 (peptide 1, rabbit 4259) 
Lanes correspond to protein lysates from: whole mouse brain, HEK293T cells transfected with GFP-tagged 
DYNC1I1.B, DYNC1I1.D, DYNC1I1.C, DYNC1I2.B, DYNC1I2.C, and lipofectamine only (LFM); membranes were 
incubated with antibodies reactive to DYNC1I2 (upper panel), IC74 (middle panel), β-actin (lower panel); 
bands correspond to DYNC1I2 – GFP chimearic (100 kDa), unmodified DYNC1I (74 kDa), and β-actin (44 kDa); 
antisera 4259 reacted with DYNC1I2 – GFP and weakly with mouse DYNC1I from brain lysate; IC74 gave 
strong signal in the brain lysate 
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Figure 6.8. Western blots probed with antibodies raised against DYNC1I2 (peptide 1, rabbit 4260) 
Lanes correspond to protein lysates from: whole mouse brain, HEK293T cells transfected with GFP-tagged 
DYNC1I1.B, DYNC1I1.D, DYNC1I1.C, DYNC1I2.B, DYNC1I2.C, and lipofectamine only (LFM); membranes were 
incubated with antibodies reactive to DYNC1I2 (upper panel), IC74 (middle panel), β-actin (lower panel); 
bands correspond to DYNC1I2 – GFP chimearic (100 kDa), unmodified DYNC1I (74 kDa), and β-actin (44 kDa); 
antisera 4260 reacted with DYNC1I2 – GFP and weakly with mouse DYNC1I from brain lysate; IC74 gave 
strong signal in the brain lysate 
 
 
 
6.5 Discussion  
The examination of different splice variants of cytoplasmic dynein intermediate chain 1 
and 2 (Dync1i1 and Dync1i2) resulted in establishing of alternative splicing pattern in 
mouse tissues. In addition, new isoforms were detected, thus increasing the complexity of 
the dynein complex. Alternative splicing was observed within corresponding regions of 
both genes, which suggests conservation of the pattern. During processing of the Dync1i1 
transcript three 3’ alternative splice sites in exon 4 can be used, and exon 5 serves as 
cassette exon, thus 6 different isoforms are produced. In the case of Dync1i2 three 
cassette exons were detected, annotated as 3b, 4, and 6, and 5 variants were confirmed. 
Although coding sequences of both genes are highly similar (83%), the region of 
alternative splicing is the most variable. On the protein level, isoforms differ in the N-
termini, which are thought to be site of interactions with adaptor complexes (Figure 6.9). 
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Figure 6.9. Exon – protein domain relationship for dynein intermediate chain genes  
Protein domains marked as blocks, numbered exons marked in grey, the coiled coil region where protein 
interactions occur is shown as is DYNLT – binding region of Tc-Tex dynein light chains, DYNLL –binding region 
of LC8 dynein light chains, DIM – intermediate chain dimerisation domain, DYNLRB – binding domain of 
Roadblock dynein light chains; seven WD40 repeats marked in green 
A. Mouse DYNC1I1 isoform 1.A (645 amino acids).  
B. Mouse DYNC1I2 isoform 2.D (655 amino acids) including exons 1 to 3 and new exon 3b; exon 4 to 18 
C. Schematic alignment of DYNC1I1 and DYNC1I2 protein sequences coded by exons 3 to 6 of Dync1i1 and 
exons 3 to 7 of Dync1i2 genes; alternative splice sites in Dync1i1 exon 4 (AS1, AS2, AS3) and Dync1i2 
exon 3b (AS1, AS2) are marked; the percent of identity (ID) and similarity (Sim) between segments of 
protein sequences coded by specific exons were compared using AliSubSimP; protein sequence of 
DYNC1I1 exon 4 was compared as two segments marked with asterix: 4* from AS1 to AS2 and 4** from 
AS2 to the end of exon 4 
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6.5.1 In silico analysis of mechanism of alternative splicing observed in 
Dync1i1 and Dync1i2 genes 
There are several features known that define alternatively spliced exons. Apart from 
conservation of exon/intron boundary sequences, the strength of alternative splice sites 
can be statistically assessed. (Koren et al., 2007) proposed the mechanism, in which 
constitutive exons accumulate mutations which create new splice site competing with the 
constitutive site. Likewise, constitutive splice sites were found to have stronger splice 
signals than alternative ones. Furthermore, as minor and new isoforms are known to have 
different cis- acting splicing signals, the strength of splice sites in the Dync1i1 and Dync1i2 
genes was assessed using ‘Splice Site Score Calculation’ (http://rulai.cshl.edu 
/new_alt_exon_db2/HTML/score.html). The comparison was performed for constitutive 
and alternatively spliced exons. Each splice site had a score calculated based on its 
sequence: for 3’AS site the maximum score was 14.2 with mean 7.9 for a constitutive 
exon; for 5’ AS site the maximum score was 12.6 with mean 8.1 for a consecutive exon. 
Intronic sequences used were genomic sequences of mouse Dync1i1 and Dync1i2 
deposited in the Ensembl (built NCBIM37) (ENSMUST00000115555 and 
ENSMUST00000112140/ENSMUST00000112144 respectively). 
 
There were 3 exons of mouse Dync1i1 examined, which are known to be consecutive 
(exon 4), alternative cassette (exon 5), and containing alternative 3’ splice site (exon 4) 
(Table 6.5). The scores for both splice sites in exon 3 (2.1 and 4.9) were higher than scores 
recorded for exon 5 (0.4 and 3.2), thus confirming bioinformatics data of alternative exons 
showing weaker splice sites. Furthermore, 5’ splice site in exon 4 was scored as very 
strong (11.3) when alternative 3’ slice sites had lower scores (AS1 – 7.9, AS2 – 3.0, and AS3 
– 0.5). These results were in agreement with observed imbalance in the strength of splice 
sites observed for exons with one site alternatively spliced (Koren et al., 2007). Based on 
the values, isoforms with AS1 in exon 4 (Dync1i1.A, Dync1i1.E) would be the major 
isoforms. However, in mouse tissues isoform Dync1i1.B, in which AS2 is used, was 
observed to be the most abundant. 
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The splicing pattern of the mouse Dync1i2 gene involved alternative use of a first exon and 
3 additional cassette exons (3b, 4, and 6) (Table 6.5). The 5’ splice site in the exon 1a was 
much stronger (12.6) than splice site in the exon 1b (2.7). Furthermore, both constitutive 
exons examined (3 and 5) showed high scores for the 5’ (7.8, 8.7 respectively) but not for 
the 3’ splice sites (-0.5, 3.0 respectively). Although exon 4 is a cassette exon found in 
minor isoforms (Dync1i2.D, Dync1i2.E, Dync1i2.A), its splice sites were scored higher than 
corresponding sites in the exon 3. On the other hand, exon 6 was characterised by weak 
splice sites when related to exon 5. Finally, a new exon 3b, which was found at a low level 
and likely represents a minor variant, had splice sites scored lower than adjoining exons 3 
and 4, but higher than exon 6. Based on the scores, exon 4 should be included more 
preferentially than exon 3, which is not the case. 
 
The analysis performed did not reflect completely the preference towards exon inclusion, 
which we observed in mouse tissues. This result suggests that the ‘strength’ of the splice 
site sequence is not sufficient to determine the pattern of the alternative splicing. 
 
 
Table 6.5. Summary of scores of 3’ and 5’ splice sites  
Values of scores calculated using ‘Splice Site Score Calculation’ for constitutive and alternative (shaded) 
exons of mouse Dync1i1 and Dync1i2 genes; sequences of intron/exon boundaries and numbers of exons 
retrieved from Ensembl (built NCBIM37), where sequence ENSMUST00000115555 referred to Dync1i1 
exons, sequence ENSMUST00000112140 referred to Dync1i2 (exon 1a), and ENSMUST00000112144 referred 
to Dync1i2 (exon 1b); exonic sequence in upper case, intronic in lower, in case of exon 1a/1b the 3’ sites 
were not defined thus omitted; in brackets shown mean values for 3’ (7.9) and 5’ (8.1) splice sites of 
constitutive exons, values higher than mean in bold; maximum scores were: 14.2 for 3’ splice site and 12.6 
for 5’ splice site 
Dync1i1 Dync1i2 
Exon 
3’ Splice site (7.9) 5’ splice site (8.1) 
Exon 
3’ Splice site (7.9) 5’ splice site (8.1) 
intron/EXON Score EXON/intron Score intron/EXON Score EXON/intron Score 
     1a - - AAG gtaagt 12.6 
     1b - - CAG gtcggt 2.7 
3 caaatcttttag G 2.1 TAG gtactt 4.9 3 ttaaaattttag A - 0.5 TTG gtaagg 7.8 
     3b AS1 ttctcaattgag G - 2.9 
TAG gtaaca 6.2 
     3b AS2 tcctcctttcag A 11.3 
4 AS1 gctcttccccag T 7.9 
AAG gtaaga 11.3 
4 ctgtacgttcag T 3.1 GGG gtaagg 8.0 
4 AS2 ttcattatttag T 3.0 5 ttcattatttag T 3.0 TAG gtatgt 8.7 
4 AS3 cttcgaaatcag T 0.5      
5 ctgcacgattag G 0.4 TTG gtatat 3.2 6 acaaccatttag G - 0.6 GGG gtattg 1.7 
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6.5.2 Comparison of the expression pattern of the cytoplasmic dynein 
intermediate chains 1 and 2 across species 
As databases are frequently updated, the summary presented aimed to revise available 
information. In order to retrieve the most accurate sequences few assumptions were 
made, and only full length transcripts containing first exon (exon 1 in Dync1i1, exons 1a, 
1b in Dync1i2) present in the majority of transcripts were taken into account. The 
transcripts retrieved displayed splicing events within exons 3 to 7 and could be translated 
into full length DYNC1I proteins. 
 
 
6.5.2.1  Comparison of the human, rat, and mouse Dync1i1 splicing 
pattern 
The alternative splicing of the Dync1i1 gene was fairly uniform when human, mouse, and 
rat sequences were compared (Table 6.6). There were 5 variants present in the human 
assemblies, which corresponded to mouse variants Dync1i1.A, Dync1i1.B, Dync1i1.D, 
Dync1i1.E, and Dync1i1C. In the rat genome assembly only 4 isoforms were found, likely 
due to fewer sequences available. Those isoforms corresponded to mouse Dync1i1.A, 
Dync1i1.B, Dync1i1.E, and Dync1i1C.  
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Table 6.6. Comparison of the Dync1i1 splice variants in human, mouse, and rat 
The sequences of various isoforms were retrieved from available genome assemblies, and annotated 
according to the UCSC Genome Browser and Ensembl release 62 (in italics); mouse isoforms annotated as in 
Kuta et al., 2010; non-curated sequences present in EST databases underlined 
 
Feature Human (GRCh37/hg19) Mouse (NCBI37/mm9) Rat (Baylor 3.4/rn4) 
Position 
(UCSC) 
Chr7 q21.3 
95,401,818-95,727,735 
Chr6 qA1 
5,675,812-5,978,039 
Chr4 q13 
30,496,410 – 30,809,621 
Length 
[bp] 
325,918 302,228 313,212 
Trans-
cripts 
and 
peptides 
uc003uoc.3/ 
ENST00000324972 
645 aa 
Dync1i1.A/ 
ENSMUST00000115555 
645 aa 
 
ENSRNOT00000013184 
643 aa 
uc003uod.3/ 
ENST00000447467 
628 aa 
Dync1i1.B/ 
ENSMUST00000115559 
628 aa 
CB703089, CB747457 
DA392898 
Dync1i1.D/ 
ENSMUST00000115556 
617 aa 
 
uc003uoe.3/ 
ENST00000437599 
625 aa 
 
Dync1i1.E 
625 aa 
CB712052 
uc003uob.2/ 
ENST00000359388 
608 aa 
Dync1i1.C/ 
ENSMUST00000115554 
608 aa 
CB616735, CB713291 
 
Dync1i1.F 
597 aa 
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6.5.2.2  Comparison of the human, rat, and mouse Dync1i2 gene 
In contrast to Dync1i1, the expression pattern of Dync1i2 was more complicated, including 
2 alternative first exons and isoforms there are potentially species specific. Because the 
start codon is located in exon 2, the transcription of two independent first exons may 
reflect an existence of additional regulation. There were 3 major isoforms found in all 
assemblies, and in mouse annotated as Dync1i2.A, Dync1i2.B and Dync1i2.C. In mouse 
tissues isoform Dync1i2.C was present in somatic tissues, thus it was sufficient for 
housekeeping functions of the dynein complex (Table 6.7).  
 
The new exon identified in mouse transcripts was annotated as 3b and was located within 
intron 3. The variant annotated as Dync1i2.D (exon1a/1b) was 51 bp long, which resulted 
in insertion of 17 amino acids. The use of an alternative 3’ splice site created a 36 bp long 
exon 3b and resulted in the additional transcript annotated Dync1i2.E (exon 1a/1b). Both 
splice variants were detected in mouse neural tissues and as they maintained the open 
reading frame, they might represent rare transcripts. The multiple alignment of the mouse 
intron 3 containing new exon generated by ‘multiz’ (UCSC/Penn State Bioinformatics tool) 
alignment of vertebrate species with the mouse genome showed high conservation only 
with rat genomic sequence. However, this region was reported to match a sequence of a 
long terminal repeat (LTR) on the complement strand (RepeatMasker). The sequence was 
annotated as Mammalian apparent LTR-retrotransposons (MaLR) class MTC (Smit, 1993). 
MaLR are super family of elements consisting only from the LTR sequence, and MTC are a 
group found only in rodents, for example in mouse multifinger gene mKr2 cDNA, 3' UTR, 
and in 3’ flanking regions of the mouse serum amyloid A-1 (Saa1) and mouse serum 
amyloid A-2 (Saa2) genes. The repeat elements were reported to contribute to protein 
sequences, the functionality of a new transcript is not easy to predict (Piriyapongsa et al., 
2007). 
 
The assembly of human sequences also contained transcripts, whose splicing pattern was 
not observed in mouse or rat. Transcripts annotated as ENST00000410079 and 
ENST00000358002 contained longer exon 5 by 54 bp but lacked exons 4 and 6. This 
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additional isoform had ORF maintained and when translated, the DYNC1I2 would be 630 
amino acids long (Table 6.7). 
 
 
 
Table 6.7. Comparison of the Dync1i2 splice variants in human, mouse, and rat 
The sequences of various isoforms were retrieved from available genome assemblies, and annotated 
according to the UCSC Genome Browser and Ensembl release 62 (in italics); mouse isoforms annotated as in 
Kuta et al., 2010; non-curated sequences present in EST databases underlined; in brackets first exon used; * 
- no longer present in the UCSC 
Feature Human (GRCh37/hg19) Mouse (NCBI37/mm9) Rat (Baylor 3.4/rn4) 
Position 
(UCSC) 
Chr2 
172,543,982-172,604,919 
Chr2 
71,050,070-71,101,351 
Chr3 
53,480,918-53,533,222 
Length 
[bp] 
60,938  51,282 52,305 
Trans-
cripts 
and 
peptides  
(1a) uc002uha.1/ 
ENST00000397119  
638 aa 
(1a) Dync1i2.A  
ENSMUST00000112140  
638 aa 
(1a) CB784025 
 
638 aa 
(1b) uc002uhe.1/ 
ENST00000409773  
638 aa 
(1b) Dync1i2.A  
ENSMUST00000112144   
638 aa 
(1b) 
ENSRNOT00000067729 
638 aa 
 
(1a)  ENST00000263811  
632 aa 
(1a) Dync1i2.B uc008kah.1 
/ENSMUST00000112142 
632 aa 
 
(1a) CF977964 
632 aa 
 
(1b) ENST00000409317  
632 aa 
(1b) Dync1i2.B  
ENSMUST00000100028  
632 aa 
(1b) 
ENSRNOT00000047243 
632 aa 
(1a) uc002uhb.1/ 
ENST00000340296  
612 aa 
(1a) Dync1i2.C uc008kai.1/ 
ENSMUST00000112138  
612 aa 
(1a) CK365527, EV774963, 
FM056664 
612 aa 
(1b) uc002uhf.1/ 
ENST00000409197  
612 aa 
(1b) Dync1i2.C uc008kak.1 
/ENSMUST00000081710  
612 aa 
(1b) 
ENSRNOT00000013400 
612 aa 
Species 
specific/
minor 
isoforms 
 
(1a) uc010zds.1*/ 
ENST00000410079  
630 aa  
Dync1i2.D  
(1a) GU992208/  
(1b) GU992211 
655 aa 
 
 
(1b) uc010zdt.1*/ 
ENST00000358002  
630 aa  
Dync1i2.E  
(1a) GU992209/ (1b) 
GU992212 
650 aa 
 
 
(1b) ENSMUST00000112136 
637 aa 
 
uc002uhc.2/ 
ENST00000508530  
611 aa 
(1a) ENSMUST00000112139  
611 aa 
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Another variation in the splicing pattern of the Dync1i2 gene was selective choice of the 3’ 
splice site within exon 18, which resulted in deletion of a glutamine residue (Q). This 
pattern was found common, with approximately 50% of alternative 3’ splice sites being 
exactly 3 bp apart (known as the NAGNAG motif) (Koren et al., 2007). This seemingly 
erroneous isoforms were recently found within transcripts of a cardiac voltage-gated 
sodium channel (Nav1.5 Na) as fully functional (Schroeter et al., 2010). 
 
In conclusion, the alternative splicing of the dynein intermediate chains 1 and 2 displays 
high similarity within mammals, which may correspond to distinct functions of the dynein 
complex. Furthermore, the Drosophila sp. orthologous gene, Dcic was also shown to be 
alternatively spliced resulting in the presence of 10 isoforms (Nurminsky et al., 1998). 
Interestingly, the splicing events were mapped to the region containing three small 
‘variable’ exons located between exon 4 and exon 5, and the use of two splice acceptors 
preceding exon 1.  
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7. General discussion  
In this work two novel mouse lines carrying single point mutations in the cytoplasmic 
dynein intermediate chains 1 (Dync1i1) and 2 (Dync1i2) were presented. During the screen 
of archive of the ENU mutagenised DNA we identified single point mutations in the dynein 
intermediate chains 1 and 2, which resulted in a substitution of glycine at the position 482 
with aspartic acid (Dync1i1
G482D
) and threonine 172 with isoleucine respectively. Mutant 
mouse lines were rederived and homozygous Dync1i1
G482D/G482D
 and Dync1i2
T172I/T172I 
mice 
and cell lines were tested for a variety of phenotypes.  
 
7.1 Characterisation of mouse line mutant in the cytoplasmic dynein 
intermediate chain 1 (Dync1i1G482D) 
The homozygous mutant Dync1i1
G482D/G482D
 allele did not cause behavioural deficits. 
Nonetheless, detailed analysis of gait revealed differences in paw placement, speed of 
movement, and weight bearing. Furthermore, homozygous Dync1i1
G482D/G482D
 animals 
tended to perform worse on the running wheel than wildtype Dync1i1
+/+
 littermates. 
Deficits in the toe spread and swing speed are often observed after denervation of foot 
muscles (Deumens et al., 2007), while shift in the base of support between front and hind 
paws was similar to reported for the homozygous Dync1li1
N235Y/N235Y
 mice (Banks et al., 
2011). Disruption of the interactions between dynein and dynactin in motor neurons 
resulted in neurodegeneration and denervation of muscles, and in live animals those 
changes were reflected by decrease of stride length and endurance on a treadmill 
(LaMonte et al., 2002). These characteristics might suggest mild neuropathy or 
denervation of sensory neurons. On the other hand, there are many factors influencing an 
animal’s performance when tested on the running wheel. Voluntary running induces 
neurogenesis of hippocampal neurons in adult mice thus improving memory (Brandt et al., 
2010), it was shown to reduce the serotonin-mediated stress response (Rozeske et al., 
2011), and have antidepressive effects via increase in the expression of brain derived 
growth factor (BDNF) (Sartori et al., 2011). However, the beneficial effects were alleviated 
in a mouse model of Huntington’s disease (Potter et al., 2010). Taken together, the 
interpretation of decrease in running is not straightforward and it might reflect 
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impairment occurring within different systems, for example abnormalities of NMJs are 
common for mice expressing mutant DCTN1/P150
Glued 
(Chevalier-Larsen et al., 2008), 
while improper synaptic organisation affects learning and acquisition of motor skills 
(Groszer et al., 2008). Finally, a single nucleotide polymorphism (SNP) in the intron of the 
DYNC1I1 gene was found associated with peripheral sensory neuropathy or neuralgia 
affecting multiple myeloma patients treated with bortezomib (Favis et al., 2011). 
 
The new mutation in the cytoplasmic dynein intermediate chain 1 lies within WD domain 
and this region is known to mediate binding to the dimer of heavy chains. We can 
hypothesise, that G482D substitution might affect intermolecular interactions, as 
structural features of the WD domains promote assembly of multisubunit complexes 
(Stirnimann et al., 2010). Likewise, loss of dopaminergic neurons and locomotor deficits 
mimicking parkinsonism were observed in Zebrafish expressing leucine-rich repeat kinase 
2 (LRRK2) lacking one of the WD40 repeats (Sheng et al., 2010).  
 
7.2 Mutation in the cytoplasmic dynein intermediate chain 2 (Dync1i2) 
perturbs molecular pathways involved in memory formation 
The behavioural phenotype of animals homozygous for the mutant allele 
(Dync1i2
T172I/T172I
) was related to an impairment in the hippocampus related short-term 
habituation. On the cellular level subtle deficits were observed in the dynamics of the 
trafficking of the EGF endosomes and Golgi membranes (in double homozygous 
Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 cells). Furthermore, levels of Dynlt3 and Dynll2 
transcripts were lower in the spinal cords and hippocampi isolated from homozygous 
Dync1i2
T172I/T172I
 animals.  
 
Mutation in the intermediate chain 2 was mapped to substitute second residue within the 
light chains (Dynll1, Dynll2) binding domain (Figure 7.1) (Hall et al., 2009). Dimeric light 
chains were shown essential in the dimerisation of the intermediate chains and 
subsequent assembly of the complex (section 1.2.5). Furthermore, expression levels of 
Dynlt3 and Dynll2 varied from the wild type animals in the presence of the mutant allele. 
We can hypothesise, that the T172I mutation might affect the structure of the 
intermediate chain 2 thus disrupting interactions with light chains. Although the 
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regulation of expression of different subunits is not well known, depletion of the Dync1h1 
transcript resulted in simultaneous down-regulation of the Dync1i (Caviston et al., 2007). 
Similar mechanisms might also govern the coexpression of the light chains. In addition, the 
dynein complex was proposed to be assembled via formation of sub-complexes with 
heavy and intermediate chains as a core subunits (King et al., 2002). Furthermore, in the 
brain homogenates of the animals carrying a homozygous mutation in the dynein light 
intermediate chain 1 (Dync1li1
N235Y
) the total level of the DYNLT3 was elevated while 
DYNLL were bound less tightly in the isolated dynein complexes (Banks et al., 2011). These 
results suggest expression regulation mechanisms, which might be sensitive to structural 
changes in the complex. Based on observations from two different mutant mouse lines 
light chains might act as a hypothetical ‘sensor’, especially as DYNLL are known to be 
present ubiquitously in the cytoplasm, for example stabilising the structure of myosin Va 
dimers (Wagner et al., 2006).  
 
 
Figure 7.1. Crystal structure of the ternary complexes of intermediate chains (DYNC1I) with light chains 
(DYNLT, DYNLL) 
Semi-transparent surface and secondary structural elements are shown for crystal structures of assembly 
intermediate chains (grey), light chains DYNLT (green) and DYNLL (yellow); the ‘linker’ between light chain 
binding domains is flexible and can adopt a range of conformations; approximate position of the T172I 
mutation marked with arrow 
This research was originally published in J Biol Chem., Hall J. et al., ‘Multivalency in the Assembly of 
Intrinsically Disordered Dynein Intermediate Chain’ 2009, vol. 284, pp. 33115–33121. © 2009 by The 
American Society for Biochemistry and Molecular Biology, Inc. 
238 
Dynein light chains DYNLT were also implicated in neurogenesis of the hippocampal 
neurons and axon formation (Conde et al., 2010). In the rat brain DYNLT1 and DYNLT3 
were found in mutually exclusive structures, with DYNLT3 enriched in the perikarya of 
pyramidal cell granule cell layers in the dentate hilus, and pyramidal cells of brain cortex 
(Chuang et al., 2001). Likewise, DYNLT3 was found abundant in dendritic spines, 
postsynaptic structures, and vacuolar tubules of the Golgi complex, suggesting its function 
in membrane remodelling during long-term potentiation. In the homozygous 
Dync1i2
T172I/T172I
 mice higher levels of DYNLT3 were detected in the spinal cord but not in 
other parts of the brain (Chapter 6). In spinal cord the expression pattern of both Dync1i2 
and Dynlt3 overlaps, however no impairment in the locomotor functions were found. This 
result might suggest a mechanism ‘buffering’ imbalance of the subunits expressed, for 
example by degrading the excess of DYNLT3 transcript.  
 
In the hippocampi isolated from homozygous Dync1i2
T172I/T172I
 animals, the expression 
level of Dynll2 was lower than observed in the wild type animals. DYNLL have been 
implicated in formation of synapses and they were found at the synaptic sites in the 
hippocampal neurons and at postsynaptic elements in the spinal cord (Fuhrmann et al., 
2002). Furthermore, direct interactions of DYNLL with gephyrin (GPHN), which acts as a 
scaffold for clusters of the glycine receptors at the inhibitory synapses, suggest the direct 
function of the light chains in trafficking of synaptic components. Bassoon (BSN) and 
Piccolo (PCLO) are another complex essential in the assembly of synapses and 
neurotransmitter release. After synthesis they are directed to synapses in Golgi-derived 
Piccolo – Bassoon transport vesicles (PTVs) (Fejtova et al., 2009). In cultured hippocampal 
neurons PTVs were found associated with molecular motors, including the cytoplasmic 
dynein complex. Further analysis revealed that BSN interacts directly with DYNLL1 and 
DYNLL2, and the authors suggested its role as an adaptor binding dynein to PTVs via 
DYNLLs. Furthermore, disruption of BSN binding to the light chains affected trafficking of 
the PTVs and the distribution of the BSN – PCLO at the synapses. Taken together, we can 
hypothesise that observed impairment of the short-term habituation is a result of many 
cellular processes triggered by mutation in the intermediate chain 2. Both Dync1i2 and 
Dynll2 are highly expressed in the hippocampal formation, where structural abnormalities 
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in the light chain binding domain may affect complex stability and expression of the 
Dynll2. The decrease in amount of the DYNLL2 would then disrupt BSN – PCLO transport 
and synapse formation. It should also be noted that dynamics of Golgi and endocytic 
membranes was also impaired in the fibroblasts homozygous for mutant alleles 
(Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
 and Dync1i2
T172I/T172I
 respectively). Finally, a decrease 
in the performance of the mutant Dync1i2
T172I/T172I
 mice in the novelty preference task was 
a new feature not associated before with the dynein intermediate chains, whereas it was 
similar to the behaviour of the Gria1
-/-
 animals (Sanderson et al., 2009). The GRIA1 AMPA 
receptor subunit is a key mediator of hippocampal synaptic plasticity and is especially 
important for a rapidly-induced, short-lasting form of potentiation.  
 
There is another line of evidence linking cytoplasmic dynein intermediate chain 2 with 
memory formation. DYNC1I2 was present in a complex with sorting nexin 4 (SNX4) and 
WWC1/KIBRA, which mediated trafficking of endosomal compartment (Traer et al., 2007). 
In the human population, KIBRA was associated with synaptic plasticity and performance 
in a recall task (Yasuda et al., 2010). Furthermore, patients with Alzheimer’s disease 
showed up-regulation of the KIBRA in hippocampus and temporal cortex, which might 
correlate with observed memory impairment in the course of the disease (Corneveaux et 
al., 2010). 
 
7.3 What do double homozygous (Dync1i1G482D/G482D Dync1i2T172I/T172I) mice 
show? 
In this work we present initial results obtained with mouse embryonic fibroblasts (MEFs) 
isolated from animals carrying double homozygous mutations in the intermediate chains 1 
and 2 (Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
), which displayed deficits in morphology of the 
Golgi apparatus. Deficits in trafficking of membranous organelles have been observed in 
hereditary spastic paraplegias (Blackstone et al., 2011) therefore mutant animals might be 
useful in studying neurological deficits.   
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7.4 Why do Dync1h1Loa mice get stressed? 
The Loa mutant mouse line has been described in section 1.5.1.2. Using fibroblasts 
isolated from mutant Dync1h1
Loa
 mice we investigated a formation of stress granules. The 
Dync1h1
Loa
 mutation was mapped to be within a region where intermediate and light 
intermediate chains bind. It was found to affect the assembly of the complex and affinity 
of the distinct subunits (Deng et al., 2010). By stronger binding of the DYNC1I associations 
with dynactin complex were impaired, which might correspond to the observed deficits in 
molecular transport (Hafezparast et al., 2003).  
 
Stress granules are heterogeneous assemblies of RNAs and RNA binding proteins which 
are formed in a dynein-dependent manner (Loschi et al., 2009). Their composition is 
known to differ depending on the cell type or stress applied (Thomas et al., 2011). In the 
homozygous Dync1h1
Loa/Loa
 fibroblasts we observed an increased number of stress 
granules when cells were treated with sodium arsenite, whereas no differences were 
observed after treatment with thapsigargin. This discrepancy might correspond to 
different cellular mechanisms, which are activated depending on the stress applied, for 
example TDP-43 was shown to regulate granules induced by oxidative stress (McDonald et 
al., 2011). Furthermore, our results also highlight a distinct role of cytoplasmic dynein in 
the assembly of the stress granules. In primary neurons treated with sodium arsenite 
DYNLRB1 was found in the structures positive for known stress granule markers (TIA-1, 
ELAVL1/HuR) (Tsai et al., 2009). Stress granules are often compared to neuronal mRNA 
granules and they were proposed to have a neuroprotective role (Thomas et al., 2011). 
We can hypothesise that disruption of the stress response pathway might result in 
neuronal cell death, which is observed in the Dync1h1
Loa
 animals.  
 
 
7.5 Mice full of surprises 
In the presented work we employed mouse mutant lines to study functions of the 
cytoplasmic dynein intermediate chains 1 and 2. As a result, distinct phenotypes were 
described, both suggesting neurological involvement, which are useful resources to study 
a specific deficits, for example short-term habitation. The role of a broad and 
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comprehensive behavioural analysis of mutant lines should be also stressed, which is 
essential in investigating mild behavioural deficits. Furthermore, we noted the influence of 
genetic background on the performance of animals, and it would be beneficial to examine 
more numerous cohorts of mice bred on at least 2 distinct genetic backgrounds. As an 
example, the modifying effects of genetic background on disease associated phenotype 
was recently described using transgenic model of amyotropic lateral sclerosis (ALS) 
(Acevedo-Arozena et al., 2011). 
 
7.6 Future work 
Further characterisation of the Dync1i1
G482D
 mutant line would be advantageous, for 
instance, detailed histological analysis of NMJs and sensory neurons would be necessary 
to dissect the physiological basis of mutant phenotype. Mutations in both heavy 
(Dync1h1
Loa
) and light intermediate 1 (Dync1li1
N235Y
) chains were shown to disturb 
molecular organisation of the dynein complex, thus investigation of native dynein complex 
containing mutant intermediate chains  would be important in the light of the assembly of 
the complex (Banks et al., 2011; Deng et al., 2010). 
 
Deficits in the memory in the Dync1i2
T172I
 mutant mouse line suggest deregulation of the 
synaptic functions affecting mostly hippocampal neurons. Therefore, in parallel with 
detailed characterisation of animals, synapse formation and trafficking of dendritic 
components should be investigated.  
 
Apart from intracellular transport, the cytoplasmic dynein complex is crucial for mitosis 
and chromosome separation, cell migration, and brain development (Friocourt et al., 
2011; Whyte et al., 2008). Although there were no morphological abnormalities observed 
in either of the mutant mouse lines, the effects of both mutations (Dync1i1
G482D
, 
Dync1i2
T172I
) on the chromosome segregation and nuclear positioning should be 
examined. 
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10. Appendices 
 
10.1 CatWalk XT gait analysis - initial analysis of paw parameters 
 
This section contains all the performed analyses of gait parameters, which did not vary in 
any cohort (Dync1i1
G482D
 or Dync1i2
T172I
). The parameters for which Dync1i1
G482D/G482D
 
mice were different from wildtype Dync1i1
+/+
 littermates are described in section 3.4.5 
and Table 3.13. All the parameters were automatically calculated by the CatWalk XT 
software and for each mouse mean values from 4 successive runs were reported; for each 
pair of paws (front, hind) an average of left and right paw was calculated. In addition, the 
bias towards reporting higher values for one side than the other (e.g. print area for 
left/right paw) has been observed (Angeby-Moller et al., 2008).  
 
Parameters can be distinguished as static (measurements of the distance, area, etc) or 
dynamic (description of the movement in time units) and both categories were included in 
the analysis, starting from the static measurements: 
Base of support (BOS) [mm] – an average width between front (left – right) or hind (left – 
right) paws; it is often used to describe stability of a moving animal 
Stride length [mm] – distance between successive placements of the same paw, 
calculated for paw position at its maximum contact; Stride length (F/H) - stride length 
expressed as a fraction of distance covered by front paws in relation to hind paws 
Print area [mm2] – surface area of a complete print measured during stand phase and it 
corresponds to the area of a footprint left on paper if a paw was painted with ink; area 
ratio of front to hind paws was also calculated  
 
Print length [mm] – length of a complete print (Figure 10.1) 
Print width [mm] – width of a complete print (measured across the broadest region of a 
foot)  
Moreover, the CatWalk XT enables measurements of dynamic parameters, which describe 
the movement of each paw in a domain of time: 
Swing [ms] – phase of a step cycle when a paw is lifted and does not touch the glass 
walkway 
Stand [ms] – phase of a step cycle describing the duration of paw contact with the glass 
walkway (phase when a print is recorded) 
Swing and Stand are components of the Step cycle, which is the duration of a single step 
defined as two consecutive contacts of the same paw – the time of a single stride 
Duty cycle – is used to express the duration of the stand in relation to the full step cycle 
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Maximum contact [ms] – time measured from the start of a run till a paw makes the 
biggest contact with the glass, described as the point at which a breaking phase of the 
step turns into a propulsion phase 
Initial contact [ms] – time since the start of the run at which a paw makes contact with 
the glass. 
 
 
 
Figure 10.1. Schematic representation of relation between print parameters generated with CatWalk XT  
A footprint is recorded for each paw when it is placed on the walkway; parameters described correspond to 
measurements taken during a stand phase: print width [mm] (vertical arrow) and length [mm] (horizontal 
arrow) parameters reflect the foot placement and toe spread. Print area [mm
2
] corresponds to the total 
surface, adapted from ‘CatWalk XT 8.1 Reference Manual’, Noldus Information Technology 
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Table 10.1. Summary of analysed gait parameters calculated for the Dync1i1
G482D
 and Dync1i2
T172I
 mice 
Raw or transformed data were analysed with either two-way repeated measures ANOVA (reports F and p) or 
unpaired t-test (p only), values for each parameter (with an unit) shown as mean ± SEM (standard error of 
the mean); genotypes annotated: wildtype Dync1i1
+/+
, homozygous Dync1i1
G482D/G482D
, wildtype Dync1i2
+/+
, 
homozygous Dync1i2
T172I/T172I
; n - number of animals tested; F and H correspond to front and hind paws 
while WTH and LTH correspond to width and length of a print respectively; mm – millimetre, mm
2
 – squared 
millimetre, ms – milliseconds, F(DFn, DFd) is F ratio calculated for DFn: degrees of freedom for the 
numerator, DFd: degrees of freedom for the denumerator (shaded); two-tailed p value significant at p< 0.05 
 
Parameter 
Dync1i1+/+ 
n=9 
Dync1i1G482D/G482D 
n=10 
Dync1i2+/+ 
n=8 
Dync1i2T172I/T172I 
n=8 
Base of support [mm] 
F 
H 
11.8 ± 0.3 
20.0 ± 0.7 
10.8 ± 0.3 
21.0 ± 0.6 
11.4 ± 0.5 
22.8 ± 0.8 
11.8 ± 0.2 
22.3 ± 0.6 
F(1,17)=0.0001, p=0.9907 F(1,14)=0.0329, p=0.8588 
Stride length [mm] 
F 
H 
54.1 ± 2.5 
54.0 ± 2.4 
50.9 ± 1.6 
50.4 ± 1.6 
52.7 ± 1.9 
51.9 ± 2.0 
51.4 ± 2.2 
50.6 ± 2.2 
F(1,17)=1.4100, p=0.2514 F(1,14)=0.2133, p=0.6513 
Stride length F/H 
1.003 ± 0.003 1.011 ± 0.006 1.016 ± 0.006 1.016 ±0.008 
p=0.2236 p=0.9413 
Print area [mm2] 
F 
H 
19.5 ± 1.8 15.8 ± 2.0 21.8 ± 1.7 21.8 ± 2.5 
29.8 ± 2.9 25.7 ± 2.8 28.6 ± 2.5 30.0 ± 2.8 
 F(1,17)=1.3780, p=0.2566 F(1,14)=0.0393, p=0.8457 
Print area F/H 
0.686 ± 0.044 0.635 ± 0.040 0.772 ±0.032 0.722 ± 0.047 
p=0.3159 p=0.3869 
Print widht [mm] 
F 
H 
5.31 ± 0.19 
6.32 ± 0.28 
4.79 ± 0.29 
5.95 ± 0.28 
5.60 ± 0.17 
6.33 ± 0.25 
5.49 ± 0.28 
6.38 ± 0.26 
F(1,17)=1.5530, p=0.2296 F(1,14)=0.0077 p=0.9314 
Print length [mm] 
F 
H 
5.30 ± 0.22 
6.85 ± 0.29 
4.60 ± 0.31 
6.08 ± 0.35 
5.69 ± 0.44 
6.47 ± 0.30 
5.61 ± 0.37 
6.56 ± 0.33 
 F(1,17)=3.3410, p=0.0852 F(1,14)=0.0002, p=0.9889 
Swing [ms] 
F 
H 
117.2 ± 4.8 
106.2 ± 6.7 
133.9 ± 6.5 
124.5 ± 7.3 
132.2 ± 5.0 
128.4 ± 5.0 
126.9 ± 4.8 
118.4 ± 8.0 
 F(1,17)=3.9360, p=0.0636 F(1,14)=0.6018, p=0.4508 
Stand [ms] 
F 
H 
87.4 ± 7.3 
100.8 ± 8.4 
85.5 ± 6.2 
95.8 ± 5.3 
102.2 ± 5.6 
105.6 ± 6.8 
92.5 ± 6.2 
101.6 ± 4.7 
 F(1,17)=0.1361, p=0.7168 F(1,14)=0.7447, p=0.4027 
Duty cycle 
F 
H 
0.417 ± 0.014 
0.479 ± 0.026 
0.390 ± 0.020 
0.438 ± 0.017 
0.422 ± 0.012 
0.441 ± 0.017 
0.411 ± 0.018 
0.456 ± 0.022 
 F(1,17)=1.787, p=0.1990 F(1,14)=0.0068, p=0.9354 
Maximum contact [ms] 
F 
H 
809.4 ± 136.2 
858.1 ± 136.9 
945.7 ± 134.5 
926.3 ± 112.1 
815.9 ± 96.3 
839.7 ± 102.5 
921.9 ± 125.2 
941.2 ± 125.0 
 F(1,17)=0.4479, p=0.5123 F(1,14)=0.4218, p=0.5265 
Initial contact [ms] 
F 
H 
705.6 ± 92.7 
751.7 ± 95.0 
810.0 ± 78.8 
846.3 ± 78.0 
785.9 ± 93.9 
808.8 ± 101.1 
893.4 ± 124.2 
905.9 ± 123.5 
 F(1,17)=0.6743, p=0.4229 F(1,14)=0.4217, p=0.5266 
Maximum contact at 
F 
H 
0.286 ± 0.017 
0.294 ± 0.016 
0.299 ± 0.010 
0.308 ± 0.006 
0.283 ± 0.023 
0.286 ± 0.006 
0.321 ± 0.017 
0.325 ± 0.013 
 F(1,17)= 0.7698, p=0.3925 F(1,14)=3.7420, p=0.0735 
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10.2 Detailed analysis of colocalisation 
 
This section contains all the performed analyses of colocalisation parameters performed 
for wildtype Dync1i1
+/+ 
Dync1i2
+/+
 and double homozygous Dync1i1
G482D/G482D
 
Dync1i2
T172I/T172I
 cell lines. The analysis and summary are presented in section 4.4.1.2 and 
Table 4.1.  
 
Cell images were annotated to relevant bins based on the value of pixel ratio (shaded 
pink), numbers of images from each cell line in bold, the results of statistical analysis and 
reported two-tailed p-values shaded grey; n - number of cell lines derived from animals; 
F(DFn, DFd) – F ratio calculated for DFn: degrees of freedom for the numerator, DFd: 
degrees of freedom for the denumerator; ANOVA – analysis of variance; * - unpaired t-
test with Welch’s correction for unequal variance. 
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Table 10.2. Analysis of colocalisation of MTs and dynein intermediate chains 
Values of each parameter shown as mean and range (pixel ratio) or mean ± stanard deviation (SD) (PCC, 
MMTs, MIC74); genotypes annotated as follows: wildtype (Dync1i1
+/+
Dync1i2
+/+
) double homozygous 
(Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
); for each genotype results shown as recorded for each cell line 
 
 
Parameter 
Dync1i1+/+ Dync1i2+/+ 
n=3 
Dync1i1G482D/G482D Dync1i2T172I/T172I 
n=3 
Pixel ratio 
MTs/IC74 
Bin 1 
(1-2) 
10 8 5 3 4 4 
1.703 
1.397-1.975 
1.782 
1.471-1.962 
1.805 
1.532-1.977 
1.723 
1.442-1.864 
1.799 
1.715-1.918 
1.796 
1.585-1.912 
Bin 2 
(2-4) 
11 15 12 16 17 15 
2.317 
2.005-2.992 
2.482 
2.011-3.644 
2.753 
2.142-3.598 
2.720 
2.171-3.878 
2.581 
2.067-3.990 
2.500 
2.042-3.209 
Bin 3 
(4-6) 
1 4 3 1 
5.330 4.884; 4.109-5.619 4.633; 4.302-4.802 5.061 
Pearson’s 
colocali-
sation 
coefficient 
(PCC) 
Bin 1 
0.213± 
0.090 
0.242± 
0.156 
0.310± 
0.204 
0.209± 
0.054 
0.149± 
0.134 
0.249± 
0.055 
Two-way ANOVA F(1,28)=1.1750, p=0.2876 
Bin 2 
0.117± 
0.104 
0.173± 
0.096 
0.168± 
0.146 
0.141± 
0.082 
0.159± 
0.054 
0.175± 
0.103 
Two-way ANOVA F(1,80)=0.0639, p=0.8011 
Bin 3 
-0.005±0.115 0.113±0.120 
 Unpaired t-test, p=0.1768 
Mander’s 
colocali-
sation 
coefficient 
MT 
intensities 
(MMTs) 
Bin 1 
0.683± 
0.064 
0.687± 
0.059 
0.696± 
0.076 
0.684± 
0.035 
0.632± 
0.042 
0.686± 
0.048 
Two-way ANOVA F(1,28)=0.9604, p=0.3355 
Bin 2 
0.526± 
0.075 
0.539± 
0.077 
0.511± 
0.082 
0.460± 
0.084 
0.492± 
0.074 
0.535± 
0.058 
Two-way ANOVA F(1,80)=3.2850, p=0.0737 
Bin 3 
0.276±0.045 0.278±0.036 
 Unpaired t-test, p=0.9504 
Mander’s 
colocali-
sation 
coefficient 
IC74 
intensities 
(MIC74) 
Bin 1 
0.968± 
0.023 
0.983± 
0.014 
0.975± 
0.029 
0.972± 
0.033 
0.982± 
0.011 
0.987± 
0.002 
Two-way ANOVA F(1,28)=0.4201, p=0.5222 
Bin 2 
0.971± 
0.012 
0.990± 
0.008 
0.983± 
0.019 
0.971± 
0.018 
0.991± 
0.012 
0.981± 
0.015 
Two-way ANOVA F(1,80)=0.0012, p=0.9729 
Bin 3 
0.976±0.026 0.995±0.006 
 Unpaired t-test, p=0.1745* 
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10.3 Reassembly of Golgi comples after nocodazole treatment 
 
This section contains all the performed analyses of the morphology of the Golgi complex 
was examined after nocodazole washout. Two experiments were performed and in each 
at least 300 cells were scored blindly to genotype and experiment for the appearance of 
the Golgi labelling. There were 3 types distinguished, corresponding to perinuclear 
complex (reticular or compact), and fragmented within a cytosol (Table 10.3). The results 
are summarised in section 4.4.2.1. 
 
In addition, a detailed analysis of the Golgi structure at different time points was 
performed by comparing high resolution images of individual cells. For each cell image 
performed analysis was based on identification of objects positive for giantin labelling, for 
which a set of parameters was automatically calculated by the software (Cell Profiler). The 
parameters compared included: ratio of Golgi stacks number to their total area, form 
factor, eccentricity, and perimeter (in pixels). For each cell a mean value of a parameter 
was recorded and those were averaged giving a mean from a cell line. Means from each 
time point were normalised to mean values recorded for untreated cells. The final relative 
values were analysed using paired t-test (the genotype effect at different time points), 
repeated measures one-way ANOVA (the time point effect on results obtained) followed 
by Dunnett's multiple comparison test (results for each time point tested against results 
for untreated cells) (Table 10.4). The results are described in section 4.4.2.2. 
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Table 10.3. Analysis of Golgi apparatus reassembly after nocodazole treatment 
Results obtained in 2 experiments were pooled and shown as fractions recorded for each cell line, total 
numbers of cells scored (bold), and mean±standard deviation; genotypes annotated as follows: wildtype 
(Dync1i1
+/+
Dync1i2
+/+
) double homozygous (Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
); results of statistical analysis 
and reported two-tailed p-values shaded grey; n - number of cell lines derived from animals 
 
Morphology/ 
time point 
Dync1i1+/+ Dync1i2+/+   
n=3 
Dync1i1G482D/G482D Dync1i2T172I/T172I  
n=3 
R
e
ti
cu
la
r 
Untreated 
799, 0.532 510, 0.551 569, 0.425 691, 0.307 751, 0.478 652, 0.463 
0.503 ± 0.068 0.416 ± 0.095 
 Paired t-test, p=0.3732 
0 min 698, 0.0 544, 0.0 597, 0.0 668, 0.0 678, 0.0 646, 0.0 
50 min 
747, 0.390 541, 0.399 561, 0.349 862, 0.347 809, 0.428 709, 0.440 
0.379 ± 0.026 0.405 ± 0.051 
 Paired t-test, p=0.5767 
C
o
m
p
a
ct
 Untreated 
0.392 0.367 0.476 0.624 0.471 0.417 
0.412 ± 0.057 0.504 ± 0.107 
 Paired t-test, p=0.3866 
0 min 0.0 0.0 0.0 0.0 0.0 0.0 
50 min 
0.347 0.347 0.396 0.447 0.333 0.313 
0.363 ± 0.028 0.364 ± 0.072 
 Paired t-test, p=0.9898 
Fr
a
g
m
e
n
te
d
 Untreated 
0.076 0.082 0.098 0.069 0.051 0.120 
0.086 ± 0.011 0.080 ± 0.036 
 Paired t-test, p=0.7412 
0 min 1.0 1.0 1.0 1.0 1.0 1.0 
50 min 
0.264 0.253 0.255 0.206 0.240 0.247 
0.257 ± 0.006 0.231 ± 0.022 
 Paired t-test, p=0.2338 
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Table 10.4. Image based analysis of shape parameters of Golgi complex membranes 
Digital images were taken and analysed at different time points after nocodazole washout; for each cell line 
mean values were normalised to values recorded for the untreated cells (in italics), while raw data are 
shown as mean ± standard deviation (SD); genotypes annotated as follows: wildtype (Dync1i1
+/+ 
Dync1i2
+/+
) 
double homozygous (Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
); results of repeated measures ANOVA or paired t-
test and reported two-tailed p-values shaded grey, for p< 0.05 in bold; for time points shown p-values 
reported by Dunnett's multiple comparison test; n - number of cell lines derived from animals 
 
Parameter/ 
time point 
Dync1i1+/+Dync1i2+/+   
n=3 
Dync1i1G482D/G482DDync1i2T172I/T172I  
 n=3 
Number 
of cells 
0 min 5 6 5 5 5 6 
20 min 5 7 6 8 6 5 
50 min 5 5 6 5 7 5 
Untreated 7 6 6 6 5 6 
Ratio 
number/ 
area 
0 min 
2.929±0.666 1.873±0.762 2.186±0.600 2.440±0.398 1.892±0.377 2.498±0.962 
3.275 2.533 2.982 2.706 2.406 3.125 
 Paired t-test, p=0.4681 
20 min 
1.144±0.284 1.126±0.116 1.003±0.374 1.048±0.151 1.126±0.170 1.016±0.161 
1.280 1.522 1.368 1.163 1.432 1.271 
 Paired t-test, p=0.0063 
50 min 
0.852±0.104 0.976±0.192 0.836±0.053 0.765±0.189 0.920±0.160 0.837±0.127 
0.953 1.319 1.140 0.848 1.169 1.047 
 Paired t-test, p=0.0183 
Untreated 
0.894±0.209 0.740±0.081 0.733±0.106 0.902±0.186 0.787±0.168 0.799±0.165 
 Paired t-test, p=0.1420 
Time points F(3,11)=38.25, p=0.0003 F(3,11)=43.70, p=0.0002 
Untreated vs. 0 min p<0.001 p<0.001 
Untreated vs. 20 min p> 0.05 p> 0.05 
Untreated vs. 50 min p> 0.05 p> 0.05 
Form 
factor 
0 min 
0.613±0.047 0.499±0.067 0.549±0.020 0.506±0.023 0.528±0.063 0.541±0.096 
1.432 1.080 1.407 1.138 1.130 1.311 
 Paired t-test, p=0.3745 
20 min 
0.482±0.043 0.433±0.061 0.394±0.071 0.448±0.040 0.455±0.052 0.449±0.040 
1.125 0.936 1.009 1.009 0.974 1.088 
 Paired t-test, p=0.9981 
50 min 
0.393±0.049 0.414±0.044 0.441±0.021 0.415±0.058 0.458±0.051 0.389±0.049 
0.917 0.896 1.129 0.934 0.979 0.941 
 Paired t-test, p=0.7540 
Untreated 
0.428±0.062 0.463±0.050 0.390±0.035 0.444±0.040 0.467±0.036 0.413±0.074 
 Paired t-test, p=0.1090 
Time points F(3,11)=6.186, p=0.0288 F(3,11)=11.17, p=0.0072 
Untreated vs. 0 min p< 0.05 p< 0.05 
Untreated vs. 20 min p> 0.05 p> 0.05 
Untreated vs. 50 min p> 0.05 p> 0.05 
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Table 10.4. continued  
 
Parameter/ 
time point 
Dync1i1+/+Dync1i2+/+  
n=3 
Dync1i1G482D/G482DDync1i2T172I/T172I   
n=3 
Eccentri-
city 
0 min 
0.703± 
0.041 
0.706± 
0.028 
0.704± 
0.031 
0.748± 
0.026 
0.711± 
0.020 
0.724± 
0.015 
0.910 0.943 0.900 1.010 0.978 0.977 
 Paired t-test, p=0.0648 
20 min 
0.707± 
0.035 
0.750± 
0.038 
0.734± 
0.027 
0.733± 
0.039 
0.747± 
0.045 
0.744± 
0.009 
0.916 1.001 0.938 0.991 1.027 1.004 
 Paired t-test, p=0.0684 
50 min 
0.749± 
0.041 
0.751± 
0.047 
0.714± 
0.016 
0.808± 
0.042 
0.755± 
0.026 
0.752± 
0.024 
0.970 1.004 0.912 1.092 1.038 1.015 
 Paired t-test, p=0.0837 
Untreated 
0.772±0.060 0.749±0.044 0.782±0.067 0.740 0.055 0.727±0.046 0.741±0.036 
 Paired t-test, p=0.0325 
Time points F(3,11)=5.439, p=0.0380 F(3,11)=3.678, p=0.0819 
Untreated vs. 0 min p< 0.05 p> 0.05 
Untreated vs. 20min p> 0.05 p> 0.05 
Untreated vs. 50min p> 0.05 p> 0.05 
Log of 
total 
peri-
meter 
[a.u.] 
0 min 
3.616± 
0.141 
3.918± 
0.102 
3.788± 
0.092 
3.661± 
0.107 
3.963± 
0.046 
3.524± 
0.339 
0.998 1.077 1.050 1.007 1.113 0.979 
 Paired t-test, p=0.8096 
20 min 
3.833± 
0.165 
3.885± 
0.352 
3.801± 
0.237 
3.579± 
0.249 
3.791± 
0.353 
4.034± 
0.233 
1.057 1.068 1.054 0.984 1.064 1.121 
 Paired t-test, p=0.9426 
50 min 
3.818± 
0.310 
3.873± 
0.116 
3.983± 
0.261 
3.354± 
0.197 
3.726± 
0.135 
3.867± 
0.133 
1.053 1.064 1.104 0.922 1.046 1.074 
 Paired t-test, p=0.2379 
Untreated 
3.625± 
0.250 
3.639± 
0.126 
3.607± 
0.200 
3.637± 
0.133 
3.562± 
0.157 
3.599± 
0.214 
 Paired t-test, p=0.4706 
Time points F(3,11)=5.974, p=0.0311 F(3,11)=0.5749, p=0.6522 
Untreated vs. 0 min p> 0.05 p> 0.05 
Untreated vs. 20 
min 
p< 0.05 p> 0.05 
Untreated vs. 50 
min 
p< 0.05 p> 0.05 
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10.4 Analysis of EGF-uptake and endosomal trafficking 
 
This section contains the performed analyses of the EGF
+/ve
 endosomes in wildtype 
Dync1i2
+/+
  and homozygous Dync1i2
T172I/T172I 
fibroblasts. Cells were observed at different 
time points after EGF stimulation: 0 min, 15 min, 30 min, 45 min, and 60 min. Images of 
individual cells obtained from 2 experiments were analysed and parameters describing 
EGF-positive (EGF
+/ve
) endosomes were calculated: the rate of translocation, endosome 
number and area. During the analysis the total number of vesicles was normalised 
relatively to the cytoplasm area. Because values of parameters obtained deviated from 
Gaussian distribution, raw data were transformed using:  = 	 and log values were 
used. Furthermore, Pearson correlation between number and area of endosomes was 
calculated (Table 10.5). The results are discussed in section 4.4.3. 
 
 
 
 
 
 
Table 10.5. Image based analysis of number and area of EGF
+/ve
 endosomes 
Digital images were taken and analysed at different time points after stimulation with EGF; due to a non-
normal distribution of values all the data were transformed before analysis using:  = 	; for each cell 
line raw data are shown as median and interquartile range (IQR) while log transformed as means ± standard 
deviation (SD) (in italics); genotypes annotated as follows: wildtype (Dync1i2
+/+
), homozygous 
(Dync1i2
T172I/T172I
); result of ANOVA and reported two-tailed p-values shaded grey (for p<0.05 in bold); R² - 
Pearson correlation coefficient squared, corresponds to goodness of linear fit (fraction of variance shared 
between both variables); n - number of cell lines derived from animals 
 
Parameter/ 
time point 
Dync1i2
+/+
  (n=2) Dync1i2
T172I/T172I
  (n=2) 
Number/ 
cytosol 
area 
0 min 
1.786 (0.698 - 5.356) 6.106 (2.068 - 12.41) 2.013 (0.652 - 5.290) 2.472 (1.073 - 5.615) 
0.285±0.508 0.673±0.453 0.254±0.549 0.362±0.590 
 F(1,64)=1.718, p=0.1946 
15 min 
2.390 (1.643 - 3.310) 2.955 (2.101 - 7.430) 2.302 (1.175 - 3.297) 4.524 (2.272 - 5.430) 
0.317±0.306 0.570±0.308 0.289±0.335 0.551±0.287 
 F(1,92)=0.1288, p=0.7205 
30 min 
2.804 (2.010 - 3.843) 3.239 (1.717 - 6.663) 2.941 (2.416 - 4.405) 2.968 (1.869 - 6.054) 
0.453±0.181 0.520±0.298 0.480±0.255 0.470±0.342 
 F(1,109)=0.0477, p=0.8275 
45 min 
2.305 (1.768 - 3.120) 1.557 (0.738 - 2.108) 2.448 (1.321 - 2.759) 1.978 (1.115 - 2.739) 
0.363±0.156 0.163±0.289 0.296±0.314 0.229±0.281 
 F(1,103)=0.0, p=0.9998 
60 min 
1.435 (0.989 - 1.998) 0.522 (0.341 - 1.099) 1.744 (1.025 - 2.711) 0.857 (0.489 - 1.396) 
0.125±0.269 -0.211±0.328 0.214±0.287 -0.084±0.316 
 F(1,96)=3.188, p=0.0774 
Test for linear trend 
F(4,9)=2.730, p=0.1501 
R
2
=0.5068, p=0.0362 
F(4,9)=2.917, p=0.1355 
R
2
=0.2852, p=0.0811 
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Table 10.5. continued 
Parameter/ 
time point 
Dync1i2
+/+
  (n=2) Dync1i2
T172I/T172I
  (n=2) 
Perinuclear 
endosomes 
NUMBER 
0 min 
10 (5 - 33) 37 (14 – 194) 19 (11 – 45) 26 (6 – 52) 
1.148±0.622 1.667±0.709 1.314±0.399 1.366±0.633 
 F(1,60)=0.1891, p=0.6653 
15 min 
52 (35 - 75) 64 (37 – 126) 34 (15 – 57) 72 (29 – 104) 
1.678±0.344 1.827±0.323 1.472±0.440 1.745±0.428 
 F(1,91)=3.112, p=0.0811 
30 min 
65 (46 - 90) 78 (45 – 178) 54 (38 – 82) 77 (42 – 134) 
1.802±0.250 1.934±0.349 1.751±0.213 1.818±0.331 
 F(1,109)=2.429, p=0.1220 
45 min 
50 (38 - 97) 40 (23 – 63) 82 (47 – 128) 51 (32 – 83) 
1.768±0.271 1.601±0.350 1.875±0.290 1.746±0.386 
 F(1,102)=3.922, p=0.0503 
60 min 
52 (26 - 94) 19 (13 – 31) 60 (35 – 88) 24 (17 – 48) 
1.694±0.345 1.307±0.270 1.715±0.286 1.400±0.306 
 F(1,94)=0.8291, p=0.3649 
Test for linear trend F(4,9)=1.439, p=0.3443 F(4,9)=3.485, p=0.1017 
Perinuclear 
endosomes 
AREA [a.u.] 
0 min 
72 (47 - 294) 302 (108 - 1891) 154 (67 - 471) 207 (45 - 383) 
2.053±0.635 2.611±0.808 2.259±0.423 2.279±0.649 
 F(1,58)=0.1450, p=0.7048 
15 min 
707 (331 - 1029) 829 (436 - 2007) 417 (156 - 807) 901 (296 - 1381) 
2.747±0.475 2.951±0.401 2.538±0.539 2.826±0.487 
 F(1,91)=2.686, p=0.1047 
30 min 
861 (556 - 1383) 1563 (714 - 3585) 886 (523 - 1332) 1032 (431 - 2174) 
2.947±0.271 3.180±0.388 2.930±0.270 2.976±0.404 
 F(1,109)=3.088, p=0.0817 
45 min 
756 (463 - 1573) 595 (228 - 893) 1346 (722 - 2086) 804 (408 - 1494) 
2.919±0.312 2.679±0.420 3.069±0.350 2.871±0.449 
 F(1,102)=5.206, p=0.0246 
60 min 
812 (335 - 1119) 225 (117 - 356) 1007 (399 - 1340) 348 (207 - 765) 
2.808±0.414 2.328±0.312 2.888±0.374 2.479±0.402 
 F(1,94)=2.195, p=0.1418 
Test for linear trend 
F(4,9)=2.262, p=0.1973 
R
2
=0.0365, p=0.5062 
F(4,9)=5.525, p=0.0444 
R
2
=0.3154, p=0.0329 
Pearson 
correlation 
coefficient 
log(number) 
– log(area) 
0 min 
0.9879 
(0.9669 - 0.9956) 
0.9972 
(0.9910 - 0.9992) 
0.9482 
(0.8316 - 0.9847) 
0.9767 
(0.9350 - 0.9918) 
R
2
=0.9759 R
2
=0.9945 R
2
=0.8990 R
2
=0.9540 
15 min 
0.9622 
(0.9201 - 0.9823) 
0.9777 
(0.9417 - 0.9916) 
0.9887 
(0.9758 - 0.9947) 
0.9769 
(0.9378 - 0.9916) 
R
2
=0.9258 R
2
=0.9560 R
2
=0.9775 R
2
=0.9544 
30 min 
0.9033 
(0.8049 - 0.9533) 
0.9586 
(0.9087 - 0.9815) 
0.8976 
(0.8011 - 0.9486) 
0.9532 
(0.8933 - 0.9798) 
R
2
=0.8159 R
2
=0.9189 R
2
=0.8057 R
2
=0.9086 
45 min 
0.9270 
(0.8528 - 0.9645) 
0.9727 
(0.9309 - 0.9894) 
0.9159 
(0.8385 - 0.9570) 
0.9606 
(0.9011 - 0.9846) 
R
2
=0.8594 R
2
=0.9462 R
2
=0.8388 R
2
=0.9228 
60 min 
0.9807 
(0.9582 - 0.9911) 
0.9416 
(0.8590 - 0.9764) 
0.9415 
(0.8620 - 0.9758) 
0.9581 
(0.9090 - 0.9809) 
R
2
=0.9617 R
2
=0.8866 R
2
=0.8864 R
2
=0.9179 
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10.5 Infection with Salmonella enterica ser. Typhimurium 
 
This section contains the performed analyses of the phenotypes of the bacterial 
microcolonies observed in the MEF lines. Infection was carried out for 8 hours; 
intracellular bacteria were observed under fluorescent microscope and various features 
were scored by eye, from each line 120 infected MEFs were examined. There were 6 cell 
lines used in the experiments, including: one of wildtype Dync1i1
+/+
 Dync1i2
+/+
 and double 
homozygous Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
, two of wildtype Dync1h1
+/+ 
and 
homozygous Dync1h1
Loa/Loa
. Cell lines derived from embryos with mutations in the 
intermediate chains (Dync1i1
G482D 
Dync1i2
T172I
) were not tested statistically (n=1), cell lines 
with mutation in the Dync1h1
Loa 
were tested for n=2 with tests for categorical data 
(Fisher’s exact test, Chi-squared). The efficiency of the infection was scored by 3 
categorical parameters, which described the position and speed of replication of bacteria 
in each fibroblast. Those included: (1) position of bacteria in regards to nucleus 
(perinuclear or periphery), (2) ability to form micro colony (clustered or scattered), (3) and 
presence of fewer or more than 20 bacteria per fibroblast (Table 10.6). The results are 
discussed in section 4.4.4. 
 
In addition, the SifA
-
 mutant strain was used, in order to examine the dynamics of the SCV 
membranes. Stability of the bacterial vacuoles was investigated by following the 
distribution of LAMP-1 staining. A number of bacteria, which colocalised with LAMP-1 
staining was scored and represented as a fraction of Salmonella found in LAMP-1
+/ve 
compartment (Table 10.7).  
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Table 10.6. Distribution of microcolony features observed in MEFs infected with wildtype Salmonella 
typhimurium (next page) 
Genotypes of cell lines correspond to wildtype (Dync1i1
+/+
Dync1i2
+/+
), double homozygous (Dync1i1
G482D/G482D
 
Dync1i2
T172I/T172I
), wildtype (Dync1h1
+/+
) and homozygous (Dync1h1
Loa/Loa
) Loa.  
Intracellular Salmonella were classified based on: (1) the position in regards to a nucleus, (2) micro colony 
formation, (3) evaluated number; categories graded as the most (bold) or least (italics) preferable (see 
paragraph for details); shaded area corresponds to the frequency distributions shown in Figure 4.11. In 
addition, parameters were analysed individually or combined in pairs; for each category number of cells is 
shown next to a relative fraction of population; because only 1 experiment was performed with 2 cell lines  
allelic in Dync1i1
G482D
 Dync1i2
T172I
 loci (n=1) the data were not tested for statistical significance, in case of 
Loa lines carrying a mutation in the dynein heavy chain (n=2) numbers are shown for both lines while a 
fraction is shown as an average value; * marks results of Chi-squared (χ
2
) test, calculated after pooling values 
from individual MEF lines; in all cases reported two sided p-values; for clarification relevant panels in Figure 
4.12 are also annotated for each comparison 
 
Category Dync1i1
+/+
 
Dync1i2
+/+
 
Dync1i1
G482D/G482D 
Dync1i2
T172I/T172I
 
Dync1h1
+/+ 
(n=2) 
Dync1h1
Loa/Loa
 
(n=2) Position 
(1) 
Microcolony 
(2) 
Number 
(3) Number of cells classified to each category and fraction it represents 
Periphery Scattered 
<20 
18 0.150 13 0.108 26, 21 0.196 31, 28 0.246 
Periphery Clustered 27 0.225 12 0.100 16, 19 0.146 28, 22 0.208 
Perinuclear Scattered 
<20 
16 0.133 13 0.108 17, 20 0.154 11, 20 0.129 
Perinuclear Clustered 36 0.300 50 0.417 39, 30 0.288 24, 30 0.225 
Periphery Scattered 
>20 
7 0.058 7 0.058 8, 11 0.079 8, 9 0.071 
Periphery Clustered 5 0.042 7 0.058 7, 8 0.063 6, 6 0.050 
Perinuclear Scattered 
>20 
5 0.042 12 0.100 5, 5 0.042 7, 2 0.038 
Perinuclear Clustered 6 0.050 6 0.050 2, 6 0.033 5, 3 0.033 
Total MEFs scored 120 1.000 120 1.000 120 1.000 120 1.000 
          
Periphery  57 0.475 39 0.325 57, 59 0.483 73, 65 0.575 
Perinuclear  63 0.525 81 0.675 63, 61 0.517 47, 55 0.425 
Figure 4.12A      Fisher's exact test, p=0.1958 
 Scattered  46 0.383 45 0.375 56, 57 0.471 57, 59 0.483 
 Clustered  74 0.617 75 0.625 64, 63 0.529 63, 61 0.517 
Figure 4.12B      Fisher's exact test, p=0.8240 
  < 20 97 0.808 88 0.733 98, 90 0.783 94, 100 0.808 
  > 20 23 0.192 32 0.267 22, 30 0.217 26, 20 0.192 
Figure 4.12C      Fisher's exact test, p=0.7490 
Periphery Scattered 
 
25 0.208 20 0.167 34, 32 0.275 39, 37 0.317 
Periphery Clustered 32 0.267 19 0.158 23, 27 0.208 34, 28 0.258 
Perinuclear Scattered 
 
21 0.175 25 0.208 22, 25 0.196 18, 22 0.167 
Perinuclear Clustered 42 0.350 56 0.467 41, 36 0.321 29, 33 0.258 
Figure 4.12D      χ
2 
(3)=4.172, p=0.2435* 
 
Scattered 
< 20 34 0.283 26 0.217 43, 41 0.350 42, 48 0.375 
 > 20 12 0.100 19 0.158 13, 16 0.121 15, 11 0.108 
 
Clustered 
< 20 63 0.525 62 0.517 55, 49 0.433 52, 52 0.433 
 > 20 11 0.092 13 0.108 9, 14 0.096 11, 9 0.083 
Figure 4.12E      χ
2 
(3)=0.580, p=0.9010* 
Periphery 
< 20 45 0.375 25 0.208 42, 40 0.342 59, 50 0.454 
> 20 12 0.100 14 0.117 15, 19 0.142 14, 15 0.121 
Perinuclear 
< 20 
> 20 
52 0.433 63 0.525 56, 50 0.442 35, 50 0.354 
11 0.092 18 0.150 7, 11 0.075 12, 5 0.071 
Figure 4.12F      χ
2 
(3)=6.551, p=0.0877* 
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Table 10.7. Summary of membrane dynamics observed in MEFs infected with wildtype (WT) and SifA
- 
Salmonella typhimurium 
Infections were carried out for 8 hours, intracellular bacteria were observed and association with LAMP-1
+/ve
 
compartment was scored by eye; genotypes of cell lines correspond to wildtype (Dync1i1
+/+
Dync1i2
+/+
), 
double homozygous (Dync1i1
G482D/G482D
 Dync1i2
T172I/T172I
), wildtype (Dync1h1
+/+
) and homozygous 
(Dync1h1
Loa/Loa
) Loa; from each line and bacterial strain 120 infected MEFs were examined; results are 
presented as relative fractions of population or number of cells displaying the feature, results of Dync1h1
Loa 
(n=2) as mean ± standard deviation, analysed with unpaired t-test, which reported two-tailed p-value; total 
number of intracellular SifA
-
 bacteria was pooled and expressed as median and interquartile range 
 
Phenotype observed 
Dync1i1+/+ 
Dync1i2+/+ 
Dync1i1G482D/G482D 
Dync1i2T172I/T172I 
Dync1h1+/+ 
n=2 
Dync1h1Loa/Loa 
n=2 
Salmonella in 
LAMP -1+/ve 
compartment 
WT 0.991 0.990 
0.989 ± 0.0001 0.986 ± 0.016 
Unpaired t-test, p=0.7767 
SifA- 0.075 0.109 
0.078 ± 0.047 0.091 ± 0.049 
Unpaired t-test, p=0.8964 
MEFs with 
Salmonella in 
2 
compartments 
WT 
5 6 10, 4 13, 2 
0.042 0.051 
0.0583 ± 0.035 0.0665 ± 0.070 
Unpaired t-test p=0.8964 
SifA- 
30 29 50, 27  32, 22 
0.250 0.242 
0.321 ± 0.136 0.225 ± 0.059 
Unpaired t-test, p=0.4560 
Salmonella 
with lost 
/retained 
LAMP -1+/ve 
membranes 
WT 0.186 0.161 
0.180 ± 0.087 0.194 ± 0.017 
Unpaired t-test, p=0.8459 
SifA- 0.164 0.184 
0.203 ± 0.059 0.151 ± 0.017 
Unpaired t-test, p=0.3580 
Median number of 
SifA
- Salmonella 
4.0 
(1.0 - 8.0) 
1.0 
(1.0 - 5.0) 
7.0 
(4.3 - 9.0) 
6.0 
(4.0 - 8.0) 
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10.6 Formation of stress granules 
 
This section contains detailed analyses of the cytoplasmic stress granules (SG). From each 
condition (sodium arsenite, thapsigargin) at least 20 pictures of each cell line were taken 
from 2 experiments, thus over 40 pictures of wildtype Dync1i1
+/+
Dync1i2
+/+
 (n=3), double 
homozygous Dync1i1
G482D/G482D 
Dync1i2
T172I/T172I
 (n=3), wildtype Dync1h1
+/+
 (n=3), and 
homozygous Dync1h1
Loa/Loa
 (n=3) fibroblasts were taken. The number and total area of 
G3BP
+/ve
 objects were recorded for individual cells. Because values obtained for each cell 
line did not have Gaussian distribution, raw data were transformed ( = 	) prior to 
statistical analysis. All the parameter were analysed with two-way ANOVA (Table 10.8, 
Table 10.9). The results are described in section 5.3.2. 
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Table 10.8. Analysis of stress granules in individual cells after sodium arsenite (SA) treatment 
Images from 2 experiments were analysed and G3BP
+/ve
 objects treated as stress granules; due to a non-
normal distribution of values all the data were transformed before analysis using:  = 	; for each cell 
line raw data are shown as median and interquartile range (IQR) while log transformed as means ± standard 
deviation (SD) (in italics); genotypes annotated as follows: wildtype (Dync1i1
+/+
Dync1i2
+/+
), double 
homozygous (Dync1i1
G482D
Dync1i2
T172I/T172I
), wildtype (Dync1h1
+/+
), and homozygous (Dync1h1
Loa/Loa
); result 
of ANOVA and reported two-tailed p-values shaded grey (for p<0.10 in bold); R² - Pearson correlation 
coefficient squared, corresponds to goodness of linear fit (fraction of variance shared between both 
variables); n - number of cell lines derived from animals; a.u. – arbitrary units 
 
Parameter 
Dync1i1+/+ Dync1i2+/+   
n=3 
Dync1i1G482D/G482D Dync1i2T172I/T172I  
n=3 
Number of 
cells 
39 39 40 40 39 42 
Number of 
G3BP+/ve foci 
39 ( 32- 59) 46 (29 - 70) 49 (35 - 71) 42 (28 - 50) 55 (46 - 74) 50 (38 - 65) 
1.642±0.189 1.653±0.226 1.687±0.197 1.600 ±0.207 1.753 ±0.193 1.681 ±0.168 
 F(1,233)=0.4717, p=0.4929 
Total area of 
G3BP+/ve foci 
[a.u.] 
9308 
(6879-
12630) 
9500 
(6487-
14313) 
10010 
(7843-
16420) 
8516 
(5668-
12397) 
11291 
(8104-
15401) 
9842 
(7554-
12760) 
3.957±0.187 3.986±0.214 4.028±0.217 3.909 ±0.247 4.063 ±0.193 3.985 ±0.160 
 F(1,233)=0.0350, p=0.8517 
Parameter 
Dync1h1+/+  
n=3 
Dync1h1Loa/Loa  
n=3 
Number of 
cells 
79 62 50 81 58 61 
Number of 
G3BP+/ve foci 
50 (28 - 82) 49 (35 - 65) 57 (35 -104) 64 (45 - 103) 64 (50 - 88) 62 (44 - 98) 
1.681±0.278 1.674±0.225 1.769±0.296 1.818 ±0.255 1.820 ±0.218 1.814 ±0.234 
 F(1,385)=17.78, p< 0.0001 
Total area of 
G3BP+/ve foci 
[a.u.] 
11796 
(6527-19425) 
12396 
(8342 -
18230) 
16556 
(7735 - 
26600) 
16211 
(10788-
26177) 
14519 
(11309-
21657) 
15956 
(9915 - 
25230) 
4.050±0.284 4.065±0.268 4.154±0.324 4.197 ±0.270 4.169 ±0.216 4.192 ±0.259 
 F(1,385)=11.97, p=0.0006 
Correlation 
log(number) 
– log(area) 
0.9324 0.9108 0.9305 0.9290 0.9024 0.9532 
R
2
=0.8694 R
2
=0.8296 R
2
=0.8658 R
2
=0.8631 R
2
=0.8144 R
2
=0.9086 
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Table 10.9. Analysis of stress granule formation after thapsigargin (TG) treatment 
Images from 2 experiments were analysed and G3BP
+/ve
 objects treated as stress granules; due to a non-
normal distribution of values all the data were transformed before analysis using:  = 	; for each cell 
line raw data are shown as median and interquartile range (IQR) while log transformed as means ± standard 
deviation (SD) (in italics); genotypes annotated as follows: wildtype (Dync1i1
+/+
Dync1i2
+/+
), double 
homozygous (Dync1i1
G482D
Dync1i2
T172I/T172I
), wildtype (Dync1h1
+/+
), and homozygous (Dync1h1
Loa/Loa
); result 
of ANOVA and reported two-tailed p-values shaded grey (for p<0.10 in bold); R² - Pearson correlation 
coefficient squared, corresponds to goodness of linear fit (fraction of variance shared between both 
variables); n - number of cell lines derived from animals; a.u. – arbitrary units 
 
Parameter 
Dync1i1+/+ Dync1i2+/+ 
  n=3 
Dync1i1G482D/G482D Dync1i2T172I/T172I  
n=3 
Number of 
cells 
40 42 39 41 38 39 
Number of 
G3BP+/ve foci 
40 (31 - 56) 45 (34 - 58) 50 (39 - 68 ) 39 ( 31- 52) 50 (35 - 59) 52 (41 - 67) 
1.620±0.156 1.638±0.190 1.736±0.181 1.596±0.188 1.686±0.185 1.717±0.164 
 F(1,233)=0.0041, p=0.9487 
Total area of 
G3BP+/ve foci 
[a.u.] 
8462 
(6583-
12360) 
8723 
(6334-
12519) 
11659 
(8119-
14032) 
8988 
(6665-
12252) 
9519 
(7258-
11862) 
10386 
(8747-
13270) 
3.942±0.185 3.944±0.197 4.078±0.194 3.931±0.208 3.973±0.172 4.018±0.173 
 F(1,233)=0.3408, p=0.5599 
Parameter Dync1h1+/+ n=3 Dync1h1Loa/Loa n=3 
Number of 
cells 
61 62 60 61 60 64 
Number of 
G3BP+/ve foci 
64 (37 - 83) 47 (34 - 57) 46 (26 - 83) 61 (47 - 91) 48 (34 - 65) 58 (40 - 71) 
1.752±0.231 1.654±0.201 1.671±0.308 1.800±0.236 1.668±0.206 1.732±0.212 
 F(1,362)=2.806, p=0.0948 
Total area of 
G3BP+/ve foci 
12342 
(9447-19540) 
10903 
(7817-13067) 
10988 
(6638-17959) 
15156 
(9519-22834) 
10523 
(6780-14666) 
11183 
(7924-15441) 
4.103±0.256 4.027±0.213 4.006±0.306 4.162±0.273 4.007±0.236 4.018±0.224 
 F(1,362)=0.4153, p=0.5197 
Correlation 
log(number) 
– log(area) 
0.9038 0.8966 0.9472 0.9439 0.9092 0.9070 
R
2
=0.8169 R
2
=0.8040 R
2
=0.8971 R
2
=0.8909 R
2
=0.8267 R
2
=0.8227 
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10.7 Analysis of splicing pattern of the mouse Dync1i1 and Dync1i2 genes 
 
This section contains detailed analyses of relative abundance of different isoforms of the 
cytoplasmic dynein intermediate chains 1 and 2.  
 
Capillary gel electrophoresis with laser induced fluorescence (CGE-LIF) provided high 
efficiency separation of nucleic acids up to a single base resolution by combining 
polyacrylamide in capillaries as medium and fluorescence based detection for better 
resolution. Chromatograms recorded contained sets of peaks separated by their sizes with 
the accuracy to one bp. By comparison of expected sizes of amplified isoforms with peak 
positions on a chromatogram, five isoforms of each gene were annotated. Relative 
amounts were calculated as fraction of peak area to the total area of peaks identified and 
individual isoforms compared between samples (Table 10.10). The results are described in 
section 6.4.1.2. 
 
Levels of transcripts of the subunits of the dynein complex were examined using real-time 
PCR. Relative quantification performed by calculating the ratio between the amounts of a 
target gene (dynein subunits) and a control gene (β-actin). Calculations were based on the 
values of threshold cycle (CT), which was number of cycle, when a fluorescence increased 
above a set threshold. Firstly, CT values of β-actin were subtracted from values recorded 
for a dynein gene (∆CT). The ∆CT values recorded for wildtype Dync1i2
+/+
 mice (n=3) were 
averaged and used as ‘calibrating’ value when calculating ∆∆CT (∆∆CT=∆CT ‘calibrating’ - 
∆CT sample). Finally, normalised expression levels of dynein subunits were calculated as  
2-∆∆CT and those values were tested for statistical significance using unpaired t-test with 
reported two-tailed p-values (Table 10.10). Detailed description of the quantitative real-
time PCR can be found in Qiagen handbook (Critical Factors for Successful Real-Time PCR). 
Each sample was run in triplicate and values averaged before analysis. The results are 
discussed in section 6.4.2. 
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Table 10.10. Relative abundance of individual isoforms of Dync1i1 and Dync1i2 (exon 1a, exon 1b) in 
mouse neural tissues  
Results shown as mean ± standard error (SEM); PCR products were amplified using reverse primers 
conjugated with 5-FAM (Appendix 10.12.4) and isoforms detected shown; isoforms Dync1i1.E, and 
Dync1i2.D were not observed due to low sensitivity of the assay; values were compared using paired t-test 
or one-way ANOVA, reported two-tailed p-values; transcripts detected at levels below 2% were not 
considered in the analysis and marked in italics; the most abundant isoforms shaded pink; values from parts 
of brain were compared against samples from hippocampus and underlined when significantly different; 
isoforms showing different levels within the sample in green, nd – not detected, n=4 in all samples except 
for * (n=3) and 
$ 
(n=2) 
 
Tissue/ Isoform 
Dync1i1 
1.A 1.B 1.D 1.C 1.F 
Brain 0.018±0.002 0.502±0.016 0.310±0.013 0.134±0.021 0.036±0.006 
Spinal cord 0.055±0.011 0.477±0.024 0.398±0.007 0.048±0.004 0.022±0.006 
Statistics p=0.0314 p=0.4127 p=0.0068 p=0.0337 p=0.2056 
Embryonic brain
$
 nd 0.647±0.008 0.112±0.006 0.220±0.014 0.021±0.000 
Embryonic sp. cord
$
 nd 0.721±0.008 0.148±0.003 0.115±0.000 0.009±0.002 
 - p=0.0208 p=0.0374 p=0.0163 p=0.0351 
Cortex 0.005±0.004 0.585±0.006 0.273±0.020 0.106±0.005 0.031±0.006 
Hippocampus * 0.004±0.002 0.493±0.051 0.298±0.018 0.160±0.024 0.045±0.007 
Olfactory bulbs 0.018±0.003 0.289±0.008 0.130±0.008 0.437±0.023 0.126±0.005 
Cerebellum 0.035±0.005 0.572±0.029 0.334±0.017 0.044±0.006 0.014±0.004 
Brain stem 0.069±0.030 0.455±0.028 0.410±0.027 0.048±0.018 0.018±0.007 
Tissue/ Isoform 
Dync1i2 exon 1a 
2.E 2.A 2.B 2.F 2.C 
Brain nd 0.359±0.010 0.313±0.007 nd 0.328±0.014 
Spinal cord nd 0.125±0.006 0.329±0.022 nd 0.545±0.024 
Statistics - p=0.0002 p=0.5521 - p=0.0039 
Embryonic brain
$
 0.009±0.001 0.083±0.019 0.633±0.025 nd 0.274±0.009 
Embryonic sp. cord
$
 0.009±0.003 0.245±0.005 0.551±0.010 nd 0.195±0.008 
 - p=0.0144 p=0.0936 - p=0.0219 
Cortex 0.004±0.001 0.333±0.061 0.301±0.007 0.003±0.001 0.359±0.068 
Hippocampus * nd 0.390±0.052 0.255±0.014 0.004±0.000 0.351±0.065 
Olfactory bulbs 0.005±0.003 0.121±0.005 0.479±0.002 nd 0.394±0.005 
Cerebellum 0.002±0.001 0.417±0.015 0.267±0.012 nd 0.313±0.011 
Brain stem nd 0.204±0.015 0.358±0.009 0.002±0.000 0.435±0.007 
Tissue/ Isoform 
Dync1i2 exon 1b 
2.E 2.A 2.B .2F 2.C 
Brain nd 0.382±0.009 0.357±0.013 0.003±0.001 0.258±0.017 
Spinal cord nd 0.206±0.009 0.398±0.014 nd 0.396±0.011 
Statistics - p< 0.0001 p=0.0902 - p=0.0017 
Embryonic brain
$
 0.008±0.001 0.050±0.002 0.699±0.015 nd 0.244±0.014 
Embryonic sp. cord
$
 nd 0.191±0.010 0.647±0.010 nd 0.157±0.003 
 - p=0.0055 p=0.1058 - p=0.0270 
Cortex nd 0.489±0.031 0.310±0.018 nd 0.200±0.014 
Hippocampus * nd 0.484±0.017 0.253±0.017 0.003±0.001 0.259±0.008 
Olfactory bulbs 0.012±0.001 0.232±0.008 0.499±0.014 nd 0.256±0.010 
Cerebellum nd 0.317±0.031 0.316±0.029 nd 0.367±0.045 
Brain stem nd 0.225±0.009 0.370±0.008 0.002±0.000 0.403±0.008 
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Table 10.11. Quantitative analysis of expression levels of dynein subunits in wildtype Dync1i2
+/+
 and 
homozygous Dync1i2
T172I/T172I
 mice  
Results shown as mean ± standard error (SEM); real-time PCRs were run using primers designed to detect 1 
population of cDNAs (Appendix 10.12.5) and subunits detected shown; isoforms of intermediate chains: 
Dync1i1.E, Dync1i1.F, Dync1i2.D, Dync1i2.E, and Dync1i2.F were not observed due to low sensitivity of the 
assay; genotypes correspond to wildtype Dync1i2
+/+
 and homozygous Dync1i2
T172I/T172I
 animals; Dync1li1 – 
dynein light intermediate chain1, Dynlt1, Dynlt3 – dynein light chains Tc-tex1, RP3, Dynll1, Dynll2 – dynein 
light chains LC8-1 and 2 
 
Gene 
Dync1i2
+/+
  (n=3) Dync1i2
T172I/T172I
  (n=3) 
Cortex Hippocampus Spinal cord Cortex Hippocampus Spinal cord 
Dync1i1
.A 
∆CT 12.57 9.943 8.167 11.79±0.415 10.38±0.372 9.307±0.318 
∆∆CT 0.000±0.543 0.000±0.326 0.000±0.360 -0.778±0.415 0.441±0.372 1.141±0.318 
2
-∆∆CT
 1.148±0.416 1.055±0.256 1.063±0.260 1.846±0.447 0.783±0.177 0.475±0.093 
  p=0.3167 p=0.4311 p=0.1000    
Dync1i1
.B 
∆CT 4.776 3.010 3.761 4.325±0.508 3.628±0.732 4.071±0.335 
∆∆CT 0.000±0.257 0.000±0.152 0.000±0.024 -0.451±0.508 0.619±0.732 0.310±0.335 
2
-∆∆CT
 1.032±0.178 1.011±0.103 1.000±0.016 1.523±0.431 0.800±0.282 0.849±0.177 
  p=0.3515 p=0.5209 p=0.4427    
Dync1i1
.D 
∆CT 5.076 4.651 4.544 4.386±0.439 4.953±0.155 4.264±0.128 
∆∆CT 0.000±0.496 0.000±0.069 0.000±0.041 -0.690±0.439 0.302±0.155 -0.280±0.128 
2
-∆∆CT
 1.115±0.338 1.002±0.048 1.001±0.029 1.754±0.452 0.820±0.083 1.224±0.113 
  p=0.3214 p=0.1316 p=0.1283    
Dync1i1
.C 
∆CT 7.511 6.590 8.044 7.697±0.745 6.836±0.273 8.583±0.446 
∆∆CT 0.000±0.170 0.000±0.139 0.000±0.089 0.186±0.745 0.245±0.273 0.539±0.446 
2
-∆∆CT
 1.014±0.118 1.009±0.092 1.004±0.063 1.119±0.498 0.875±0.172 0.760±0.247 
  p=0.8478 p=0.5313 p=0.3925    
Dync1i2
.A 
∆CT 4.246 2.249 5.438 3.804±0.435 2.990±0.407 4.975±0.165 
∆∆CT 0.000±0.278 0.000±0.261 0.000±0.072 -0.443±0.435 0.741±0.407 -0.462±0.165 
2
-∆∆CT
 1.039±0.206 1.031±0.168 1.002±0.051 1.479±0.401 0.650±0.194 1.396±0.165 
  p=0.3836 p=0.2125 p=0.0852    
Dync1i2
.B 
∆CT 3.976 2.725 3.699 3.453±0.331 3.104±0.320 3.545±0.335 
∆∆CT 0.000±0.124 0.000±0.343 0.000±0.203 -0.522±0.331 0.380±0.320 -0.154±0.335 
2
-∆∆CT
 1.008±0.090 1.059±0.254 1.021±0.152 1.509±0.313 0.809±0.187 1.169±0.242 
  p=0.1987 p=0.4724 p=0.6309    
Dync1i2
.C 
∆CT 5.836 4.956 4.028 5.756±0.141 5.245±0.267 3.868±0.183 
∆∆CT 0.000±0.087 0.000±0.275 0.000±0.196 -0.081±0.141 0.289±0.267 -0.160±0.183 
2
-∆∆CT
 1.004±0.062 1.036±0.189 1.019±0.140 1.068±0.104 0.847±0.157 1.135±0.145 
  p=0.6243 p=0.4855 p=0.5947    
Dync1li
1 
∆CT 3.607 3.443 4.644 3.915±0.661 3.519±0.143 4.487±.184 
∆∆CT 0.000±0.599 0.000±0.195 0.000±0.744 0.308±0.661 0.076±0.143 -0.157±0.184 
2
-∆∆CT
 1.198±0.523 1.018±0.131 1.306±0.667 1.011±0.497 0.958±0.094 1.132±0.135 
  p=0.8087 p=0.7280 p=0.8107    
Dynlt1 
∆CT 13.38 12.90 12.88 12.26±0.489 12.65±0.262 12.08±0.230 
∆∆CT 0.000±1.124 0.000±0.092 0.000±0.383 -1.119±0.489 -0.252±0.262 -0.805±0.230 
2
-∆∆CT
 1.523±0.656 1.004±0.063 1.066±0.242 2.437±0.824 1.230±0.217 1.790±0.268 
  p=0.4346 p=0.3739 p=0.1153    
Dynlt3 
∆CT 3.354 3.795 3.168 3.680±0.065 3.911±0.042 2.695±0.084 
∆∆CT 0.000±0.176 0.000±0.073 0.000±0.135 0.325±0.065 0.116±0.042 -0.473±0.084 
2
-∆∆CT
 1.015±0.129 1.003±0.051 1.009±0.090 0.800±0.036 0.924±0.027 1.392±0.079 
  p=0.1824 p=0.2429 p=0.0329    
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Gene 
Dync1i2
+/+
  (n=3) Dync1i2
T172I/T172I
  (n=3) 
Cortex Hippocampus Spinal cord Cortex Hippocampus Spinal cord 
Dynll1 
∆CT -0.415 -0.462 1.218 0.051±0.497 -0.478±0.179 1.212±0.333 
∆∆CT 0.000±0.289 0.000±0.044 0.000±0.327 0.466±0.497 -0.016±0.179 -0.006±0.333 
2
-∆∆CT
 1.040±0.201 1.001±0.030 1.056±0.257 0.823±0.310 1.027±0.127 1.056±0.227 
  p=0.5877 p=0.8522 p=0.9985    
Dynll2 
∆CT -0.046 0.641 0.528 0.012±0.565 0.969±0.111 -0.330±0.135 
∆∆CT 0.000±0.483 0.000±0.058 0.000±0.379 0.058±0.565 0.329±0.111 -0.858±0.135 
2
-∆∆CT
 1.127±0.408 1.002±0.040 1.072±0.282 1.128±0.465 0.801±0.060 1.828±0.168 
  p=0.9985 p=0.0491 p=0.0823    
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10.8 Alignment of human, rat, and mouse protein sequences of identified 
isoforms of DYNC1I1  
 
282 
 
The above alignment corresponds to the isoform DYNC1I1.A, which is the longest isoform 
found in human, mouse, and rat. 
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10.9 Alignment of human, rat, and mouse protein sequences of identified 
isoforms of DYNC1I2  
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The above alignment correspond to the isoform DYNC1I2.C, which is the longest isoform 
found in human, mouse, and rat. 
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10.10 General consumables 
10.10.1 Chemicals and reagents 
Agarose (electrophoresis grade) Invitrogen NEB Buffers (10x) NEB 
Agarose, High Resolution Ambion Nocodazole Calbiochem 
Benzonase Roche NP-40 Sigma – Aldrich 
Better Buffer Microzone NuPAGE LDS Sample Buffer (4x) Invitrogen 
Bovine Serum Albumin (BSA) Sigma – Aldrich  NuPAGE Novex Bis-Tris gel Invitrogen 
Bromo-chloro-propane (BCP) Sigma – Aldrich NuPAGE Reducing Agent (10x) Invitrogen 
BSA (10mg/ml) NEB NuPAGE Transfer Buffer (20x) Invitrogen 
Deoxycholate Sigma – Aldrich Oligo dT primer Qiagen 
Deoxyribonuclease I (DNase I) Invitrogen Penicillin – streptomycin (100x) Gibco Invitrogen 
DEPC-treated water Invitrogen Quick Load 50 bp DNA ladder NEB 
Dimethyl sulfoxide (DMSO) Sigma – Aldrich RNAlater Qiagen 
DNA loading buffer (5x) Qiagen RNase-free Mussel Glycogen Sigma – Aldrich 
Ethanol (absolute, >99%) VWR RNAZap  Ambion 
Ethidium bromide Sigma - Aldrich RsaI (10 000 U/μl) NEB 
Foetal Bovine Serum (FBS) Invitrogen Saponin (from quillaja bark) Sigma – Aldrich 
Fluorescence Mounting Medium DakoCytomation Sodium acetate (NaAc, 3M) Sigma – Aldrich 
Glutaraldehyde (25%, EM grade) Sigma - Aldrich Sodium arsenite (SA, 0.05M) VWR 
Glycerol Sigma - Aldrich Sodium cacodylate Agar Scientific 
Hyperladder I Bioline Sodium chloride (NaCl) Sigma – Aldrich 
Hyperladder IV Bioline Sodium citrate  Sigma – Aldrich 
Isopropanol VWR Sodium dodecylsulfate (SDS) Sigma – Aldrich 
Kanamycin  Sigma – Aldrich  Sodium hydroxide (NaOH, 1M) VWR 
LB Agar, Miller Sigma – Aldrich Taq DNA polymerase (5 U/μl) Fermentas 
LB Broth, Miller Sigma – Aldrich  Thapsigargin (1mM in DMSO) Calbiochem 
Leibovitz’s L-15 GlutaMAX I Gibco Invitrogen Tris-HCl (1M, pH 7.0) Sigma - Aldrich  
Lipofectamine 2000 (LFA) Invitrogen Triton X-100 Sigma – Aldrich  
MboII (5000 U/ml) NEB TrypLE Express Gibco Invitrogen 
MegaMix Blue Microzone Trypsin 0.25% Gibco Invitrogen 
MegaMix Gold Microzone Tsp45I (4000 U/ml) NEB 
Methanol (Normapur) VWR Tween-20 Sigma – Aldrich  
MgCl2 (25 mM) NEB Water nuclease-free  Ambion 
Paraformaldehyde (PFA) Sigma - Aldrich β-mercaproethanol (β-ME) Sigma – Aldrich 
 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, 1M) Gibco Invitrogen 
4’,6-diamidino-2-phenylindole (DAPI) Sigma-Aldrich 
AccuScript High Fidelity Reverse Transcriptase Stratagene 
Deoxyadenosine triphosphate (dATPs) Invitrogen 
Deoxyribonucleotide triphosphate (dNTP) Invitrogen 
Dulbecco’s Modified Eagle Medium (D-MEM GlutaMAX I) Gibco Invitrogen 
Dulbecco’s PBS (with Ca
2+
/Mg
2+
) Gibco, Invitrogen 
Dulbecco’s PBS (without Ca
2+
/Mg
2+
) Gibco Invitrogen 
EGF Alexa Fluor 555 conjugate Molecular Probes Invitrogen 
Emetine dihydrochloride hydrate Sigma – Aldrich  
Ethylenediaminetetraacetic acid (EDTA, 0.5M) Sigma – Aldrich 
GeneScan – Liz 1200 Size Standard Applied Biosystems 
Halt Protease and Phosphatase Inhibitor Cocktail  Thermo Scientific 
Hi-Di Formamide Applied Biosystems 
Horse Serum (with 0.09% sodium azide) AbD Serotec 
N, N-Dimethylformamide (DMF, >99%) Sigma - Aldrich 
Normal Horse Serum Jackson Immuno Research Laboratories 
NuPAGE MOPS SDS Running Buffer (20x) Invitrogen 
Oligonucleotyde primers Eurofins MWG Operon, Sigma 
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Opti-MEM I Reduced Serum Medium Gibco Invitrogen 
PCR Buffer IV Applied Biosystems 
PfuUltra High Fidelity DNA polymerase Stratagene 
Phosphate buffered saline (PBS, 10x) Fisher Scientific 
ProLong Gold Antifade Reagent with DAPI Invitrogen 
PVDF membrane ImmobilonP, Milipore 
SeeBlue Plus2 Pre-Stained Standard  Invitrogen 
TRIreagent Sigma – Aldrich, Ambion 
Tris/Borate/EDTA (TBE, 10x) National Diagnostic 
X-Gal (5-Bromo-4-chloro-3-indolyl b-D-galactopyranoside) Sigma – Aldrich  
10.10.2  Commercial kits 
BigDye Terminator Ready Reaction Kit Applied Biosystems 
DNeasy Blood & Tissue Kit  Qiagen 
GenElute Plasmid Miniprep Kit Sigma-Aldrich 
Multiplex PCR Kit Qiagen 
QIAquick PCR Purification Kit Qiagen 
QIAshredder Qiagen 
QuantiTect Reverse Transcription Kit  Qiagen 
RNase-free DNase Set Qiagen 
RNeasy Mini Kit Qiagen 
TOPO TA Cloning Kit for Sequencing Invitrogen 
DC Protein Assay Bio-Rad Laboratories 
10.10.3  Equipment 
3130XL Genetic Analyser Applied Biosystems Microscope slides VWR 
5 and 15 ml tubes Falcon Microwave Proline 
96-well PCR microplate ABgene, StarLab Odyssey Imager LI-COR Biosciences 
Bright-Line 
Haemocytometer 
Sigma - Aldrich PCR plate seal Thermo Scientific 
Centrifuge Allegra 25R Beckman Coulter Phase contrast microscope Olympus CK40 
Cryo-freezing container Nalge Nunc Plastic spreaders VWR 
Cryogenic vials (1.8 ml) Corning Life Science Shaking incubator Orbital 
Dounce Tissue Grinder Wheaton Industries Tissue culture flasks Nunc 
Electrophoresis power pack Bio-Rad Laboratories Plastic Petri dishes Sarstedt 
Electrophoresis tank Life Technologies Inc UV transluminator Bio-Rad Laboratories  
Gilson pipettes Anachem Water bath Grant Instruments 
Glass coverslips (d. 12 mm) VWR XCell SureLock Mini-Cell Invitrogen 
Heat block Grant Instruments Microcentrifuge Eppendorf S415C 
Incubator LTE Scientific   
DH Autoflow Air-Jacketed Incubator  Nuaire 
DNA Engine Tetrad 2 Peltier Thermal Cycler Bio-Rad Laboratories 
NanoDrop® ND-1000 Spectrophotometer Labtech 
RNase-free tubes (1.5 ml, 2.0 ml) Biopur, Eppendorf 
Tissue culture multi-well plates TTP, Corning Life Science, Nunc 
10.10.4 Software  
BioEdit Sequence Alignment Editor v5.0.9 (freeware)   
Gene Mapper Applied Biosystems Volocity Perkin Elmer 
GraphPad Prism v5.02 GraphPad Software Photoshop CS3 Adobe 
Sequence Analysis 5.2 Applied Biosystems Odyssey Imaging Software LI-COR Biosciences 
UCSC Genome Browser www.genome.ucsc.edu   
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10.11 Antibodies  
PRIMARY ANTIBODIES USED IN IMMUNOFLUORESCENCE 
Antigen/Antibody Host Dilution Supplier 
Dynein intermediate chain 1 
DIC1 (51/52) 
Rabbit 1:100 
Affinity purified, generated by G. 
Banks 
Dynein intermediate chain 2 
DIC2 (60) 
Rabbit 1:100 
Affinity purified, generated by A. 
Kuta 
Dynein intermediate chain 
(IC74) 
Mouse  1:200 Chemicon (Milipore) 
G3BP Mouse  1:200 BD Transduction Laboratories 
GIANTIN Rabbit 1:600 Covance 
GM130 Mouse 1:250 BD Transduction Laboratories 
LAMP1 (1D4B) Rat 1:1000 
Developmental Studies 
Hybridoma Bank, Iowa University 
TIAR (C-18) Goat 1:50 Santa Cruz Biotechnology 
α-tubulin Alexa Fluor 488 Mouse  1:200 Milipore 
SECONDARY ANTIBODIES USED IN IMMUNOFLUORESCENCE 
Antigen/Antibody Host Dilution Supplier 
anti – rat Rhodamine Red-X IgG Donkey 1:400 Jackson ImmunoResearch Lab. 
anti – goat Alexa Fluor 546 IgG Donkey 1:600 Molecular Probes, Invitrogen 
anti – mouse Alexa Fluor 488 IgG Donkey 1:200 Molecular Probes, Invitrogen 
anti – mouse Alexa Fluor 633 IgG Donkey 1:200 Molecular Probes, Invitrogen 
anti – mouse Alexa Fluor 647 IgG Donkey 1:400 Molecular Probes, Invitrogen 
anti – rabbit Alexa Fluor 546 IgG Donkey 1:500 Molecular Probes, Invitrogen 
PRIMARY ANTIBODIES USED IN WESTERN BLOTTING 
Antigen/Antibody Host Dilution Supplier 
[pSer52]EIF2α Rabbit 1:1000 Assay Designs, Stressgen 
β-actin Mouse 1:15000 Sigma - Aldrich 
Dynein intermediate chain 1 
DIC1 (51/52) 
Rabbit 1:1000 
Affinity purified, generated by G. 
Banks 
Dynein intermediate chain 2 
DIC2 (59) 
Rabbit 1:250 
Affinity purified, generated by A. 
Kuta 
Dynein intermediate chain 2 
DIC2 (58, 59, 60) 
Rabbit 1:300 Affinity purified, glycerol stock 
Dynein intermediate chain (IC74) Mouse  1:1000 Chemicon (Milipore) 
SECONDARY ANTIBODIES USED IN WESTERN BLOTTING 
Antigen/Antibody Host Dilution Supplier 
anti – mouse IR Dye 800 Goat 1:7000 LI-COR Biosciences 
anti – mouse IR Dye 680 Goat 1:7000 LI-COR Biosciences 
anti – rabbit IR Dye 680 Goat 1:7000 LI-COR Biosciences 
anti – rabbit IR Dye 680 Goat 1:7000 LI-COR Biosciences 
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10.12 Primer sequences 
10.12.1 Genotyping primers 
Gene Primer Sequence 
Dync1i1 
DIC1_Mbo_FOR1 
DIC1_Mbo_REV2 
5’: TTG CTT TGC AAA GGT CAC TG 
5’: TTG CCC AGA TAG ATG GAG TTC 
Dync1i2 
DICg2_FOR 
DICg2_REV 
5’: TTC ACT TAT TTA GAC GAG GAC C 
5’: ACT CCC TCA CCA CTA AAT GC 
Dync1h1 
Loa_F_MDN1767 
Loa_R_MDN2313 
5’: ATT GAG GAG GTG AAC CTG GCC 
5’: CAG TCA TCG AAG ATC TCC TGG G 
 
10.12.2 Primers used during cloning 
Ex’ refers to the number of the exon containing the primer binding site e.g. Ex 1 is exon 1. 
Gene/Vector Primer Sequence 
Dync1i1 
DIC1_Ex 1 for 
DIC1_Ex 17 rev 
5’: CTC CAC GAC CTC CAG TGA G  
5’: ACG CAC ATG CTC TAA GAT CG  
Dync1i2 
DIC2_Ex1a for 
DIC2_Ex1b for 
DIC2_Ex18 rev 
5’: GGC CGG TGT ATC TGT TTC AAC  
5’: CAG TTG GAG AGG GAC GTT C  
5’: AGA AGG GAA ATG GCA TCA AC 
Gapdh 
Gapdh for 
Gapdh rev 
5’: ACT CCA CTC ACG GCA AAT TC 
5’: ATG TAG GCC ATG AGG TCC AC 
pCR4-TOPO® 
M13_FOR 
M13_REV 
5’: GTA AAA CGA CGG CCA G 
5’: CAG GAA ACA GCT ATG AC 
 
10.12.3 Dync1i1 and Dync1i2 sequencing primers 
Ex’ refers to the number of the exon containing the primer binding site e.g. Ex 1 is exon 1. 
Gene Primer Sequence 
Dync1i1 
DIC1_Ex 1 for 
DIC1_Ex 3 rev 
DIC1_Ex 9 for 
DIC1_Ex 10 rev 
DIC1_Ex 16 for 
5’: CTC CAC GAC CTC CAG TGA G  
5’: CTC CGG TGA TAT GCC AAT GC 
5’: TGA ACA TTG GTC TAA GCA TCG G 
5’: TGG AAG ACA TAT TCT GGT GTG G 
5’: AGG AGC ATC TGC CCT AAA C  
Dync1i2 
DIC2_Ex1a for 
DIC2_Ex1b for 
DIC2_Ex9 for 
DIC2_Ex14 for  
5’: GGC CGG TGT ATC TGT TTC AAC 
5’: CAG TTG GAG AGG GAC GTT C  
5’: CGA GAA TTG TAG AAA GAG CC     
5’: GTT GTG GGC AGT GAA GAA G      
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10.12.4 Dync1i1 and Dync1i2 primers used in the PCR based survey of 
the alternative splicing 
Ex’ refers to the number of the exon containing the primer binding site e.g. Ex 1 is exon 1. 
Gene Primer Sequence 
Dync1i1 
DIC1_Ex 1 for 
DIC1_1.1 for 
DIC1_AS4 rev 
DIC1_5 rev 
DIC1_iso14 rev 
DIC1_R rev 
5’: CTC CAC GAC CTC CAG TGA G  
5’: CTC TAG TGC AGC CGT TGC AT 
5’: GGG AGT GCT CAC TGA TTT GG  
5’: AAG TTC TGA GTC TGA CTG CAG  
5’: GCA GTC GTC TCC TTG TTA ATG G  
5’: CTA GGC AGG AAA TCC ACC TG  
Dync1i2 
DIC2_Ex1a for 
DIC2_Ex1b for 
DIC2_N4 rev 
DIC2_6 rev 
DIC2_iso24 rev 
DIC2_2.1 rev 
DIC2_R rev 
5’: GGC CGG TGT ATC TGT TTC AAC  
5’: CAG TTG GAG AGG GAC GTT C  
5’: GAG GGA CCC AGT ACT CAG  
5’: AAA TCG GAA TCT GAG TGA AGC  
5’: CAA GTT TAA TAG GTC CTC GTC TA  
5’: AAC TTG ATT GAA GCT AGA ATC CTC  
5’: CTC GAG GGG GAA AGT CAA C  
 
10.12.5 Primers used in the quantitative real time PCR  
Gene Primer Sequence 
Dync1i1 
DIC1_A_for 
DIC1_B_for 
DIC1_C_for 
DIC1_R 
5’: CTC TAG TGC AGC CGT TGC AT 
5’: CTC TAG TCC CAA CCC CTA TGT 
5’: CTC TAG TGA GCA CTC CCA GT 
5’: CAG TCG TCT CCC AAG TTC TG 
Dync1i2 
DIC2_D_for 
DIC2_E_for 
DIC2_A_for 
DIC2_B_for 
DIC2_R 
5’: CCC TAT TGG CTT CCT CCT TTC 
5’: CCC TAT TGA GGA TTC TAG CTT C 
5’: CCC TAT TGT TTT TTC TGA GTA CTG 
5’: CC T ATT GTC CCT CCT CCT ATG 
5’: ATA GGT CCT CGT CCC AAA TCG 
Dync1li1 
Forward 
Reverse 
5’: GTG CAA GCC CCA GTT TGC  
5’: GTG AAC ATC TGA AAG CAC AGG TTT 
Dynlt1 
Forward 
Reverse 
5’: TTT CAG CCA ACT CAC CAA TC 
5’: TGG TCT TGT TCT CCC ATC GG 
Dynlt3 
Forward 
Reverse 
5’: CAA TGC TGA TGA AGC CCA TAA TAT A 
5’: GCT TGC AGT CCA TTG GTT GA 
Dynll1 
Forward 
Reverse 
5’: AAG GCG GTG ATC AAA AAT GC 
5’: ATG GGC CGC AAT ATC CTT CT 
Dynll2 
Forward 
Reverse 
5’: GTG ATC AAG AAC GCA GAC ATG TC 
5’: GAT ATA GGC AGC AAT GTC CTT CTC T. 
Rpl L13A 
Forward 
Reverse 
5’: GGA AGC GGA TGA ATA CCA AC 
5’: GGA TCC CAT CCA ACA CCT T 
 
 
